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ABSTRACT 
This thesis describes the dose response relationships, qualitative and 
quantitative observations of cutaneous erythema in 236 patients treated on 
three prospective clinical radiobiological studies, utilising Fractionated Low 
Dose Rate (FLDR) and Fractionated High Dose Rates (FHDR) external beam 
radiotherapy. 
• Patients with incurable, locally advanced head and neck cancer and 
bone and soft tissue metastases from a variety of other solid 
malignancies, were treated on a modified Caesium 137 teletherapy 
unit , at dose rates ranging from 0.8 to 8.2 Gy/hr in 10 fractions over 
12 to 14 days (FLDR). 
• Patients with bony and soft tissue metastasis from a variety of solid 
malignancies were treated on a Clinac 1800 (6 MV photons), utilising 
four fractionation schedules (5, 10, 12 and 20) over 5 to 35 days 
(FHDR). 
• Patients with localised carcinoma of the prostate were treated on a 
Clinac 1800 (6 MV photons), in 30 - 32 fractions over 45 to 55 days 
(FHDR). 
Skin reactions were quantitatively assessed using a reflectance 
spectrophotometer and graded qualitatively using a modified EORTC/RTOG 
grading scale (FLDR). Qualitative skin scoring was unreliable and subject to 
considerable inter- and intra-observer variation. Qualitative scores were over 
estimated (relative to reflectance observations) in female patients and at non-
UV exposed anatomical sites. Pre-treatment reflectance readings were 
significantly higher in male patients and in anatomical sites which had 
previously heavy UV exposure. Pronounced dips in erythema readings during 
the second week of therapy and "reciprocal vicinity" effects adjacent to the 
treatment field, undetected by the naked eye, were observed in a subset of 
patients. Peak erythema values were found to provide the best measure of 
radiation effect. Peak erythema was found to depend on biologically effective 
skin dose, patient age, sex and treatment site. Considerable inter- and intra-
patient heterogeneity (both before and during treatment) was demonstrated. 
No dose-rate effect was seen in the FLDR group and a negative dose 
response relationship was demonstrated for 0.8 Gy/hr patients. FHDR data 
was under-predicted by the Linear Quadratic model at doses less than 1.5 
Gy/fraction. This finding is potentially explained by the "Induced Repair Model" 
of Joiner et al. For doses above 2 Gy/fraction a reasonable fit was obtained 
giving an a/13 ratio in the range of 4-8 and a repair half time of 0.05- 0.15 
hours. This short VA value is not consistent with other reports and may reflect 
multi-component cellular repair processes. This study also suggests that 
radiation-induced erythema is not exclusively related to basal cell kill. 
KEYWORDS: Skin, Erythema, Radiotherapy, Low Dose Rate, High Dose 
Rate, Reflectance Spectrophotometry, UV radiation, a113 ratio, Repair Kinetics. 
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CHAPTER I BACKGROUND TO STUDY 
1 INTRODUCTION AND SCOPE OF STUDY 
Radiotherapists and research scientists have been observing the effects of 
ionizing radiation on mammalian skin for the better part of the twentieth 
century. Quantification and qualification of acute radiation effects in 
mammalian skin systems, such as the mouse, rat and pig, have received 
extensive attention in the radiobiological literature, however, apart from the 
work of Turesson, little systematic scientific study of the radiation response of 
human skin has occurred. (Turesson & Thames 1989; Reisner 1933; 
Overgaard et al. 1985; Dutreix et al. 1973; Bentzen et al. 1987; Russell et al. 
1994) The reasons for this are diverse, however principally revolve around 
the intrusion of clinical and medical demands on both the patient and 
radiotherapist in the setting of ionizing radiation delivered for the primary 
purpose of treating malignant disease. Assessment of cutaneous radiation 
erythema at both high and low dose rates offers the opportunity for 
considerable insights to be gained into fractionation sensitivity and repair 
characteristics without having to resort to prescribing a wide range of fraction 
sizes. Ideally in a study such as this, one would select a cellular endpoint 
which reflects basal cell kill in response to irradiation. However, the 
invasiveness of biopsy procedures required to do this are significant. The 
relationship between basal cell kill and a physiological endpoint such as 
erythema, in the human setting remains unknown and traditional assumptions 
that erythema is monotonously related to basal cell kill (at least over a limited 
dose range) have not been rigorously tested. 
Mammalian experimental radiobiology has evolved a series of functional end-
points which are readily applied to a variety of organ systems; such as 
respiratory rate and fore-leg paralysis in the mouse, for lung damage and 
spinal cord damage respectively. Arriving at similar functional end-points for 
acute radiation epidermal erythema, is not so easy a task. Semi-quantitative 
descriptive scales have been employed, which produce their own special set 
of mathematical, conceptual and analytical problems. Thus a quantitative 
measure of cutaneous erythema, such as is provided by reflectance 
spectrophotometry, has been and remains a potentially attractive tool for 
evaluating acute radiation effects in the skin. This project describes the 
application, results, interpretations and pitfalls of this technique in three 
prospective clinical radiobiological studies. 
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2 CUTANEOUS PHOTOBIOLOGY 
It is clear that the human organism requires certain exposure to natural 
sunlight, for instance, the ultraviolet photo-chemistry of vitamin D and the 
visible light photo-chemistry of the retina, to allow visual perception. However, 
it is equally clear that excessive solar irradiation of the skin causes immediate 
inflammation and altered vascular pathophysiology in the short term and in the 
long term, actinic damage leading to malignancy. Human skin has developed 
peculiar optical and chemical mechanisms which protect against ultraviolet 
radiation and in some instances regulatory feedback mechanisms for 
increasing the degree of protection. Photobiology is the study of the 
interaction of ultraviolet visible and near infra-red radiation with various bio-
molecules and the sequelae of that interaction. 
2.1 Ultraviolet Effects 
Visible light occupies a range from approximately 400 - 700 nanometres in 
the electromagnetic spectrum. Tissue interactions over this range do not 
cause any photo-chemical events that result in recognisable tissue 
alteration or damage. (Figure 1) This is not the case with ultraviolet 
radiation, whose deleterious effects in overdosage are well described. 
(Soter 1990; Biochemistry and Physiology of the Skin 1983; Dermatology 
in General Medicine 1987; Textbook of Dermatology 1987). 
Photobiologists generally divide the ultraviolet spectrum into three portions 
UVA, UVB and UVC in order of decreasing wavelength. Radiation in the 
UVC band causes erythema of normal skin and photokeratitis very 
efficiently. UVB radiation reaches the earth in relatively smaller quantities 
but is very efficient in causing erythema in human skin. Epidemiologic 
evidence suggest that solar UVB causes skin cancer in man. UVA 
radiation is both melanogenic and erythmogenic, however, is not as 
efficient as either of the other two ultraviolet bands. Both the 
phenomenon of erythema and melanin production in human skin alter the 
optical properties of the derrnis in such a manner as to minimise further 
optical damage. 
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Fig. 1 	Electromagnetic spectrum with expanded scale 
of ultraviolet radiation 
2.2 Optical Properties of Human Skin 
Any given incident radiation beam on human skin may suffer one of two 
basic interactions: 
i) scattering 
ii) absorption 
Absorption involves the transfer of energy from an incident photon into the 
absorbing material, producing an excited state in the absorbing molecules. 
In optical and UV wavelengths this excited state does not result in 
ionisation of the molecule. Scattering on the other hand does not involve • 
the transfer of energy to the absorbing medium but merely alters the 
direction of propagation of the radiation. Thus the reflection of light from a 
mirror represents the phenomenon of regular or specular scattering. 
Scattering occurs whenever radiation encounters boundaries between 
media of different refractive indices. When radiation strikes the skin, a 
portion is scattered back to the environment, a further portion is absorbed 
in the various layers of the skin and the remainder is transmitted inwards 
through successive cellular layers until the energy of the incident beam 
has been dissipated. (Figure 2) Because the epidermis is thin and 
primarily cellular as opposed to fibrous, optical scattering other than the 
diffusion occurring at the skin/air interface does not appear to be of major 
importance in determining its transmission of UVA visible and near infra-
red radiation. The epidermis can be approximated in the first instance to 
mimic the optical properties of an unpolished glass absorption filter, 
underneath which are various chromophores and further layers. 
INCIDENT RADIATION REMITTANCE 
REGU 
L REMITTANCE 
STRATUM CORNEUM 
(10 um) 
EPIDERMIS 
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Fig 2. 	Schematic diagram of optical pathways in skin. 
Scattering within the dermis is an inverse function of wavelength 
(Anderson & Parrish 1980). Because of this approximately 50% of UVA 
radiation which penetrates fair caucasian epidermis is largely attenuated 
within the first 50 micrometres of the papillary dermis, whereas radiation in 
the optical range (eg. green at 500 nanometres) may penetrate several 
hundred microns and red and near red infra-radiation several millimetres 
more. (Figure 3) It is this phenomenon, combined with the minimal 
reflectance of the epidermis, which is responsible for the major reflected 
optical properties of human skin. This applies both to subjectively 
perceived colour, (ie the human retina) and objective measures of 
reflectance in the optical range. The colour of healthy human skin is 
determined largely by the quantity and degree of oxygenation of blood in 
the dermis and the presence or absence of the brown/black epidermal 
pigment melanin. These principles may also account for the appearance 
of the so called "blue naevus" due to dermal melanin. (Anderson and 
Parish 1981) In this instance, shorter wavelength light, ie blue light 
experiences a shorter path length from relatively superficial layers of the 
dermis and hence comparatively less absorption by melanin than do 
longer wavelengths. Because human colour perception is largely 
comparative, the relative depletion of reflected longer wavelengths relative 
to shorter wavelengths account for the appearance of the "blue naevus". 
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Fig. 3 	Approximate depth for penetration of optical radiation in 
fair caucasian skin to a value of lie (37%) of the incident 
energy density. 
Despite the multitude of factors affecting reflectance, the properties of 
human skin even across different races are surprisingly constant. 
Regardless of melanin content, the 250-300 nanometres region is strongly 
absorbed (Anderson & Parish 1981). The epidermal transmittance of 330- 
1300 nanometres radiation is high for fair Caucasian skin but decreases 
markedly at progressively shorter wavelengths as the melanin content is 
increased. Haemoglobin and deoxyhaemoglobin absorb strongly in the 
blue and green visible regions. Between the infra-red absorption bands of 
water and the green visible absorption band of haemoglobin lies the 
spectral region of greatest penetration. Because of the increased dermal 
scattering and optical absorption in-vivo for wavelengths less than 600 
nanometres, and the high optical absorption of wavelengths longer than 
about 1300 nanometres by water, an optical "window" exists in skin and 
most other soft tissues in the region of 600-1300 nanometres. Figure 3 
displays the calculated attenuation levels of various wavelengths of light in 
human skin to levels of 1/e of their incident intensity. (Anderson and 
Parish 1981). Obvious from Figure 3 is the observation that both 
ultraviolet and visible radiation reach the level of cutaneous blood vessels. 
Thus endothelial cells, the blood elements, lymphatics and neural 
processes passing through the skin may be directly or indirectly affected 
by incident light in the ultraviolet and visible range and similarly may also 
contribute to the intensity and wavelengths of reflected light. 
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3 THE ASSESSMENT OF SKIN COLOUR 
3.1 The CIE System 
The exact perception of skin colour and grading on an arbitrarily defined 
scale by trained human observers is a complex task. The perception of 
subtle colour and surface changes by the human eye, along with all the 
other familiar causes of inter and intra-observer variation have meant that 
for some fifty years imperfect attempts have been made to quantify skin 
colour. Surface colour may be quantified when using the CIE System, 
Commission Internationale de l'Eclairage (1986), (Nimeroff 1964). Other 
workers have subsequently employed this system for the evaluation of 
erythema following local irritants and ionising radiation (Serup & Agner, 
1990; Lebesque 1992 personal communication). The CIE System is 
adapted to the non-linear colour perception of the human eye. In this 
model, a colour is expressed on a 3-dimensional co-ordinate system; 
along the A axis (green/red), B axis (yellow/blue) and L axis (brightness). 
(Figure 4). The CIE System is appropriate when simple colour matching 
is required eg. in paint or fabric manufacture, but does not give any 
information about the substances actually responsible for absorption and 
reflection. The CIE system and indeed any other reflectance system does 
not take into account the subtle physiological changes which maybe only 
observable by the human eye, following noxious insults to the skin. (eg 
early dry desquamation, skin oedema, or pen-follicular erythema). 
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Fig. 4 	The Commission International de l'Eclairage (CIE) colour 
system. This system is a three-dimensional coordinate 
system with an a* -axis, a b* -axis and an L -axis. 
3.2 Reflectance Methods 
Edwards and Duntley (1939), first quantified skin colour some fifty years 
ago by measuring visible light reflectance of the skin with a 
spectrophotometer. Since that time the principles of reflectance 
spectrophotometry have been employed in a range of anthropological and 
genetic studies (Green and Martin 1990; Westerhoff et al. 1990). 
Reflectance spectrophotometry has found its principle use in the area of 
quantification of ultraviolet induced skin erythema. (Chu et al. 1960; 
Sayre et al. 1966; Kollias & Bager 1988; Farr & Diffey 1984; Wan et al. 
1983; Whitman et al. 1985; Anderson & Bjerring 1990). Reflectance 
spectrophotometry has also been employed in the evaluation of colour 
changes in the behaviour of port wine stains (Lanigan & Cotterill 1988), 
therapy for psoriasis (Ryatt et al. 1983), tumour blood flow (Feather et al. 
1988) and assessment of patch test responses (Mendelow et al. 1986; 
Malm and Tonnquist 1988). The development of the science of 
photomedicine has stimulated the production of a number of reflectance 
instruments in the response to the need to precisely characterise the 
inflammatory response seen in a variety of dermatological conditions, 
since the visual assessment of erythema does not fulfil this criteria, even 
when aided by various comparative visual grading scales. The human 
eye is an excellent device for sensing a quantal event but is inadequate in 
delineating graded differences of erythema or changes in time. (Daniels & 
lmbrie 1958) 
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3.3 Laser - Doppler Methods 
Another method which has been used for the evaluation of erythema has 
been laser-Doppler blood flow measurements. This method depends on 
light reflectance from a helium-neon laser beam. The reflected light is 
detected by two separate detectors and the doppler shift measures the 
total movement of particles in the skin, allowing quantification of skin 
blood flow. This method has proved sensitive and valuable in the 
evaluation of UV induced erythema. (Anderson & Bjerring 1990; Weiss et 
al. 1992; Kimura et al. 1988; Serup & Agner 1990; Duteil et al. 1990). 
Laser-Doppler measurements have also been reported by Simonen et al, 
in the evaluation of radiotherapy induces skin reactions post-mastectomy 
and in pig skin. (Nicklen et al. 1994; Simonen et al. 1994) 
3.4 Comparison of Reflectance Spectrophotometry to Other Methods of 
Skin Colour Assessment 
There have been limited studies on the parallel evaluation of both 
subjective assessment of erythema and objective assessment using 
reflectance spectrophotometry. Wan et al. 1983, studied six fair skinned 
caucasian volunteers who were exposed to sample doses of broadband 
UVB and assessed using a reflectance spectrophotometer which utilised 
three wavelengths 544, 577 and 610 nanometres. The investigators also 
subjectively graded erythema according to the following scale: 
0 	- no erythema 
trace 	- minimally perceptible erythema 
1+ 	- minimal erythema with definite borders 
2+ 	- more pronounced erythema 
3+ 	- erythema with oedema 
At corresponding times they derived a blood volume parameter related to 
the superficial plexus based on reflectance values. As shown in Table 1, 
they demonstrated that each subjective grade of erythema corresponded 
to a broad range of blood volumes and vice versa. That is, a wide 
overlap in blood volumes was present between consecutive grades. They 
also noted that the threshold erythema which determines the minimum 
erythema dose (MED) and which should be accurately sensed visually, as 
a sharp threshold observation, also showed a wide variation in measured 
blood volumes. 
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TABLE 1 
Subjective Objective 
Grading Definition Number of 
Assessments 
Range of Cutaneous 
Blood x 104 (mVcm2) 
Mean t S.D. 
x 104 (mWcm2) 
0 No erythema 80 33.7 - 130.4 75.9 t 24.4 
Trace Minimally 
perceptible 
erythema 
23 71.6 - 133.3 104.8 ± 21.3 
1+ Minimal 
erythema with 
definite 
borders 
30 84.5 - 203.4 120.8 ± 28.4 
2+ More 
pronounced 
erythema 
31 89.8 - 215.4 160.1 ± 35.3 
3+ Erythema with 
oedema 
55 129.1 - 253.4 189.5 ± 31.7 
Table 1 Ultraviolet-B (290-320 nm) induced erythema; 
comparison of subjective and objective assessment. 
(Wan et al. 1983) 
The authors concluded that reflectance spectrophotometry was a far more 
sensitive method than visual grading and appeared to relate to UV 
dosimetry in a far more consistent fashion. 
Anderson and Bjerring (1990), performed a similar study with nine 
volunteers exposed to a combination of UVA and UVB irradiation. They 
divided their clinical evaluation of erythema into four grades, and likewise 
found reflectance spectrophotometry to be suitable for detecting minor 
degrees of erythema which were linearly related to the reflectance score 
over the wavelength 540-575 nanometres. They also employed a Laser-
Doppler blood flow meter in this study and demonstrated that reflectance 
spectrophotometry showed a higher sensitivity for the detection of early 
erythema than the Laser-Doppler method. Blood flow parameters with the 
erythema score, however, indicated that the Laser-Doppler blood flow 
measurements paralleled the dose response curve for the erythema index. 
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4 LIGHT REFLECTANCE THEORY 
4.1 Reflectance and Transmission Cells 
The theory of reflectance spectrophotometry shares many of the physical 
principles associated with conventional transmission spectrophotometry. 
This is a technique which is widely used particularly in medicine to 
measure the concentration of an absorbing, non scattering pigment in 
solution. The Beer-Lambert law of light transmission is given as equation 
1: 
/ = /0e - (Pcx) 	 ( 1 ) 
where p is the specific absorption coefficient of the pigment to be 
measured. The unknown quantity is C the pigment concentration. It can 
be simply shown that C is proportional to the natural log of 1/T, were T is 
the transmission factor (T = I/10). If we consider the situation where a 
perfectly reflecting surface, for example, a mirror is placed at the exit wall 
of the transmission cell we now have a simple reflectance cell, (Figure 5) 
in which the path length of the light is now 2x rather than x. In this 
situation however, C is now proportional to the natural logarithm of 1/R 
where R is the measured reflectance (1/1 0). Most authors refer to this 
expression as the Logarithm of the Inverse Reflectance (LIR) (Dawson et 
al. 1980; Wan et al. 1983; Anderson & Bjerring 1990). 
Reflected 
light intensity 
/ 
/ I 
/ 
/ Mirror 
/ 
Incident / 
light intensity I o > / 
x 
/ 
< 
Fig 5. 	A simple reflectance cell. 
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4.2 Application of the Model 
The proposed theoretical model may be applied to non-pigmented skin in-
vivo, by assuming that R1, R2 and R3 are all much less than 1. In this 
case the reflectance R of the skin approximates to equation 3: 
R = III 0 = 7";7"; T1R4 	 (3 ) 
If the inverse of the reflectance (equation 3) is expressed in logarithmic 
form (equation 4) and plotted against wavelength, the resulting curve 
corresponds to the composite absorbance spectrum of the upper layers 
minus the logarithm of the reflectance function of the lowest layer 
(equation 5). If we let L = Ig (1/R) then: 
L = - IgTi2 - IgT; - Ign - IgR4 	 (4) 
By substitution for T to exp( -Kd) 
L = -Ig exp( -2k4) -Ig exp( -2k2d)4g exp( -2k30 -Ig R4 
Let 
A =2 kd Ig e 
Then equation 5: 
L =A 1 +A2 +A3 - Ig R4 	 (5) 
where the terms A l , A2 and A3 correspond to the absorbances of the 
constituent layers, that is, layer 1 - fibrous protein, layer 2 - melanin and 
layer 3 haemoglobin, respectively, while R4 is the reflection coefficient of 
the basal, collagen and fat layer. L is the logarithm of the inverse 
reflectance (properly abbreviated as LIR). This summation of 
absorbances implies that it may be possible to separate and quantify the 
contribution of each of the major components of skin colour. In order to 
make use of this theory Dawson and associates have drawn on the work 
of others and performed a series of verification experiments themselves 
which justify the assumptions given above. 
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4.3 Justification of The Model 
The observations of Findlay, (1970) on the optical properties of connective 
tissue may be used to test the validity of the proposed model. Findlay's 
experiments consisted of progressively incrementing layers of neonatal 
dura mater over a non-reflecting black tile. He plotted reflectance over 
the entire optical wavelength and demonstrated essentially that connective 
tissue reflects more blue light and transmits more red. The equation used 
by Dawson et al. (1980), derived from the Kubelka-Munk Theory, agreed 
very closely with Findlay's experimentally derived curve. Since it was 
known that the intensity of reflectance from human skin is principally 
dependant on three absorbing pigments, oxyhaemoglobin, de-
oxyhaemoglobin and melanin, Dawson et al. designed a reflectance 
instrument which utilised a continuous rather than discontinuous selection 
of wavelengths over the entire optical range. This is in contrast to other 
contemporary instruments (Diffey et al. 1984) which utilise a two 
wavelength skin reflectance approach for quantifying ultraviolet induced 
erythema. 
Figures 7 and 8 indicate the complexities of reflectance for a variety of in-
vitro and in-vivo pigments showing the range of overlap for the absorption 
peaks of each. These figures demonstrate the necessity to utilise a 
reflectance instrument which measures over a continuous range of 
wavelengths to allow for compensation of values due to the presence of 
multiple pigments in varying concentrations in the skin under 
consideration. 
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Fig 7. 	LIR and spectra of in vivo human skin. A: dark negroid. 
B: light negroid. C: pink tile. D: Caucasian.E: glazed 
white tile. 
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Wavelength !net 
Fig 8. 	Opto-electronic response of Haemelometer together with 
in vitro absorbance spectra of oxyhaemoglobin, 
deoxyhaemoglobin and melanin. (Dawson et al. 1980). 
4.3.1 Effects of Haemoglobin 
The colour of non-pigmented skin is determined largely by the 
quantity of blood in the dermis, particularly the sub-papillary 
venous plexus (Lewis 1926). Dawson et al. (1980) performed a 
series of experiments in-vivo and in-vitro to determine the effect of 
blood in the sub-papillary venous plexus. They developed a 
parameter H, (Haemoglobin Index) which was based on differences 
between 3 isobestic points (544, 527.5 and 573 nm.) in the LIR 
spectra and which was found to be strongly correlated with 
erythema and negative for skin blanching. This index was then 
tested against an accurately quantified, increasing scale of 
colouring pigments which were similar to healthy caucasian skin. 
The rank correlation coefficient between the pigment concentration 
and haemoglobin index had an average value of 0.97. The 
haemoglobin index was significantly more accurate than subjective 
rating by separate individuals who had average correlation 
coefficients of 0.32 - 0.37. They also tested the instrument with UV 
induced erythema and adrenaline induced blanching and again 
found excellent sensitivity with moderate to good observer-based 
correlation (average correlation coefficient 0.87). 
Background to Study - 15 
4.3.2 Effects of Melanin 
By subtracting the caucasian skin reflectance curves from the 
curves derived from a group of negro subjects, a spectral response 
may be obtained, which is attributable to melanin alone. Dawson 
and colleagues (1980) used this difference, which is quite linear 
over the measured optical wavelength range to derive a 
pigmentation index, which is proportional to the melanin 
concentration in the skin of the subject. 
4.3.3 Effects of Connective Tissue 
In a similar manner, the absorption and scattering properties of light 
by in-vivo fibrous protein, connective tissue and fat may be 
determined by subtracting the haemoglobin absorbancies from the 
experimentally determined reflectance spectrum of vitiligious skin. 
This result is almost equivalent to zero and implies that fibrous 
protein, collagen and fat do not contribute significantly to the LIR 
spectrum of skin and that the diffuse reflectance of the lowest layer 
R4 closely approximates one. 
4.3.4 Other Optical Factors 
Hajizadeh-Saffar et al. (1990) performed further verification 
experiments on the original Dawson instrument. They measured 
and corrected for the intensity of light scattered at the skin surface. 
As superficially scattered light has not penetrated to the 
chromophore containing layers of the skin, it contains no 
information about the absorbing pigments. They developed a 
method of eliminating air-skin interface reflectance from the 
measurements, by means of crossed polarisers incorporated into 
the reflectance probe. They were also able to demonstrate that 
there was a minor difference in the effective optical path length for 
suspensions of whole cells containing haemoglobin rather than 
simple solutions of extra-cellular haemoglobin. These corrections 
were also incorporated in their revised reflectance unit. 
5 RELEVANT STRUCTURE AND FUNCTION OF HUMAN SKIN 
The human integument on average weighs approximately 2.1kg and has a 
surface area of approximately 2m 2. Its primary function is to provide a 
physical barrier against environmental hazards. These might include water 
and electrolyte loss, protection from atmospheric factors including ultraviolet 
light, chemicals, physical protection as well as its important thermo-regulatory 
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function. Specialised skin appendages are important for sensory functions, 
excretion, milk production and production of pheromones. The epidermis is 
composed of tightly compacted layers of dead cells which are packed with a 
specialised protein; keratin. Below this is the loosely packed elastic and 
flexible connective tissue, the dermis. At the junction of the two there is a 
specialised membrane, the basement membrane. Throughout the dermis are 
specialised regions of skin the most important of which is the hair follicle 
which consists of an infolding of the epidermis. Other accessory organs in the 
integument include the paired multi-lobed sebaceous glands associated with 
each hair follicle and eccrine and apocrine sweat glands. Other specialised 
cellular structures include the Langerhans cell and melanocytes. 
5.1 Epidermal Structure and Cell Kinetics 
5.1.1 Structure 
The stratified keratinising epithelium comprising the epidermis 
varies significantly in thickness across the body with unexposed 
sites such as those on the abdomen, thigh and axilla having the 
thinnest epidermis and soles and palm the thickest and most 
complex structurally (range 1-3mm). In many sites throughout the 
body, the epidermis invaginates into the dermis. These 
invaginations are termed rete-pegs, however it should be born in 
mind that these are in fact 3-dimensional network structures. The 
epidermis is commonly divided into several layers based on light 
microscopic findings. (Figure 9) These include the so-called 
granular layer and spinous layer which are derived from nuclear 
and organelle breakdown products and intra-cellular bridges 
respectively. The most important layer in terms of cytokinetic 
activity is that of the basal layer. It is this layer which replaces the 
cells lost through surface desquamation or damage. Basal cells in 
the human epidermis are cuboidal or columnar with their long axis 
perpendicular to the surface plane of the skin. The keratocytes of 
the basal layer include both proliferative cells (keratoblasts) and 
non proliferative keratocytes. It is impossible to accurately quantify 
the exact proportions of these cells and indeed the exact point in or 
above the basal layer where differentiation and maturation take 
place. All basal cells have a primitive keratin based cyto-skeleton, 
however histologically it is clear that increased keratinisation is 
restricted to the suprabasal layers. 
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Fig 9. 	Diagrammatic cross section through normal skin (Feather 
et al. 1989) 
5.1.2 Kinetics 
In functional cell kinetic terms, a critical distinction must be made 
between a stem cell and a non-stem cell. We can define stem cells 
as those cells in an adult tissue that are ultimately responsible for 
all cell replacement including their own. For example, in the 
laboratory mouse, a marrow stem cell may undergo two hundred 
divisions in the life of a laboratory mouse and then be grafted at 
least five times into further mice. Hence from the point of view of 
an individual mouse, its marrow stem cells can be regarded as 
immortal since they have division potential which is many times 
greater than is required by an individual mouse life span. Because 
of their large division potential and their role of the as the ultimate 
ancestors of all other cells, the stem cells of the skin are most likely 
to be the cells responsible for tissue regeneration after physical, 
chemical or radiation damage. Because of the physical and ethical 
difficulties involved in sectioning human skin, most data on the 
distribution of stem cells has been derived from mouse 
experiments. These included tritiated thymidine administration and 
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labelled nuclear counting, percent labelled mitosis techniques and 
continuous labelling techniques. These results suggested that the 
proliferative compartment in mouse epidermis is heterogenous and 
contains relatively few stem cells (10%-12%). Potten (1985) has 
suggested that a proliferative model such as Figure 10 might 
describe the pre-migratory kinetics of the epidermis. 
Kerattnization 
--maturation 
Suprabasal 
migration 
Stem 
 
Transit 
 
  
"0---.--BOSCI l layer 
Fig 10. A diagrammatic representation of the model which it is 
believed most adequately explains the cell replacement 
process in mouse epidermis. 
Cell cycle times can be measured in-vivo using a variety of 
techniques, however the most direct and accurate is probably the 
percent labelled mitosis technique. Technical difficulties have 
meant that comprehensive studies have been few. Table 2 
indicates cycle times and S Phase durations measured for various 
small mammals and man. Other difficulties with these techniques, 
include the possibility that at least two subsets of cells with different 
cell cycle times may be present, and that Circadian rhythm 
variations may impact on both the timing and synchronicity of cell 
replication and therefore that artificial errors may have been 
introduced with the use of empirically based "convenient" skin 
sampling times by the investigators. 
The mechanisms which are responsible for migration of cells to the 
basal and suprabasal layers are uncertain. It is likely that G i cells 
in the basal layer randomly migrate upward, altering basal cell 
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density and that this reduced density forms the stimulus for further 
division. The evidence for this theory comes from three sources: - 
i) simple histological observation of the epidermis from the 
back of a mouse indicating that basal cells are not 
packed tightly together. 
ii) minor wound healing in the mouse results in rapid 
immigration of basal cells which is then followed by a 
burst of mitotic activity. 
iii) experiments in guinea pig epidermis and more notably in 
the mouse intestine indicate that cell migration continues 
even when mitosis is stopped by radiation or drugs. 
Most of the relevant cell kinetic data for man has been deduced 
and extrapolated from other animal data and comparisons of the 
cell populations in the mouse and human epidermis are given in 
Table 3. This table assumes a three layer transmission cell 
compartment model. 
TABLE 2 
Cell cycle length and the duration of S phase as determined from percent labelled mitosis experiments 
Strain Site Sex Age 
(weeks) 
3HTdR dose 
(pCi/mouse) 
Length of S 
phase (h) 
Length of 
cycle (d) 
References 1 
hr/hr Dorsum cli 	9 8 10 5.5 - Iversen et al. (1968) 
e 	9 8-13 —25 7.2-11.2 - Clausen et al. (1981) 
Swiss A Ear e 16 25 20.2 - Laurence and Christopers (1976) 
Sole or foot e 16 25 19.7 - Laurence and Christopers (1976) 
StA Lumbar e 4-8 25 8.5 - Olsson (1976) 
SAS/TO Dorsum e 8-9 25 11.5 4.2 Hegazy and Fowler (1973) 
C57BL Dorsum e 20 20 100 —16 —3.25 Gelfant in Potten (1981) 
Ear e 20 20 100 —11 —5.0 Gelfant in Potten (1981) 
DBA-2 Dorsum iro ir o
 'co
 " o
 
7-8 25 8.5 3.1(9.1) Potten (unpublished) 
Ear 7-8 25 12.0 3.5(7.1) Potten (unpublished) 
Tail 7-8 25 12.7 3.5(7.1) Potten (unpublished) 
Foot 7-8 25 —12.5 —3.2(8+) Potten (unpublished) 
Guinea-pig Body skin e Young 5 i.d. 9.5 - Yamaguchi and Tabachnick (1972) 
Man Body - - 5 i.d. 16 - Weinstein and Frost (1969) 
Psoriatic - - 5 i.d. 8.5 - 
Psoriatic - - 10 i.d. 7.7 - Duffill et al. (1976) 
Psoriatic - - 10 i.d. 10 3.8 Goodwin et al. (1974) 
Man Psoriatic - - - - 6.8 days Gelfant et al. (1982) 
Large White Pig Flank 9 12-16 10 7-10 5-6 Morris and Hopewell (1986) 
Table 2 	Cell kinetic data for various small mammals and man. Figures in parentheses are the possible values for a second 
cell population with a long cycle - the stem cell compartment in some models of epidermal proliferative organisation. 
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TABLE 3 
Mouse Man 
Cornified cell layers —6 >10 
Nucleated cell layers' —4 > 5.5 
Transit tome of a cell through the 
layers 
8 days (range 5-11) —24 days (range 12-48) 
Transit rate (cell layers per day) —1 >-1 
Basal layer: 
Stem cells (St) 
Transit cells 	Ti t' 
T2 
T3 
—10-12%,T,=180h 1 
	
—12% 	Tc=180h I 
—12% 	Tc= 90h 	Tc=126hr 
—25% 	T0= 90h J 
?I 
?I Tc=125(very wide 
?}. 	range in 
?J 	estimates) 
Post-mitotic cells(Pm) —25% 	T,A=30h ? 
Melanocytes — 3%(-400/mm2) 0.3-2.4% of epidermal volume (700- 
1600mm2) d 
Langerhans cells —10%(800-1400/mm 2) 1-2% of epidermal volume 
(400-1000/mm2) 
Proliferative fraction 0.61 ? 
Cell production 
(cells/day/basal cell) 
0.13 ? 
Cell populations in mouse and human epidermis. 
a 	including the basal layer 
b 	
I1-T3 are first to third amplifying transit cell divisions 
c 	Percentage of all basal cells 
(Potten 1985) 
Table 3 
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5.2 The "EPU" Concept 
Potten has developed the concept of an epidermal proliferative unit (EPU), 
each of which contains approximately 10-11 cells, most of which are basal 
cells, although on probability there is likely to be a single Langerhans cell, 
Merkel cell or infiltrating lymphocyte. (Figure 11) Cell kinetic studies 
suggest that the more slowly cycling cells are located towards the centre 
of a group of basal cells. Three or four of the basal cells tend to be 
clustered towards the centre of the outline of the EPU with the remaining 
cells spaced further apart towards the periphery. In this model it is 
assumed that the centrally located stem cell or cells tend to have longer 
cell cycle times perhaps in the order of 180hrs and the surrounding 
proliferating cells of two or three compartments may well have shorter cell 
cycle times in the order of 90hrs. If one accepts this model of an EPU the 
destruction of stem cell would result in the loss of all the basal cells in the 
EPU in a time of around 9 days. 
4 4 I St Average 
phase length 
ell cycle 
Umes (h) 
linrillbIIIIMIEI 
itimmilimm  
11111011111111111111 
Len 	o 
phase (h) 
pprox ° o 
keratocytes 
Stem cell divisions/lifetime = 130 
Cell production/day - 10 7 
Cell production/lifetime 10 10 
Fig 11. Diagrammatic representation of the proliferative cellular 
organisation of the epidermal proliferative unit (EPU) of 
the mouse. 
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5.3 Keratin 
Keratin is a complex protein manufactured into a filamentous network 
which fills the keratinocytes. The protein network is rich in disulphide 
linking bonds and as a consequence it is a very tough insoluble molecule. 
The functional integrity of a mature keratinocyte is achieved by the heavily 
cross linked keratin filaments and the protein is only detected in the larger 
cells after they leave the proliferative compartment, that is, the basal layer 
of the epidermis. 
5.4 Blood Vessels and Capillaries 
The vessels of the dermis form rich networks throughout the integument 
and particularly around structures such as hair follicles. The functions of 
the capillary network are manifold and include thermo-regulation, inter-
cellular communication, oxygen absorption, excretion, immune 
responsiveness and tactile sensation. These capillaries are particularly 
evanescent in their flow rates and dynamics. The arteries and arterioles 
of the skin are possessed with muscle cells in the vessel wall, however 
the capillaries lack any muscle or organised elastic tissue and hence 
consist merely of an endothelial tube with a diameter of approximately 10 
micrometers. Fibroblasts and pericytes are also found in close apposition 
to the endothelial cells and considerable doubt revolves around whether 
the pericyte may be involved in a contractile response also. Upstream 
from the capillary networks are plentiful arteriovenous "shortcuts". At the 
commencement of each capillary network a final muscle cell is found, the 
so called pre-capillary sphincter. The activity of this muscle at the final 
part of the arterial tree is predominantly influenced by local chemical and 
hormonal changes (auto-regulation). Local mediators are released from 
various cells including mast cells and are capable of adjusting blood flow, 
vascular permeability and alter endothelial growth and structure. 
(Biochemistry and Physiology of the Skin, 1983 Vol 2 Chapter 34; 
Dermatology in General Medicine Vol 1 1987; Textbook of Dermatology 
1988 Chapter 41; Effects of Ionising Radiations on Connective Tissue 
1983 Part 2; Pollen 1985). 
6 RADIOBIOLOGY: GENERAL PRINCIPLES 
6.1 Modelling Radiation Lethality 
One of the key concepts in understanding the biologic expression of injury 
resulting from any given radiation dose, is that energy deposition from 
penetrating X-rays at least over a microscopic scale must be of a random 
nature. In early studies of the radiobiology of simple organisms such as 
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viruses and bacteria this principle was clearly demonstrated. Radiation 
lethality in such a system is described by the Poisson Law. That is, if we 
assume an average of 1 lethal hit per cell delivered in a random fashion 
then E" ) (equal to 37% of cells) will experience no hit and therefore 
survive. An equal increment in the number of hits would produce a 
probability of survival E (-2) (.37x.37). Thus, a geometric decrement in 
survival may be plotted as a straight line on a semi-logarithmic coordinate 
system. The general expression for this process is of the following form: 
S 
The pivotal principle involved in this function, is that for any given equal 
dose increment, the same proportion of cells are killed and not the same 
number. S is the fraction of surviving cells of an initial population, K is a 
constant specific to the cell population (Gy -') and D (Gy) is the given 
dose. This form of cellular killing is referred to as a linear or straight line 
relationship. 
6.1.1 Mammalian Cell Survival Curves 
The first survival curve for mammalian cells (Hela) was obtained by 
Puck & Marcus 1956. Cells derived from a human Ca. cervix line 
were irradiated in vitro and their viability was assessed according to 
their ability to form visible colonies in culture medium. Subsequent 
mammalian cell survival assays either in-vivo or in-vitro have all 
tended to conform to a similar overall shape. The essential features 
of this curve are usually a shoulder, followed by a linear or near-
linear tail out to high doses. Exact agreement on whether the first 
portion of the shoulder is linear and on whether the tail continues to 
slowly bend is still awaited. A variety of mathematical models have 
been applied in order to describe these observed curves (Alper 
1984). All these models can be used to deduce a curve shape that 
is consistent with experimental data, but it has not been possible to 
choose amongst different models on the basis of accuracy of fit to 
all the experimental data. Insufficient precision exists in data of this 
nature and when this is combined with the very subtle quantitative 
differences between the predictions of models, generally speaking 
no clear picture emerges. 
6.1.2 The Linear-Quadratic Model 
The most widely used of the mathematical models include the multi- 
target, multi-hit model (Hall 1988) and more latterly the linear 
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quadratic model (Barendsen 1982). This model was first employed 
in relation to radiation damage by Kellerer & Rossi (1972) and 
Chadwick & Leenhouts (1973). The central tenant of the linear 
quadratic model is that radiation effect results from two distinct 
processes. In the first process, a sensitive site within the cell is 
irreversibly damaged in one single event. In the second process, the 
sensitive site is damaged by separate radiation events and if only 
one event occurs, then this is insufficient to kill the cell. In this 
situation we consider the cell to be sublethally damaged. The 
general expression of the linear quadratic model is as follows: 
S = e 	 (6) 
where S represents the surviving fraction, D is the given dose and a 
and 13  are constants which have theoretical significance in terms of 
the relative contributions to each of the two processes alluded to 
above. This model assumes that only 2 sensitive targets may co-
operate to produce cell lethality, however, it is recognised that 3 or 
more sensitive targets may do this and therefore cubed and higher 
dose terms may theoretically be possible (Schultheiss et al. 1987). 
Figure 12 illustrates in general diagrammatic terms the components 
making up the linear quadratic model. 
dose (Gy) 
Fig 12. 	Linear quadratic cell survival model. 	The a 
component represents lethal lesions produced by a 
single track. The 13 component represents lethal 
lesions produced by the co-operation of two 
independent tracks. The ratio a/13 is the dose at 
which the respective contributions of the a and the 
13 components are equal. 
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Mathematically the linear quadratic model is continuously bending and 
therefore, has no true linear portion, which differentiates it subtly from 
the multi-target, multi-hit model and other repair equations. 
It is theorised, that as the radiation dose increases, the density of 
radiation events likewise increases and the second of the two 
processes of radiation lethality referred to above becomes more 
dominant over and above the single hit process. When the two 
processes produce equal contributions to overall cell killing, (that is, aD 
=I3D2), then that particular dose is numerically equal to the ratio a/13. 
During the 1980's the linear quadratic model has gained general 
acceptance as an appropriate model for quantifying a biological 
response (Barendsen 1982; Moore et al. 1983; Stuben et al. 1991; 
Yaes 1988; Fowler 1986; LeBesque et al. 1986; Tucker 1984; Travis 
and Tucker 1987; Ang et al. 1987; Bentzen et al. 1989; de Boer 1988; 
Hendry and Moore 1985; Wong et al. 1992). The major documented 
deficiencies of the linear quadratic model, lie in the high dose range 
where it appears that most experimental observations indicate that the 
tail of the curve from a mammalian cell survival at high doses is truly 
linear rather than continuously bending as the linear quadratic model 
predicts. In practice, however, this only becomes modestly significant 
for doses in excess of 10 Gy, which is largely irrelevant for practice of 
clinical radiotherapy. 
6.2 The Effect of Dose Fractionation 
Early split dose in-vitro cell studies clearly demonstrated that if a dose is 
divided into two or more fractions, the initial observed shoulder of the curve is 
repeated at each fraction. This phenomenon has almost universally been 
interpreted as reflecting the ability of mammalian cells to repair radiation 
lesions between fractions. The size of the shoulder exhibited between each 
fraction depends essentially on the size of the fractional dose. Thus, for a 
very large number of small fractions cell death is predominantly by lethal 
damage and the cumulative survival curve follows a simple exponential 
(linear) function. At this level the exponential curve represents the limit to the 
sparing effect of any fractionation. (Travis et al. 1987; Joiner & Denekamp 
1986). The size of the shoulder is reflected in a small value for the a/f1 ratio 
and therefore a higher sensitivity to fractionation and conversely a narrow 
shoulder associated with a large a/f3 ratio implies a low fractionation 
sensitivity. 
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6.3 Repair Modelling 
In-vitro data from CH 3 cells (Elkind 1965) and from in-vivo experiments 
(Denekamp 1973; Ang et al. 1985) indicate that recovery kinetics maybe 
quite reasonably described by a first order expression involving time. The 
expression is: 
N = No.e - lit 	 (7) 
Where No is the number of sub-lesions present for interaction at the initial 
time (t=0), N is the remaining number of sub-lesions after any time t and p 
is the time constant of the repair kinetics. (Fe). It is assumed that the 
repair constant p does not relate in any way to the level of effect. In a 
manner analogous to isotopic decay, the half-time of repair is expressed 
as: 
1172 ty = 
2 	P 
(8) 
The methodology that is used to derive repair constants in the in-vivo and 
in-vitro situations are disparate. That is, in cell culture experiments, two 
fractions of constant size are delivered with increasing intervals and the 
resulting gains in survival are recorded. In tissue systems however, the 
relationship between cell survival and effect is unknown. Therefore, split 
dose experiments are carried out, keeping a constant level of effect and 
the parameter investigated is the additional dose necessary to 
compensate for repair between fractions. This concept of repair has been 
integrated into the linear quadratic model by Thames (1985), giving the 
"incomplete repair model", whose basic formula for two fractions 
separated by an interval of delta t is: 
- Log(S) = 2aD + 23D 2 + 9(20D 2 ) 	 (9) 
where 0 =et 
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6.4 Repopulation and Slow Repair 
Quite apart from the effect of repair between fractions, the protraction of a 
given fractionated course over longer time periods, will also reduce the 
effectiveness of radiation, particularly on early reacting tissues. Given the 
rapid proliferation rate of these types of tissue systems, this time sparing 
effect is likely to be related to the proliferation of donogenic cells 
occurring during treatment. This phenomenon has been documented by 
Ang et al. (1985). This phenomenon has also been demonstrated by 
Denekamp (1973), Morris and Hopewell (1986) in mice and pigs 
respectively. The exact kinetics of this phenomenon have not yet been 
adequately described to suggest meaningful models at this stage. Late 
responding tissues are much less influenced by repopulation. In the rat 
cervical spinal cord, repopulation is shown to be negligible within 8 weeks 
after the initiation of irradiation (van der Kogel 1979; White and Homsey 
1980). 
In some late reacting tissues, a third time sparing effect has been 
described which can not be explained by repopulation. This has been 
attributed to "slow repair" (Field et al. 1976; Turesson and Thames 1989) 
The underlying mechanism of this phenomenon is not yet understood. 
6.5 Application of the Linear -Quadratic Model to Organised Tissue 
Radiation biology workers in the early 1980's (Barendsen 1982; Thames 
et al. 1983) considered that similar reasoning could be applied to gross 
organ end-points. For any given single target cell population within the 
organ we may consider that any level of clinically measurable effect E 
may be monotonously related to a given target cell survival S by the 
following formalism 
E = - Log(S) 
and therefore from the previous linear quadratic model 
E = aD OD' 
	 (1 0) 
Measurable tissue end-points in animals and humans have been found to 
correspond to a more limited range of target cell survivals than the in-vitro 
cell survival methods. Thus, unless target cell depletion exceeds 
something of the order of 50% then no measurable effect may often be 
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discerned and at the other end of the scale when surviving fractions fall 
below 1% then irreversible damage and or animal death may occur. 
Douglas & Fowler (1976), were the first workers to apply the mathematical 
theory of the linear quadratic model to observed erythematous reactions in 
mouse skin. For fractionated radiotherapy; 
D = Nd 
where N is the number of fractions and d is the dose per fraction. If 
we substitute that into the previous equation then 
E = aNd + 13Nd 2 	 (11) 
therefore 
1 	a 
D E 
This enables a straight line plot of 1/D against d on a linear graph. a/E is 
the intercept and 13/E is the slope of the straight line so formed. This plot is 
derived by determining the total dose necessary to produce a given effect 
(iso-effect) using various fractionation schemes (or different dose rates), 
plotting the data and performing a least-squares regression analysis. A 
disadvantage of this approach, is that all experimental data grading the 
tissue effect under consideration, is reduced to only one iso-effect level, 
thus, "wasting" considerable measurable data. A more statistically elegant 
approach has been suggested by Thames et al. (1986), based on a direct 
quantal response analysis. Other authors have employed alternative 
approaches, with Hendry & Moore (1985), utilising the steepness of dose 
incidence curves for tissue failure to derive absolute values of alpha and 
beta. Tucker (1984), Stuschke (1989) and de Boer (1988), have developed 
further indirect approaches which appear to give reasonably consistent 
results in terms of grouping and differentiating a/6 ratios for acute and late 
reacting systems. Equation 12 maybe rearranged to display an organ-
based "survival" curve, by plotting effect per fraction against dose per 
fraction. The resultant curve displays the familiar, continuously-bending 
linear-quadratic shape. 
13d 
(12) 
= ad + 13d 2 	 (12a) 
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Subsequent modifications to the linear-quadratic formula have included an 
adjustment for possible tissue repopulation after treatment. In its simplest 
form, this adjustment consists of a subtracted factor which reduces the 
overall effectiveness of any given dose. 
This is given as 
p T 
a 
where /2 is given as 
1n2 
P - T
0 
where Toot is the potential doubling time of the cells under consideration. 
As there maybe some delay in onset of repopulation, this expression maybe 
further elaborated by introducing a "kick-off' time T k. In this instance the 
repopulation correction factor becomes 
p( T- TO 
a Tpot 
where T is the total treatment time in days and Tk is the time in days until 
repopulation commences. 
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6.6 The Dose Rate Effect 
There remains considerable debate in the world of clinical radiobiology, as 
to whether Low Dose Rate (LDR) radiotherapy is intrinsically associated 
with a therapeutic gain when compared with standard fractionated 
treatment. As most experience has been gleaned from brachytherapy, 
comparison of results with this modality to external beam or even different 
brachytherapy approaches with different dose rates, is fraught with difficulty. 
Recent evidence from laboratory studies, clinical studies and 
biomathematical considerations suggest that lowering of the dose rate itself 
may well be responsible for a therapeutic differential (Cooper et al. 1990; 
Dutreix 1989; Hall 1988; Hill & Bush 1973; Mann et al. 1991; Pierquin et al. 
1985; Wilson 1978; Nilsson et al. 1990). Teletherapy using low dose rates 
in the brachytherapy range was developed at the Henri Mondor University 
Hospital, Creteil, France, by Bernard Pierquin in the hope of extending the 
perceived advantages of brachytherapy to the many clinical situations 
where brachytherapy is impossible. A trial comparing low dose rate 
external beam therapy (using a modified Cobalt teletherapy unit) with 
conventionally fractionated external beam teletherapy was reported on in 
1987 (Pierquin et al. 1987). Highly significant differences in local 
recurrence rate were observed between patients treated by low dose rate 
irradiation (5/32, 16%) and patients treated with conventional high dose rate 
fractionation (20/32, 61%). This benefit apparently extended to an 
improved survival of patients in the low dose rate arm (44% versus 24%). 
Unfortunately, difficulties in interpretation arise because patients were not 
adequately randomised. Total doses and dose rates used in that study 
were arbitrarily chosen and no systematic observation of normal tissue end-
points was reported. 
For sparsely ionizing radiation such as gamma or x-rays, the dose rate is 
one of the other principal factors which determines the biological 
effectiveness of any given dose. This is particularly evident in the range of 
approximately 1 to 10 cGy per minute. As the dose rate is further reduced 
beyond this range, and any treatment becomes excessively protracted, 
repair of sub-lethal damage and repopulation occurring during treatment 
over come the effects of radiation induced cell kill and the "survival curve" 
will tend to a zero or a positive slope. Above the range of 10 cGy per 
minute, the dose rate effect becomes less important as exposures at this 
rate tend to mimic the effects of conventionally fractionated high dose rate 
treatments. Apart from the effects of repair and repopulation occurring 
during protracted exposure, it is possible that cell cycle redistribution 
may play a role in increasing the effectiveness of any given dose. The 
biological effectiveness of fractionated low dose rate radiation has 
been modelled principally by two authors in an incomplete 
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repair modelling situation (Thames et al. 1984; Dale 1985; Nilsson et al. 1990; Dale et 
al. 1988). These authors employ different mathematical approaches, however the 
predictions of each with respect to continuous low dose rate therapy and fractionated 
high dose rate therapy are identical (Nilsson et al. 1990). Dale defines a new 
parameter KR which is broadly equivalent to the dose per fraction d in fractionated high 
dose radiation. The quantity KR depends upon the parameter 1,1 (the repair constant, 
units h -1 ). Thames expresses the same character by small g.t. Dale's expression for 
the parameter K for fractionated low dose rate therapy is as follows: 
K = —
2 (1 - —1 (nY - SY2)) 	 (13) 
,u 
where 
- K - nK-2z + K-n+ izn 
(1 - K-Z)2 
where 
IC = exp(-0t) 
where 
Y = 1 - exp( 
where 
z = 1 - Y = exp(-p.t) 
Thames formalism is given as 
cosh(gt) - 	1  C(n,p.,T,At) = g (pt) + 2 	x h n (4)) 
(W)2 
(14) 
where n is the number of fractions, is the repair rate constant, is the duration of a 
single fraction and At is the inter-fraction interval for 13 and 14. Is exp(-4(t+At)) for 
14. By substituting the parameter K into equation 12, we can therefore rewrite the Fe 
plot as 
1 	cc 
D E 
P KR (15) 
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7 RADIOBIOLOGY OF MAMMALIAN SKIN 
7.1 Radiation Erythema : Definitions and Units 
By virtue of its location as the first port of call for any noxious agent 
emanating from the environment to man, it was the skin in which early 
workers with ionising radiation first noticed biological changes. The first 
reported example of a skin reaction may have been Lister, in 1896 or 
possibly the radiation erythema observed by Becquerel in 1901 after he 
carried he carried radium salt in his coat pocket for some days. In the 
years that followed, diagnostic and therapeutic radiation workers rapidly 
learnt from their patients and themselves, of the nature and severity of 
both the short and long term effects of radiation. Indeed until modem 
methods of dosimetry evolved and the roentgen was defined, the units of 
therapeutic radiation were quantified by the skin erythema dose (SED). 
This was defined as that quantity of X irradiation administered at 23cm 
focal distance at 180kv to a field of 6 x 8cm which produced a reversible 
skin reaction. A similar but different quantity is the MED or minimal 
erythema dose, which is that dose which will produce an erythema of an 
arbitrarily defined intensity in a particular percentage of individuals so 
treated. The MED is still used widely as a concept in ultraviolet erythema 
work, due to the extreme difficulties of ultraviolet dosimetry. Quite apart 
from the objections to grading what is a continuous spectrum of reaction, 
the SED was greatly hampered as a unit of measurement due to its 
dependence on the physical characteristics of the radiation exposure, skin 
site, texture, pigmentation and racial background. Hopewell (1990) has 
re-defined the terminology for describing the acute responses of the skin 
to radiation. 
1 	Dry desquamation (3-6 weeks for fractionated therapy): and a 
typical keratinisation of the skin due to the reduction in the number 
of clonogenic cells within the basal layer of the epidermis. 
2 	Moist desquamation (4-6 weeks fractionated therapy): the loss of 
the epidermis due to the sterilisation of a high proportion of 
clonogenic cells within the basal layer of the epidermis. 
3 	Secondary ulceration (>6 weeks fractionated therapy): secondary 
damage to the dermis as a consequence of dehydration/infection 
when moist desquamation is severe and protracted due to the 
reproductive sterilisation of the vast majority of clonogenic cells in 
the irradiated area. 
4 	Dermal Necrosis (>10 weeks fractionated therapy): necrosis of 
dermal tissues as a consequence of vascular insufficiency. 
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7.2 Stages of Erythema 
i) Early Erythematous Reaction 	This is a well documented 
phenomenon which is seen within a few hours of treatment using large 
doses and large fields. This response has been linked with increased 
capillary permeability which has been assessed using protein bound vital 
dyes (JoIles 1972). This reaction fades quickly and is now considered to 
be of little importance in influencing or predicting the main erythematous 
reaction. 
ii) Main Erythematous Reaction This second erythematous wave 
begins on or about the 10th day and its intensity has been found to be 
dose dependent and peaks on or about the 14th day. Resolution of this 
phase tends to be variable but usually is prolonged no further than 4 
weeks. This phase of erythema has been quite clearly demonstrated to 
be due to a local inflammatory reaction and the process of epidermal cell 
death and reduction in epidermal cellularity. (Hopewell 1986). 	The 
overwhelming majority of all radiobiological studies in the mouse, pig, 
monkey and human have relied on various arbitrarily defined grading 
scales to semi-quantify observed end-points. A typical example of one of 
these scales relating to mouse skin was used by Douglas and Fowler 
(1976) (Table 4). 
iii) Late Erythema, Dermal Ischaemia and Necrosis This secondary 
wave of erythema has been best described in pig skin after irradiation with 
single doses or fractionated doses involving a small number of large 
doses per fraction of photons or fast neutrons (Hopewell et al. 1988; 
Archambeau et al. 1985; Fowler et al. 1963). This secondary wave of 
erythema (mid-term reaction) is not seen with increasing fractionation of 
the dose. It is probably for this reason that this second wave of 
erythema is not seen in the human situation. However, at the Chemobyl 
nuclear accident, some victims exposed to high energy 13-irradiation 
displayed this late erythematous phenomenon. (Barabanova and Osanov 
1990). The development of the late phase erythema reaction and of 
dermal necrosis is preceded by the loss of endothelial cells, a reduction in 
capillary density and increased separation of the remaining endothelial cell 
nuclei (Archambeau et al. 1984). Oedema and impaired lymphatic 
clearance also precedes the measured reduction in dermal blood flow. 
	0.0 
	
Normal 
0.125 
0.25 
	
Fifty-fifty doubtful if different from normal 
0.375 
0.5 
	
Slight hair loss and/or very slight reddening 
0.625 
0.75 
	
Definite but slight reddening t hair loss 
0.875 
1.0 
	
Severe reddening, often with distended blood vessels or slight swelling 
1.125 
1.25 
	
Severe reddening with white scales and/or severe swelling; red "papery" skin when 
healing 
1.375 
1.5 
	
Moist breakdown of one small area (usually on bottom of foot first) with scaly 
appearance 
1.625 
1.75 
	
Moist desquamation in more than one small or one slightly larger area (tips of toes 
stuck together with no other breakdown when healing) 
1.875 
2.0 
	
Breakdown of larger area and/or toes stick together; possibly moist in places 
2.125 
2.25 
	
Breakdown of one-third skin area on foot 
2.375 
2.5 
	
Breakdown of one-half area of foot (usually first on bottom) 
2.625 
2.75 
	
Breakdown of about two-thirds area of foot 
2.875 
3.0 
	
Breakdown of most of the skin of foot, possibly with slight moist exudate 
3.125 
3.25 
	
Breakdown of entire skin of foot with slight moist exudate 
3.375 
3.5 
	
Breakdown of entire skin of foot with severe moist exudate; may be stuck to body 
fur 
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TABLE 4 
Table 4. 	Mouse dorsal skin reaction grading system (Douglas and Fowler 1976). 
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7.3 Epidermal Clonogenic Cell Survival 
7.3.1 Mouse Skin Nodule Model 
In 1967, Withers devised a technique for counting re-growth of skin 
nodules on the dorsal skin of mice. The technique involved 
sterilising several large areas with high doses of low penetrating X-
rays and then exposing central shielded areas to various test 
doses. By counting the number of regenerating nodules and 
assuming that each nodule represented the survival of one basal 
cell the average number of cells surviving for each dose could be 
extrapolated using Poisson statistics. Several authors have 
subsequently employed Withers' technique ( Figure 13 ) and in 
general have provided reasonably consistent results, with survival 
curves having similar D o values between 0.95 and 1.5 Gy. 
Extrapolation numbers, however, vary significantly and all the 
experiments suffer in terms of using different qualities and 
techniques of radiation, animal strains, and proliferative status of 
the skin (time after hair plucking). There are also considerable 
technical difficulties associated with this technique with respect to 
exudates over test areas, erratic growth of nodules and the 
likelihood that proliferating nodules form from hair follicle units 
rather than individual cells. This experimental technique does not 
allow for measurements of celUcolony/EPU survival at low doses 
and most extrapolation numbers derived from such experiments 
correspond to approximately 1 x 10 4 cells/mm2 (a number very 
close to the actual basal cell density in mice). It must be assumed, 
with the presence of an as yet unmeasured shoulder on these 
curves, that the actual clonogenic number of cells/colonies is in fact 
considerably less than 1 x 10 4 cells/mm2. This indirect evidence 
suggests that the epidermis contains both clonogenic and non-
clonogenic proliferating cells. 
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Fig 13. Survival curves for macroscopically visible colonies in 
mouse skin. The number of surviving cells per mm 2 of 
epidermal surface which produce colonies is plotted on a 
logarithmic scale against radiation dose. The scale on the 
right shows the surface area needed to provide one 
surviving cell. the arrow shows approximately the entire 
surface area of a mouse. 
7.3.2 Histologic and Labelling Studies 
Pathological changes seen in the skin after exposure to ionising 
irradiation include pyknosis, karyontexis, coagulative necrosis and 
apoptosis. All are seen in association with cell death. The first 
histological events seen prior to cell death are a combination of 
cytoplasmic and nuclear material, a shrinkage and rounding up of 
the cell and fragmentation of the nucleus and cytoplasm. 
Histological sectioning in animal studies has proven an extremely 
difficult and highly variable measure of radiation damage in terms of 
the time course of the various pathological end-points mentioned 
and there does not appear to be any clear dose relationship 
between the dose of ionising radiation and such changes. The 
absolute yield of dead and dying cells after any given dose of X-
rays never appears to exceed approximately 10% of basal cell 
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numbers. Of course a substantial number proportion of cells may 
be sterilised but persist histologically unchanged in the tissue. 
Others still may continue to differentiate and function and take 
some further days or weeks to die histologically. 
Sectioning pig skin some two to four weeks after radiation enables 
counting of viable basal cells. Various workers have defined 
different "runs" of healthy cells as representing a colony and 
attempted to plot survival curves. These results give somewhat 
divergent values for Do and are difficult to interpret in the light of 
other known mouse or human data. (Archambeau et al. 1979; 
Nyman and Turesson 1991). One of the difficulties associated with 
this micro-colony approach via histological sampling is to orientate 
healthy looking cell runs in three dimensions. For example, it 
maybe impossible to say whether small islands of viable cells 
represented sections through the middle of roughly circular colonies 
or sections that skimmed the edge of large or irregularly shaped 
colonies. Colonies associated with hair follicles or ducts of glands 
display similar problems. 
An alternative method to gain some insight into target cell survival 
in the mouse model is to use auto-radiography to detect rapidly 
growing micro colonies. Again this technique is fraught with 
problems including background counts and selection of an arbitrary 
density of counts to qualify as a proliferating clone. Generally 
these experiments have produced higher D o values and lower 
extrapolation numbers than the skin nodule technique. (Figure 
14) Drawing significant conclusions from any of these studies with 
respect to extrapolation numbers which are derived by back 
extrapolation to a logarithmic scale is extremely fraught. It is clear, 
however, from both approaches that an exponential dose 
dependent survival phenomenon is being measured, which must 
reflect an EPU either follicle associated or epidermal associated 
which might account for measured higher Do values. 
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H Al Barwari and Potten 	1976 
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J Dover and Potten 	1983 
Fig 14. Survival curve for human epidermal cells grown in culture 
(curve J) compared with the in vivo curves for mouse 
obtained by scoring microscopic (curve H) and 
macroscopic (curve A) colonies. 
Nyman and Turesson (1991), utilised a histological basal cell 
density count and again encountered problems with technical 
factors such as fixation artefact and decisions regarding an arbitrary 
length of basal cells along the epidermal surface on which to count. 
They found that changes in basal cell density after irradiation 
showed a great variation from day to day but did demonstrate that 
depression of basal cell density and recovery, post radiation could 
be approximated by a linear plot of density against time. (Figure 
15) They concluded that the histological method gave results 
consistent with macroscopic scoring of traditional gross tissue 
injury. They felt, in common with other authors that the labelling 
index was not sensitive enough to be used as a reliable end-point 
for quantifying acute skin effects. Morris and Hopewell (1986), 
performed a similar series of experiments using fractionated 
radiotherapy and demonstrated that the severity of damage and the 
rate of recovery were both dose dependent in terms of basal cell 
density and labelling index. They also demonstrated from their 
auto-radiographic studies that the proliferative response following 
radiotherapy was confined to the first layer of basal cells rather than 
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supra-basal layers. Although mitosis had been noted in the first 
one or two suprabasal layer pre-radiation, the percentage of mitosis 
in the suprabasal layers did not change post-radiation. This 
suggests that the suprabasal layers have limited proliferative 
potential when compared with the immediate basal cells. This 
phenomenon tends to support the concept of a hierarchical 
proliferative cell population (Potten 1985). These authors were also 
able to provide data on in-vivo measures of repopulation during a 
protracted radiation schedule. (6 week treatment, daily fractionation 
to doses ranging from 52.3 to 80 Gray). Labelling indices in the 
basal cells had approximately doubled by day 28, and cellular 
turnover time had approximately halved to 50 to 60 hours by day 
28. 
(a) 
(b) 
Fig15. a) Cell density variations with time after a single dose of 
24 Gy with the high dose rate (1.5 Gy/min). Linear 
regression analysis was used for day 0-30 and 30-45 
(dashed lines), with regression coefficient (r) 0.75 and 
0.20 respectively. Horizontal lines indicate mean value of 
BCD for unirradiated skin with SD. Error bars indicate SD 
of each sample. b) Cell density variations with time after 
a single dose of 24 Gy with the low dose rate (0.02 
Gy/min). Linear regression day 0-25, r-.0.71, and day 25- 
45, r=0.67. 
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7.3.3 Human In-Vitro Survival Curves 
Dover and Potten (1983), generated human keratocyte survival 
curves from circumcision specimens from young boys. Figure 14 
shows their results superimposed on previous micro-colony and 
macro-colony data for comparison. The human cell line provided a 
Do value of 0.74 Gray which was not markedly different from the 
lowest value obtained in mice using the macro-colony approach. 
The graphical representation in figure 14 assumes that human skin 
has approximately 1400 colony-forming cells per mm 2 . 
7.3.4 Studies of Gross Skin End-Points 
There have been a large number of other general radiobiological 
studies of predominantly mouse dorsal skin and foreleg which have 
used traditional gross tissue appearances to test the effects of 
fractionation, dose rate, dose split effects and the time factor. 
(Fowler et al. 1963; Denekamp 1973; Field et al. 1975; Douglas 
and Fowler 1976; Moulder & Fischer 1976; Turesson & Notter 
1979; Denekamp et al. 1984; Joiner et al. 1986; Vegesna et al. 
1988; Hamlet & Hopewell 1988; van den Aardweg et al. 1988; 
Vegesna et al. 1989; van den Aardweg and Hopewell 1992). 
These studies have all contributed to our understanding of mouse 
and pig skin as an acute cell renewal system which responds to 
radiation with cell death essentially confined to the basal cell layer 
and a compensatory repopulation demonstrable from split dose and 
top-up experiments, starting at somewhere around 9-14 days in the 
mouse. A similar pattern is seen in pig skin, however, Archambeau 
et al. (1979) demonstrated that the time of onset to epidermal 
regeneration was between 17 and 28 days and that the exact time 
of onset was dose dependent. No evidence has been found as yet 
to demonstrate the phenomenon of slow repair which has been 
suggested as a possibility in mouse lung. (Field et al. 1976) Later 
workers (van den Aardweg & Hopewell 1992) have performed more 
complete split dose studies and suggest that repair mechanisms in 
pig skin may be best explained with a bi-exponential equation 
rather than a simple mono-exponential model. They report a fast 
and a slow component of repair half-time values of 0.14 hours and 
2.7 hours respectively. 
Later workers in the 1980's have applied cdp formalism to 
fractionation studies in the mouse skin. Vegesna et al. (1989), 
derived cdp ratios from the dose-fractionation response of growing 
and resting mouse hair follicles, inducing proliferation in follicles by 
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hair plucking, pre-treatment. Their estimates for a/13 ratios were 6 
Gy and 3.6 Gy for growing and resting follicles respectively (dose 
per fraction <7 Gy). For resting follicles, however, they noted the Fe 
plot was non-linear suggesting that incomplete repair was occurring 
between fractions or that the linear quadratic model was 
inappropriate to their data. Unpublished data from Withers confirms 
this phenomenon with higher measured a/I3 ratios for anagen hairs . 
(7.7) then telogen hairs (5.5), in the mouse. This was accompanied 
by substantially shorter repair half-times in the anagen hair (0.63 
hours versus 1.5 hours in telogen hairs). Data such as this suggests 
that more rapidly proliferating epidermal cells have a reduced 
fractionation sensitivity, more rapid repair mechanisms and shorter 
cell cycle times. 
7.4 The "Volume" Effect 
The first demonstrations of the dependence of the severity of the radiation 
reaction on the area or volume of tissue irradiated, was obtained by JoIles 
(1941) from experiments in rat skin. Various authors since that time have 
constructed iso-effective tables and guidelines principally derived from 
unquantified clinical observations, to support the existence of the volume 
effect (Ellis 1942; JoIles & Mitchell 1947; Patterson 1963). Hopewell & 
Young (1982), studied the treatment area effect in pig skin by comparing 
the severity of erythematous reactions and the dose required to produce 
dermal necrosis in field sizes of 4x4cm and 16x4cm. They found no 
significant relationship between area of skin irradiated and end-point. In 
experiments related to radiological protection, (Hopewell et al. 1986), 
circular areas of pig skin 5 mm to 40 mm diameter were irradiated with 
Strontium 90 sources. They found no change in the ED 50 for sources of 
22.5 mm and 40 mm diameter. 
It seems likely that a substantial proportion of observed "volume-effects" in 
the clinical practice of radiotherapy relate more to local dosimetric 
differences influencing clinical end-points, dosage inhomogeneity 
increasing with increasing field size and or volume and local 
pathophysiological processes. For some late reacting tissues, however, 
there is a clearly demonstrable sigmoidal volume response curve which is 
currently the subject of considerable research. (Withers et al. 1988). At 
present, best available evidence for both human and pig skin is that there 
is no significant volume-effect operating for acute reactions. Clinical 
experience, based on studies of human skin in patients receiving 
radiotherapy treatment, has suggested that their may be both age, and 
body site, related differences in acute radio-sensitivity. For example, in 
some treatment centres •for patients showing skin with an aged or 
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weathered appearance, a dose reduction of up to 10% maybe made. 
These observations are entirely empirical and no hard data support their 
use. 
7.5 Radiation Effects on Vascular Tissues 
7.5.1 Cellular Effects 
In addition to the basal cells of the epidermis, there exists other 
potential target(s) in the skin and other organs of mammalian 
systems. Endothelial cells and associated smooth muscle cells have 
long been identified as responsive to radiation and have been 
thought for many years to be responsible for many of the functional 
deficits identified in various organ systems, particularly many months 
or years after radiation (Hopewell et al. 1986). A variety of labelling 
index studies have been performed on skin and other organs and 
uniformly demonstrate labelling indices well under 1% (Hopewell et 
al 1986). Comparative data is not widely available for smooth 
muscle cells, however, limited experiments have confirmed an even 
lower turnover rate for these cells (Hopewell et al. 1986). A variety 
of other, mainly histological sectioning experiments have shown that 
as expected, the morphological changes in small and medium size 
vessels do not appear till 2-4 months post-treatment when 
endothelial cell nuclear loss, micro-vascular occlusion and intimal 
thickening are seen. (Takahashi & Kallman 1977; Archambeau et al. 
1984; Hopewell et al. 1986; Young & Hopewell 1982; Hopewell 
1975). 
Archambeau, Ines & Fajardo (1984) took serial biopsies from pig 
skin over a comprehensive time scale following irradiation and were 
able to derive fractional endothelial cell density and fractional 
change in lumen density following three separate single exposures 
(Figure 16a & b). 
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Fig 16a. Variation in time of the fractional endothelial cell density 
following acute single exposures of 1700, 2300, and 2700 
R. 
Fig 16b. Variation in time of the fractional change in lumen density 
following the same single exposures. 
These and other studies (Hopewell 1975; Moustafa & Hopewell 
1973) have suggested that the pattern of endothelial cell depletion 
and repopulation is similar to that reported for other cell renewal 
systems, apart from the elongated time scale. That is, in most 
other systems of an acute renewal nature there is a linear cell loss 
followed by an exponential repopulation. Dermal endothelium 
appears to manifest with a long period of no change in cell density 
followed by an abrupt decrease. Thus, it appears clear that the 
initial first wave of erythema and moist reaction following irradiation 
is primarily based on epidermal population loss and that further 
reactions or ulcerations that occur beyond approximately forty days 
parallel the changes seen in endothelial cells. 
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7.5.2 Functional Effects 
Assessment of the functional response of the vasculature to 
radiation can be achieved using isotopic tracing techniques. 
Moustafa & Hopewell (1979), irradiated pig skin with a variety of 
single doses and measured clearance rates from an intradermal 
injection of technetium-99 (9 1-cm). They identified two components 
of clearance in normal pig skin, a fast and slow component and 
were able to derive a relative clearance index for the isotope which 
equalled the ratio of irradiated to normal isotope clearance half-
lives. This was calculated for both the fast (t 2) and slow (t1 ) 
exponents. After a period of three weeks a decrease in the relative 
clearance index was observed for both components, however, by 
twelve weeks the reverse was true with areas of irradiated skin 
taking much longer to clear isotope from the site of injection than 
normal control skin. 
This data suggests that the acute phase of a skin reaction is 
associated with a vasodilatation of the fine vasculature and or a 
change in vascular permeability. Direct histological evidence of 
vasodilatation in the mouse skin has been reported by Takahashi & 
Kallman (1977), and a wide variety of data similarly supports this 
concept with respect to the effects of ultraviolet irradiation. 
(Biochemistry and Physiology of the Skin, Goldsmith 1983). 
Studies in human skin to demonstrate similar functional end-points 
are extremely rare. Roswit et al. (1953), studied the clearance of 
intradermal Na24 and concluded that increased clearance rates were 
seen corresponding to the wave of clinically evident erythema. 
Clearance rates likewise return to normal value as erythema 
subsided. 
Argenbright & Forbes (1982), studied the inflammatory response in 
the skin of pigs and mice following application of a photosensitiser 
and UV irradiation. They utilised a method which involved the 
systemic administration of 51 Cr-labelled red blood cells. They also 
used a visual erythema grading scale which consisted of 
comparative matching with serially layered red Kodak gelatine 
filters. Their results were somewhat conflicting. Mouse skin 
showed a nine-fold labelled red blood cell response to UVA induced 
inflammation but with no noticeable change in visible erythema. 
Conversely, pig skin was found to respond markedly with an 
erythematous reaction, however, an increase only by a factor of 2 
in labelled skin blood content was noted. They concluded that a 
stimulus which produces hyperaemia need not necessarily manifest 
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as observable erythema and speculated that the cutaneous vascular 
pattern (in particular the presence or absence of capillary loops) may 
be a large factor in determining the potential for erythema 
expression in the skin. In this regard the pig skin with its well 
developed capillary loops similar to the human differs markedly 
anatomically from the hairless mouse and other rodents. 
7.6 Radiobiology of Human Skin 
Among the first systematic observations of acute or late skin reactions in 
human subjects for single dose and fractionated treatment were those 
made by Reisner (1933) and Coutard (1932). In 1986, Trott replotted 
Reisner's fractionation data on an Fe plot to derive an a/6 ratio of 
approximately 400 R. (Figure 17) 
-- 400 R 
200 400 600 	800 1000 1200 1400 
Dose per fraction (R) 
Fig 17. The relationship between inverse of total dose and dose 
per fraction for the same degree of pronounced erythema 
and exudative radiodermatitis in man. (Reisner 1933) 
This value is lower than the value of 10 Gy derived by Overgaard et al. 
(1985) for acute radio-dermatitis after radiotherapy to the chestwall in 
breast cancer patients. As can be seen in Figure 17, the Reisner data is 
well fitted by a straight line and indeed better than many similar animal 
experiments. Reisner's data was collected and initially analysed some fifty 
years before the a113 formalism and hence an a/I3 ratio in the range of 
approximately 4 Gy is rather compelling, given that Reisner's data 
extended from 1-12 fractions only. Later authors, such as, Overgaard et al. 
(1985) and Turesson & Notter (1983) utilised fractionation schedules which 
were protracted over more than four weeks, when recruitment, accelerated 
repopulation and redistribution may become important factors over and 
above the repair processes operating between fractions. 
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A re-analysis of the Turesson data by Turesson and Thames (1989), 
indicated a reduced fractionation sensitivity (that is, higher a/13 ratio for skin 
desquamation, when treatment was protracted beyond 29 days). Bentzen 
et al. (1987), analysed the acute erythema and subcutaneous responses in 
two groups of breast cancer patients to derive both a113 ratios and RBE's 
for the electron treatment used in irradiating the chest wall. They studied 
two groups of patients. The first group had post-mastectomy radiotherapy 
to a minimum target dose of 36.6 Gy in 12 fractions at 2 fractions per week. 
The second group of patients had a dose of 40.92 Gy and 22 fractions at 5 
fractions per week. Using standard iso-effect plots they were able to derive 
an a43 ratio for erythema (at a 50% iso-effect on a standard grading scale 
of 1 to 3) of 10, with 95% confidence intervals of 1.8 and 22.8. This 
extreme range, along with the substantial dosimetric problems involved in 
this study (inherent with the electron beam), the case selection and 
physical factors involved in dosimetry and difficulty scoring uniform 
reactions in a surgically disturbed site, illustrate many of the difficulties 
associated with human studies. 
The largest human data source regarding acute and late skin reactions has 
been derived from the work of Turesson. Since 1972 Turesson and co-
workers have studied the skin reactions in the parasternal areas of almost 
600 women irradiated post-mastectomy for breast cancer. This study was 
performed on a prospective basis, with highly standardised field location, 
field size, absorbed dose and radiation quality. All doses were checked 
with thermoluminescent dosimetry. These studies were specifically design 
to test the predictions of the NSD (Normal Standard Dose) and CRE 
(Cumulative Radiation Effect) formula in changing fractionation number, 
rest periods during a course of radiotherapy, and measuring the amount of 
repair occurring with 15 minute, 4 hour and 8 hour interfraction intervals. 
Patients were treated with 12 and 13 MeV electrons and 200 kV X-rays 
(HVL 1.2 ml of copper). The total fraction number ranged from 4-50 and 
overall treatment time varied from 11 days to 40 days. The fraction size 
ranged from 1.1 Gy/fraction (CRE V) to 7.08 Gy/fraction (DIII). Erythema 
was assessed both quantitatively and qualitatively. A photo-electric 
reflectance unit which utilised two wavelengths (578 nm. and 660 nm.) to 
assess absorption by oxyhaemoglobin and melanin respectively was 
employed. In addition weekly photographs were taken and two observers 
scored skin reactions on a quantitative scale. 
Turesson & Thames (1989), have recently summarised all this work using 
direct analysis of quantal response and maximum likelihood estimation 
(Thames 1985). They also applied the generalised form of the Linear 
Quadratic model, the incomplete repair model (IR). Endpoints analysed 
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included erythema (reflectance measurements), desquamation (in a 
quantitative scale) and telangiectasia (semi-quantitative scale). They 
concluded that the repair capacity for human skin was similar for 
erythema and desquamation with cd13 ratios measured between 7.5 and 
11.2 Gy. They noted that as the time over which the radiotherapy was 
given, exceeded four weeks, repair capacity decreased and the a/f3 ratio 
increased to between 18.3 and 34.5 Gy. The authors postulate that this 
may be due to redistribution in the cell cycle, resulting in a net 
sensitisation of target cells or possibly recruitment of cells into the actively 
dividing phase. The authors also speculate that their data might suggest 
a bi-exponential repair time for acute effects with a fast component having 
a half time of approximately 0.3-0.4 hours and a slower repair component 
of 1.1-1.3 hours (for acute effects). Overall, they concluded that 
quantification of erythema by reflectance spectrophotometry was a reliable 
and sensitive method. Pigmentation proved to be a less sensitive and 
less radiation dependent endpoint than erythema as measured by 
reflectance. 
Wambersie & Dutreix (1986), (Dutreix et al. 1973; Dutreix 1986), reported 
a total of 77 patients who were treated with bilateral supraclavicular fields 
using identical techniques and overall times, apart from the fractionation 
pattern. Each patient had on one supraclavicular area, N fractions and on 
the other 2N fractions. Reactions were visually scored without a grading 
scale, by simply specifying which supra-clavicular field had the greater 
peak reaction. This enabled an approximation of repair capacity to be 
ascertained. By assuming that full repair occurred between fractions 
(minimum interfraction interval 6 hours) and that repopulation was the 
same in both schedules they were able to derive a theoretical cell survival 
curve for the stem cell population under consideration, that is, the basal 
cells of the epidermis. This approach, like all LQ analyses also assumed 
that any given biological end-points which were measured or in this case 
compared, corresponded to a definite survival level in the relevant stem 
cell population and that equal end-points implied equal stem cell survival. 
They expressed their data using the multi-target model and derived a D o 
of approximately 4.05 Gy. They confirmed the experience of others in 
deriving higher values of D r (repair capacity for late rather than early 
effects). 
7.6.1 In-Vivo Assays of Sensitivity 
Bumet et al. (1994), was able to derive 10 fibroblast strains 
(including 4 duplicates) from a group of patients originally treated by 
Turesson receiving post-mastectomy radiotherapy. In a blinded 
experiment they used a standard clonogenic assay to assess 
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intrinsic cellular radiosensitivity of fibroblasts derived from the 
buttocks of 19 patients treated from CRE IVb. Using standard 
grading of late effect they were able to demonstrate a significant 
correlation of cellular radiosensitivity with late effects. There was 
no clear association between cellular radiosenitivity and early 
effects. Geara et al. (1992) were unable to demonstrate any 
correlation between the radiosensitivity of lymphocytes and 
fibroblasts in the same individual (with high and low dose rate 
irradiation). They concluded that there was significant variation in 
normal cell radiosensitivity in the one individual. In another study, 
Begg et al. (1993) were unable to find any correlation between 
erythema in relation to radiotherapy post-mastectomy and fibroblast 
radiosensitivity in vitro. 
7.7 Comparison of UV and X-ray Induced Erythema 
Responses to UV irradiation by the skin are mostly concerned with 
erythema, carcinogenesis or pigmentation. The action of ultraviolet light 
on cells is different to that which occurs with ionising radiation (Painter 
1973; Han and Elkind 1977). Al-Barwari and Potten (1979), irradiated 
male hairless mice with both x-rays and Ultraviolet radiation and used 
identical reaction scores for dorsal skin observations. Their reactions 
scales were similar to those described by others (Fowler et al. 1963). 
Figures 18a and 18b show the observed skin reactions for various single 
doses of x-rays and Ultraviolet radiation respectively. Relevant features of 
these curves are that both have minimum threshold doses of 1200 rads 
and 2 "minutes" respectively. Peak reactions showed less dependency on 
the dose, than on durations of reaction at any given grade. X-ray studies 
revealed, that irrespective of quality or dose, reactions appeared on day 5. 
Ultraviolet radiation, irrespective of dose, produces reactions which are 
visible within 1 day. Histological studies on the number of epidermal 
basal cells and the number of dead or dying basal cells, after doses of x-
ray or UV, that produce the same level of skin reaction have shown the 
following. 
1 Up to 20 times more cells appear dead or dying after UV over the 
period 1 to 5 days following treatment. 
2 Within a period of three days the basal layer can be completely lost 
after UV doses that produce reactions of grade III. X-ray doses 
that produce the same reaction grade rarely show more than a 
small percentage of dead cells and basal cell density takes 10 to 
12 days before it is significantly depleted. (Al- Barwari 1978) 
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Fig 18a. Skin reactions for hairless dorsum after various doses 
(1200-4500 rads) of 300 kVp X-rays, plotted against time 
after irradiation. Each point represents the mean of five 
or six mice with the standard error of the mean being 
shown for one set of data (1600 rads). (o) 1200 rads; (•) 
1600 rads; (v) 2000 rads; (x) 2700 rads; (A) 3500 rads; * 
4000 rads. Al-Barwari and Potten (1979). 
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Fig 18b. Skin reaction for hairless dorsum after various doses (2- 
25 min exposure which is equivalent to 16-200 x 10 6 
ergs/4cm2) of u.v. (250-410nm). Each point represents 
the mean of five or six mice with the standard error of the 
mean being shown for one set of data (6 min exposures: 
48 x 106 ergs/4cm2). Length of exposure in min: (0) 2; 
(9) 3; (v) 4; (a) 6; (x) 8; (*) 10; (III) 15; (*) 25. 
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The x-ray doses used to produce skin reactions above Grade II, must kill 
at least 99.9% of the clonogenic stem cells in the epidermis, (Withers 
1967; Al-Barwari and Potten 1976; Potten et al. 1978). This data supports 
the idea that the epidermal basal layer is composed of two types of cell, a 
minority class, the clonogenic stem cells and a majority transitory class 
that are capable of proliferation but not clonogenicity and therefore are 
relatively unaffected by x-rays. Thus the extra cells killed by ultraviolet 
light in all likelihood, represent the discreet class of cells that are relatively 
unaffected by x-rays, that is the non-clonogenic proliferative cells. 
7.7.1 Mechanisms of Erythema 
The gross appearances and skin histological changes associated 
with acute radiation erythema are well documented (Radiation and 
Skin 1985, CS Potten; Dermatology in General Medicine Vol 1 1987 
Chpt 123, Fitzpatrick et al; Biochemistry and Physiology of the Skin 
1983 Vol 2 Chpt 34, A. Lowell and M.D. Goldsmith), however, less 
has been reported on the exact biochemical and physiological 
mechanisms which result in the observed capillary and arteriolar 
vaso-dilatation, increased vascular permeability and other 
associated changes. It has always been assumed that epidermal 
cell death produces various vaso-active mediators resulting in the 
above changes. In ultraviolet erythemogenesis, a large body of 
work has implicated a number of possible intermediate vaso-active 
cytokines and other growth factors which are thought to exert there 
action by autocrine, paracrine or endocrine modes of action. At a 
molecular level there is some evidence that free radical production 
may be involved in ultra violet light mediated erythema (Black 
1987). Kelfkens et al. (1990), have employed a thermometry 
technique to evaluate UVA induced erythema and concluded that a 
vaso-active mediator released from the epidermis, diffusing into and 
around dermal blood vessels, represents the best model for UV 
induced erythema. 
The study of these mediators in relation to X-rays has become 
known as humoral radiopathology. Prostaglandins and related 
compounds have received most attention in this regard (Anderson 
et al. 1989; Pentland et al. 1990; lmokawa and Tejima 1989; 
Eicosonoids in Tissue Inflammation 1993; Takahashi and Kal!man 
1977). The role of these compounds in modulating radiation effects 
has largely been deduced from experiments which measure their 
production following radiation and demonstrations of reduced 
radiation effect using drugs which inhibit their production. 
Michalowski has recently reviewed the literature on eicosonoid 
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production in relation to radiation treatment (Michalowski 1994). 
Eicosonoids include a number of potent natural vasoactive 
substances. (prostaglandins, thromboxanes and leukotrienes). 
These compounds are likely to be responsible for the vaso-
dilatation and vaso-constriction, increased micro-vascular 
permeability, thrombosis and extravasation of leucocytes which are 
observed after radiation exposure. Many studies in small mammals 
and a small number of studies in man have indicated that various 
organs respond to radiation by rises in the level of endogenous 
prostaglandins and thromboxanes in the days and weeks following 
irradiation. Glucocorticoid steroids and NSAID's (Non-Steroidal 
Anti-Inflammatory Drugs) can ameliorate radiation reactions. 
Glucocorticoids inhibit eicosonoid synthesis primarily by interfering 
with phospholipase A2 and NSAID's prevent prostaglandin 
/thromboxane synthesis by inhibiting cyclo-oxygnase. These 
studies have involved small mammal experiments using various 
lung, gastrotestinal and renal endpoints. Other reported possible 
mediators include transforming growth factor alpha (TGFct) (James 
et al. 1991)and bradykinins. (Pentland and Jacobs 1991) 
In relation to x-ray induced erythema, Eassa and Casarett (1973) 
demonstrated that epsilon-amino-n-caproic acid (EACA), reduced or 
eliminated completely both the first and second phases of 
increased capillary permeability in irradiated rabbit skin. EACA is 
known to be a potent anti-proteolytic agent, however, its mode of 
action in this setting is unclear. 
8 RAW DATA ANALYSIS OPTIONS 
Despite the fact that this study employs a continuous quantitative variable for 
evaluating erythema, one still has to keep in mind that the erythema scale is 
likely to be non-linear in relation to effect. That is an increase in the radiation 
dose (and therefore the amount of damage producing an increase in x units 
on the erythema scale) may well not be equal for all levels of erythema effect. 
This point is graphically demonstrated in Figure 18a. One can see that 
graded erythema increments in terms of the peak erythema, are non-linearly 
related to dose increases. These authors, in common with many 
radiobiological studies have derived these average reaction scores by taking 
the mean score at fixed time points. This method has two disadvantages; (1): 
averaging is done on a non-linear scale, which is statistically incorrect and (2): 
reactions for individual animals or patients may peak on different days and the 
shape of the resultant reaction curve is modified, that is the peak will reduced, 
resulting in an under-estimation of the maximum reaction. 
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These disadvantages can partly be overcome by a second method of 
averaging. That is, calculating the average time at which a certain damage 
level is observed. In this way averaging is done on a linear scale (time) and 
the average curves always indicate the maximum level of reaction predicted. 
The gain in accuracy with this second technique is difficult to predict. In 
practice in radiobiological experimental practice, both these methods are 
employed and generally speaking give consistent results. (Vanuytsel et al. 
1986). 
Figure 19 shows other parameters which may have theoretical usefulness in 
describing reaction curves. Temporal measures such as latency for the peak 
and time to reach any given reaction grade tend to be generally insensitive as 
most acute animal and human responses are consistent and relatively 
independent of dose and dose rate. Given the non-linearity of association 
between peak and net radiation effect, the two most likely parameters useful in 
the human situation, where reaction curves show considerable heterogeneity, 
are likely to be duration of reactions at given levels and areas under the peak 
above a given level. The latter takes into account both the peak values and 
duration by virtue of its integrative nature. Table 5 summarises these analytic 
options. Both the duration and area under curve ("AUC") methods will be 
more properly treated by non parametric statistical methods rather than taking 
the mean values of these quantities for any given group of patients. It would 
seem, therefore, reasonable to rank these quantities and derive median or 
interpolated median values for iso-effect analysis. 
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average reaction 
average peak reaction 
MORPHOLOGICAL 	mean peak reaction 
ENDPOINT 
latency for the peak 
Fig 19. Schematic representation of typical acute reaction 
displaying the options of descriptive quantitative 
parameters for individual or averaged reaction curves. 
When the ordinate scale is a quantitative measure such as derived from 
reflectance values, the investigator has the choice of utilising normalised values or 
an absolute change in erythema units. The normalised approach has the 
advantage of mathematical simplicity (with each patient beginning at a starting 
value of unity) and has many other physiological precendents. (eg pulmonary 
function tests) Because this method relies on a proportional change, it does 
however have the disadvantage of relatively accentuating the response at the low 
end of the erythema range versus the high end. By using an absolute change in 
erythema (taking the starting value as baseline) a more standardised measure 
may be obtained, but may be inappropriate for an instrument with nonlinear 
response. 
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By taking the mean 
peak reaction as 
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Quantification of the reaction 
on erythema scale 
Individual reaction curves 
Problem 1: How to construct an 
average curve 
A. By calculating the average 
time at which a certain 
reaction is reached 
TABLE 5 
Group of patients after 
a particular treatment 
Daily score of the 
individual reactions 
By averaging the 
individual scores 
on consecutive days 
Analysis of the reaction 
using a "yes or no" test for 
a given reaction level 
Percentage of patients treated 
reaching the given reaction 
level 
Probit analysis 
NOT USED : Advantage : Averaging 
is done on a LINEAR scale. 
Problem : can only be used 
when ALL patients reach the 
same damage levels. 
Problem 2 : How to quantify 
the reaction pattern 
By taking the average 
skin reaction over 
a given time period 
as representative 
Dose-response curves 	 Dose-response curves 
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9 RATIONALE, AIMS AND OVERVIEW OF STUDY 
9.1 Rationale 
The initial stimulus for this project arose from the observation that 
there existed no systematic quantitative observations on the effects of 
fractionated low dose rate radiotherapy in human skin. This situation 
was paralleled for hypofractionated high dose rate treatment where 
only the work of Turesson had been reported in the post war period. 
With increasing application of the linear quadratic model to 
experimental data since 1980, derivation of a/13 ratios and t% values 
for acute effects in human skin over a variety of anatomical sites 
would clearly be useful to augment animal data. For the safe and 
rationale design of new radiotherapeutic protocols (e.g. 
hyperfractionated or accelerated radiotherapy), accurate measures of 
dose rate effects, fractionation effects and repair values are required 
from clinical radiobiological studies such as this one. Finally, with the 
development of modem reflectance techniques, we had an 
opportunity to collect quantitative rather than qualitative measures of 
human erythema. 
9.2 Aims 
• To qualify and quantify cutaneous erythema in response to 
Fractionated Low Dose Rate (FLDR) and Fractionated High Dose 
Rate external beam radiotherapy. (FHDR) 
• To test and validate Reflectance Spectrophotometry as a suitable tool 
for quantifying Radiation Erythema. 
• To relate quantified versus qualified observations of cutaneous 
erythema for FLDR. 
• To test the iso-effective predictions of the incomplete repair model for 
FLDR and FHDR. 
• To derive a/13 ratios and repair half-time data for human skin from 
FLDR and FHDR. 
• To examine the influence of various other physiological and historical 
co-variants in radiation effects with FLDR and FHDR. 
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9.3 Overview of Study Design 
This study was performed in the setting of a small to medium sized 
radiotherapy department, in a provincial city. The study patients were 
drawn from patients presenting for palliative treatment of various 
malignancies and patients treated curatively for carcinoma of the 
prostate (vide infra). 
1 Patients treated as part of a clinical radiobiological research project; 
Low Dose Rate Teletherapy (Cooper et al. 1990; Hamilton et al. 
1993). These patients were further sub-divided into two treatment 
groups: (10 fractions) 
A Head and Neck primary sites; treated with parallel 
opposed Cs 137 portals at dose rates of 0.8, 1.8 and 3 
Gy/hr. 
B Skin patients (various sites); treated with direct Cs 137 
fields at dose rates of 3, 4.8 and 8 Gy/hr. 
2 The second portion of the study evolved as an extension of the Low 
Dose Rate Teletherapy protocol. The study population in this 
instance, consisted of patients treated with conventional palliative 
regimes (5,10,12,20 fractions at 240 Gy/hr, 6 MV X-rays) and total 
skin doses in the range of 4 to 52 Gy. (various sites) 
3 Patients undergoing conventional external beam radiotherapy 
(32 fractions at 240 Gy/hr, 64 Gy, 6 MV X-rays) for localised 
carcinoma of the prostate were enrolled on a study assessing the 
response of hair follicle cortical cells to X-rays. (Pollen et al. 1994) 
(supra-pubic only) 
Both study populations 1 and 2 consisted of patients with incurable and 
almost invariably metastatic malignancy, having symptoms justifying 
palliative radiation treatment. The central theme behind utilising both 
the study populations, was that of deriving quantitative endpoint data 
(using reflectance measurements) in a setting where a range of total 
doses, dose rates and fraction numbers could be employed. 
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CHAPTER II MATERIALS AND METHODS 
1 REFLECTANCE TECHNIQUE 
1.1 Construction of Reflectance Unit 
The portable reflectance unit used in this study is a robust integrated unit 
which employs 240 volt mains supply and consists of two major separate 
components. 
1 The electronic drive and signal processing unit and 
2 The skin reflectance measuring head. 
1.1.1 Electronic drive and signal processing unit 
Wavelength selection is via a circular variable interference filter 
whose rotation is driven by a computer controlled stepper motor. 
The spectral range from 400 to 700 mm may be scanned in 2.8 s. 
The light source was a 6 V, 20 W quartz halogen lamp and optical 
linkage between the source, measuring head and 
spectrophotometer is provided by the fibre optics. Incoming 
reflectance signals generated in the measurement head are 
detected by a silicon photo-diode detector, amplified and 
transmitted through logarithmic amplifiers (ICL 8048 CCPE). 
Pigment indices are calculated by simple arithmetical treatment of 
the incoming reflectance voltages. Measurements on a standard 
white surface (smooth magnesium oxide powder) are made prior to 
each series of experimental measurements. The readings for 
haemoglobin and melanin indices thus obtained are then subtracted 
from subsequent experimental measurements, since the definition 
of a white surface is that the two indices should be zero for 
magnesium oxide. 
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1.1.2 Skin reflectance measuring head 
The measurement head consisted of a hollow black plastic 
hemisphere 2.5 cm in diameter mounted inside a metal cylinder for 
ease of handling and exclusion of ambient light. The illuminating 
optical fibre was mounted in the hemisphere at right angles to the 
specimen surface while the fibre collecting the reflected light was 
mounted at 450  to the specimen surface. A second optical channel 
carried light directly from the light source to the interference filter to 
provide a reference signal. Light intensity was measured by means 
of two photodiodes. The ratio of the amplified output signals was 
digitised and transferred to microcomputer for conversion to LIR 
values, storage and data manipulation. 
1.2 Measurement of Haemoglobin Index 
Reflectance readings were taken pre-treatment and at twice-weekly 
intervals during and after the course of radiotherapy, until the acute 
erythematous reaction returned to base line. This generally took some 
two to four weeks following the completion of radiotherapy. Patients were 
measured in a recumbent position, in an air-conditioned environment, with 
a constant ambient temperature of 22°C. The patient was positioned in a 
comfortable consistent manner and given five minutes in their recumbent 
position prior to measurements being taken. A suitable measurement site 
was selected, usually closely corresponding to field centre, over an area 
of flat, hairless skin. The measurement site chosen, was if possible, that 
displaying the least amount of previous solar damage (elastosis, hypo and 
hyper-pigmentation and actinic change). The chosen site was referenced 
using a small non-permanent skin mark which was consistently aligned on 
subsequent measurements with a reference mark on the external surface 
of the measurement probe. The probe was rested gently on the skin 
surface and haemoglobin and oxygenation readings each taken five times 
in succession. This process required approximately five to eight minutes. 
The mean of each of these five values was then taken to represent the 
reflectance reading for that day. 
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As has been demonstrated previously, the degree of erythema in the skin 
is directly proportional to the haemoglobin index and therefore we define a 
quantity: 
El = 	 (16) 
E0 
where El equals the erythema index at time t. E 0 is the erythema reading 
pre-treatment and E, is the erythema reading at time t. An entirely 
analogous procedure may be used to calculate the oxygenation index 01. 
An identical procedure was followed to measure control or background 
erythema and oxygenation readings outside the field. That is, a suitable 
point at least three centimetres beyond the field and if possible at the 
same vertical level on the patient as the test site was selected and pre-
treatment and twice weekly readings were performed at the same time as 
test values were taken. (Figure 20). 
Superior 
Test Points 	Control Points 
Right 
0 
Left 
Inferior 
Thick bolus 1 5 cm 
L_ 	= Thin bolus 0.75 cm . 
= No bolus 
Fig 20 	Schematic representation of the field sub-division (total 
field area greater than 175 cm 2) into differentially bolused 
areas along with test and control points for reflectance 
readings. NB. FLDR study did not include the use of any 
bolus as illustrated here. Location of test and control 
reflectance points is however entirely analogous. 
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1.3 Calibration of Reflectance Unit 
The reflectance unit required a twenty minute daily warm-up and prior to 
each set of readings was recalibrated against a matt black and pure white 
ceramic tile. Two other additional constancy checks were performed. 
1 A flesh coloured pink ceramic tile was used for daily constancy 
checks over a two to three week period every several months to allow 
checking of the constancy of haemoglobin and wry-haemoglobin 
reflectance values. 
2 a specific artificial absorbence filter (Wratten filter) was used on a 
once weekly basis, to check for constancy of haemoglobin and 
oxygenation indices. 
Over a forty five day time period the pink ceramic tile recorded a mean 
haemoglobin index of 10.7 ± 0.59 (one standard deviation). 
Corresponding oxygenation values were 59.97 ± 21.75. The Wratten filter 
showed similar constancy with haemoglobin values of 53.33 ± 2.23 and 
oxygenation values of 52.7 ± 45.84. 
1.4 Patient Consent 
Following determination by medical staff that patients were suitable for 
either of the studies under consideration, (FLDR and FHDR), the patients 
were requested as to whether they would consent to their entry on either 
of these programs. Treatment protocols were explained in considerable 
detail, along with an accompanying colour photographic package to 
illustrate the logistics of the study. Patient consent forms for each of 
these studies are included in appendix 1. These studies were approved 
by the Regional Ethics Committee. 
2 FRACTIONATED LOW DOSE RATE STUDY (FLDR) 
2.1 Study Background 
The Department of Radiation Oncology at the Newcastle Mater 
Misericordiae Hospital embarked on an experimental fractionated low 
dose rate (FLDR) teletherapy project in 1989. This project was designed 
with the aim of accurately assessing acute normal tissue end-points 
(mucosal and skin response) in an effort to provide a systematic iso-effect 
data for a range of total doses and dose rates. A modified Caesium-137 
teletherapy unit was utilised for this project which ceased in 1994 with the 
accrual of one hundred and forty one patients. This thesis reports on 
reflectance data and clinical observations from skin reactions in one 
hundred and nine patients treated in the FLDR project. (reflectance unit 
arrived 1990). 
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2.2 Study Population 
Consenting patients for the FLDR project were drawn from two categories. 
2.2.1 Locally Advanced Head and Neck Cancer 
These patients were assessed at a combined multi-disciplinary 
Head and Neck Cancer clinic and felt to have incurable head and 
neck cancer. If these patients were otherwise suitable for 
conventional palliative external beam radiotherapy, they were 
offered low dose rate therapy on the FLDR project. Patient 
selection criteria are given in Table 6a. 
TABLE 6a 
Patient Selection Criteria 
Head and Neck Cancer 
(1) Patients with squamous carcinoma of the head and neck that fulfil the 
RTOG modification of the AJC stage grouping criteria in the categories 
IVB, C and D and V, excepting oral cavity turnouts and laryngeal 
tumours that may be amenable to surgery. 
(2) Patients under 80 years of age with an anticipated survival of more than 
8 weeks. 
(3) Patients who do not have intercurrent illness such as dementia, severe 
epilepsy, incontinence, severe musculo-skeletal disorders, that are likely 
to make treatment lasting several hours each day difficult 
(4) Patients who do not have severe dental canes requiring major dental 
work prior to treatment. 
(5) No prior treatment (radiation or chemotherapy). 
(6) Written informed consent to treatment on protocol. 
Table 6a Criteria for study inclusion (FLDR) 
2.2.2 Bony and Soft Tissue Metastases 
The second group of patients enrolled on the FLDR project were 
patients with a variety of metastatic solid tumours, who would 
otherwise be suitable for conventional external beam palliative 
therapy. Selection criteria are given in Table 6b. 
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2.3 Irradiation Methods 
2.3.1 Equipment and Technique 
The Caesium-137 teletherapy unit employed in this study normally 
operates at treatment distances of between 20-30 cm SSD and 
delivers incident dose rates of greater than 1 Gy/min. Because the 
50% depth iso-dose line is less than 5.5cm deep at these SSD's the 
use of the use of the machine is confined to the palliative treatment 
of relatively superficial primary and secondary tumours. 
Modification of this unit for low dose rate use involved the 
construction of a set of collimation cones using low melting point 
alloy. These cones improved beam flatness, beam 
coverage and minimised penumbra at extended SSD (Figure 21 
and 22). 
TABLE 6b 
Patient Selection Criteria 
Bony and Soft Tissue Metastases 
(1) Proven symptomatic metastatic cancer involving sites that can be 
encompassed satisfactorily by modified caesium beam at 60 or 80 cm 
SSD. 
(2) A disease site that has not been previously irradiated, is not situated 
in a pressure area, and in which there is no evidence of skin or 
subcutaneous involvement by tumour. 
(3) The patient has not received Adriamycin, Actinomycin D, or 
Bleomycin containing regimes, or is being concurrently treated with 
cytotoxic chemotherapy or other agents that may modify radiation 
response. 
(4) Ability to lie still for a period of up to 1 hour. 
(5) Written informed consent for treatment on protocol. 
Table 6b Criteria for study inclusion (FLDR) 
lead attenuator 
mounted on 
perspex in a 
perspex "pocket" 
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virtual 
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2.5 cm source width 
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peiST3ex mount 
attached with 
bolt 
I 
\I—diverging 	100cm 
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i 
attached to perspex 
(detachable)  
— . .. 
Fig 21 The Caesium teletherapy unit "head" illustrating the design 
and positioning of the "inner" and "outer" diverging low 
melting point alloy collimators in relation to the caesium 
source. 
A series of beam flattening and attenuating filters were used to 
achieve instantaneous dose rates of between 0.5 and 5.0 Gy/hr at 
7cm depth in tissue. This corresponded approximately to the 65% 
isodose, depending on field size. Patients were accepted for 
treatment provided that target volume heterogeneity of total 
absorbed dose did not exceed ± 5% using a parallel opposed field 
setup. A typical beam profile is shown in figure 22 and its depth 
dose characteristics given in figure 23. 
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LDR(10x15) 
BEAM FLATNESS 
BO cm SSD 
Fig 22 Beam profile for a 10 x 15 cm cone showing the flatness of 
the beam and its penumbra at 80 cm SSD. 
LDR ( 10 x15) 
DEPTH DOSE 
80 cm SSD 
Depth in mm 
Fig 23 Depth dose characteristics of a 10 x 15 cm field at 80 cm 
SSD. Peak dose is estimated to be 0.5 - 0.7 mm below the 
surface. 
Two irradiation setups were employed. 
1) For Head and Neck patients, right and left parallel opposed 
fields. 
2) 	For bony and soft tissue metastatic disease, a single 
appositional field. 
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Treatment times varied between 40 minutes and 5 hours per day and 
careful consideration was given to patient comfort and immobilisation 
during treatment. Patients treated for locally advanced head and 
neck cancer were positioned reclining on a modified dental couch 
with hourly rest breaks allowed. Immobilisation was achieved using a 
customised polystyrene head rest and velcro strapping. Patients 
treated with single fields had 3mm of tissue equivalent bolus placed 
over the entire field to eliminate the small build-up effect seen with a 
Caesium 137 beam. Optical proximity switches were used to confirm 
patient position and switch off treatment if the patient strayed from 
the prescribed field settings. A TV and VCR unit were provided for 
entertainment during treatment. The treatment itself was supervised 
by a closed-circuit TV. Full technical details are given in appendix 2. 
2.3.2 Doses and Dose Rates 
The range of total doses and dose rates chosen in this study were 
selected as a compromise between practical logistic difficulties and 
allowing the data envelope to encompass as wide a range of the 
potential influence of the dose rate effect as possible. Figure 24, 
conceptually demonstrates the spread of the chosen doses and dose 
rates which correspond to predicted iso-effect lines (Dale et al. 
1988). A central composite design was chosen with the central point 
being represented by 38 Gy at 1.8 Gy/hr. Head and neck patients 
were treated at dose rates of 0.8, 1.8 and 3 Gy/hr and soft tissue and 
bony metastatic patients treated at dose rates of 3, 4.8 and 8 Gy/hr. 
Of the 141 patients accrued for the FLDR study, 109 formed the 
basis of this report, having had reflectance studies performed. This 
includes 33 patients from the head and neck group and 76 from the 
skin group (figure 25). 
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Head and Neck Patients 
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Fig 24 Dose and dose rate points chosen for FLDR study 
superimposed on FLDR iso-effect predictions. (Dale et al. 
1988). 003=10 rA=0.5 hours 
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Fig 25 Matrix of measured skin dose and dose rates for the subset 
of patients (n=109) from the FLDR study, forming the basis 
for reflectance observations in this study. 
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2.4 Erythema Scoring 
Patients on treatment were evaluated twice weekly by two independent 
observers who scored both skin and mucosal reactions according to a 
modified EORTC/RTOG scale (Table 7). 
TABLE 7 
EORTC/RTOG Toxicity Criteria 
SKIN 
0 No change over base line 
1A* Follicular, faint erythema / epilation / dry desquamation / decreased 
sweating 
113* As above but confluent bright pink erythema 
2 Tender or dusky erythema, patchy moist desquamation / moderate 
oedema 
3 Confluent, moist desquamation other than skin folds, pitting oedema 
4 Ulceration, haemorrhage, necrosis 
* This distinction is a local one and therefore represents a modification. 
Table 7 	Skin and mucosal scoring criteria for FLDR 
project. 
3 FRACTIONATED HIGH DOSE RATE STUDY (FHDR) 
3.1 Study Population 
Consenting patients who were undergoing a course of palliative 
radiotherapy for metastatic incurable malignancy, were entered onto this 
study, having one or more of the following fractionation schemes. 
20 Gy / 5 fx 
30 Gy /10 fx 
36 Gy /12 fx 
40 Gy / 20 fx 
Patient age was restricted to the range 18 to 80. 	The patients 
performance status was required to be ECOG 2 or greater and no 
previous irradiation to the area concerned was allowed. The patient was 
required to have had no previous history of significant dermatological 
illnesses or have had recent known photosensitising drug intake. 
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3.2 Irradiation Technique and Doses 
Patients in the FHDR study were irradiated exclusively with 6 MV photons 
and suitable sites were confined to the truncal portion of the body 
between larynx and groin. Field configurations included single fields, 
parallel opposed pair and 4 field techniques. In order to generate a 
greater number of dose points, patients with field sizes greater than 100 
cm2, had their fields arbitrarily divided up into two sections. The first of 
these sections was treated through a layer of full wax bolus (for 6 MV 
photons, 1.5 cm). The second of the sub-divisions of the treatment field 
was treated with no bolus. This resulted in approximately a 30 to 40% 
dose differential to skin in the two areas concerned. For field sizes 
greater than 175 cm2, the treated field was artificially divided up into three 
sections in an analogous manner with, on this occasion, the third section 
being treated daily through a layer of thin wax bolus (0.75 cm). 
Reflectance readings were done in the centre of each of these arbitrary 
sub-divisions of the field. (Figure 20) 
3.3 Other Recorded Variables 
In addition to the physical quantities and parameters already described, 
FHDR patients had several other variables recorded and transcribed to 
the Medlog data base for later analysis. These included, medications, 
natural hair colour in early life, natural tanning pattern, historical UV score, 
prior UV exposure on face and prior UV exposure in treated area. The 
later three of these parameters were graded on a simple semi-quantitative 
scale, using published criteria (Cameron et al. 1988). A comprehensive 
list of recorded variables is given in appendix 3. 
3.4 Hair Cortical Project 
Patients undergoing conventional external beam radiotherapy for localised 
carcinoma of the prostate (T1-T3,N0 ) (n=49), had reflectance readings 
taken (vide supra) (without bolus) as part of a study to assess the 
response of human hair to X-rays. Full details of the technique are given 
in Potten et al. (1994). In brief; approximately 100 groin hairs are removed 
pre-treatment and again after a given dose (in this case 4,8,16 or 32 
fractions). Hair cortical cell density is measured using confocal microscopy 
and the fractional reduction represents a measure of follicle cell kill. 
Patients were treated using 6 MV photons with a 4-field box set-up to a 
target absorbed dose of 64Gy in 32 fractions. Care was taken to separate 
the test and control points from the hair sampling point . Field sizes were 
CT- planned to cover the prostate gland plus a margin only. 
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4 IRRADIATION DOSIMETRY 
4.1 Introduction 
The most accurate in-vivo skin dosimetric method available in radiation 
physics is thermoluminescence dosimetry (TLD). This method of 
dosimetry was employed in both the FLDR and FHDR studies and is 
particularly applicable due to its ability to estimate dose at the basal cell 
layer in the epidermis. The International Commission on Radiation Units 
and Measurements (ICRU report 39) recommends 0.07 mm as the most 
appropriate depth of measurement for the individual dose equivalent. 
Direct measurement of this skin dose is preferable over calculation due to 
the many parameters which influence the surface dose. This includes 
factors such as electron contamination of the original beam, field size, 
shadow trays, beam blocks, patient geometry and obliquity of the beam. 
Carbon-loaded black TLD's (Francis et al. 1989; Thomas and Palmer 
1989) are particularly designed for surface dose measurements following 
the recommendations of the ICRU. These TLDs are loaded with carbon 
which absorbs all light emitted from anywhere in the crystal except the 
very surface. Therefore, only the light from a shallow surface layer of 
lithium fluoride (LiF) reaches the light detector in the TLD reader. This 
results in a dose reading for a very shallow depth depending on the 
carbon loading. 
4.2 TLD Characteristics 
The dimensions of black TLDs (Vinten) can be seen with other 
parameters in Table 8. As a comparison, the dimensions of a standard 
LiF ribbon (Harshaw) are given. The dimensions of the chips were 
measured by means of a caliper with digital readout (Starrett). The weight 
of the chips was determined using a microbalance (Mettler) and the 
density of each chip calculated from weight and volume. 
4.3 TLD Methodology 
4.3.1 FLDR Project 
Skin dose measurements on patients treated on the FLDR project 
were performed using paired conventional lithium fluoride chips 
which were applied to the field centre on each patient and a build 
up of 1 mm of dental wax was utilised. Dose results were averaged 
and if the two readings differed by more than ten percent, the 
readings were repeated. 
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TABLE 8 
Standard ribbon Carbon-loaded chip 
Manufacturer Harshawa Vintenb 
Material LiF: Mg, Ti, TLD 
100 
Teflon with LiF 
carbon-loaded 
Surface shape square round 
Dimensions (mm) 3.19 x 3.19 diameter 14.3 
Physical thickness (mm) 0.88 t 0.01 0.41 t 0.01 
Area (mm2) 10.16 t 0.12 161.3 t 0.8 
Weight (mg) 23.6 t 0.4 103.5 t 2.0 
Density (g/cm3) 2.64 t 0.11 1.57 t 0.08 
Thickness (g/cm2) 0.232 0.064 
Dose response DR (nC/Gy) 347.8 32.0 
Precision of dose measured 
using standards (2 SD) 
3% 5% 
Variability of DR between 
chips of one set (2 SD) 
8% 10% 
Table 8 	Characteristics of the TLD chips used in the 
present study 
a Harshaw Chemical Company, Solon Ohio 44139, USA 
b 
	
	Vinten Analytic Systems, Bedfordshire SG19 IRB, 
England 
4.3.2 FHDR 
A more sophisticated dosimetry approached was utilised in the 
FHDR study. Paired carbon-loaded TLDs were inserted into a 
tissue equivalent polystyrene holder and applied to the field centre 
on the patient's skin. No additional build up was utilised for these 
measurements. If patient geometry and field size permitted, two 
further paired conventional chips were utilised. Firstly as an 
additional check of the D r,,,,, of the applied megavoltage (6 MV field), 
a 1.5 cm layer of tissue equivalent was applied over 1 pair and to 
estimate dose to the basal layer, 0.7 mm of bolus was applied over 
an additional pair of conventional lithium fluoride chips. Again the 
paired results were averaged and if the two readings differed by 
more than ten percent, the reading were repeated. The measured 
doses were compared with estimated skin doses in this project, for 
the evaluation of the accuracy of surface entry dose. Entry doses 
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were open field surfaces doses measured by a Markus chamber on 
a solid phantom for 6 MV photons, and corrected by the Rawlinson 
surface correction (Rawlinson et al. 1992). 
4.4 TLD Readout and Evaluation 
The TLDs were read in two different types of TLD readers with contact 
planchet heating (Victoreen 2800M and Vinten Toledo 654 with automatic 
sample changer). The carbon-loaded chips are teflon based, and could 
not be annealed at 400°C as recommended for lithium fluoride (Driscoll et 
al. 1986). In addition, the carbon chips should be annealed under a 
nitrogen atmosphere to avoid oxidisation of the carbon, therefore a 
combined readout and annealing procedure was used. The TLDs were 
heated in the Victoreen reader directly to 350°C and kept at this 
temperature under nitrogen atmosphere for 45 seconds. In the Vinten 
reader, the chips were annealed after readout at 300°C for sixteen 
seconds, under a nitrogen atmosphere. For the physical tests, 10 chips 
were combined to one set where each chip was individually calibrated in 
the 6 MV X-ray beam of a medical linear accelerator (Varian, USA; Clinac 
2100C). In these regular dose response checks, 100 cGy was given to 
the chips at the depth of maximum dose in a solid water (Radiation 
Measurements Inc. RMI, USA) phantom. Each chip was characterised by 
its number in the set and a sensitivity value which relates the individual 
dose response of the chip to the mean dose response of the set (Kron et 
al. 1993). Experiments were performed with pairs of chips. One pair out 
of the set of ten chips was irradiated under standard conditions to a 
known dose of the same order of dose expected for the other TLDs. The 
readings of the other chips were evaluated using the sensitivity values for 
each single chip (Kron et al. 1993). 
Exposures of the TLDs were made in the 6 MV X-ray beam (D 20/D10 = 
0.577) of the linear accelerator using solid water slabs (30 x 30 cm 2) of 
various thickness as phantom material. For X-rays, the accelerator was 
calibrated to give a dose of 100 cGy per 100 monitor units (MV) at the 
depth of maximum dose 1.5 cm (field size 10 x 10 cm 2 , FSD 100 cm). 
The exit dose measurements were performed using a polystyrene slab 
phantom, (30 x 30 cm 2) for three separations, 7.9 cm, 13.2 cm and 18.5 
cm. Clinical black TLDs consisted of a set of 30 chips, machine annealed 
in the Vinten reader. Chips were calibrated for 100 cGy at Dmax for 6 
MV photons, and 660 kv output from an external beam Caesium unit. 
Both individual sensitivity and energy dependence were recalibrated at 
regular 3 monthly intervals. A check of the supralinearity was made for 
each energy used, and regular dose response adjustments were made for 
effects of supralinearity. 
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5. CONTROL STUDIES ON REFLECTANCE UNIT 
5.1 Normal Individual 
In order to test the daily reproducibility of erythema and oxygenation 
indices in a physiological sense. daily readings were taken on four paired 
abdominal points in one normal individual (female, age 40). Each of 
these points were 3 cm from mid-line and spaced vertically (Figure 26). A 
total of 20 consecutive daily readings of erythema and oxygenation 
indices were performed to test the dependency of each of the paired sites 
and their constancy on a day to day basis. 
"Contror 
• • 
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Fig 26 Schematic representation of the control study performed in 
a normal individual showing four paired measurement points 
analogous to the "control" and "test" points performed in the 
experimental situation. 
5.2 Cancer Patients 
In order to assess acute variation of erythema and oxygenation in relation 
to physiological parameters, a further control study was designed. The 
aims of the study were twofold, 
1 To establish whether a radiotherapy field at a distant site (to the 
measurement point) had any demonstrable effect on haemoglobin 
or oxygenation indices. That is, to exclude a possible abscopal 
effect of the radiotherapy. 
2 To demonstrate a possible relationship between haemoglobin, 
oxygenation parameters and other physiological variables. 
(systolic blood pressure, diastolic blood pressure, pulse rate and 
skin temperature). 
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Consenting patients were selected from the normal treatment population 
of the Department of Radiation Oncology, to conform as nearly as 
possible in terms of age, performance status and radiation dose to 
patients on the FLDR and FHDR studies. The important distinction 
between this control study and the FHDR/FLDR studies was that 
measurement points were taken from a single mid-abdominal point which 
was required to be at least twenty five centimetres outside the treated 
radiation field. Measurements were taken under standard conditions on a 
twice weekly basis with each measurement being spaced at five to eight 
minute intervals over a half hour period. Synchronously with each 
erythema and oxygenation reading, the patients' blood pressure, 
respiratory rate, pulse and skin surface temperature adjacent to the 
measurement point (Medtel instruments) was performed. Three males 
and three female patients were enrolled into this study. 
A second series of control studies was performed on patients having 
radiotherapy to abdomino/pelvic sites. On this occasion, measurement 
sites were chosen at a distance from the abdomen in sun-exposed areas. 
Thus, this situation represented the converse of the initial six control 
patients. Again, six patients were enrolled to this second study (three 
males, 3 female). Physiological parameters were not studied in this 
second series. 
5.3 " Artificial Erythema Study" 
In an effort to relate the performance of the reflectance unit to the grading 
ability of various clinical observers, a control study was designed, which 
involved the production of several artificial grades of erythema utilising 
flesh coloured acrylic plates which were superimposed on an arbitrarily 
designated light flesh colour. (to represent background skin) This 
enabled the quantification of reflectance measurements, with a linear 
increase in red pigment concentration and an estimation of the 
performance of the human eye in the arbitrary grading of the erythema, 
both with respect to inter-observer variation and intra-observer variation. 
5.3.1 Tile Construction 
A light flesh coloured "background" tile (20cm x 10cm) was 
constructed by the local Dental Prosthetic Department using two 
standard prosthetic pigments (Ariabel Rose 300504-red and ICI 
Tioxide R-CR6-white). The best approximation to normal non sun-
exposed skin was determined by trial and error by the two clinicians 
involved (CH and JD). This background slab had a 7cm x 7cm 
inset into which could be mounted "test" tiles. Fifteen further test 
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tiles were produced, with incrementally, linearly increasing 
concentrations of red pigment (range 0 - 2 mcg/MI). Erythema 
readings were performed on each of the test tiles. 
5.3.2 Grading Experiment 
Under standard lighting conditions, five clinical observers (two 
consultants, two registrars and research nurse), were asked to 
visually grade the test tiles in succession, using the modified 
EORTC grading criteria from 0 to 2 inclusive. No time limit was 
applied and the clinical observers were not permitted visual 
reference to any other test tiles during the experiment apart from the 
large background "inset tile" upon which the "test file" was laid. The 
grading experiment was repeated a day later in order to test intra-
observer variability. 
6 Data Collection and Statistical Analysis 
All data was transcribed from individual patient data sheets onto a temporal 
database (Medlog, Information Systems Analysis Pty Ltd, California). Data 
quality assurance and descriptive statistics (means, frequency distributions, 
students T-test and Chi-squared tests), were also performed on Medlog. 
(Appendix 3). 
6.1 Analysis of Normal Individual Reflectance Readings 
In order to test for systematic differences in reflectance readings in the 
normal individual in both the superior-inferior and right to left direction, 
pooled means of four points on each day were subtracted and a students 
T-test performed comparing this difference to a constant (0). To assess 
the temporal pattern of reflectance values in the normal individual, two 
methods were employed; 
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1 Control Theory - pooled daily means (for each of eight points), were 
plotted against time and the overall mean ( x ) was also calculated. Control 
limits were taken above and below x as 
3TSD 
A 
	 (17) 
where 
TSD = 1 (SD1 )2 + (SD2)2 + 	(SD8)2 
and SD, 	SD8 equal the standard deviations of pooled daily means. 
2 All single point reflectance data was plotted against time and a 
polynomial smoothing algorithm employed to visualise significant trends 
with time (TableCurve, Jandel Scientific). 
6.2 Analysis of Variables Effecting Erythema Response 
Among the most important readily identifiable physiological factors 
potentially effecting erythema response are age, sex, site of measurement, 
skin type, tanning history and sun exposure. Our data clearly had several 
of these variables strongly correlated with one another. For example, 
males generally tended to have a higher rate of sun exposure and of 
course, sun exposure was also strongly site dependent. In addition, dose-
related factors such as dose rate or dose per fraction were related to some 
of the physiological variables. Potentially important variables were first 
screened using uni-variate analysis. Variables which were significantly 
correlated (or nearly so) with peak erythema index on uni-variate analysis 
were included in a best sub-sets regression analysis (Sigmastat, Jandel 
Scientific). Variables with substantial multicollinearity were excluded from 
the model. The dependent variable (erythema index) also required a 
natural logarithmic transform to satisfy conditions of normality. Treatment 
site was modelled as four separate binary variables to eliminate further 
(artificial) numeric dependence with sun exposure. Other semi-quantitative 
variables (sex,sun-exposure) were modelled as binary or quaternary 
variables (skin type, hair, tanning history). Dose was modelled as the 
Extrapolated Response Dose (ERD) in order to incorporate the effects of 
dose rate/dose per fraction. (a46 = 10, t 112 =0.5 hrs) 
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6.3 Area Under Curve and Curve Fitting Procedures 
The time course of individual patient reactions had cumulative area under 
curve calculations performed in one of two ways; 
1 Trapezoidal rule - in this approach no intrinsic curve smoothing is 
applied and a sum of trapezoids defined by each data point allows the 
area to be calculated. 
2 Peak function cumulative area - in this approach a peak function was 
fitted to each individual patient reaction (Extra Value Function n=94, 
Lorentzian Function n=15). (TableCurve:Jandel Scientific) The curve is 
then integrated to give the area. 
In both methods x-min was taken as 0 and x-max as 80 days. Other data 
curve fitting was performed in TableCurve or SigmaPlot (Jandel Scientific) 
both of which use iterative non-linear regression processes to converge to 
a residual sum of squares. 
6.4 Quantal Analysis Techniques 
6.4.1 Binned Dose Response Plots 
Raw FLDR peak erythema index dose response plots were 
converted to quantal probability plots in the following manner; The 
data set was divided using the median peak erythema index (1.6) as 
a cut point and measured dose data was binned into five to seven 
dose groups with cut points adjusted to ensure each bin included in 
the vicinity of ten to fifteen patients. The probability of response 
was then simply calculated as the probability of patients in each bin 
exceeding the median peak erythema. Standard error bars for each 
data point on the quantal plot, were given by equation 18: 
SE - J P (1-M  N n (1 8) 
where P equals the probability of response; that is of exceeding the 
median peak erythema index and n is the number of patients in 
each dose bin. 
Binned dose response plots for the FHDR and prostate patients 
were derived in an identical manner with a peak erythema index cut 
point of 1.8. 
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6.4.2 Logit Dose Response Curves 
For all iso-effect calculations (F e, de Boer and Tucker plots) dose 
response curves were fitted by converting the peak erythema index 
data into quantal responses using cut points of: 
1.5 (for comparison with Turesson's data) 
1.6 (FLDR data analysis) 
and 1.8 (FLDR, FHDR combined analysis). 
1 
P - 	  
+ e (8 + bx) 
(19) 
A variety of cut points were checked for each data set to test their 
effect on ED 50 values. Quantal plots were fitted using a logit function, 
(19) where P equals the observed probability of response and a and 
b are constants and x is the quantal response. Logit fits were 
derived without dose-binning. 
Modified Fe plots (see equation 15 Chapter 1) were constructed from 
ED50 points derived from quantal logit fits as above. de Boer and 
Tucker plots were derived from the same dose response data 
according the methods described by these authors. (de Boer 1988; 
Tucker 1984) Direct analysis of the data was performed using the 
ABest program on a Fortran Compiler (Nilsson et al. 1990). Effect 
per Fraction vs. Dose per Fraction plots were fitted using Table 
Curve, with a fit forced through the origin. (without dose-binning). 
These plots are displayed with binned data points for clarity of 
presentation only. 
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CHAPTER III RESULTS 
SECTION A 
1 CONTROL STUDIES 
1.1 Normal Individual 
1.1.1 	Erythema Data 
Figure 27 displays the daily pooled means and pooled right and left 
erythema values for 20 working days in a normal female individual. 
The overall mean of the data is 13.15 (standard deviation 2.36). 
Total range of values is from 7.5 to 20.7. It is readily appreciated 
that the daily mean of each of the eight measured points varies over 
a narrower range, from approximately 11 to 16 units. This figure 
also displays the pooled right and left measurement points for 
comparison. This figure suggests a systematic difference between 
the right and left side with right sided values almost always lower on 
average than left. This is confirmed with a Students T-test, (pair 
wise) with a mean difference of 1.26 units (p <0.001). 
Normal Individual: Daily Mean Erythema 
Fig 27 Daily mean erythema over 20 working days (± 1 standard 
deviation). Open symbols denote pooled right and left 
measurement points. 
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Figure 28 displays similar information, with on this occasion, superior 
and inferior groupings displayed with the mean data. Again a significant 
trend between superior to inferior is demonstrated with a mean 
difference of 1.19 units (p< 0.001). 
Normal Individual: Daily Mean Erythema 
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Fig 28 Daily mean erythema over 20 working days (t 1 standard 
deviation). Open symbols denote pooled inferior and 
superior measurement points. 
1.1.2 	Temporal Trends 
Application of control theory to the results reveals that over the 
twenty days studied at no point did daily mean values exceed upper 
and lower control limits. This suggests no significant external 
influence or systematic variation in abdominal erythema values in 
the control subject. A polynomial smoothing algorithm applied to 
the raw data, also suggested no systematic temporal trends to this 
control data. 
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1.1.3 	Oxygenation 
Figure 30 displays mean oxygenation trends for the same individual. 
It is apparent that the range of oxygenation values and their 
reproducibility is substantially less than erythema. The overall mean 
was 17.44 (standard deviation 9.88). The range of values extended 
from -1.8 to 52.3. No significant trends with respect to laterality or 
superior-inferior position nor temporal variation could be determined. 
Normal Individual: Daily Mean Oxygenation 
Fig 29 Pooled daily averages of oxygenation (± one standard 
deviation) over 20 working days. 
1.2 Cancer Patients 
1.2.1 	Erythema Data 
Figures 30 to 33 display raw erythema values (± one standard 
deviation) over a typical four to five week course of treatment for the 
radiotherapy control patients. Each figure describes the time course 
of raw erythema values over a 5-7 week period for each of 3 patients 
per figure. 
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Controls Non-Exposed Females 
Fig 32 
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Mean daily erythema readings for control patients, 
grouped by sun exposure to measurement site and 
sex. Each symbol represents the mean of eight 
values, (± 1 SD) over an half hour period on each 
day on one patient. Figures 31 & 32 represent non-
abdominal measurement sites and figures 33 & 34 
abdominal measurement sites. (Radiotherapy 
delivered to a site distant to the measurement 
point) 
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With few exceptions, these trends show relatively steady state 
reflectance values over a relatively narrow and quite reproducible 
range. This data clearly show differences between individuals and 
suggests that males have higher baseline erythema readings than 
females in both non-exposed and exposed sites. The effect of 
previous sun-exposure on the measurement site is also evident with 
both higher values and greater variability, in contrast to the non sun-
exposed skin. 
1.2.2 	Physiological Relationships 
No relationship between erythema values and any of the 
physiological parameters studied, was able to be demonstrated. 
(systolic/diastolic blood pressure, pulse rate, respiratory rate and 
skin temperature) A poorly defined, but statistically significant 
inverse relationship was found in the cancer control patients, for 
skin temperature and oxygenation (figure 34). 
Oxygenation vs Skin Temperature 
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Fig 34 Skin temperature versus oxygenation for cancer control 
patients (n=6) (r2=0.045) (probability that slope=0, p=0.003) 
(probability that intercept = 0, p=<0.0001). 
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Controls; Oxygenation vs Erythema 
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Fig 35 Oxygenation versus erythema for cancer control patients 
(n=6). 
A relationship is demonstrated in the same group of patients, 
between oxygenation and erythema values (figure 35). This figure 
displays clustering of erythema values for certain patients (cf. figs 
30-35) and patient groups (based on sex and previous sun-
exposure) and an overall positive correlation between oxygenation 
and erythema for the whole control population. 
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1.3 "Artificial Erythema Study" 
Figure 36 demonstrates the relationship between measured erythema and 
concentration of pink pigment used in tile construction. Reflectance unit 
response is evidently linear with pigment concentration, until reflectance 
values of approximately 55 are encountered, when some supra-linearity may 
be present. 
Erythema vs Pigment Concentration 
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Fig 36 Concentration of pink "flesh equivalent" pigment versus 
measured erythema in acrylic tile. (error bars ± 1 SD) 
Figure 37 shows the performance of five clinical observers in grading tiles of 
known pigment (and therefore known erythema) concentration. Clearly the 
range of overlap between grades is substantial, showing that the 
discriminatory power of the human observer in an individual case is limited. 
Figure 38 demonstrates the intra-observer variation of grade assignment and 
clearly suggests an even greater range of overlap between subjectively 
assigned grades of "erythema". 
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Fig 37 Likelihood of observer agreement (5 clinical observers) 
between assigned grade (0-2) and tile pigment 
concentration. 
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Fig 38 Probability of intra-observer agreement (day 1 vs day 
2) for assigned grade (0-2) versus pigment 
concentration. 
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SECTION B FLDR 
2 CLINICAL GRADING OF ERYTHEMA (FLDR) 
2.1 Correlation 
A similar exercise can be performed for the entire FLDR study (919 
synchronous clinical grading and reflectance values). Table 9 reveals a clear 
linear correlation between observed erythema grades and measured 
continuous erythema values. This table demonstrates that females tend to 
have higher measured reflectance values at any given observed grade than 
males and a similar, even more pronounced trend is evident for non-exposed 
versus sun-exposed areas. General linear model regression analysis 
demonstrated that the slope coefficients differed significantly between males 
and females, non-exposed and exposed areas, and between the three major 
site classifications (Table 9) 
TABLE 9 
Groups 
(no. obs) 
RHO i'cept p value slope p value p value 
for 
equality 
of slopes 
p value 
for 
equality 
of 
i'cepts 
All ptts (919) 0.432 1.910 <0.0001 0.219 <0.0001 
Females (290) 0.587 1.235 ., 0.341 . <0.0001 =0.001 
Males (629) 0.360 1.169 ,. 0.162 0 
Non-Exposed 
(278) 
0.643 1.212 n 0.426 . <0.0001 =0.055 
Exposed (650) 0.364 1.173 0 0.153 0 
Site 1 0.267 1.156 0 0.097 " 1 vs 2 
<0.0001 
NS 
Site 2 0.542 1.230 ,, 0.297 " 2 vs 3 
=0.030 
NS 
Site 3 0.610 1.195 " 0.376 ,, 1 vs 3 
<0.0001 
NS 
All ptts 
Oxygenation 
0.077 - NS - NS 
Table 9 General linear model regression analysis of reaction grade versus 
erythema index on the same day in the same patient (n=109)(site 1= 
head and neck, site 2 = upper torso, site 3 = lower torso, site 4 
omitted due to low numbers). 
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2.2 Concordance 
Figure 39 displays the relative frequency of recorded erythema indices at 
patient encounters when any given reaction grade was assigned by clinical 
observers. This figure demonstrates, in common with the artificial erythema 
study, a wide overlap of observed reaction grades in erythema index range. 
This spread of values for any given grade is more marked for the higher 
reaction grades. 
Concordance of Erythema Index with Reaction Grade (all ptts.) 
Erythema Index 
Fig 39 Relative frequency distribution of patient encounters at 
each of four observed grades (n=109). For 
demonstrative purposes, frequency histograms at each 
grade have been fitted with Gaussian functions 
(average RHO 0.65). (Grade 0 - 478 observations, 
Grade 1A - 280 observations, Grade 1B - 143 
observations, Grade 2 - 13 observations). 
3 VALIDATION OF ERYTHEMA INDEX (FLDR) 
3.1 Usefulness of Control Erythema 
Given the reproducibility and close concordance of anatomically adjacent 
points, with respect to erythema readings, the FLDR project utilised an 
adjacent control point just outside the treatment field to account for possible 
variation in baseline erythema during and after the treatment period. 
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3.1.1 	Initial Values 
Again, in common with the normal individual study, a high degree 
of linear correlation was found between the initial erythema reading 
in the test area and initial erythema control readings adjacent to the 
test area (n=109). Linear regression analysis reveals a slope of 
0.827 with a probability that the slope=0 of p<0.001. RHO value for 
the linear regression analysis was 0.811. Mean initial test erythema 
value was 22.4 (t standard deviation of 8.4), and the mean value 
of the initial erythema control was 20.2 (± standard deviation of 
8.44). (difference not significant on T-testing) 
3.1.2 	Inter- and Intra -patient Variation of Control Values 
Table 10 demonstrates the mean control erythema values and 
coefficients of variation at an inter- and intra-patient level for the 
FLDR patients and the 12 cancer physiology control patients. Both 
these groups of patients clearly demonstrate significant differences 
in erythema readings related to both sex and sun exposure of the 
site under consideration. As previously demonstrated, males with 
sun-exposed measurement sites had higher baseline erythema with 
greater coefficients of variation. Both groups of patients 
demonstrated similar intra-patient variability with mean coefficients 
of variation of 12% and 11.9% respectively. 
TABLE 10 
INTER-PATIENT 
VARIATION 
FLDR (n=109) CONTROL (n=12) 
Mean CV Mean CV 
MALES Sun-exposed 20.6a 40% 25 22.3% 
Non-exposed 15.6b 34% 13.1 14.5% 
FEMALES Sun-exposed 17.4c 28.3% 17.5 8.6% 
Non-exposed 14.5d 31.7% 8.1 29.7% 
ALL 19.5 40.5% 16.3 41% 
INTRA-PATIENT 
VARIATION 
Mean CV 12% Mean CV 11.9% 
Range 4 - 30% Range 5 - 24% 
Table 10 
	
Inter- and Intra-patient coefficients of variation 
(CV) for the FLDR group (control readings) and 
the physiology cancer control study group. The 
FLDR group had an average of 8.5 sequential 
readings per patient and the physiology control 
group an average of 62 readings per patient. 
Students T-test for mean erythema values FLDR 
patients; AD<0.001, BC<0.001 and CD<0.001. 
Resutts - 91 
3.1.3 	Effects of Treatment on Control Values 
If all compared test and control values for the FLDR study are 
correlated (n=908), then a less marked but still statistically 
significant correlation exists (slope=0.74, probability that slope=0 
of p<0.001), and a RHO value of 0.602 (p<0.001). That is, despite 
the perturbing effect of treatment, a strong correlation exists 
between each test and control reading. This is displayed graphically 
in figure 40 where pooled data and descriptive statistics for all 
control and test erythema data for each dose-rate group is 
presented. The means corresponding to each dose-rate group for 
both test and control areas are seen to be correlated. Erythema 
values are higher for the 0.8 Gy/h group and the 3 Gy/h group, as 
a consequence of the head and neck treatment sites involved in 
these dose-rate groups. This figure also demonstrates the very 
considerable spread of data for both the test and control sites for 
the FLDR patients. 
The mean control value during and after treatment did not differ 
significantly from the initial value, apart from the patients treated at 
4.8 Gy/hr (p<0.001), where a slight rise and fall of values with time, 
may be noted. ( Fig 41) 
Closer scrutiny of individual control values and their time course, 
revealed that some 23% of patients exhibited a clear tendency 
during their reaction, for control values to mirror the temporal 
pattern of test values. A typical example of this is displayed in 
figure 42. This subgroup of patients revealed no consistent trends 
with respect to sex, age, site, sun exposure, measured dose or 
dose rate in comparison with the parent FLDR group . Linear 
Regression Analysis of peak control erythema index also failed to 
demonstrate any dependence on dose, age, sex, site,sun-exposure 
or melanin. 
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Fig 40 Mean Control (blue) and Test (red) erythema 
values (over time range 0-80 days) +/- one standard 
deviation for each of the dose rate groups 
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Control Erythema Index vs Time (4.8 Gy/hr) 
Fig 41 All control erythema data from start of treatment expressed 
as a normalised erythema index (Transform2, ref: Section4) 
for the 4.8 Gy/h dose group. Peak function fitted for 
demonstration. 
Erythema and Control vs Time (ptt 46) 
Time From Start of Treatment (days) 
Fig 42 Example of control erythema "mirroring" test erythema. 
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4 DEVELOPMENT OF A SUITABLE ERYTHEMA INDEX 
Five separate transformations were applied to measured erythema data in 
order to find an "erythema index" with the greatest utility for data analysis. 
1 Raw erythema values 
E 
El = --I 
E0 
Ell =E —E 
El x Ec 
El2 = 	 
Eco 
5 	El 
El l x EC = 
3 	Eco 
Et = test erythema value at any given time. E0 = initial test erythema. E c 
= erythema control value at any given time. E 0  = initial erythema control 
value. 
Each of these five transformations was applied to three areas of data 
analysis and the results intuitively and mathematically compared to assess 
the utility of each approach. 
1 The time course of each individual patient's reaction was scanned by 
eye for each of the transforms above. Pooled data was also examined 
for goodness of fit of a suitable peak function to the time course data. 
Transform 2 provided the most cohesive plot, with the best fit of any 
given peak function (or by eye fit) in comparison to the other four 
methodologies. All other transformations produced noticeably worse fits, 
broader data spread and lower peak values. 
2 The influence of age, sex, site and sun-exposure on peak erythema 
values was examined using each of the five transformations (linear 
regression modelling). The strongest and most consistent correlations 
were again demonstrated with method 2. 
3 In a similar manner all five transformations were compared utilising raw 
dose response scatter plots. Again, the most coherent data set, with the 
best second order polynomial curve fits were achieved using the second 
transformation method. 
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4.1 Effects of Age, Sex, Sun-Exposure and Site on Initial Erythema (FLDR) 
Univariate linear regression analysis demonstrated that age, sex, sun 
exposure and site all had important influences on the initial test erythema 
value for the FLDR patients. These trends reinforce results from the control 
patients, that is; males tend to have higher initial erythema readings as do 
sites in the upper part of the body. It is self evident that sex, site and sun-
exposure are strongly inter-related, in that males tended to have higher rates 
of sun-exposure and heavily sun-exposed sites tended to be in the upper 
half of the body. Sub-set regression analysis confirmed these observations 
with significant correlation coefficients being demonstrated for sex 
(p=0.0013), site 2 (p=0.0021), site 3 (p<0.0001), site 4 (p=0.0001). Sun-
exposure, age, site1 and initial melanin content were not significant. (site1 
= head and neck, site2 = chest, site3 = lower torso, site4 =pelvis and others) 
4.2 Effects of Age, Sex, Sun-exposure and Site on Peak Erythema Index 
(FLDR) 
Sub-set linear regression analysis revealed age and sun-exposure to be 
significantly negatively correlated with the peak erythema index.(p=0.009, 
p=0.005) Initial melanin content was negatively correlated with peak 
erythema. (p=0.015) Females displayed a higher response. (p=0.03) 
Biologically effective dose (ERD assuming an aii3 ratio of 10 and a repair 
half-time of 1.5hrs.) and the adjacent control erythema were also strongly 
positively predictive of peak erythema index. (p=0.006, p=0.0001) For this 
analysis, site ceased to be significant. Field size was not significant. 
Regression analysis of peak oxygenation index revealed no significant 
influence due to the effects of site, sex, age, dose, melanin or previous sun-
exposure. 
4.3 Effects of Melanin 
Melanin indices were assessed from spectrophotometry readings as a paired 
variable with each erythema index. Melanin index was recorded as an initial, 
peak and final value. Melanin index was found not to be significantly 
associated with initial erythema or skin reaction grade in linear regression 
analysis, however was negatively associated with the peak erythema index. 
In general, melanin indices did not alter in the same dramatic fashion as that 
noted for erythema. There was however, a small but statistically significant 
peak in melanin index in comparison to initial readings. This peak generally 
tended to be at or near the last of the erythema readings (mean pre-
treatment melanin index 21.8 standard deviation ± 12.1, mean peak of 
melanin index 25.1 standard deviation ± 12.7, students T-test p value < 
0.001). 
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5 TIME COURSE OF REACTIONS (FLDR) 
The time course of observed and measured skin reactions  in the FLDR study 
tended, in most instances, to follow a typical pattern. Reactions usually peaked 
between 0.6 and 1.5 months of starting treatment and had subsided completely 
by 1.5 to 2.8 months. Figure 43 displays the time course of reactions for the 
different dose rate groups. The higher dose rate groups clearly peaked higher 
and later than the 0.8 Gy/hr. group. The 0.8 Gy/hr. group reaction also returns 
to baseline well before the higher dose rates. 
Erythema Index vs Time (FLDR) 
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4 8 Gy/hr 	C;yihr 
Fig 43 All FLDR patients reaction plots with time. Curve fits for 
each dose rate group by eye. Error Bars: +1-1 standard 
error. Elapsed time binned in 8 day intervals. 
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In 46% of cases graded skin reactions correlated well with the erythema index over 
the time course of the reaction (figure 44). 
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Fig 44 Typical patient reaction curve demonstrating close matching 
of measured erythema index and observed skin reaction 
grade with time 
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Fig 45 Typical patient reaction plot demonstrating clear rise in 
erythema index prior to observed erythema. 
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In 34% of cases there is a clear rise in the erythema index before any observable 
skin reaction and a return to baseline levels of both parameters simultaneously (figure 
45). This figure also demonstrates a clear dip in the early portion of the erythema 
index reaction plot. This dip was usually noted during the second to third week of 
therapy and was seen in 34% of cases. The dip was not visible to the naked eye. 
In a smaller number of patients (5%), the observed skin reaction clearly occurs before 
any measured erythema response is seen (figure 46). 
Ptt. 91 
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Fig 46 Typical patient reaction plot demonstrating a rise in 
erythema index prior to observed erythema. 
In approximately 15% of cases no correlation between observed skin erythema 
and measured erythema could be discerned. This group of cases tended 
generally to exhibit no typical reaction pattern, with no clear rise or fall of 
measured erythema values. 
6 TLD DOSIMETRY RESULTS (FLDR) 
Figure 47 displays the prescribed skin dose for the FLDR patients versus the TLD 
measured dose. Because prescribed dose was specified to the mid-plane in the 
head and neck patients, there is a consistent 10-15% reduction in the measured 
skin dose versus prescribed mid-line dose. This is not seen in the skin patients 
with only a 1-3% under-estimate of prescribed skin dose versus measured dose 
in the 25-30 Gy region. Above 35 Gy the under-estimate rises to 3-5%. 
Er
yt
he
m
a  
in
de
x  
—4 
 
—3 
G
ra
de
  o
f S
ki
n  
R
ea
ct
io
n  
—2 
 
  
o 
 
 
-(>79' 45 — 
a) 
w o 
a 
V 40 — 
a) 
.ci 
.5 
co Cl) 
0_ 35 — 
25 	i 	I 	1 
20 	25 30 35 
	
40 
	
45 
Results -99 
A second consequence of the parallel opposed treatment field set up in the head 
and neck patients, was that each fraction of treatment was in fact given at two 
different dose rates when considering skin as the target organ. (this of course 
was not the case for mid-line mucosa). Entry and exit dose rates for the skin in 
this group of patients varied again by approximately ±15% from the specified mid-
line dose rate. In the range of dose rates under consideration the dose rate 
effect is expected from the LQ predictions to be relatively minimal and a simple 
linear interpolation between the two dose rates produces an "effective" dose rate 
almost identical to a more formal LQ adjustment 
Prescribed Dose vs Measured Dose 
Measured Dose (Gy) 
Fig 47 Prescribed skin dose to FLDR patients versus the measured 
skin dose for each treatment group. Each treatment group 
is fitted by a linear plot. 
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7 DOSE RESPONSE; DURATION METHOD (FLDR) 
Figure 48 displays the relationship of duration of measured erythema at set levels 
above baseline, with dose. This figure displays a relatively wide spread of data, 
however, all four lines of best fit for each duration display similar slopes. Data 
has been presented on a semi-logarithmic plot for clarity and first order 
regression equations with confidence intervals fitted. The 95% confidence limits 
of 06 and D12 data overlap minimally suggesting these are the best two 
parameters of radiation effect in utilising the duration methodology. 
Examination of durations of measured erythema for each of the different dose 
rate groups revealed closely superimposed lines with similar slope, (excluding 0.8 
cGy/hr which displays a negative dose response plot), suggesting minimal impact 
of dose rate itself on the dose response curve using duration of erythema as 
response parameter over the range of doses in this study. 
Separate dose response curves for males and females (using duration +6 and 
duration +12), display a trend for females to experience higher durations of 
erythema at both the D6 and D12 levels. In a similar manner a trend for greater 
durations of erythema for any given dose was seen in non sun-exposed 
treatment sites versus exposed treatment sites. 
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Erythema Duration vs Measured Dose 
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Fig 48 Semi-log plot of duration of measured erythema  at 6, 12, 18 
or 24 units above baseline for each individual patient versus 
the measured dose. Each duration "grade" is fitted with a 
first order regression equation with 95% confidence limits 
D18 and D24 confidence limits overlap widely and are not 
displayed for reasons of clarity. 
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8 DOSE RESPONSE; PEAK METHOD (FLDR) 
Figure 49 displays the raw peak erythema index data, for individual patients in 
the Head & Neck and Skin treatment groups, plotted against measured dose. A 
clear dose response trend is seen. In common with the duration methods, a 
marked but non significant difference in radiation sensitivity between the sexes 
is shown (figure 50). 
Figure 51 displays the grouped anatomical sites and as indicated in the 
regression analyses, there appears to be an increased radiosensitivity associated 
with responses in site 2. 
Figure 52 displays the apparent increased radiosensitivity in sites which have had 
previous significant UV exposure, however once again the confidence limits of 
these plots overlap. 
Figure 53 displays the raw dose response plots for the individual dose rates 
employed in the FLDR study. Similar overall patterns are seen when compared 
to the duration plots and no coherent separation could be ascertained for any of 
the dose rates employed. 
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Peak Erythema vs Measured Dose 
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Fig 49 Peak erythema index plot for individual patients in the FLDR 
study versus measured dose (head and neck patients - 
circular symbols, skin patients - square symbols). Data best 
fitted by second order polynomial. 
Peak Erythema Index vs Measured Dose 
Measured Dose (Gy) 
Fig 50 Peak erythema index versus dose for FLDR patients by sex. 
95% confidence limits on second order polynomial fits 
overlap significantly. 
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Peak Erythema Index vs Measured Dose 
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Fig 51 Peak erythema index versus measured dose for different 
body site groupings, site 1 = head and neck, site 2 = upper 
torso, site 3 = lower torso, site 4 excluded due to insufficient 
numbers. 
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Fig 52 Peak erythema index vs dose for previously sun-exposed 
and non-exposed sites. 
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Fig 53 Peak erythema index by dose rate for FLDR patients 
against measured dose. 
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9 DOSE RESPONSE; INTEGRAL METHOD (FLDR) 
Dose response plots using the individual patient "area under curve" values 
calculated for each patient using the "trapezoidal rule" and cumulative area 
function respectively were indistinguishable from the peak erythema index 
approach. This was confirmed when the integral erythema values were compared 
to the peak erythema index. Both were seen to be highly linearly correlated with 
an r2 value of 0.83 for the trapezoidal method and 0.74 for the cumulative area 
function method. 
Similar trends were observed with respect to sex, sun-exposure, site and dose 
rate differences in the integral erythema plot methodology when compared to the 
duration and peak methods. 
10 RATE OF DEVELOPMENT OF ERYTHEMA (FLDR) 
Figure 54 displays the relationship of the rate of rise of erythema for the FLDR 
patients plotted against the measured dose. There is only a weak dose response 
relationship and a suggestion that higher dose rates produce greater peak 
values, dose for dose. (cf. figure 43) 
Rate of Erythema Development vs Dose (FLDR) 
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Fig 54 Rate of development of erythema in FLDR patients versus 
measured dose. 
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A more interesting relationship is demonstrated in figure 55, which relates 
peak erythema index in any given patient, to the rate of development of 
radiation erythema. Like the relationship of Peak to Area under Curve, there 
is a clear correlation between these two parameters, with significant linear 
correlation (typical correlation coefficients 0.3-0.5), below rates of 
approximately 0.05 erythema units per day. Although not statistically 
significant, there is a suggestion that higher peak erythema indices develop 
in association with higher dose rates (3, 4.8 and 8 Gy/hr). The only significant 
difference between rates of development of erythema for FLDR patients for 
each of the different dose-rate groups was in comparing the 4.8 and 8 Gy/hr 
group (p<0.05 Kruschal-Wallis) 
Peak Erythema Index vs. Rate of Development of Erythema 
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Rate of Development of Eythema (/day) 
a Dose Rates (3,4.8,8 Gy/hr) • Dose Rate 0.8 Gy/hr 
Fig 55 Peak erythema index for FLDR patients versus their rate of 
development of erythema. Higher dose rates have been 
pooled. First order regression fits through 0.8y/hr and pooled 
group. 
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11 DOSE RESPONSE; QUANTAL METHOD (FLDR) 
The raw dose response data from the duration, peak, integral and peak erythema 
data may be converted into a probability response plot (see section 6 in the 
Materials and Methods section). Figure 56 displays the same data as fig. 53, but 
converted into quantal responses for the peak erythema index (method 2). No 
clear separation of dose response for each of the different dose rate groups could 
be discerned and therefore this figure uses pooled data for all the dose rate 
groups. 
Quantal Response Plot (Peak Erythema Index) 
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Fig 56 	Logit fit through dose-binned quantal responses. (ie. the 
probability of peak erythema index exceeding the median 
value of 1.6, versus dose). (data is pooled for all dose rates) 
Formal logit fitting of un-binned dose response data for the FLDR patients showed 
a negatively sloped dose response function for the 0.8 Gy/h group and marginally 
positive response for the 8 Gy/h group. (figure 57) Only the 3 and 4.8 Gy/h group 
produced reasonable fits with almost super-imposable sigmoid shaped curves and 
an ED50 almost identical to that of the pooled data seen in figure 56. 
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Fig 57 Logit plot of the probability of peak erythema index 
exceeding the median value of 1.6 versus un-binned dose 
for raw data (FLDR). 95% confidence limits displayed for 
the 3 and 4.8 Gy/h groups only .  
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Table 11 summarises the logit fits (RHO values and ED 	for a variety of 
acute erythema reaction parameters for the FLDR patients. This table confirms 
the by eye impression that the peak erythema measure produces the most 
coherent dose response measure. Peak and duration measures based on semi-
quantitative reaction grading consistently failed to produce response plots with 
a positive slope. 
Table 11 
RHO ED 50 
Peak erythema index 0.518 33.4 
Integral erythema index 0.312 35.5 
Duration 6 0.326 32.8 
Duration 12 0.290 36.2 
Peak oxygenation index 0.273 34.2 
Rate of development of erythema 0.110 33.1 
Table 11 	Quality of logit fits for a variety of acute reaction 
parameters for the FLDR patients. 
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SECTION C FHDR 
12 CONTROL ERYTHEMA VALUES 
Intra-patient variability in the FHDR treatment group was similar to that in the 
FLDR group at approximately 14%. (Table 12). Inter-patient coefficients of 
variation were also in the 30-40% range,. It should be noted that the prostate 
patients exhibited an almost identical inter-patient coefficient of variation (33%) to 
the patients in the 5-20 fraction groups despite the wide variety of sites in those 
patients. 
Table 12 
FHDR 
Prostate (n=51) 
FHDR 
5-20 fractions 
INTER-PATIENT 
VARIATION 
Mean CV Mean CV 
Area 1 10.8 33% 16.6 36.8% 
Area 2 14.3 34.7% 
Area 3 14.8 40% 
INTRA-PATIENT 
VARIATION 
Mean Coefficient of 
Variation and (Range) 
Mean Coefficient of 
Variation and (Range) 
Area 1 14% (4%-55%) 14.3% (3% - 55%) 
Area 2 14.6% (4% - 34%) 
Area 3 15.6% (1% - 57%) 
Table 12 Inter- and intra-patient coefficients of variation (CV) 
of raw erythema values for the FHDR group broken 
down into the hair cortical patients (32 fractions) 
and the remainder of the FHDR patients (5-20 
fractions). The prostate patients have an average 
of 13.2 sequential readings/patient and the 
remainder of FHDR patients had an average of 9.5 
sequential readings/patient. 
Figure 58 displays the same data for both control readings and test readings in the 
FHDR patients. In common with fig. 40, there is heterogeneity of control and test 
erythema between groups. Similar causes exist for this variation. (vide infra) 
• 
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Mean Test and Cantrd Erythema (F1-CF) 
5 	r 	I 	I 	I 	1 
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Fraction No. 
• Control Areal 	. Control Area2 	• Caltrd Area3 
• Test Area 1 	• Test Area 2 	• Test Area3 
Fig 58 Mean and standard deviation of all test and control 
erythema values for each of the FHDR groups. Error bars 
are displayed in one direction for clarity. 
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13 TIME COURSE OF REACTIONS (FHDR) 
	
13.1 	In-field Reactions 
In general, the pattern of rise, peak and fall of measured erythema 
values for the FHDR study mirrored that of the low dose rate study with 
the mean rates of development of erythema not significantly different in 
either study. Inspection of the raw erythema index versus time plots for 
each of the fractionation groups (5, 10, 12 and 20), revealed a slightly 
more heterogenous spread of data than the FLDR project. (figure 59) 
This figure also displays a general trend towards later peaks and more 
prolonged reactions with increase in fraction number. The rate of 
development of erythema was clearly higher for the five fraction group 
(0.127 units/day), however, this was not significantly different to any 
other FHDR or FLDR groups. The five fraction group receives, a high 
dose/fraction (median dose 4.4 Gy/fraction) and therefore a greater dose 
intensity/week. Again a subset of the patients also demonstrate a 
pronounced dip in their reactions at approximately 10-14 days from the 
commencement of treatment. 
13.1 	Out-of-field Reactions 
In common the FLDR data set there was a subset of patients who 
displayed interdependence, or "mirroring" of control readings outside the 
field, with the in-field values. This is evident in figure 60 which displays 
plots from area 1 and area 3 in the one patient For the first area there 
is a clear interdependence of the control readings with the test readings, 
however for the second area the control readings remain static while the 
test area demonstrates a typical radiation response. The FHDR out-of-
field reactions peaked significantly earlier for the 5 fraction group, at 
approximately 20 days from the initiation of treatment The rate of 
development of erythema for this group was significantly different to the 
rate of development of erythema for the hair cortical patients and the 20 
fraction group (Kruschal-Wallis test p<0.05). (figure 61) The time 
course of out-of-field reactions in the FHDR patients showed 
considerable heterogeneity, however there was a general trend towards 
later peaks and more prolonged reactions particularly with increasing 
fraction number. 
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Time Course of FHDR Reactions 
0 10 20 30 40 50 60 70 80 90 100 
Days after Starting Treatment 
• 5 Fractions (4.4 Gy/Fraction) 
10 Fractions (3.1 Gy/Fraction) 
• 12 Fractions (3.4 Gy/Fraction) 
• 20 Fractions (2.0 Gy/Fraction) 
• 32 Fractions (0.4 Gy/Fraction) 
Fig 59 Time course of FHDR reactions. Best fits drawn  by eye. 
Error bars: +1-1 standard error. Total duration of treatment 
displayed graphically at the top of the figure. 
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Fig 60 Raw erythema plots of test and control readings over 
two treated areas in one patient Area one has no bolus 
and demonstrates a clear rise in control readings outside 
the field. Area three has full thickness bolus and 
demonstrates no significant change in control readings 
outside the treated field. 
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Time Course (Out of Field) of Reactions (FHDR) 
0 	10 	20 	30 	40 	50 	60 	70 	80 
Days after Starting Treatment 
• 5 Fractions (4.4 Gy/Fraction) 
10 Fractions (3.1 GY/Fraction) 
• 12 Fractions (3.4 Gy/Fraction) 
20 Fractions (2.0 Gy/Fraction) 
Fig 61 Time Course of Control Erythema readings (Out of Field) for 
the FHDR group. Curve fits by eye. Error bars . +1-
standard error.. 
Results-ill 
14 EFFECTS OF AGE, SEX, SITE AND SUN-EXPOSURE (FHDR) 
In general terms, identical trends were noted with respect to both initial erythema 
and peak erythema for the FHDR data set in comparison to the FLDR patients. 
Multi-variate linear regression analysis demonstrated that the initial erythema 
reading was strongly dependant on treatment site (p<0.0001), with sites in the 
lower half of the body displaying both lower initial erythema readings and higher 
peak erythema index readings relative to sites in the superior half of the body. 
Again age was found to correlate negatively with peak erythema index. 
(p=0.0028) Similar trends were seen with the FHDR patients in terms of the 
effects of sex and previous ultraviolet exposure on both the initial erythema and 
peak erythema index however, these co-variates failed to reach significance on 
multi-variate linear regression analysis. The most powerful predictors of peak 
erythema index proved to be the treatment dose (ERD) (p<0.0001) and the 
control value, both of which were positively correlated with peak erythema index. 
Field size (partial area) correlated negatively with peak erythema index. (p=0.015) 
Hair colour, tanning history and melanin content failed to reach significance. Out-
of-field peak erythema indices displayed similar trends, however only age 
reached significance. 
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15 TLD DOSIMETRY RESULTS (FHDR) 
Figure 62 displays the calculated dose versus measured TLD dose for the FHDR 
patients. This plot displays a small (1-3%) reduction in measured dose over 
predicted. 
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Fig 62 Calculated skin doses versus TLD measured doses for 
FHDR patients (n=158 measurement areas). Dashed line 
represents line of unity and the solid line represents the best 
linear fit to the data. 
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16 DOSE RESPONSE PARAMETERS (FHDR) 
This derivation of meaningful dose response data from this group of patients 
proved more difficult in comparison to the FLDR patients. Duration parameters, 
rate of development of erythema and integral measures failed to provide 
meaningful dose response relationships and the peak erythema index proved to 
be the only reliable parameter. Figure 63 displays the raw dose response 
relationships for the 5, 10, 12, 20 and 32 fraction groups. Figure 64 displays the 
same data, binned for dose. 
Figure 65 displays the relationship of the peak erythema index to the rate of 
development of erythema and in common with the FLDR data set, there is a strong 
linear correlation, particularly at lower rates of development of erythema. There 
is a trend to higher peak erythema indices for any given rate of development of 
erythema for the more prolonged fractionation groups (20 and 32 fractions) versus 
the lower fraction numbers. 
Figure 66 displays the logit fits for quantal dose responses for the FHDR patients 
using a peak erythema index value greater than 1.8 as the cut-off point for 
response. This figure clearly demonstrates the more prolonged hyperfractionated 
regimes (20 and 32 fractions) shifted to the left (instead of the right) of the 5, 10 
and 12 fraction data. No fit is applied through the 32 fraction data due to the 
uniformity of dose/fraction. 
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Erythema Index (FHDR) 
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Fig 63 	Peak Erythema Index FHDR patients. 
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Quantal Response Plot (All FHDR Ptts) 
0 
	
10 	20 	30 	40 
Measured Dose (Gy) 
Fig 64 Binned quantal dose response for peak erythema index >1.8 (Error 
bars +1- one standard error) 
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Peak Erythema vs. Rate of Development of Erythema 
Pe
ak
 E
ry
th
em
a  
In
de
x  
6 
5 
• • 	• 
12Fractions 
1 OF ractions 
5Fractions 
0 
0.0 	 02 	 0.4 
4 — 	V 
V 
v 
3 — 
2 — 
Rate of Development of Erythema (/Day) 
Fig 65 Peak erythema index for FHDR patients versus rate of development 
of erythema for each of the fractionation groups (5, 10, 12, 20). 
Each data set has been fitted with a first order polynomial for 
demonstrative purposes only.(32 fraction data superimposable on 20 
fraction data.) 
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Quantal Dose Response FHDR (El > 1.8) 
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Fig 66 	Logit fits for quantal response data for the 
FHDR patients (El>1.8). 95% confidence 
limits displayed for the 5, 10 and 12 fraction 
data. Confidence limits for the 20 fraction 
data extend outside the graph 
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SECTION D FLDR AND FHDR ANALYSIS 
17 COMPARABILITY OF GROUPS 
Table 13 displays the make-up of the FLDR, FHDR patients with respect to the 
previously identified important physiological co-variates (sex, sun-exposure and 
site). Chi-squared analysis reveals significant biases in distribution of treatment 
site for each of the groups. This is principally manifest with respect to the head 
and neck site, with the inclusion of a large group of patients irradiated for head 
and neck cancer with parallel opposed portals. A similar check of imbalances 
between co-variates was performed for the FHDR group. Table 14 displays the 
distribution of the same physiological co-variates amongst each of the 
fractionation groups. Although statistically not significant on this occasion, there 
remain some potential imbalances with respect to treatment site. 
Table 13 
Study 
FLDR FHDR 
Sex 
p=0.64 
Male 73 (68%) 58 (73%) 
Female 34 (32%) 22 (28%) 
Sun-exposure 
p=0.35 
No 33 (31%) 17 (23%) 
Yes 74 (69%) 56 (77%) 
Site 
p<0.001 
1 
Head & Neck 59 (55%) 10 (13%) 
2 
Chest 17 (16%) 35 (44%) 
3 
Abdomen 9 (8%) 31 (39%) 
4 
Hip & other 8 (21%) 4 (5%) 
Table 13 
	
Absolute and percentage breakdown of FLDR and 
FHDR patient groups with respect to sex, previous 
sun-exposure and site groupings. p values refer 
to Chi-squared analysis. 
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Table 14 
Number of Fractions 
5 10 12 20 
Sex 
p=0.58 
Male 9 (60%) 25 (76%) 11 (79%) 9 (64%) 
Female 6 (40%) 8 (24%) 3 (21%) 5 (36%) 
Sun-exposure 
p=0.3 
No 3 (20%) 3 (12%) 5 (29%) 4 (28%) 
Yes 12 (80%) 23 (88%) 9 (71%) 10 (72%) 
Site 
p=0.09 
1 
Head & Neck 0 8 (24%) 0 1 (7%) 
2 
Chest 7 (47%) 11 (33%) 9 (64%) 8 (57%) 
3 
Abdomen 7 (47%) 14 (42%) 5 (36%) 5 (36%) 
4 
Hip & Other 1 (6%) 0 0 0 
Table 14 Absolute and percentage breakdown of fractionation groups 
in FHDR study with respect to sex, previous sun-exposure 
and site groupings. p values refer to Chi-squared analysis. 
17 INDIRECT ANALYSIS 
Figure 67 displays the F e plot for the pooled FLDR data and individual 
fractionation groups for the FHDR patients. ED 5c, values are derived from the logit 
fits for the quantal response data (peak erythema index>1.8). If a linear fit is 
applied to the 5, 10 and 12 fraction and FLDR data then an a/13 ratio in the range 
of 4-10 is obtained. However, from the inset figure, if one assumes the linear 
quadratic predictions are valid then this implies a short VA value of 0.05-0.1 hours. 
The major difficulty arises from the 20 and 32 fraction data which clearly is not 
fitted by a positively sloped linear function through the remaining data point. If 
anything the 20 and 32 fraction data suggest a negative a113 ratio. The poor fit of 
the FHDR data to the linear quadratic model is further confirmed in a de Boer and 
Tucker plot. ( figures 68 and 69) Neither of these plots approximate a linear 
function. 
The entire data set may also be viewed on a "survival curve" plot (figures 70 - 72). 
Figure 70 displays binned FHDR and FLDR data with predicted LQ curves (for 
high dose rate only) superimposed. It is readily apparent that the FHDR data does 
not fit well on any of the LQ predicted curves in the low dose per fraction region. 
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The best R2 value for a linear quadratic fit is 0.21. Fits using a third order 
polynomial (with a negative coefficient on the quadratic term) produces the "S-
shaped" curve with an R2 of 0.89. 
Fe Plot Peak Erythema Index (FHDR & FLDR) 
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Fig 67 Modified reciprocal dose plot for all FLDR (pooled) and FHDR 
patients. Inset refers to the relationship of the ordinate 
intercept (a18) to the t 1/2. (see Section 8; Introduction) Solid 
line refers to a fit through 5, 10, 12 fraction and FLDR data. 
Dotted line represents a fit through 20 and 32 fraction data. 
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de Boer Plot: (FHDR) 
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Fig 68 de Boer plot of FHDR data (peak erythema index > 1.8) 
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Fig 69 Tucker plot for FHDR data (peak erythema index >1.8) 
Reference fractionation group taken as 10 fractions. 
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Effect per Fraction vs Dose per Fraction 
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Fig 70 Plot of peak erythema index per fraction vs dose per fraction for all 
FHDR and FLDR patients (excluding H & N ptts). Data has been binned 
and patient numbers are given for each point. Error bars: +/- 1 
standard error. Predicted high dose rate linear-quadratic curves are 
superimposed for comparison. 
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Figure 71 displays the same data, however, on this occasion with linear-quadratic 
predictions modified for the effective time (assuming a potential doubling time of 5 days 
and a "kick-off" time of 10 days)(no time correction for FLDR data). In this instance, again 
the fit of the FHDR data to LQ prediction is poor, particularly in the low dose per fraction 
region 
Effect per Fraction vs Dose per Fraction 
0 	1 	2 	3 	4 	5 
Dose per Fraction (Gy) 
Fig 71 	Plot of peak erythema index per fraction vs dose per fraction for all 
FHDR and FLDR patients (excluding H & N) with time correction. Data 
has been binned and patient numbers are given for each point. Error 
bars: +/- 1 standard error. Predicted high dose rate linear-quadratic 
curves are superimposed for comparison. 
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Other approaches were sought to explain this poor linear-quadratic fit. Figure 72 
displays the results of a "survival" curve derived from the absolute change in 
erythema units (peak values) rather than a normalised approach. (This transform 
is given in Results, Section 4: Transform 3) Again it is clear that there is a less 
marked but evident S-shape to the dose response function. (R 2 for Linear 
Quadratic fit; 022. R 2 for cubic fit; 0.78) 
Effect per Fraction vs Dose per Fraction 
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Fig 72 Absolute change in erythema per fraction vs dose per 
fraction for all FHDR and FLDR data. Data has been 
binned with patient numbers given at each point. Error bars: 
+/- 1 standard error. 
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In light of the out-of-field effects noted particularly in the FHDR data set, dose 
response data comparing patients having one or multiple test sits was performed 
(this was on the assumption that adjacent bolused areas may have contributed 
to the radiation response in an adjacent unbolused area).(Figure 73) Although 
there may be some tendency for the single areas to show less effect at the same 
dose level than the bolused areas, these data points (along with the prostate 
data) still do not fit the Linear Quadratic function well. (R 2 = 0.31) 
Multiple /Single Test Areas 
0.0 
Prostate Data 
01 	
Single Test Area 
Area i (un - lpolused) with multiple test areas 
I, Area 2 
Area3 
0 	1 	2 	3 	4 	5 
Dose/Fraction (Gy) 
Fig 73 Peak erythema index per fraction vs dose per fraction for 
FHDR patients having one or more test areas. Error bars: 
±1 standard error. 
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18 DIRECT ANALYSIS 
Direct analysis using the ABest program for all patient in the FHDR, FLDR study 
groups produced negative a values and therefore a negative a/13 ratio of -0.9 and 
a t% value 0.23 hours. Positive a/13 ratios could only be obtained by restricting the 
analysis to dose rates above 0.8 Gy/hr (FLDR) and exclusion of the 20 and 32 
fraction data (FHDR) or exclusion of all the low dose per fraction data (FLDR). 
Subset analysis of the FHDR, FLDR groups to confine the FHDR data to the 10 
fraction group only and the FHDR data to single field data only (excluding head 
and neck sites, in view of the possible effect of different dose rates to the skin 
during each treatment) gave an a/13 ratio of 6.9 and t% of 0.06 hours. These later 
figures correspond closely to the direct analytic technique results given in figure 
67. Similarly, ABest analysis of the high dose per fraction data gives an a/13 ratio 
of 7.1 and VA of 0.08 hours. Table 15 displays the a/f3 ratios, VA values and their 
confidence limits for the entire FHDR, FLDR groups and subset analyses. 
Table 15 
Poisson Logistic 
Groups a113 (Gy) t1/2 (hrs) a/f3 (Gy) t1/2 (hrs) 
FHDR FLDR range range range range 
5,10,12,20 all -0.9 0.2 -0.6 0.2 
,32 fx (-2.2 - 2.1) (0.11-1.4) (-2.1- 2.9) (0.11-1.97) 
5,10,12,20 all 7.1 0.08 NC NC 
high d/fx (-3.0- 10) (-0.14-3.2) 
10 fx skin only 6.9 0.06 NC NC 
(NC) (-0.19, 0.31) 
Table 15 ABest maximum likelihood estimates of a113 and t 1/2 for FHDR 
and FLDR study groups and subgroups. Confidence limits 
are indicated in parenthesis where they are able to be 
calculated. 
19 SUMMARY 
• Reflectance spectrophotometry provides an accurate and reproducible 
quantitative measure of baseline human skin erythema. Considerable intra-
patient heterogeneity has been demonstrated with both extrinsic and intrinsic 
physiological factors impacting on initial and x-ray perturbed erythema values. 
These variable include; 
sex - females showing a lower initial erythema but higher peak erythema 
index than males. 
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treatment site - sites in the lower portion of the body having a lower 
initial erythema but higher peak erythema index. 
age - older patients having a higher initial erythema but lower peak 
erythema index than younger. 
sun-exposure - showing identical trends to site, with non sun-exposed 
sites exhibiting lower initial erythema readings but higher peak erythema 
indices relative to sun-exposed sites. 
melanin content - higher initial melanin content of the skin was 
associated with a higher initial erythema reading but lower peak 
erythema index. 
• Reflectance spectrophotometry was significantly more sensitive than a semi-
quantitative grading scale. 
• Reflectance spectrophotometry demonstrated dips (which often extend below 
base-line values) at approximately 10-14 days in a subset of patients. 
• Reflectance spectrophotometry demonstrated measurable reciprocal vicinity 
effects at approximately 3 cm from the field in a subset of patients. 
Reciprocal vicinity effects were demonstrated predominantly in the FHDR 
data set, demonstrated similar time coursed to in-field reactions and were 
most marked in younger patients. 
• Dose time plots were best derived using a normalised erythema index 
approach (E l= Et/ED). 
• Peak erythema index provided the best measure of radiation dose response. 
• Peak erythema index was strongly correlated with the rate of development 
of erythema. 
Rate of development of erythema was dependent on size of dose per 
fraction in the FHDR group and there was a suggestion of a similar 
dependence on dose rate in the FLDR group. 
• Inverse fractionation effects were seen in the FHDR data set resulting in a 
negative a/13 ratio for the entire group of patients. 
• Subset analysis on patients treated at high doses per fraction suggested an 
a/f3 ratio in the vicinity of 7.1 and t 1/2 of 0.08 hrs. 
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• Direct and indirect analytic techniques demonstrated a poor fit of FHDR data 
to the linear quadratic function, particularly at low doses per fraction. 
• The FHDR data was well fitted by a third order function. (negative quadratic 
coefficient) 
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CHAPTER IV DISCUSSION 
1 STUDY DESIGN 
Any clinical radiobiology project which seeks to accurately define the fractionation 
sensitivity (or dose rate effect), in a human population would ideally encompass 
a wide range of doses per fraction (or dose rates) in order to derive a maximal 
data envelope on which to base direct or indirect analyses. Similarly, a wide 
spread of inter-fraction intervals in a data set is optimal to allow modelling of 
inter-fraction repair processes (or intra-fraction for FLDR). A variety of patient, 
physical, engineering and logistic problems inevitably meant that this study 
design represented a compromise between these two competing considerations. 
With regard to dose rate, the 0.8 Gy/hr treatment group represented the only 
dose rate group which would be considered to be in the low dose rate range, with 
3, 4.8 and 8 Gy/hr more conventionally considered to be in the medium dose rate 
range. Treatment times over 5 hours per day are impractical and the dose rates 
selected, represented a range over which it was felt that a dose rate effect might 
be detectable clinically, in acutely responding tissue systems such as skin and 
mucosa. Similarly, in the FHDR group, it was not possible to design a study 
which encompassed a range of dose per fraction sizes beyond the range 50 cGy 
to 550 cGy. 
Patients were accrued sequentially onto a central composite design which should 
minimise selection bias. Differing field arrangements, field sizes and patient 
anatomy inevitably dictated that precise prospective dosimetry could not be 
guaranteed. This has produced a relative lack of dose data in the range 2-3.5 
Gy per fraction. This may have contributed to some of the difficulty in coherent 
separation of dose response curves and later LQ analysis, however one major 
benefit of the clustering of doses under 1 Gy/fraction was that evidence was 
produced for under-prediction of the LQ model for effects at low doses per 
fraction. 
Quite apart from these physical and dosimetric considerations, previously 
published differences in skin response to radiation at varying sites would normally 
dictate that an "ideal" study should confine itself to one skin site. In the context 
of a medium-sized radiotherapy treatment centre, with study patients treated 
palliatively, one is faced with a very limited set of choices. Given that accrual to 
this project required some four years, then selection of an appropriate single site 
for the FHDR study became an impossibility. (apart from the prostate group) It 
may also be argued that derivation of parameters for the radio-responsiveness 
of skin at one site in a select group of patients may have limited clinical 
applicability to the wider arena of therapeutic radiology where a multiplicity of 
treatment sites are involved. A similar argument applies for the heterogeneity of 
important intrinsic and extrinsic physiological co-variates such as sex, age and 
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previous sun-exposure. Given our time again, we would have prospectively 
stratified for these variables, however their importance was not appreciated (or 
published) at the outset of the study. Heterogeneity of the study population with 
respect to all these factors contributed significantly to pre-treatment and treatment 
related inter-patient variability and therefore the quality of both the indirect and 
direct quantal analyses, however on the plus side, did allow for significant new 
quantitative insights to be gained into the effect of these variables on radiation 
response. 
The matrix of total doses and dose rates chosen for the FLDR study were based 
on known linear quadratic predictions and measured skin doses therefore tended 
to cluster reasonably reliably around prescribed doses (prescription point to 
midline for head and neck patients and to Dr„,, for skin patients). This was not 
the case for the FHDR project where prescription points were commonly at depth 
for multi-field setups and a much broader spread of measured doses were seen. 
The other important difference in design between the FHDR and FLDR projects, 
relates to the common use of multiple measurement points within the one field 
in one patient in the FHDR project. (75% of patients had more than one 
measurement point). (see section 1.2 Materials and Methods). This 
methodology was adopted from the outset of the study as a means of generating 
a greater number of dose response points. "Out of field" effects of radiation were 
not appreciated or anticipated at the inception of the study. Similarly, the decision 
to obtain a control reading 3cm. outside of the field was found in retrospect, to 
be of no value in terms of serving as a useful control, however the finding that 
these control points exhibited erythema dose responses which were similar to in-
field responses proved equally valuable in its own right. 
2 DOSIMETRIC CONSIDERATIONS 
The derivation of meaningful dose response curves for a study such as this is 
critically dependant on reliable skin dosimetry. Although parallel plate ion 
chamber measurement can be performed in the in-vivo situation, (Russell et al. 
1994) TLD's represent a more practical solution to the majority of radiotherapeutic 
applications. The TLD results in this study are within the commonly accepted 
range (3-5%) of variation in results using this technique. In both the FLDR and 
the FHDR projects, they correlate well with predicted dose. In both studies there 
is a marginal negative difference in the measured doses versus predicted, 
particularly in the higher dose region (35 Gy +). This may reflect a small under-
adjustment for supra-linearity of TLD response. Alternatively, this observation 
could be due to the reduction in side-scatter and back-scatter occurring with 
irregular surfaces or non-orthogonal patient set-ups, when compared to the 
original phantom measurements, in which the beam incidence is always 
orthogonal and full back scatter conditions exist In order to assess the effect of 
this possible under-prediction of supra-linearity, the indirect analysis of the FLDR 
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and FHDR data was repeated using a +3% supra linearity dose correction at 40 
Gy. This adjustment made no material difference to the dose response curves 
or Fe plots. 
Patients treated in the FLDR study to the head and neck region with parallel 
opposed fields, in effect, received each fraction of FLDR at two different dose 
rates, differing by approximately 15%. Given that the iso-effect curves in the 
dose rate region under consideration are relatively flat, then an average of these 
two dose rates should provide reasonable equivalence with the two actual dose 
rates delivered. Similarly, for multi-field patients in the FHDR study, the 
measurement point may have received two or more, nearly instantaneous, 
contributions from entry, exit and possibly lateral fields over a period of 5-10 
minutes. Again for instantaneous dose rates in the range 100-500 cGy/min and 
an overall fraction delivery time which is considerably less than the expected 
repair half times, then one would not expect any significant biological difference 
than the same total dose delivered in one continuous FHDR fraction to a single 
field. 
Finally, the other major potential physical difference between the study groups 
relates to average beam energy. For Caesium 137 this is 660 kv and for 6 MV 
photons is 3.8 MV. Traditionally the relative biological effectiveness (RBE) of 6 
MV and Cobalt 60 have been assumed to be unity and likewise most workers 
have assumed the RBE of caesium 137 to be equivalent to that of cobalt 60 
(Millar and Canney 1993). 
3 REFLECTANCE SPECTROPHOTOMETRY UNIT 
3.1 The Physical Characteristics 
We found the unit employed in this study to be a robust and reliable 
instrument, capable of highly reproducible data in terms of haemoglobin 
index and to a lesser extent, oxygenation and melanin index on artificial 
surfaces. The measurement technique proved to be simple and independent 
of observer. For baseline readings in unperturbed skin, the haemoglobin 
index showed further variation over and above that recorded for artificial 
surfaces, however, was still relatively low with an intra-patient coefficient of 
variation of 11.9 - 12%. Consistent re-measurement of the same site of skin 
proved readily possible, as did the elimination of the effect of skin blanching 
due to excessive pressure on the skin by the measurement head. 
The unit employed in this study is significantly different in terms of 
methodology to derive a haemoglobin index, to that reported in other studies. 
(Nias 1963; Turesson and Notter 1976; Russell et al. 1994) Previously 
utilised reflectance units assess reflectance at single wavelengths, 
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corresponding to oxy or de-oxyhaemoglobin peak absorbancies. Because the 
total reflectance value for haemoglobin is dependent on the amount of de-
oxyhaemoglobin present, the unit employed in this study derives a 
haemoglobin index via the difference in LIR at 3 isobestic points. 
(wavelengths at which the LIR values of oxy and de-oxy haemoglobin are 
equal), which is a function of the haemoglobin content of the skin, 
independent of de-oxyhaemoglobin. 
Other workers have noted the dependence of measured erythema on 
melanin content (Russell et al 1994; Turesson and Notter 1976) however, the 
present instrument quantitatively accounts for the presence of melanin in 
varying concentrations by a subtractive correction based on a "pigmentation 
index" derived from the slope of the melanin absorbence spectrum at several 
different wavelengths. Oxygenation index as measured by the reflectance 
unit had large intra-patient variation and was found to be of extremely limited 
value in terms of both a baseline measure and in response to radiation. This 
parameter is more closely dependent on blood flow rates in the skin and is 
therefore more analogous to Laser-Doppler measurements, which have also 
tended to display higher variability rates.(personal communication. W. Darr) 
3.2 "Artificial Erythema Study" 
In common with Dawson et al. 1980, we demonstrated a strong linear 
dependence of haemoglobin index values on the concentration of a suitable 
flesh coloured pink powder used for construction of prostheses. The 
concentrations of pigment chosen for the tiles were deliberately selected to 
correspond to realistic shades of erythema seen in the clinical situation. The 
highest concentrations of pigment represented various significant reaction 
grades in an artificial sense and were associated with a supra-linear 
response from the reflectance unit. In both the FLDR and the FHDR studies, 
erythema values rarely exceeded 50 and most peak reactions were more 
commonly in the range of 20 - 40, where supra-linearity. was not evident. 
Given the lack of a translucent reflective surface (forming the wall of a 
reflectance cell) in the tile experiment, then application of these results to the 
human situation must be cautious. Dawson and Feather 1980 and 1989, 
have provided additional evidence for a linear dependence of the 
haemoglobin index on the concentration of haemoglobin by construction an 
artificial reflectance cell from a matt slide, red cell suspension and cuvette, 
in order to simulate the in-vivo situation. For both whole red cells and 
haemolysed cells, they demonstrated a clear linear response over a three 
fold change in concentration of red cells. There is good evidence from these 
and other studies that this reflectance unit reliably measures the "pinkness" 
of human skin but just what relationship this bears to micro-vascular anatomy 
and physiology awaits further study. 
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4 CONTROL STUDIES 
4.1 Normal Individual 
Erythema readings performed daily over eight abdominal measurement points 
in a normal female initially suggested some cyclical variation with a phase of 
some 3 - 4 days. This was not confirmed with a smoothing algorithm and 
control theory suggested that no systematic variations were occurring in the 
data set as a whole. Significant geographical variation in erythema readings 
was noted in a superior to inferior direction in common with Turesson and 
colleagues 1976. They noted slightly decreased erythema values in the lower 
portion of parasternal fields and attributed this to a higher skin sympathetic 
tone in the region. Interestingly this study also demonstrated a significant left 
to right difference in erythema readings. Neither of these trends could be 
attributed to a systematic drift in the reflectance unit associated with warm-up. 
This lateralised difference must therefore be either due to chance or 
lateralised physiological or neuro- physiological processes. Small left to right 
differences in pre-treatment erythema were noted by Turesson & Notter 1984, 
(Dose Rate III) possibly as a result of the previous mastectomy. 
4.2 Cancer Control Patients 
The motivation for the cancer control study on erythema measurements was 
two fold; firstly to detect any systematic trend that may be occurring in 
erythema measurements related to factors other than the radiotherapy 
delivery to the treated site itself. This included possible non-specific 
environmental and or emotional effects, possible effects due to the 
malignancy itself and abscopal effects due to the delivery of radiotherapy at 
a site distant from the measurement site. Patients selected for this study were 
of similar age and were matched for sex and history of ultraviolet history to 
the measurement site. They were however, generally treated with radical 
intent, often in adjuvant settings and therefore represented a different 
biological subset, in terms of their malignancy, to those patients undergoing 
treatment in the FLDR and FHDR studies. Not withstanding, the cancer 
control studies broadly confirmed the same findings as those demonstrated 
in the normal individual. That is, there was usually a clear absence of 
significant temporal trends and typical intra-patient variance of around 10%. 
There were however, two control patients who showed a significant upward 
and downward trend during their course of radiotherapy which proved 
impossible to clearly explain. 
Secondly, this study failed to demonstrate any meaningful relationship 
between erythema index and the physiological parameters of blood pressure, 
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pulse rate, respiratory rate and skin temperature. This finding is probably 
related to the relatively steady state of physiology under which the patients 
were measured. Feather and Dawson 1989 have previously demonstrated 
reproducible changes in the haemoglobin index associated with positioning 
of the forearm at different heights relative to the heart. Raising the forearm 
well above the level of the heart produced a clear drop in haemoglobin index 
and a rise in oxygenation index. Kollias and Baquer 1988 demonstrated a 
clear relationship between measured erythema (reflectance 
spectrophotometry) on the forearm of volunteers related to inflatable cuff 
pressure of a proximal arm pressure cuff. We did observe a significant 
negative correlation of the oxygenation index with skin temperature. This 
may reflect reduced dermal oxygen transfer occurring with altered 
microvascular blood flow (e.g. reduced A-V shunting). Similarly, there was 
clear correlation of the oxygenation index with the erythema index in the 
cancer control patients. This presumably reflects enhanced oxygen transfer 
and blood flow rates associated with greater vasodilatation. 
4.3 Pre-treatment Inter- and Intra-patient Variation 
Of more interest in terms of deriving radiobiological data, is the observation 
that pre-treatment erythema values had inter-patient coefficients of variation 
of the order of 40%. This immediately implies that there are at least several 
possible pre-treatment variables (intrinsic or extrinsic) which impact on 
baseline values (quite apart from x-ray perturbed values). It was readily 
apparent from both uni-variate, multi-variate and generalised linear 
regression analysis that the predominant factors impacting on this inter-
patient heterogeneity were sex, previous significant sun-exposure to the 
measurement site and the location of the measurement site itself. 
Depending on the methodology chosen and the exact number of covariates 
employed, either previous sun-exposure or treatment site proved significant 
on multi-variate linear regression analysis and given their intimate inter-
dependence, it is impossible to meaningfully state that either are 
independently significant. Forward stepwise regression techniques and best 
sub-set analyses allow selection of the optimum combination of co-variates 
and did suggest that site was the stronger of the two. Thus, sun-exposed 
sites in males were found to have the highest baseline erythema readings 
and in turn the highest intra-patient coefficient of variation. At the other end 
of the scale, non-exposed females tended to have considerably lower initial 
erythema readings with a lower intra-patient coefficient of variation. Identical 
patterns of initial erythema variability were seen in both the cancer control 
group and the FHDR group. 
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These findings almost certainly reflect intrinsic micro-vascular anatomy 
associated with previous UV exposure and/or site with probable additional 
effects associated with sex, which may be intrinsic (e.g. hormonal) or lifestyle 
related. High intra-patient coefficients of variation in previously sun-exposed 
sites may reflect impaired micro-vascular homeostatic mechanisms. A further 
possible explanation for the observed baseline erythema difference between 
the sexes, is the known difference in serum haemoglobin concentration. 
A consistent but numerically weak negative correlation existed in both the 
data sets, with respect to age and baseline erythema. Kelly et al. 
(unpublished data 1994) have demonstrated, using video capillaroscopy and 
fluorescein angiography together with Laser Doppler measurements, that 
there was a significant reduction in dermal papillary loops (nutritional 
exchange vessels) in older skin compared to young subjects. This reduction 
was found in both the forehead and forearm suggesting that it may result 
from both chronological and photo-ageing. Sub papillary plexus vessels 
however, were not significantly diminished in the elderly, and they noted 
gross dilatation, tortuosity and disorganisation of these vessels. It may be 
that changes such as this group observed are responsible for the finding of 
a negative correlation with age. 
Anderson and Bjerring (1990) demonstrated significant regional variation in 
erythema measured by reflectance spectrophotometry in six volunteers (5 
males, 1 female). The results closely mirrored the findings of this study. For 
example, an erythema reading of 5.7 was found for the thigh and on the 
cheek 59.5. A gradient of measures between these two sites corresponded 
closely to the measured values of this study. They reported no significant 
differences between identical sites on the left and right side of the body. 
Their measurements also demonstrated a greater coefficient of variance for 
sites in the superior portion of the body which are more commonly sun-
exposed. The cancer control patients demonstrated an intra-patient 
variability of 12% for this reflectance unit, which compares with a value of 
31% reported by Russell et al. 1994. In their study a tri-stimulus colorimeter 
was employed at a single site (post-mastectomy chest wall). This unit does 
not measure haemoglobin concentration per se, rather it assesses the 
colorimetric contribution of any red pigment in the site under consideration. 
Their higher degree of intra-patient variability may reflect technical or 
possibly post-operative factors. 
It therefore seems likely, based on ours and others observations of 
unperturbed erythema values, that a variety of intrinsic physiological and 
extrinsic factors (principally previous significant UV erythema), contribute not 
only to the baseline level of erythema at any given site, but to its degree of 
variation at an inter and intra- patient level. 
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4.4 Defining the Erythema Index 
In common with Turesson and co-workers (1976), we found the most 
valuable measure of erythema change to be an erythema index as defined 
by relating any given value at time t to the initial erythema readings. 
E, = —L 
E0 
This is essentially a simple normalisation technique which will correct for 
baseline inter-patient variation. It has the disadvantage of relatively inflating 
erythema increases with treatment for sites with a low initial erythema value 
over sites with a higher initial value. This of course, assumes that the rise in 
erythema with treatment is independent of the initial starting value.(ie 
depends only on time/dose factors) Several key analyses were reproduced 
using the absolute change in erythema (transform 3; section 3.2) rather than 
the normalised approach. For multi-variate analysis of peak response, nearly 
identical trends were demonstrated for age, sex, site etc., however the dose 
response plots were inferior to transform 2. The Fe plot derived from 
transform 3 produced a somewhat lesser degree of inverse fractionation for 
the 20 and 30 fraction data, but still not sufficient to suggest a linear fit. This 
is seen in the organ based "survival" plot (figure 72) which displays a poor 
fit to the linear quadratic model at low doses per fraction (adjusted R 2=0.21). 
Re-analysis of the data using Turesson's definition of erythema index; 
E, - E0 
= 	 x 100 
E0 
produces identical dose response plots to the previous expression. This is 
not surprising given the mathematical similarity of the two expressions. 
4.5 Usefulness of Control Erythema Readings 
In view of previously published observations and our own expectations with 
respect to intra-patient variation in baseline erythema, we recorded control 
erythema data outside the field (?.3 cms for all patients). Unfortunately, it did 
not prove possible to use symmetrically matched contra-lateral sites for all 
field configurations (e.g. midline axial skeletal fields, head and neck parallel 
opposed pair fields). We had anticipated that a normalisation or subtractive 
correction method would eliminate some of the intrinsic and extrinsic factors 
impacting on intra-patient variability over time. This did not prove to be the 
case, as several different correction methods clearly produced less coherent 
individual reaction plots and often meaningless pooled dose response plots. 
This situation was not improved when control values confined to contra-
lateral sites were considered. In multi-variate regression analyses, both the 
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initial erythema reading at the test site and the peak erythema reading were 
very strongly dependant on the adjacent control erythema reading and in the 
FHDR study, equally strongly dependant on any adjacent test site reading 
(bolused or unbolused). These observations suggest that, as yet undefined, 
intrinsic loco-regional factors (and/or to a greater or lesser extent, extrinsic 
or systemic factors), contribute greatly to local erythema readings over and 
above the perturbing influence. (in this case, x-rays) Although erythema 
readings in the cancer control study patients were relatively stable, in a small 
number, major shifts occurred for uncertain reasons. Whether these shifts 
would be mirrored in other sites in the body (and/or in irradiated fields) must 
await further study. If large local changes in erythema can occur without a 
corresponding systemic change, then this may suggest that the use of 
adjacent or distant control values may be of extremely limited usefulness. 
Our finding, that approximately one third of patients in the FHDR and FLDR 
study had clear rises in control erythema readings outside the irradiated field, 
suggests the possibility of humoral factors mediating an inflammatory 
response and altering capillary blood flow, both inside and outside the 
irradiated field. Nyman 1995 (Thesis), found that bilateral internal mammary 
node irradiation (as opposed to unilateral) was associated with an enhanced 
erythema response, possibly reflecting the same phenomenon. JoIles & 
Mitchell 1947, has suggested that such a reciprocal vicinity effect may occur 
in irradiated human skin. Mortimer et al. 1991, also reported on x-ray effects 
outside irradiated fields in pig skin. He demonstrated reduced dermal 
clearance of 99Tc-colloid between two 4x4 cm 2 test fields, some 8 cms from 
either field. In this instance the authors felt that the likely explanation related 
to the anatomy of lymphatics in the pig, which drain horizontally across the 
flank towards the limb roots. Although no patients enrolled in this study had 
overt skin involvement with tumour, underlying nodal or bony disease may 
also have had local effects on blood flow, influencing basal in-field and out 
of field erythema values. This hypothesis received some support from the 
reflectance data, in that pre-treatment reflectance scores in-field, exceeded 
control scores in approximately 20% of patients (FHDR and FLDR data). 
This difference however, was not statistically significant. 
No significant rises in erythema at distant measurement sites were seen in 
the cancer study control group, demonstrating that the reciprocal vicinity 
effect is likely to represent only a local phenomenon and therefore may not 
be considered as a true abscopal effect. In a small number of patients in the 
FHDR study, it was apparent that the reciprocal vicinity effect was identifiable 
adjacent to one part of the field but not another. Furthermore, it was clear 
from both the FLDR and FHDR studies that only a subset of patients clearly 
demonstrated this phenomenon with a further subset maintaining very stable, 
unperturbed control values and another subset in whom apparently random 
variation of the control values did not permit any clear conclusions regarding 
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interactive effects. Whether the reciprocal vicinity effect is a result of differing 
local physiology or whether there exists a genetically distinct subset of 
"reciprocal reactors" is unknown. 
4.6 Time Course of Erythema Reactions 
In general terms, the onset, peak and recovery of erythematous reactions 
described in this study match those previously published in the literature 
(ICRP 1990; Coutard 1932). The trend towards a more rapid development of 
erythema in the hypo-fractionated data is consistent with the greater dose 
intensity (Gy/week) delivered in those patients. The rate of development of 
erythema showed significant variability, however in both studies tended to 
cluster at somewhere between 0.02 to 0.2 units per day. The observation that 
the 0.8 Gy/hr group tended to display higher rates of development of 
erythema for any given peak, (ie the opposite to the 20 and 32 fraction 
groups) is difficult to explain. Normally hyperfractionation may be thought of 
as biologically equivalent to lowering the dose rate, however in this instance 
it is likely that the low dose intensity (Gy/week) of the 20 and 32 fraction 
groups, produced low rates of development of erythema, and given the longer 
total duration of treatment, physiological mechanisms produced higher peak 
values. This implies time-dependent kinetics of release (or effect) for the 
humoral mediators concerned. This hypothesis is supported by the time 
courses of "out-of-field" reactions, which mirror those of the in-field reactions. 
Alternatively, longer treatment courses may be associated with the release of 
secondary mediators or other pigments (such as melanin) which might 
augment the peak radiation response. 
Reaction durations also showed considerable variation, with longer durations 
usually being associated with higher peak erythema index, higher doses and 
in particular higher fraction numbers (20 & 32 fractions, FHDR group). In both 
studies a sub-population of patients clearly demonstrated a dip in erythema 
values during the evolution of their reaction at approximately two to three 
weeks from the initiation of treatment. A proportion of patients showed quite 
uniform rises and fall without significant "noise" or dips in the reaction at any 
stage. A further percentage of patients demonstrated test sites with no clear 
pattern of rise or fall in their reactions. Despite this heterogeneity in reaction 
pattern, the consistent presence of this "dip" which often extended to below 
baseline values (i.e. erythema index value <1), might suggest the presence 
of a vaso-constrictive influence during the evolution of the erythema reaction, 
or a bi-phasic reaction course. Fowler et al. 1963 demonstrated a dual wave 
of erythema in pig skin experiments. In single dose and five 
fraction experiments, this dip commonly occurred at approximately 
one month from treatment. These experiments employed doses 
and damage levels which were biologically higher than the present 
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study an therefore probably represents a different phenomenon. Hopewell 
1986 also reported on two distinct peaks of erythema seen in the first 16 
week period after pig skin irradiation. Based on isotope clearance studies 
and histological sectioning, Hopewell believes that the first erythema wave 
was indicative of a secondary inflammatory process resulting from the death 
of epithelial cells. Fowler comments that proliferative cell survival is not 
likely to be the only mechanism of damage to skin and underlying tissues 
and that other processes such as modification of vascular supply, could be 
contributing to the total effect. Our data also demonstrate that erythema 
production both in and out of field is clearly a complex event and is highly 
unlikely to be linearly (possibly even monotonously) related to basal cell kill. 
The demonstration of an "inverse volume effect" (ie increasing effect for 
smaller field sizes) in the FHDR data may also have an explanation via the 
same mechanism. That is, fields with bolus (which were necessarily smaller 
as they represented subdivisions of a larger "parent' field) may have "added 
to" the reaction of an adjacent field subdivision without bolus via the 
reciprocal vicinity effect. 
5 QUANTITATIVE VERSUS QUALITATIVE EVALUATION OF ERYTHEMA 
In a large proportion of our FLDR and FHDR patients, the reflectance unit was 
clearly more sensitive in detecting the onset of radiation erythema than the naked 
eye. In both the "artificial erythema study" and the patient data set, there was a 
strong correlation between reflectance values of erythema and semi-quantitative 
reaction grades. Dawson et al. 1980 performed a similar artificial erythema study 
by asking observers to rank five pink tiles of different concentration of red 
pigment. Using a by eye ranking, the average ranking correlation coefficient was 
0.48 (Kendall's tau). In contrast to this, the reflectance unit produced a ranking 
correlation coefficient with an average value of 0.97. The artificial erythema 
experiment performed in this study demonstrated marked inter-observer variation 
in tile grade assignment as well as significant intra-observer variation from day 
to day. This phenomenon was reproduced to an even greater extent in the FLDR 
study where massive overlap of erythema values over assigned grades by eye 
indicated a poor overall discriminative utility of the semi-quantitative scale. 
Despite these problems with concordance of semi-quantitative versus quantitative 
measures of erythema, there remained a reasonable degree of correlation 
between these two parameters in the FLDR data set. Russell and co-workers 
1994, reported a correlation coefficient of 0.33 for redness scores and clinical 
score of erythema in their post-mastectomy population. The nature of the 
correlation between semi-quantitative and qualitative evaluation of erythema was 
significantly dependant on sex, site and melanin index. Both the correlation 
coefficient and the slopes of the erythema index versus reaction grade regression 
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line, were greater for females versus males and non sun-exposed versus sun-
exposed treatment sites. To a large extent, these two factors are related, in that 
females generally tend to have less heavy previous sun-exposure. A similar 
inter-relationship between these variables and treatment site is also inevitable in 
this data set Quite why the eye should perceive sun-exposed sites and females 
as relatively pinker than males and non sun-exposed sites over and above 
reflectance readings is difficult to explain. As this study involved temporal 
variability in erythema, we must presume that the human eye (unlike the 
reflectance unit) cannot reliably recall the pre-treatment erythema and thus must 
rely on an intuitive estimate of previous erythema, erythema in the skin 
surrounding the treated field or untreated skin on a contra-lateral matched body 
surface. Any number of objections and possible biases may render these 
intuitive estimates or matching processes invalid. 
The second major difficulty with semi-quantitative grading scales, results from 
the situation where one observer is uncertain as to whether a subtle skin reaction 
may be present. For this study we adopted a policy of specifying the quantal 
grade above that level of uncertainty, however, this is obviously open to criticism. 
Daniels and lmbrie 1958, discussed these problems in considerable detail and 
concluded that the human eye is an excellent device for sensing a quantal event 
but is inadequate in delineating graded differences of erythema or most 
importantly, changes over time. Dutreix and colleagues (1973), successfully 
utilised this quantal discriminatory ability to produce a dose response curve for 
human skin with relatively small patient numbers. 
6 THE EFFECT OF MELANIN 
The doses employed in both the FLDR and FHDR studies were not significant in 
terms of producing visible (to the naked eye) pigmentation. Reflectance readings 
however did discern a small but statistically significant peak in melanin values of 
approximately 10-15% over baseline. This peak is considerably lower than 
values measured by Turesson and colleagues and appeared to exhibit no 
consistent effects on multi-variate linear regression analysis apart from being 
positively correlated with initial erythema in the FHDR patients. This presumably 
reflects the higher sun exposure of these sites. Future in-vivo reflectance 
research could usefully concentrate on the possible effect of melanin on the 
measurement of the haemoglobin value, as variation in melanin either between 
sites or over time might critically effect response data. (UV or X-ray) The melanin 
index did however, appear to influence the perception of erythema by eye, in that 
skin in those regions with higher melanin indices tended to be assigned higher 
reaction grades. This supports the hypothesis that semi-quantitative subjective 
evaluation of erythema takes into account many other factors over and above 
simple skin redness. For example, it is possible that subtle changes in skin 
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texture, skin oedema and distribution of early erythema (e.g. pen-follicular), may 
also influence grading of skin reactions. 
7 INFLUENCE OF PHYSIOLOGICAL VARIABLES ON PEAK ERYTHEMA 
7.1 Piffalls of Multivariate Linear Regression Analysis 
In a noisy data set such as found in this study, the limitations of this 
technique should be considered. If 20 co-variates are tested, then one will 
often show significance (at a conventional level of p<0.05) purely by chance. 
A more rigorous test of significance in this situation is to divide the selected 
"significant" p value by the number of co-variates. In this instance the 
melanin content ceases to be significant for initial and peak erythema and 
field size likewise, for peak erythema. The effect of sex is retained for initial 
erythema, but lost for peak values. Several of the variables involved in this 
analysis were discrete, (eg. site, hair colour, sun-exposure) and are best 
considered by reduction to binary variables.(ie yes/no for each separate 
grade ) If all are reduced in this way however, then the number of significant 
results, arising purely by chance, is increased. Other problems with the data 
set included non-normal distribution of the dependent variable for the FLDR 
patients (this related to a small number of outliers) and frequent multi-
collinearity of co-variates. Best-subset regression analysis represents a 
method in which it is possible to select the best number of strongest co-
variates for the development of a model. Ultimately a judgement based on 
strong uni-variate relationships and plausibility was combined with the linear 
regression results. 
7.2 Physiological Variables 
Apart from the effects of sex and measurement site on baseline erythema, 
our study has clearly demonstrated a dependence of peak erythema index 
on these and other factors. Tucker et al. (1992) hypothesised that patient 
characteristics such as age and smoking habits influenced the physiological 
response to radiation exposure. Our study demonstrated that treatment site, 
sex and age all influence the value of the peak erythema index. When 
analysed separately, previous ultraviolet exposure to the treatment site was 
also strongly negatively correlated with peak erythema index. Although this 
factor was not significant on sub-set analysis, this may simply reflect the 
small numbers involved in the study or the fact that previous sun-exposure 
was modelled as a single binary response and treatment site modelled as 
four separate binary responses, thus artificially increasing the probability of 
a significant result for treatment site over previous sun-exposure. Other 
authors have noted differences in erythema response to ultraviolet light with 
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body site. (VVesterhoff et al. 1986). Rhodes and Friedmann 1992 
demonstrated a significant difference in MED for UVB radiation of buttock skin 
in comparison to the mid-back for 36 dermatology patients and normal 
volunteers. They could not explain this finding on the basis of any difference 
in baseline erythema readings and postulated that differences in visual 
perception, epidermal thickness, mast cell behaviour, melanin concentration 
and blood flow might explain their observations. It would be expected that 
less sun-exposed sites, such as the buttock should have a lower MED, 
paralleling the observations in our study, with x-irradiation. In several patients 
treated in the FLDR study, where treatment fields spanned a de-colletage 
area, .a clear difference in visual erythema response was noted, suggesting 
that previous ultraviolet exposure may be acting, in addition to the effect of 
treatment site, in determining peak erythema index. No quantification of the 
effect of previous ultraviolet exposure on radiation response has been 
published in the literature, although the ICRP noted, (1990) that it is common 
practice for some radiotherapy departments to reduce the dose by 
approximately 10% for heavily sun-exposed areas. This is at odds with our 
findings, in that sun-exposed skin exhibited, on average, a lower peak 
erythema index reading. In arriving at a dose reduction recommendation, 
clinicians may in fact be observing end-points other than erythema (e.g. 
marked early inflammatory response which surrounds pre-malignant solar 
damage with radiation). Nyman 1995, (Thesis) demonstrated that older age, 
post-menopausal status and higher blood pressure were associated with a 
greater erythema peak. This is in contrast to our finding, of a negative 
correlation with age. This may be due to the fact that only internal mammary 
fields were used in that study, without any significant previous sun-exposure. 
That is, age may be acting as a surrogate variable for sun-exposure in our 
study. In common with our observations, he also found that pre-treatment 
erythema values were negatively correlated with the peak score. Clearly 
further studies are required to better identify the effects of factors such as 
those identified above and to quantify their contributions to inter- and intra-
patient heterogeneity of radiation response. 
DOSE RESPONSE DATA 
8.1 FLDR 
Although several different individual patient reaction parameters proved 
capable of generating dose response data from the FLDR study, peak 
erythema index proved to be the most robust parameter with respect to 
goodness of logit or even linear fit. This is in keeping with the observations 
of Turesson and others. Russell et al. 1994, utilised the rate of development 
of radiation erythema, however, was unable to generate a meaningful dose 
response function from relatively low patient numbers (n=44) and a low 
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range of doses per fraction and total dose. Duration parameters, area under 
curve and rate of development of reaction all correlated strongly with the 
peak erythema index. Rate of development of erythema in the FLDR 
patients was only weakly, positively correlated with measured dose, although 
there was a suggestion that for any given rate of development of erythema 
at the lower end of the low dose rate spectrum, a lower peak erythema index 
was reached in comparison to the higher dose rates employed in the study. 
The association of lower peak erythema indices for any given rate of 
development of erythema for the lower dose rates, may however, simply 
reflect the known sparing effect as the dose rate is lowered. Dose for dose, 
it did not prove possible to separate out the separate dose response curves 
for each dose rate in the FLDR study due to widely overlapping confidence 
intervals. Given the LQ predictions for the existence of only a modest dose 
rate effect over the range 0.8 to 8 Gy/hr and the significant inter-patient 
heterogeneity in this data set it is perhaps not surprising that this study failed 
to demonstrate a dose rate effect. Experience gained in the companion set 
of observations to this study, (semi-quantitative mucosal observations) 
(Appendix 4) indicated that a clear and coherent separation of separate dose 
response plots at different dose rates could be achieved. On that basis and 
having identified several of the major extrinsic and intrinsic causes of inter-
patient heterogeneity, the FLDR peak responses were corrected (on the 
basis of the derived coefficients from the regression analysis) for the possible 
effects of age, site and sex. This did not improve the discriminatory power 
of either separate dose rate quantal plots or indeed allow a better logit fit for 
the pooled data. 
The dose response plots for the 0.8 Gy/hr and 8 Gy/hr groups were 
negatively and marginally positively sloped respectively. This is indicative 
of the amount of noise in this data set and clearly requires greater patient 
numbers and possibly restriction of treatment site and technique in order to 
improve dose response coherence. Because of this inability to separate out 
dose response plots for each of the dose rate groups data was pooled for 
comparative analysis with the FHDR group. 
It is of interest to note that no reaction parameter related to the semi-
quantitative skin observations produced a meaningful dose response 
relationship. This must cast doubt on the ability of clinicians to reliably detect 
dose differentials in the order of 10 - 15%, from observations on skin in a 
day to day clinical setting. This has recently been confirmed in both 
radiation underdose and overdose incidents in the UK. (Ash & Bates 1994; 
Tobias 1992) where dose differentials of this order of magnitude occurred 
undetected over several years. 
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8.2 FHDR; Inverse Fractionation Effects 
Dose response plot for the FHDR group (figures 63) clearly demonstrates an 
unexpected shift of the 20 and 30 fraction data to the left of the curves for 
the 5, 10 and 12 fraction data. As a complementary display method, dose-
binned quantal response plots were also constructed, as the logit fits to 
quantal data do not display the raw distribution of values (figure 64). The 
binned quantal dose response data for FHDR patients again reveal the 
unexpected finding of higher responses at low doses per fraction for the 20 
and 30 fraction data set, but not for the 5,10 and 12 fraction groups. 
As a check of the validity of the dose binning procedure, individual dose bins 
in each of the studies were surveyed to exclude excessive skewness of dose 
distribution. This was noted in two dose bins in the FHDR study, however 
adjustment of the selected median values did little to alter the final plots. In 
addition, the quantal plots were constructed using several different cut points 
for peak erythema index (1.5, 1.6, 1.8). Again these procedures did little to 
alter the relative relationships of the data in each of the final plots. Although 
the 95% confidence limits for the 5, 10, 12 and 20 fraction groups are widely 
overlapping there is a clear reversal of the traditional left to right order of less 
fractionated to fractionated data. This observation is further strengthened by 
the 30 fraction data point, which in contrast to the 5, 10, 12 and 20 fraction 
groups, represents a single body site with highly uniform skin dosimetry. 
In endeavouring to explain these aberrant results, several checks were made 
on the data. Firstly, patients having only one (rather than two or three) 
measurement sites were assessed, however limited numbers permitted no 
definitive dose response conclusions to be drawn in the 5 and 12 fraction 
groups. For the 20 fraction group there was no difference, dose for dose. For 
the 10 fraction group there was a slight suggestion that the 'single' area 
curve was shifted to the right.(ie less effect dose for dose) Although the 
reciprocal vicinity effect might explain some of the aberrant fractionation 
observations seen in this study, figure 73 still indicates a substantial under-
prediction by the LQ model for observations where the reciprocal vicinity 
effect could not be operating. (30 fraction group and single test areas) 
Secondly, the data was checked for any significant differences in distribution 
of sex, sun-exposure, site and age with respect to the different fractionation 
groups. Apart from the greater presence of head and neck sites in the 10 
fraction group, no significant differences were found and exclusion of the 
head and neck patients from the 10 fraction group made no material 
difference to the dose response curve. 
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9 ANALYTIC TECHNIQUES 
9.1 Fe Analysis 
This study employed a modified F e plot analytic technique which was 
originally proposed by Scalliet (Thesis). This report has further adapted 
Scalliet's technique by utilising the incomplete repair equation for fractionated 
low dose rate radiotherapy from Dale et al. 1988. Since the dose rate 
modifying factor K depends on both a/I3 and p, then the modified Fe plot 
methodology should be capable of deriving an a1I3 ratio for the data set 
when a value of p is selected which produces the best linear arrangement 
of data points. It is clear from the Fe plot relating to this study, (fig 67) that 
the data in no way approximates a straight line. If the 20 and 30 fraction 
data is considered alone, then a negative a/I3 is suggested and conversely 
if it is excluded from the data set, then there is a reasonable approximation 
to a positive a/I3 in the region of 4-8, implying a very short t1/2 value (<0.15 
hrs). This short tY2 is not consistent with results from other human or pig 
data (table 16). The poor fit of the FHDR data to the linear quadratic formula 
is further supported by the Tucker and de Boer plots, where again non-
linearity is clearly evident. 
9.2 Direct Analysis 
ABest analysis of the whole data set (5, 10, 12, 20 and 30 fractions) 
produced negative a values and therefore negative a/I3 ratios. This was not 
unexpected, due to the inverse fractionation effects seen in the raw quantal 
dose response plots. Of interest, the calculated repair half-times in these 
data sets still remain relatively low. Figure 74 displays the predicted fits for 
the entire data set and graphically demonstrates this effect in the low dose 
per fraction and low dose rate range. In this instance, a negatively sloped 
dose per fraction response for the FHDR data in the low dose per fraction 
range is conceptually implausible. (ie. greater effect, dose for dose as 
fraction size reduces is unlikely) 
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Erythema Index/Fraction vs Dose/Fraction (FHDR) 
• 5fx 	• 10fx 	• 12fx 	V 	 • 32fx 
Fig75 Peak Erythema Index per Fraction vs Dose per fraction. Raw data for all 
the fractionation groups fitted with third order polynomials. Solid black 
line represents the fit for the whole FHDR data set. with equation given. 
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TABLE 16 
Author a/I3 ratio Repair half time 
(hrs) 
Comments 
Turesson 18 - 34 
7-11 
0.3 - 0.4 
1.1 - 1.3 
long tmt duration 
short duration 
Overgaard 10 - 
Bentzen 12 - post- mastect 
Wambersie 15 - 
van den Aardweg 3.5 0.27 ( At = 0.25) 
1.4 	( At = 4) 
pig 
3 fractions 
Chougule 9.1 - 9.3 
7.5 - 7.9 
- 
- 
mild erythema 
intensive 
Trott 4 - Roentgen 
Table 16 	Reported cdP and VA parameters 
An additional problem in fitting our data to the LQ model is that the repair 
half time for acute erythema must be under 0.15 hours for an a/13 ratio to be 
positive and in the range 4 - 8. 
The LQ model assumes a mono-exponential repair model for the FLDR 
patients and complete repair between fractions for the FHDR patients. 
Turesson has found evidence of a bi-exponential repair process operating for 
acute effects in human skin. This may explain the very short repair half-
times suggested by our data, in that it may only be the fast component of a 
multi-component repair process which is being measured. In addition, it is 
possible that the repair processes themselves are fundamentally influenced 
by dose rate. That is, repair mechanisms may be relatively saturated at high 
dose rate versus the low dose rate situation. Alternatively, repair processes 
may be different in the inter-fraction time period for the FLDR patients with 
respect to intra-fractionation repair processes. The modelling of these 
potential repair processes during and between low dose rate fractions must 
await further studies. 
In summary, the inverse fractionation effects seen in the FHDR data set may 
have three possible explanations; 
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9.3 Study Design Flaw 
An intrinsic study design flaw (ie. utilising individual patients, for two to three 
separate measurement points) could potentially enhance the effect of inter-
patient heterogeneity, (by smaller effective patient numbers) and dilute the 
ability of the study to produce unique dose response curves. This is unlikely, 
as the composition of the 5,10,12, and 20 groups was similar for the 
important variables affecting radiation response. That same design flaw 
might potentially cause enhanced reactions at low doses per fraction via the 
reciprocal vicinity effect. This hypothesis is difficult to support, as the 30 
fraction data clearly reinforce the trend seen in the other fractionation groups, 
and this group represent a totally homogeneous set of observations, with 
respect to site, sex, dose and sun exposure. 
Another possible explanation for the inverse fractionation effect, is that we 
are measuring responses in the very early part of the sigmoid response 
curve and that noisy response data could be expected to produce an 
enhanced effect in one or two groups by chance alone. Again, this is difficult 
to reconcile with the quantal responses of the 5 and 10 fraction group, which 
are minimal in the low dose region. If the problem were just due to 
experimental error then one would expect this to be seen across all groups. 
As all the low dose per fraction data was derived from un-bolused fields, it 
is possible that large dose gradients across the dermis and epidermis could 
explain the results. If one assumes that the target depth for radiation effect 
is 3-5 mm. rather than 0.07 mm. then the effect per fraction curve would fit 
a quadratic function quite nicely. We are unaware of any suggestion that the 
target site for radiation effects in the skin might be dermal or sub-dermal. 
9.4 Physiological Theory 
A further possibility is that there exist physiological process(es) which are 
more pronounced in a prolonged course of radiotherapy, (ie 20 and 30 
fractions) resulting in greater erythema per total dose, than in shorter 
courses. Alternatively there may be a substantial physiological "threshold" 
which is exceeded only in the more prolonged courses. The finding that the 
prolonged courses were associated with higher peaks, for any given rate of 
development of erythema is also be consistent with this theory of time 
dependent erythema kinetics. However, this is not as plausible when the 
effects of time are accounted for, in the effect per fraction vs. dose per 
fraction plots. In this situation, the fraction number is equivalent to the total 
time of treatment. (This is not strictly the case, as treatment was given only 
5 days per week, however this does not affect the results.) Figure 75 
indicates that there is a gradation of inverse fractionation effects across the 
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groups. The 5 fraction group exhibits the greatest deviation from the LQ plot 
and the 20 fraction group, the least. (When this is translated to a dose 
response plot however, the multiplying effect of the fraction number en" 
produces a much more marked left shift in the 20 fraction group over the 5 
fraction group) 
The application of the linear quadratic model to whole organ systems such 
as the skin requires the assumption that iso-effect always equates with iso-
survival of the putative target cell. Nyman & Turesson 1994, has 
demonstrated (n=11) that accelerated fractionation is not associated with a 
greater or more rapid basal cell depletion than conventional treatment, 
despite a more rapid (but no more intense, erythema reaction). This is in 
contrast to clinically observed endpoints in mucosa where reactions are more 
rapid and severe with accelerated treatment. (personal comm. Prof J. 
Denham, re: Trans-Tasman Oncology Group Phase Ill Trial; Accelerated 
vs.Conventional Radiotherapy for Head and Neck Cancer) Whether this 
reflects a difference in cell cycle kinetics for skin vs. mucosa is unknown. 
Given that measured erythema is a complex end-point subject to a variety 
of physiological parameters, then the question must be asked as to whether 
iso-effect may indeed not necessarily relate to iso-survival. If for instance, the 
degree of measured erythema relates to the rate of basal cell kill and 
therefore the rate of release of any humoral mediators rather than the net 
cell kill, then this may render the application of the traditional LQ formalism 
invalid. Thus, studies such as these may in fact be measuring the 
"fractionation" sensitivities and "repair" capacities of physiological 
mechanisms rather than target cell kill per se. Further investigation of in-vivo 
cellular end-points, such as the hair cortical cell technique or basal cell 
density estimation (Nyman and Turesson 1994) may alleviate these 
problems. 
9.5 Radiobiological Theory 
Figure 75 displays the raw effect per fraction vs. dose per fraction data, with 
groups individually fitted by third order functions All groups show the "S" 
shape, however this effect is most marked in the shorter fractionation groups. 
Joiner et al (1993) have reported on radiation response to very small doses 
per fraction (FHDR) in mouse skin, lung and kidney via neutron top-up 
experiments. They showed that the LQ model significantly under-predicts 
for both acute and late effects, at fractional doses less than 0.6 Gy. Our 
data was also well fitted by the "Induced Repair Model" of Joiner et al. They 
suggest that this under-prediction may be due to the induction of repair 
mechanisms at higher doses per fraction. It is possible that our observed 
inverse fractionation effects (at low doses per fraction) may reflect the same 
phenomenon although this appears to start at doses of approximately 1.5 Gy 
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in our data which might argue against this conclusion. Joiner even suggests 
that a negatively-sloped dose per fraction response curve (figures 74 & 75) 
might be possible, if the magnitude of this effect were high enough. They 
also reported that this effect is more pronounced in shorter courses. (30 vs 
20 fractions in mouse skin and 20 vs 40 fractions in mouse lung) Although 
our data also displayed this trend, this may simply have been due to the 
numerical effect of the fraction number "n", in its own right. 
Alternatively, the inverse fractionation effect may represent greater cell kill 
per fraction, developing during the more prolonged courses. This implies a 
change in LQ coefficient(s) for longer total treatment times. In this dose per 
fraction range, this will be mainly due to a change in a. Turesson found no 
evidence for an increase in a with prolonged treatment time in her analysis. 
(Turesson and Thames 1989) 
It is also possible that re-distribution of target cells into a more sensitive 
phase for the more prolonged treatments could explain the results. However 
the difficulty here, is that re-distribution would have to be confined to the low 
dose per fraction treatments only. This hypothesis is also difficult to support 
in viewing the time course of the 20 and 30 fraction data. One would expect 
a slower rate of development of erythema to be seen until recruitment 
occurred. (say at 2-4 weeks from start of treatment, Hopewell and van de 
Aardweg 1991; Turesson and Thames 1989) In fact, we see a constant rate 
of rise of erythema right from day 1. 
9.6 Relationship to Other Reflectance Data 
A comparison can be made with some of the sub-series published by 
Turesson where her data covers the same total number of fractions, fractions 
per week and fractions per day. This has included CREll (total number of 
fractions 10, dose/fraction 2.39 Gy), CREVII, (total number of fractions 20, 
dose/fraction 1.74 Gy), CREVIl b (total number of fractions 20, dose/fraction 
1.83 Gy), CREVIl b (total number of fractions 20, dose/fraction 1.83 Gy) and 
30 fraction data derived from a variety of series of longer duration. 
(Turesson and Thames, 1989) For this analysis, Turesson used an endpoint 
of a 50% increment in base-line erythema for the peak and our data is 
plotted in this fashion in figure 76. There is a marked disparity between 
dose response points for each of the data sets. Our FHDR data set 
displays shallower dose response plots. Whether this is a function of overall 
patient heterogeneity or differing responses of the reflectance units involved 
or both is impossible to say. Informal comparison of the response of the 
Gothenburg unit to ours, using "pink tiles" demonstrated that it displayed a 
greater "erythema" response than the Gothenburg probe. 
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No published reflectance data exists for fractionated low dose rate 
radiotherapy, however one of the series published by Turesson & Notter 
(Dose Rate III) may give some approximation of the dose rate effect as 
demonstrated by our data. In this experiment, weekly fractions of 7.2 Gy 
where given as 1 continuous fraction over 4 minutes or divided up into 3 
subfractions given at 15 minute intervals over a total delivery time of 32 
minutes. In crude terms this corresponds to a dose rate delivery of 14 Gy/hr. 
Turesson demonstrated a relative biological effectiveness for the prolonged 
treatment in relation to the short treatment time of approximately 1.1 for 
erythema. A similar RBE value maybe obtained by comparing our 10 
fraction FHDR data with pooled FLDR data. Unfortunately, the dose per 
fraction used in our study did not exceed 5.5 Gy and therefore a direct 
comparison cannot be made, however at 4 Gy per fraction, an RBE of 1.25 
has been observed for our data, which given our median dose rate of 4.8 
Gy/hr for the FLDR group, is consistent with Turesson's observations. 
10 FUTURE RESEARCH DIRECTIONS 
Monitoring of radiation effects using complex endpoints such as erythema, in 
humans clearly requires a greater level of understanding of the mechanisms of 
erythema, humoral mediators of erythema and a better understanding of the 
extent of and reasons for inter- and intra-patient variability in radiation response. 
Little is known of the mechanisms of production of these various humoral factors 
in relation to ionising radiation. Young and Hopewell 1982 in isotope studies of 
irradiated pig skin, believed that the observed erythema was secondary to 
inflammatory processes relating to epithelial death. Physiological modulation of 
the expression of radiation damage may occur at a number of levels. 
Inflammatory mediators such as the ecosanoids and related compounds, TGF, 
TNF and other cytokines (Anderson et al. 1989; Black 1987; lmokawa and Tejima 
1989; James et al. 1991; Kelfkens et al. 1990; Pentland and Jacobs 1991; 
Pentland et al. 1990) are likely to be involved in the expression of erythema. 
Hopewell et al, 1993, demonstrated that certain unsaturated essential fatty acids, 
which are known to be precursors of the ecosanoids, are able to modulate skin 
reactions to radiotherapy in the pig. Two essential fatty acids (gamma-linolenic 
and eicosapentanoic) where tested and found to produce amelioration of the 
erythema and/or moist desquamation component of the skin reaction, if 
administered during the time course of expression of the radiation damage. Other 
mediators such as histamine and epsilon amino caproic acid may also be 
involved in the production of erythema via altered vascular permeability (Eassa 
et al. 1973). From work performed in relation to ultraviolet induced erythema 
(Kelfkens et al. 1990) there is considerable evidence to indicate that a vaso-
active mediator released from the epidermis, diffusing into and around dermal 
blood vessels, represents the most appropriate model for the generation of UV 
induced erythema. Further studies assessing the nature and kinetics of release 
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of these secondary mediators are required to better elucidate the link between 
cytology and physiology. Our observations regarding the higher peak erythema 
indices noted in females may relate to enhanced vascular reactivity secondary 
to hormonal effects. Larger clinical studies, directed at other acute and late 
endpoints (and tumours) are required to confirm a sex difference in radiation 
response. The negative correlation of peak erythema index with age may reflect 
reduced vascular reactivity associated with degenerative micro-vascular disease 
or possibly ageing effects due to cumulative ultraviolet exposure. Normal tissue 
radiation response in the elderly also requires further systematic study. 
It is appropriate that future research aiming to model radiation effects in humans, 
utilises endpoints which are functionally and temporally closer to the presumed 
target cell in the skin. Techniques such as basal cell density counting (Nyman 
and Turesson 1994) and hair cortical cell counting (Potten et al. 1994) may 
provide better measures of in-vivo cell kill than the physiologically based 
endpoints used up until now. If endpoints such as these prove useful then it may 
be possible to identify radiation sensitive subsets in the population or alternatively 
more radio-resistant individuals and thus achieve some degree of dose or dose - 
volume individualisation of radiotherapy prescription and delivery. Attractive as 
these techniques may be, there are still several potential draw-backs in their 
utilisation. Unfortunately, direct visualisation in histological sections of basal cells 
do not clearly tell the observer what proportion of cells are abortively dividing or 
ultimately viable. Better histological or immuno-histochemical techniques are 
required to more clearly identify the subset of target cells which are dead or 
about to undergo either apoptopic or mitotic death. Hair cortical cell counting 
suffers from similar problems. 
Possible future areas for further study in terms of radiation erythema include 
more formal assessment of the extent of the reciprocal vicinity effect, by mapping 
its anatomical extent around radiation fields. Demonstration of agents which may 
block some of the modulators of erythema (either topically or systemically) may 
also provide clues as to radiation erythema mechanisms and kinetics. This might 
include the topical administration of steroids, prostaglandin inhibitors or capsaicin. 
(Szallassi and Blumberg 1989) 
A final research imperative arising from this data includes a more rigorous 
assessment of human skin response at low doses per fraction. An experimental 
design using uniform dose distributions over the dermis (eg. orthovoltage) would 
overcome objections related to build-up dosimetry. More patient numbers with 
better spread of dose per fraction data under 1 Gy in a consistent non-unexposed 
site would be important to confirm both our results and the in-vitro and animal 
work of Joiner et al. 1993. 
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Fig 76 Logit fits for FHDR data using a quantal response cut-off of erythema 
index equal to 1.5 for peak erythema. Single dose response points for 
Turesson's data are displayed for comparison along with fitted dose 
response for her 32 fraction data. (figure 4, Turesson and Thames 
1989) 
Discussion - 161 
11 CONCLUSIONS 
• Reflectance spectrophotometry is a sensitive and reproducible measure of human 
erythema, pre and post radiation exposure. 
• It exhibits considerably greater sensitivity and discriminatory power than semi-
quantitative grading scales. 
• Human pre-irradiation and post-irradiation erythema shows marked inter-patient 
heterogeneity. 
• Initial erythema readings are influenced by sex, (males higher) and site. (sites in 
the upper half of the body higher) 
• Normalised peak erythema values give the best measure of radiation dose 
response. 
• Normalised peak erythema readings are positively related to; biologically effective 
dose, female sex and negatively related to age, melanin and previous sun-exposure 
to the site. 
• Erythema readings, adjacent to the field, display reciprocal vicinity effects, 
demonstrating the existence of local vaso-active humoral factor(s) responsible for both 
in-field and out-of-field effects. 
• Dips in erythema response may indicate the presence of vaso-constrictive 
component within 2 weeks of the start of treatment. 
• These findings strongly suggest that radiation-induced erythema in humans is not 
exclusively related to basal cell kill in the epidermis. 
• The FHDR data set demonstrate inverse fractionation effects at low 
doses/fraction, which may be due to different repair mechanisms operating at fraction 
sizes less than 1.5 Gy. 
• Both FHDR and FLDR data were poorly fitted by the linear quadratic model 
unless the prolonged treatment data and 0.8 Gy/hr data was excluded. 
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INFORMATION AND CONSENT FORM 
FOR PATIENTS PARTICIPATING 
IN THE HAIR COUNTING STUDY 
This research project will use two methods to study the way in which radiation affects the skin. The 
first method will involve sampling hair which has been exposed to X-rays and examining it under a 
special microscope. It will then be possible to accurately measure the damage to the cells in that hair. 
This process has not been studied before and will have great importance in measuring the dose 
received to persons accidentally exposed to X-rays, (e.g. nuclear accident). We currently do not have 
any test which will measure this dose accurately in humans. 
The second method used in this study will measure the amount of skin reddening appearing in the skin 
towards the end of and just after your course of radiation. This reddening (erythema) is a normal 
consequence of radiation treatment and relating this to the actual amount of cell damage occurring in 
the hair will enable better understanding of how humans respond to radiation, and ultimately better 
treatment methods. 
Research procedures 
The study requires that we take some hair samples just prior to your radiation treatment and on one 
further occasion during the course of your radiation treatment. On each occasion we will use a small 
electric epilator (hair removal instrument) to take the hairs from an area of approximately 2cm 2 (about 
the size of a postage stamp). The sampling area will have an anaesthetic cream used before epilation 
and will be painless. The area of hair sampled will depend on where your radiation treatment is being 
given, and your doctor will explain details of this to you. The radiation therapy treatment given to you 
for your cancer has, as a normal side-effect, a greater or lesser amount of hair loss in the area being 
treated, and this is almost always only temporary. 
The skin reddening effects will be studied using a simple machine called a reflectance meter. It uses 
harmless white light (not ultra-violet) to measure skin colour. A gentle small probe will rest on your skin 
for about 10 second for each reading. Each set of readings will take 5-10 minutes. You will feel 
absolutely nothing during the measurement. We will need to do one set of readings before treatment, 
twice weekly during the treatment sessions, and a further two to four readings after treatment has 
finished, necessitating either your return to the Department, or the visit of our Research Assistant to 
your home. 
Form 687 
This study will have no effect on the radiotherapy treatment for your cancer, and your doctor will look 
after you in just the same manner as if you were not participating in this study. On one of your 
treatments we will perform a double-check of the X-ray dose received, using a tiny measuring probe 
placed on the skin. Again, with this instrument you will feel absolutely nothing, and it will have no effect 
at all on your treatment. You are completely free to withdraw from this measurement program at any 
time without prejudice to your medical care. Any skin reddening occurring during treatment will be a 
normal side-effect of the treatment and should be mild and short-lived. Your doctor or nursing sister 
will give you the appropriate advice and creams for this if required. The information collected on this 
study will include your name, address, medical record number, and all the measured parameters 
relevant to the scientific portion of the study. This will be stored, filed, and bound in our Data Managers 
office, and only she and medical staff involved with the project will have access to this. Data stored 
on the computer will not have your name, address or medical record number. The data will be kept 
indefinitely for possible future comparison studies both at this Hospital and at others. At no point will 
your name or any personal details be released or published from this study. 
Complaints 
The Hospital requires that all participants are informed that if they have any complaint concerning the 
manner in which a research project is conducted, it may be given to the researcher or an independent 
person if preferred. (Quality Assurance Officer, HAREC, Room 315 Nurses Home, Royal Newcastle 
Hospital, Pacific Street, Newcastle, NSW 2300, Telephone (049) 266 432. 
Consent 
I agree to participate in the hair counting project, and give my consent freely. I understand that the 
project will be carried out as described in the information statement, a copy of which I have retained. 
I realise that whether or not I decide to participate, my decision will not affect my further medical 
treatment. I also realise that I may withdraw from the project at any time and not have to give any 
reasons for withdrawing. I have had all my questions answered to my satisfaction. 
Signature 	 Date 
CH.KL 9/93 ..forms 
Information and Consent Form for patients participating in the Skin 
Reflectance Study 
X-ray treatment is used to kill cancer and it is by this means that the treatment 
you are about to undergo, will improve your symptoms. We also know that some 
damage occurs in some normal cells. The skin (because it is the most visible 
body organ) is very useful to study this damage. This damage is seen as 
reddening or "erythema" in the skin, appearing towards the end of and just after a 
course of radiation. The treatment your Doctor has prescribed in your case will 
result in a very mild or even invisible reddening of your skin just over the area 
being treated. 
We are able to study these invisible or mild skin effects using a simple machine 
called a reflectance meter. It uses harmless white light (not ultraviolet) to 
measure skin colour. A gentle, small probe will rest on your skin for about 10 
seconds for each reading. Each set of readings will take about 5-10 minutes. 
You will feel absolutely nothing during the measurement. We will need to do 
one set of readings before treatment, twice weekly during the treatment sessions 
and a further 2-4 readings after treatment has finished. This will mean you will 
have to return to the Hospital twice per week in the 1-2 weeks following 
treatment. 
This study will have no effect on your treatment and your Doctor will look after 
you in just the same manner as if you were not participating in this study. 
On one of your treatments we will perform a simple double check of dose, using 
a small measuring probe placed on your skin. A small patch of material called 
"bolus" may also be placed over the part of the treatment field for each treatment 
to slightly increase the dose to the skin in that area. None of the technicalities 
will detract from the effectiveness of your treatment in any way. 
You are completely free to withdraw from this measurement program at any time 
without prejudice to your medical care. 
Any skin reddening occurring will be mild and short-lived. Your Doctor or 
Nursing Sister can give you hydrocortisone cream for this if required. 
	 [signature] 	 have fully explained the nature of this 
Study to 	 
	 [signature] 	 agree to participate in this research 
program, having read this information sheet and understand that I may withdraw 
at any stage without prejudicing any aspect of my medical care or follow-up. I 
understand that this study will be entirely confidential with respect to my 
personal details. 
[Date] 	 / 	 /199... 
CONSENT TO TREATMENT FORM 
	 the undersigned, hereby consent to 
my involvement in a research program into new therapies entitled "Low Dose 
Rate Teletherapy" conducted by the Department of Radiation Oncology, Mater 
Misericordiae Hospital. 
I understand that my participation in this program will involve my treatment on 
the Caesium Teletherapy Unit at the Mater Hospital, involving treatments of 
several hours per day for up to two weeks. 
The nature, purpose and contemplated effects of the program as far as it affects 
me have been fully explained to my satisfaction by my specialist and my consent 
is given voluntarily. 
I am informed that no information regarding my medical history will be divulged 
and the results of any tests involving me will not be published so as to reveal my 
identity. 
I understand that my decision to become involved in the program will not affect 
my relationship with my medical advisers in their management of my health. I 
also understand that I am free to withdraw from the program at any stage. 
I understand that this program has the approval of the Regional Research and 
Ethics committee. 
(Signed) 
	
(Witness) 	 (Date) 
	  have explained the nature, purpose and 
contemplated affects of this program to 	  and have 
also explained the randomised process. I am satisfied that he/she understands 
what he/she has been told and that he/she participates of his/her own violation. 
(Signed) 	 (Date) 
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ABSTRACT 
Low dose rate teletherapy aims to combine the suppos-
edly superior results obtained with low dose rate implants 
with the convenience and staff protection characteristics 
of external beam therapy. Previous investigators have 
used telecobalt units to produce dose rates of 1.1 to 1.8 
Gy/hr to treat in daily sessions lasting 6-10 hours to total 
doses of 60-70 Gy. These studies have not discounted the 
possibility that much of the advantage of interstitial 
implants results from the low dose rates used per se, and 
from the fact that the total dose is delivered in a short 
overall time. The relationship between total dose, dose 
rate and volume giving normal tissue and anti-tumour 
effects, however, remains ill-defined. At the Newcastle 
Mater Misericordiae Hospital a Caesium teletherapy unit 
has been modified to treat at low dose rates and a study 
has been designed with a view to establish which permu-
tations of total dose and dose rate are isoeffective for 
acute mucosal and acute skin reactions in the dose rate 
range between 0.8 and 9.6 Gy/hr (1.3 and 
16 cGy/min) 
THE DOSE RATE EFFECT — BASIS FOR 
ENVISAGING A THERAPEUTIC GAIN 
Dose rate is one of the key factors in determining the 
biological effect of any given total dose. In general terms 
reduction of dose rate and consequent elongation of expo-
sure time reduces the biological effect of a given dose. 
Interestingly, in spite of this reduction in effect, it has 
been suggested that the therapeutic efficacy of intracavi-
tary and interstitial brachytherapy is as much due to an 
improvement in therapeutic ratio caused by treating at low 
dose rates as to the dose differential between tumour and 
normal tissue that is commonly achieved by these tech-
niques. It has even been suggested that some of the 
impressive results produced by the first teletherapy units 
in the 1920's and 1930's were due more to the prolonged 
exposure times required for treatment than the physical 
characteristics of the beams achieved! 
This proposal has some foundation in experimental 
fact. According to Hall (Hall 1988), reductions in effec-
tiveness due to progressive reduction in dose rate occur 
largely because repair (predominantly sublethal repair) 
takes place during exposure itself. As dose rate decreases 
the amount of repair that is possible during exposure 
increases until all repairable cellular lesions do repair. 
Once this happens the usual "shoulder" to the cell survival 
Key Words: 
Radiation Dose Rate Effects 
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curve disappears altogether and cell killing is effectively 
exponential. While this effect does not in itself lead to a 
therapeutic gain, the factors that influence repair of sub-
lethal cellular damage certainly may. Cellular hypoxia is 
one of these (Hall and Cavanagh 1969). Chronically 
hypoxic cells, which exist in abundance in many human 
tumours, appear to be less efficient in repairing sublethal 
injury (Nias 1988). As a result, the differential effects of 
radiation on well oxygenated and hypoxic cells reduce as 
dose rate decreases, leading to a reduction in oxygen 
enhancement ratio and a potential therapeutic gain (Fu 
and Phillips 1975) (Hill and Bush 1973). 
Another important factor to influence sublethal repair 
is the intrinsic repair capacity of the target cell itself. The 
cells of late reacting normal tissues characteristically shed 
sublethal injury more effectively than the cells that govern 
the response of early reacting tissues. Reductions in the 
rate at which radiation is applied will therefore be expect-
ed to result in differential sparing of late reacting tissues 
because these are able to repair sublethal injury more effi-
ciently. The situation is summarised by Steele (Steele et 
a/ 1989) in graphical form (Figure 1). 
EARLY REACTING TISSUE a / B 	10 
	 LATE REACTING TISSUE 0 IS = 3.7 
FIGURE 1 — The dependence of biological effect (in this case ED50) 
upon dose rate for early and late reacting tissues according to whether 
treatment is given continuously or divided into 10 or 20 equal fractions 
(modified from Steele eta! 1989). 
According to Hall (Hall 1988), the application of radia-
tion at low dose rate is analogous to the application of an 
infinite number of very small fractions at high dose rate. 
The reasons for suspecting that low dose rate irradiation 
may be associated with a therapeutic advantage are there- 
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fore the same as those for suggesting that hyperfraction-
ation may be beneficial. 
These are not the only biological reasons why 
brachytherapy has been mooted to be more effective than 
conventional fractionated irradiation in human tumours 
with rapid cell turnover times. Repopulation of tumour 
clones during a fractionated course of treatment is now 
being cited as a potential cause for treatment failure. 
According to Withers et at (Withers et at 1988) there is 
some evidence that this process may be responsible for 
escalating dose requirements when the treatment course is 
protracted over periods of more than four weeks. One 
reason that brachytherapy may be successful, therefore, is 
because treatment is rarely protracted over more than two 
or three weeks. 
Another factor of potential importance is an effect that 
has become known as the "inverse dose rate effect" (Hall 
1988). When the duration of exposure exceeds 1-2 cell 
cycle times of the tissue under consideration, cell cycle 
progression sensitivity phenomena begin to dominate the 
response. Accumulation of cells due to progression block 
at G2 would be expected and would result ma relative 
sensitisation of these cells. Cell killing of rapidly cycling 
populations would therefore be expected to increase at 
low dose rate with possible differential sparing of tissue 
composed of slowly proliferating cells. 
Unfortunately, despite the encouragement that has 
come from the laboratory that treatment at low dose rate 
itself might be responsible for a therapeutic gain in the 
clinic, the matter remains conjectural. The concept that 
hyperfractionation of dose is associated with a therapeutic 
gain in head and neck cancer has received some support 
from controlled clinical trials (Horiot et al 1989). The 
notion that acceleration of the treatment may be beneficial 
has also received some support from uncontrolled studies 
(Gray 1986). The gain that might be expected from treat-
ment at low dose rate, however, has not been clearly 
shown in any study. 
Teletherapy using dose rates in the (low dose rate) 
brachytherapy range was developed at the Henri Mondor 
University Hospital, Creteil, France, by Bernard Pierquin 
in the hope of extending the perceived advantages of 
brachytherapy to the many clinical situations where 
brachytherapy is impossible. After preliminary pilot stud-
ies with advanced head and neck cancer. Pierquin's group 
embarked on a trial comparing low dose rate external 
beam therapy using a modified Cobalt teletherapy unit 
with conventionally fractionated external beam therapy (at 
high dose rates) for moderately advanced oropharyngeal 
tumours. This study was first reported in 1985 (Pierquin 
et al 1985) and subsequently updated in 1987 (Pierquin et 
al 1987). Highly significant differences in local recur-
rence rate were observed between patients treated by low 
dose rate irradiation (5/32, 16%) and patients treated with 
conventional high dose rate fractionation (20/33. 61%). 
44% of patients in the low dose rate arm versus 24% in 
the conventional treatment arm were alive with no evi-
dence of disease at the time of the latter report. 
Unfortunately, however, difficulties in interpretation 
arise because patients were not truly randomised. As a 
result the two treatment arms were not entirely compara-
ble with respect to some potentially important variables. 
For example. there was a higher proportion of node-posi-
tive patients in the conventionally fractionated arm. while 
in the low dose rate arm the primary site was boosted with 
an Iridium-192 implant in a higher proportion of cases 
permitting higher overall total tumour doses to be  
achieved. Biological considerations such as the effect of 
the split in the low dose rate treatment course, and the 
range of dose rates used, have added further complexity to 
the interpretation of the results. 
Perhaps of even more importance is the fact that no 
clear indication of a therapeutic gain emerged from this 
trial. While the tumour responses achieved were indeed 
impressive (and possibly quite unexpected) these results 
were accompanied by five major necroses and two treat-
ment related deaths. This, of course, raises the question 
that a higher biologically effective dose had been used in 
the low dose rate treatment arm of the trial. Indeed, 
despite the extensive experience gained with brachythera-
py this century, and the more limited experience gained 
with low dose rate teletherapy at other centres (Kuipers 
1978, Wilson 1978), it remains difficult to predict what 
modification of total dose is necessary to avoid exceeding 
the tolerance of any normal tissue if dose rate is altered 
either by circumstance or design. In the absence of this 
fundamental information on normal tissue effects, it is 
therefore hardly surprising that the question of therapeutic 
gain from treatment at low dose rate has not been 
resolve& 
The reasons why there is this dearth of information are 
not hard to understand. The maximum doses that can be 
delivered without unacceptable risks of late damage for 
interstitial/intracavitary therapy are a complex function of 
total dose, volume and dose rate. These are in addition to 
factors such as source type, configuration and anatomical 
site. In attempting to resolve these difficulties, Paterson, 
from Manchester, produced a guide indicating that reduc-
tions in total dose should occur if an implant geometry 
unintentionally were to deliver a reference dose above 
0.35 Gy/hr (Paterson 1963). The Paris group suggested 
more recently, on the other hand, that no such dose reduc-
tion is required in the range 0.3-1 Gy/hr (Pierquin et at 
1973). While debate continues over dose rate modification 
requirements for interstitial therapy, some progress has 
been made for intracavitary therapy. Hunter and Stout, 
from Manchester, have produced data from a well-
designed clinical trial indicating that there is a necessity to 
reduce overall dose when after loaded gynaecological 
sources are used to treat cervical cancer at 1.4-1.8 Gy/hr 
(2.3 — 3 cGy/min) when compared to the standard use of 
manually placed radium sources at 0.53 Gy/hr (0.9 
cGy/min) (Hunter and Stout 1989. Stout and Hunter 
1989). The dose modifying factor is in the range between 
10% and 19% which is significantly lower than predicted 
from models based on the linear quadratic equation. A 
dose rate modifying factor for the development of pneu-
monitis has also been suggested by data from bone mar-
row transplantation programs using preliminary total body 
irradiation (Barrett and Depledge 1982). Quantification of 
this effect, however, has been confounded by the high 
incidence of pneumonitic processes due to other causes 
such as graft versus host disease and opportunistic 
infection. 
In summary. therefore, while some encouragement has 
come from the laboratory, the issue of a therapeutic gain 
in the clinic from the use of low dose rates remains unre-
solved. Perhaps even more important. however, is the fact 
that there remains a dearth of basic clinical data concern-
ing the effects of dose rate on normal tissue tolerance. 
Until this information becomes available the question of 
therapeutic gain can never be satisfactorily answered. 
It was these uncertainties and the availability of an 
aged but functional Siemens Caesium teletherapy unit that 
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FIGURE 5 — Depth dose characteristics of a 10 x 15 cm field at 80 cms 
SSD. Peak dose is estimated to be 0.5 — 0.7 mm below the surface. 
Because treatment times between 1 and 5 hours per day 
are projected in the dose rate study proper, careful consid-
eration has been given to patient comfort and immobilisa-
tion during treatment. The best conditions for treatment 
have been achieved with patients reclining on a modified 
dental couch with hourly rest breaks allowed (Figure 6). 
Immobilisation in head and neck cases has been achieved 
by using customised polystyrene head rests with suitable 
Velcro strapping. The earlier patients were monitored 
remotely by closed-circuit TV and their position checked 
against a standard. Currently, a series of optical proximity 
switches are being trialled so that arrays in two planes can 
confirm patient position and switch off the unit as 
required if the patient strays from the prescribed field set-
ting for more than a few seconds. This will permit the 
measurement of elapsed time of the patient outside of the 
optimal treatment position. A TV equipped with a VCR 
and a radio-cassette are provided for entertainment during 
treatment 
FIGURE 6 — A patient in treatment position. A modified dental chair 
with a customised headrest is positioned on a lifting palette. A television 
with video is available for entertainment and contact is maintained via a 
microphone and closed circuit television. 
Beam direction is established by front and back point-
ers and from the light beam produced by the unit. The 
treatment itself is supervised on closed circuit TV. 
In a feasibility study to establish techniques five 
patients with incurable head and neck cancers have been  
treated. Three patients with squarnous head and neck can-
cer have been treated using opposing lateral fields. Two of 
these were treated to midline doses of 30 Gy in ten daily 
treatments lasting approximately 5 hours per day at 0.6 
Gy/hr (1 cGy/min) using lateral fields opposed at hourly 
intervals and one has received a total midline dose of 45 
Gy at 0.6 Gy/hr. Two of these patients have had lasting 
partial response to treatment while one showed little 
response. 
Two patients have been treated with direct fields. One 
of these patients had recurrent basal cell carcinoma encir-
cling the trachea and invading the superior mediastinum 
after several attempted resections and received a dose of 
30 Gy at D4 cms in 10 daily sessions of 5 hours per day at 
0.6 Gy/lu. Skin healing has taken place and his tumour 
remains controlled eight months after treatment. The other 
patient had recurrent melanomatous nodal disease in the 
neck following resection and received an incident dose of 
30 Gy in 10 daily sittings at 0.6 Gy/hr responded entirely 
but relapsed two months later. Because evidence of dis-
ease at other sites had not appeared at that stage he was 
offered retreatment using conventional external irradiation 
using 6 MV X-rays at 2 Gy/day. He received an additional 
total incident dose of 50 Gy before skin reactions drew 
treatment to a close. 
It has been noted that skin and mucosal reactions have 
been characterised by a specific time course: commencing 
during the first week of treatment, building to a peak at 2- 
3 weeks after the commencement of treatment, and resolv-
ing rapidly and entirely by 6 weeks. Severity of reactions 
have not exceeded Grade III in the mucosa and Grade II in 
the skin according to RTOG/EORTC criterial (Table 1) in 
any of the patients. 
TABLE 1 
EORTC/RTOG Toxicity Criteria 
SKIN 
	
0 No change over base line 
* 	IA Follicular. faint erythema/epilation/dry 
desquamation/decreased sweating 
* IBM above but confluent bright pink erythema 
2 Tender or dusky erythema, patchy moist 
desquamation/moderate oedema 
3 Confluent, moist desquamation other than skin 
folds, pitting oedema 
4 Ulceration, haemorrhage, necrosis 
MUCOUS 
MEMBRANE 0 No change over base line 
I Injection; mild pain not requiring analgesics 
2 Patchy mucositis which may produce an 
inflammatory serosanguinous discharge/may 
experience moderate pain requiring analgesics 
3 Confluent fibrinous mucositis/may include 
severe pain requiring narcotics 
4 Ulceration, haemorrhage or necrosis 
* This distinction is a local one and therefore represents a modification. 
In addition to perfecting the techniques for the dose 
rate study outlined below, the feasibility study has shown 
the potential of very modest doses of radiation given in 
this way to produce tumour responses that appear to be 
just as satisfactory as those produced by intensive 
chemotherapy or conventional fractionated palliative 
therapy. 
STUDY DESIGN ADOPTED TO EXAMINE THE 
DOSE RATE EFFECT ON EARLY REACTING 
NORMAL TISSUES 
The present study has been designed to address the 
effect of dose rates between the conventional brachythera-
py range and the high dose rate external beam range on 
normal acutely reacting tissues: the skin and oropharyn- 
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geal mucosa. Late normal tissue effects have not been 
addressed in the study design and nor has anti-tumour 
efficacy. 
As shown in Figure 7 isoeffect curves, calculated using 
a modification of Dale's formalism (Dale 1985), change 
significantly in the low and 'medium' dose rate ranges for 
both acute and late reacting tissues. The major question to 
be addressed in the present study is how reliable these 
estimates actually are. Six different points on the predict-
ed isoeffect curves have been selected (according to 
Figure 7) to test the veracity of these predictions or serve 
to provide data for fresh predictions. 
Bony and Soft tissue metastases 
(1) Proven symptomatic metastatic cancer involving sites that can be 
encompassed satisfactorily by our modified caesium beam at 60 or 
80 cms SSD. 
(2) A disease site that has not been previously irradiated, is not situated 
in a pressure area, and in which there is no evidence of skin or sub-
cutaneous involvement by tumour. 
(3) The patient has not received Adriamycin, Actinomycin D. or 
Bleomycin containing regimes, or is being concurrently treated with 
cytotoxic chemotherapy or other agents that may modify radiation 
response. 
(4) Ability to lie still for a period of up to 1 hour. 
(5) Written informed consent for treatment on protocol. 
Table 2: Criteria for study inclusions 
• Because it is anticipated that some patients with RTOG [VB. C. D and V disease will 
respond favourably to this protocol. it is planned that further therapy using "conventional" 
teletherapy techniques or implantation will be offered to such patients after normal tissue 
reactions have subsided — as in the Creteil study. 
In a separate arm of this study a similar set of observa-
tions are conducted for skin reactions in patients with 
bony metastases. In this instance, however, the starting 
dose is 32 Gy at 4.8 Gy/hr (8 cGy/tnin) and isoeffective 
conditions are to be looked for at 1.8 Gy/hr (3 cGy/min) 
and 9.6 Gy/hr (16 cGy/rnin). 
5 	 10 
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FIGURE 7 — Curves for early and late reacting tissues for effects predict-
ed to be equivalent to 65 Gy in 32 fractions over 6.5 weeks and 40 Gy in 
20 fractions over 4 weeks using conventional (high dose rate) tele-
therapy according to Dale's formalism (Dale R.G. 1985). The data points 
addressed in the present study are enclosed in the shaded area. The accu-
racy of Dale's formalism will be predicted by the isoeffectiveness of the 
square data points. 
Consenting patients with extensive and incurable head 
and neck cancer (according to the criteria laid down in 
Table 2) and metastatic bone cancer are allocated accord-
ing to a central composite group design. According to this 
design patients are treated for head and neck cancer to 38 
Gy at 1.8 Gy/hr in 10 daily sessions until sufficient nor-
mal tissue data are accumulated to characterise the time 
course and severity of reactions at this particular permuta-
tion of dose and dose rate. Subsequent patients are then 
allocated to receive doses 10% greater or less than the 
total doses predicted to be isoeffective at 0.8 Gy/hr and 
3.0 Gy/hr (i.e. 40 Gy and 36 Gy) in 10 daily sessions. 
Skin and mucosal reactions are scored on a weekly basis 
by two observers independently according to the 
EORTC/RTOG criteria (see Table 1). Tumour response is 
documented by weekly calliper checks and, where indicat-
ed, by CT and or EUA. 
TABLE 2 
Patient Selection Criteria 
Head and Neck Cancer 
(1) Patients with squamous carcinoma of the head and neck that fulfil 
the RTOG modification of the AJC stage grouping criteria in the cat-
egories IVB. C and D and V *, excepting oral cavity tumours and 
laryngeal turnouts that may be amenable to surgery. 
(2) Patients under 80 years of age with an anticipated survival of more 
than 8 weeks. 
(3) Patients who do not have intercurrent illnesses such as dementia. 
severe epilepsy, incontinence, severe musculo-skeletal disorders, that 
are likely to make treatment lasting several hours each day difficult. 
(4) Patients who do not have severe dental caries requiring major dental 
work prior to treatment. 
(5) No prior treatment (radiation or chemotherapy). 
(6) Written informed consent to treatment on protocol. 
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Abstract 
The purpose of this study was to determine the influence of changes in dose rate over the range 0.8-240 Gy/h on acute 
oropharyngeal mucosal reactions in human subjects, and to estimate the values of the important parameters that influence these 
reactions. Sixty-one patients requiring radiotherapy to palliate incurable head and neck cancer were treated on a telecaesium unit, 
using opposing lateral portals to total midline doses, varying between 30 and 42 Gy in 10 daily fractions over 2 weeks, at dose 
rates of 0.8, 1.8, 3.0 and 240 Gy/h according to a central composite study design. The severity and time course of reactions were 
charted at least twice weekly for each patient, using the EORTC/RTOG acute mucosa] reaction grading system. Duration of reac-
tion at each grade was observed to provide a more sensitive reflection of effect than the proportion of patients reaching any particu-
lar reaction grade. Analysis of duration by direct and indirect methods suggest affl ratios in the range 7-10 Gy and half-time (t in) 
values in the range 0.27-0.5 h, if mono-exponential repair kinetics are assumed. The t in values are short and raise the question 
as to whether the repair kinetics of this tissue are well described by a mono-exponential function. Further prospective studies involv-
ing multiple daily fraction treatment regimes delivered at high dose rate, in which interfraction interval is deliberately varied, are 
needed to find out whether the parameters derived from this project are applicable to fractionated treatment courses at high dose 
rate. 
Keywords: Mucosa; Low dose rate; High dose rate; Alpha/beta ratio; Repair kinetics 
1. Introduction 
Over recent years, considerable progress has taken 
place towards the development of models that will be 
helpful to clinicians in estimating the effects that are 
likely to be observed for many commonly used permuta-
tions of total dose, fractionation, and dose rate. The in-
complete repair model, for example, provides very 
reasonable fits to many sets of laboratory and clinical 
data [23,24]. Of course, few clinical data are generated 
with the specific intention of defining the values of the 
parameters of the predictive models, therefore much of 
what is known is based on the re-analysis of historical 
clinical data [23]. In the past few years, increasing in-
terest in the use of accelerated fractionation schedules 
• Corresponding author, Tel.: +61 (0)49 211177; Fax.: +61 (0)49 
602566.  
delivering more than one treatment fraction per day has 
drawn attention to the importance of the rate at which 
repair occurs between fractions [10,14,15,18,28]. The 
process, which for operational purposes is considered, 
mono-exponential in the incomplete repair model [22], 
is best described by its half-time (t u2). Unfortunately, a 
dearth of relevant clinical data has prevented suitable 
values for this parameter from being derived with any 
certainty for any acute or late reacting human tissue. At 
the present time, therefore, a better understanding exists 
concerning appropriate values for a43 than for t 1,2 [23]. 
Increasing use of accelerated and hyperfractionated 
treatment regimes in locally advanced head and neck 
cancer has also drawn attention to the importance of the 
severity of acute mucosa] reactions in determining treat-
ment tolerance [18,25]. 
The fractionated low dose rate (FLDR) teletherapy 
project at the Mater Hospital, Newcastle, Australia [5], 
0167-8140/95/509.50 C) 1995 Elsevier Science Ireland Ltd. All rights reserved 
SSDI 0167-8140(95)01545-R 
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was therefore designed in response to the need for more 
-- prospective clinical data to describe ali3 ratio, and t 112 
• parameters, for acute mucosal reactions as well as the 
•dose rate effect itself. This has been done by examining 
reactions caused by identically fractionated treatment 
regimes, delivered at low to medium dose rates (i.e., 
under 10 Gy/h), and at high dose rate (240 Gy/h). This 
report describes the indirect and direct quantal analysis 
of these data and discusses the implications and remain-
ing uncertainties of our results. 
2. Patients, materials and methods 
2.1. Patients 
The 61 patients enrolled for treatment on this project 
had locally advanced squamous cancer of the head and 
neck (RTOG modification of AJCC criteria Stages P/C 
and V [16]), deemed incurable by any means, by the 
multidisciplinary consultative head and neck clinic of 
the Mater Hospital, and suitable for palliative treatment 
only. Also included were four patients with lesser stage 
disease, but concurrent incurable second primary 
cancers arising from other sites (two from lung, one 
from pancreas, one from cervix). Ineligibility criteria in-
cluded severe intercurrent illness likely to result in fail-
ure to comply with the treatment and follow-up 
monitoring laid down below. Also ineligible were pa-
tients who had received prior treatment for head and 
neck cancer, including previous radiotherapy or chemo-
therapy. Informed, written consent to participate was 
the fmal prerequisite for entry. The study protocol was 
approved by the Hunter Area Research Ethics Commit-
tee in September 1988. 
2.2. Treatment details 
Technical details of the project have been published 
elsewhere [5]. Briefly, a Siemens Caesium teletherapy 
unit has been adapted to treat at 80 cm SSD, using 
specially designed rectangular collimating cones pro-
viding field sizes of between 80 and 168 cm 2 (median 
size used 100 cm 2). Adjustments to instantaneous dose 
rate has been achieved using lead filters. Treatments 
have been conducted using large opposing equally 
weighted lateral beams, with dose and instantaneous 
dose rate specified at the midplane point on the central 
axes. All 51 patients treated at low dose rate received 10- 
week daily treatment fractions with both fields treated 
on each treatment day. Beam direction has been achiev-
ed through the use from front and back pointers and 
verified using portal films. Dosimetry based on water 
phantom depth dose measurements for each individual 
treatment cone, has been verified during treatment using 
entrance and exit thermoluminescent dosimetry on the 
central axes of the beam. All treatments have been con-
ducted with the patients sitting or semi-reclining in a 
dental chair, modified for comfort with a customised 
headrest to minimise movement of the head. In addition 
to the monitoring of patient movement by the operator 
(SAS) on closed circuit television, a specifically designed 
optical proximity switch was used as a failsafe mecha-
nism to temporarily suspend treatment if a predetermin-
ed degree of excessive movement had taken place. The 
operation of this switch is reported elsewhere [13]. Rest 
breaks were allowed at frequent intervals during each 
daily treatment because the shortest treatment was 1 h 
4 min per day in the patient group treated to 32 Gy total 
dose at 3 Gy/h. 
The 10 patients treated at high dose rate on this pro-
ject were treated using opposing lateral 6 MV beams on 
a Varian Clinac 1800 linear accelerator. Once again, all 
patients had 10 daily fractions with both fields treated 
each day and dose specified at the midplane point on the 
central axes of the beams. All treatments were con-
ducted with the patient supine. 
Anti-fungal prophylaxis was not administered to any 
of the patients. 
2.3. Study design 
As previously described [5], a modification to the cen-
tral composite design concept has been used in this pro-
ject, with the aim of determining isoeffective doses for 
10 daily fractions delivered at 0.8, 1.8, 3.0 and 240 Gy/h 
(high dose rate). The central point of the composite de-
sign was 38 Gy at 1.8 Gy/h. The dosing levels at each 
dose rate selected have been structured around isoeffect 
predictions, using the incomplete repair model [7,17], 
and separated by intervals of approximately 10% in total 
absorbed dose. This decision was based in part on the 
need to establish the sensitivity of the endpoints used 
[8], and ensure adequate sample size. For logistic 
reasons, allocation to each group was determined con-
secutively (as opposed to random assignment). The final 
dosing groups are described in Table 1. 
2.4. Study endpoints 
Oropharyngeal mucosal reactions were graded at least 
twice weekly during treatment and after, until full recov- 
Table 1 
Details of 'dosing' groups used in the project; total dose and instan-
taneous dose rate is specified at the midplane in the central axes of the 
beam 
Dose rate 
(Gy/b) 
Total dose 
(GY) 
No. of 
patients 
No. of 
fractions 
Overall time 
(days) 
240 30 10 10 12-14 
3 32 10 10 12-14 
3 36 9 10 12-14 
1.8 38 10 10 12-14 
0.8 36 7 10 12-14 
0.8 38 6 10 12-14 
0.8 42 9 10 12-14 
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Table 2 
Muccsal grading criteria used in FLDR study (EORTC/RTOG toxic-
ity criteria) 
Mucous membrane 
0 	No change over base line 
I 	Injection; mild pain not requiring analgesics 
II Patchy mucositis which may produce an inflammatory 
serosanguinous discharge; may experience moderate pain re-
quiring analgesics 
III Confluent fibrinous mucositis; may include severe pain requir-
ing narcotics 
IV Ulceration, haemorrhage or necrosis 
ery had taken place using the EORTC/RTOG acute 
reaction grading criteria (Table 2). Often observations 
were obtained more frequently to better estimate the day 
on which the reaction changed from one grade to 
another. Time in days, from the start of treatment, to 
the onset and recovery from each reaction grade was 
recorded for each patient in addition to the peak grade 
reached. This enabled calculation of the duration of 
time that each patient spent at each reaction grade. Also 
measured were qualitative skin reactions using a modifi-
cation of the EORTC/RTOG acute reaction grading cri-
teria (Table 2), and reflectance spectrophotometry skin 
readings and tumour response rates reported elsewhere 
[9,12]. 
2.5. Analytical methods 
All data were entered onto a temporal database 
(MEDLOG). Non-parametric exact tests such as the 
Fisher, Wilcoxon and ICruskal-Wallis tests, were per-
formed using the StatXact , software package. Direct 
estimates of a/13 and t 112 were derived using the afflest 
program [2]. Log likelihood based 'goodness of fit' pro-
babilities were derived using a custom designed spread- 
sheet program on Lotus 1-2-3, while FLDR reciprocal 
dose plots [19], and other curve-fitting procedures were 
carried out using the Sigmaplot software package. 
Reciprocal dose plots were derived using the method 
used by Scalliet et al. [19], and described by Dale et al. 
[6]. A dose rate correction factor 'IC is applied to each 
dose rate to derive an equivalent fractional dose 'd'. Full 
details are given in Scalliet et al. [19]. 
3. Results 
3.1. Time course of reactions 
Complete data sets (i.e., days to onset, recovery and 
duration of each reaction grade) for 56 of the 61 patients 
were collected. Death due to intercurrent causes in four 
patients, (one from myocardial infarction; one from 
cerebrovascular accident; and two from pneumonia), 
and haemorrhage from the primary tumour in one pa-
tient occurred after treatment but prior to full recovery 
of all mucosal reactions, and therefore prevented calcu-
lation of reduction durations at all grades in the remain-
ing five patients. In Table 3, median times for each 
group of patients to reach and recover from each reac-
tion grade are presented. It will be noted that median 
time to recovery from each reaction grade increases as 
total dose increases. Data concerning the duration of 
time spent at each reaction grade for each group, 
together with the proportions in each group that reach 
each reaction grade, are summarised in Table 4. These 
data confirm the impression gained from Table 3 that 
reaction duration increases with total dose. Strong lin-
ear relationships were found to exist between the dura-
tion of time spent at any one reaction grade and 
another. 
3.2. Isoeffect conditions 
ED 	probability of reaction duration reaching a 
specific value) estimates at each dose rate, have been de- 
Table 3 
Median times in days (range in parentheses) to the onset and recovery from reactions at Grades I, II and III level (the values with asterisks are 
derived from data obtained from less than five patients) 
Group 	Onset 
 
Recovery 
    
Grade I 
 
Grade II 	Grade III 
 
Grade III 
 
Grade II 	Grade I 
           
           
median (range) median (range) median (range) median (range) median (range) median (range) 
30 Gy @ 240/h 7.5 (6-9) 12.5 (9-16) 16 (11-23) 20 (16-31) 23 (13-33) 26.5 (18-46) 
32 Gy @ 3/h 8 (2-14) 13 (11-18) 17* (15-17) 19* (18-20) 21.5 (17-28) 25 (17-33) 
36 Gy 	3/h II (4-12) 13.5 (9-16) 16.5' (14-18) 21* (18-28) 26 (21-31) 27.5 (16-37) 
38 Gy @ 1.8/h 6.5 (3-11) 10.5 (7-15) 15.5 (10-22) 22 (17-30) 24 (21-37) 27.5 (24-44) 
36 Gy @ 0.8/h 10.5 (5-14) 15 ' (6-17) 15' (8-17) 17* (17-20) 23.5 (21-30) 26 (23-37) 
38 Gy @ 0.8/h 10 (5-13) 14 (7-16) 17.5 (12-22) 20 (18-24) 22.5 (16-27) 27 (21-37) 
42 Gy @ 0.8/h 8 (5-10) 12 (7-16) 15 (9-18) 21 (18-24) 26 (19-31) 31 (26-36) 
Table 4 
Median times in days spent at each reaction grade; proportions reaching each grade are also provided 
Group 	 n Duration of time spent at: 	 Proportions reaching: 	 ED so (Gy) 
Grade I Grade II Grade III Grade I 	Grade II Grade III 
n median (range) n median (range) n median (range) 
30 Gy @ 240/h 	10 10 19 (11-37) 10 12 (3-17) 10 3.5 (0-8) 10/10 	10/10 7/10 30 
32 Gy @ 3/h 	10 10 16.5 1 (7-28) 10 8 1 (0-15) 10 0 1 (0-5) 10/10 9/10 10 35.5 
36 Gy @ 3/h 	9 
38 Gy @ 1.8/h 	10 
8 
10 
192 
22.5 
(9-30) 
(17-33) 
8 
10 
12.5 2 
14 
(0-16) 
(11-24) 
9 
10 
4 2 
2 
(0-10) 
(0-10) 
9/9 	8/9 
10/10 10/10 
36/6121 
7/10 36.5 
36 Gy @ 0.8/h 	6 6 14.5 (9-29) 6 8.5 (5- 18) 6 1 (0-9) 6/6 	6/6 3/6 
38 Gy @ 0.8/h 	7 6 20 (11-25) 6 11.5 (2-16) 6 2.5 (0-8) 7/7 7/7 6/7 39 
42 Gy @ 0.8/h 	9 6 25.54 (16-30) 7 134 (11-29) 9 74 (0-9) 9/9 	9/9 6/8 4 
Composite group: 
37 Gy @ 0.8/h 	13 12 19 3 (9-29) 12 10 3 (2-18) 12 1.5 3 (0-9) 13/13 	13/13 9/13 3 
(= 36 + 38 Gy 
groups) 
Wilcoxon 1-S Exact 1 vs. 2 0.27 1 vs. 2 0.028 1 vs. 2 0.03 Fisher Exact 1 vs. 2 0.128 
p values 3 vs. 4 0.04 3 vs. 4 0.086 3 vs. 4 0.21 p values 	3 vs. 4 0.628 
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Fe Plot Mucosal Data (Duration at Gd. 2) 
Fe Plot of HDR and LDR Mucosa' ED50 Data based Duration at Gd. 2 
Repair Half Time = 0.2- 0.25 his, gives best straight fine fit (see inset) 
Alpha/Beta Ratio = 7.8 - 8.5 (see inset) 
95% Confidence Intervals 	 
Fig. 1. Reciprocal dose plot for ED 50 estimates for reaction durations 
at Grade II level. The inset graph describes correlation coefficient 
values (rho) for a straight line fit to the data points using various 
values of al 13 and tin. Best fit conditions are achieved by a/0 values 
in the range 7.6-8.5 Gy and f in values in the range 0.2-0.25 h. 
rived by interpolation from median and mean reaction 
durations at each reaction grade, as well as from the 
proportions in each treatment group whose reactions 
equal or exceed the median duration of reactions at each 
grade for the entire study population (Table 4). These 
estimates suggest that reactions to 30 Gy at 240 Gy/h are 
approximately equivalent to those caused by 35.5 Gy at 
3 Gy/h (range 34.5-37 Gy), 36.5 Gy at 1.8 Gy/h (range 
34.5-38 Gy), and 39 Gy at 0.8 Gy/h (range 38-40 Gy) 
at the three grades examined. 
The ED 50  estimates for Grade H reactions have been 
plotted on a modified reciprocal dose plot (Fig. 1). Best  
fit conditions are achieved by a/0 values in the range 
7.6-8.5 Gy, and t 112  in the range 0.2-0.25 h. 
3.3. Direct quantal analysis, statistical uncertainty 
estimates 
Direct quantal estimates of ali3 and t in, using the 
proportion of each group whose duration of reaction at 
each different reaction grade, equals or exceeds the me-
dian value obtained for the entire patient population 
combined, are provided in Table 5. Convergence on all3 
estimates in the ranges alt1 6.7-10.4 Gy and t in 
0.19-0.49 h are consistent with the results produced by 
the reciprocal dose plot methodology. It will be noted, 
however, that the 95% confidence intervals are quite 
wide, providing reason to explore the issue of statistical 
confidence further. 
In Fig. 2, predictions of response proportions derived 
from the incomplete repair model are superimposed on 
the quantal responses actually observed in this project. 
It will be noted that while the all3 and tin parameters 
estimated for Grade II reactions (namely cr.63 = 8, 
tin = 0.25 h) provide a reasonable fit to the data, the 
parameters a/0 = 15, tin = 0.75 h, provide a poor fit. In 
order to measure the goodness of fit of any given pair 
of parameter values to the observed data, the log 
likelihood ratio test for similarity between observed and 
expected binomial proportions was applied to a range of 
a/0 and t in permutations, between a/0 5-15 Gy and t 12 
0.1-0.75 h. The results of this procedure for reactions at 
Grade II level are summarised in Fig. 3 and are in rea-
sonable agreement with the direct analysis. This figure 
indicates that all3 values in the range 7.5-10 and t 1,2 in 
the range 0.2-0.55 h have a probability greater than 0.5 
of fitting the data. Parameter values outside these ranges 
provide rapidly declining probabilities of fit, particular-
ly for t in times below 0.2 h and a/0 values above 15. 
4. Discussion 
An a/0 estimate in the range 7-10 Gy, is entirely 
consistent with previous estimates [4,23]. The t in esti- 
Table 5 
Direct computations using the afflest program of a/0 and t in  using the numerical proportion of patients in each group whose reaction durations 
equalled or exceeded the median duration of reactions at each reaction grade for the entire study population (the 95% CI for a/0 and t in at Grades 
I and III are indefinite) 
(95% CI) t in (95% Cl) 
Grade I Logistic 10.3 Gy (-) 0.18 h (-) 
Poisson 10.4 Gy (-) 0.19 h (-) 
Grade H Logistic 9.0 Gy (4.7-22.7) 0.24 h (0.13-1.9) 
Poisson 9.3 Gy (5.8-17.9) 0.25 h (0.14-1.5 ) 
Grade III Logistic 6.6 Gy (-) 0.43 h (-) 
Poisson 6.7 Gy (-) 0.49 h (-) 
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Fit of data to a family of predicted dose response curves 
generated using the incomplete repair model 
For M3 = 8 Gy, Repair Half-time = 0.25Hrs 	 For a/8= 15 Gy, Repair Half-time = 0.75 Hrs 
Fig. 2. Observed quantal responses superimposed on predicted response probability curves that were based on two different permutations of cf/i3 
and t in i.e., 8 Gy and 0.25 h and 15 Gy and 0.75 h. (N.B. The 'composite' group treated to 37 Gy at 0.8 Gy is formed from the groups treated 
to 36 and 38 Gy has been plotted.) 
mate (range 0.25-0.5 h), however, is short and raises the 
question of the magnitude of uncertainties that may 
have impacted on the result. 
These uncertainties can be addressed under three 
headings: technical aspects, the accuracy of the end-
points used, and sample size considerations. 
4.1. Technical aspects 
Turning first to the technical aspects it is clear that a 
number of factors could have impacted on dosimetric 
uncertainties. As discussed in an earlier report [5], the 
telecaesium beams used were not perfectly flat even at 
the 80-cm SSD used. Contour variations, scattering con-
ditions and, above all, patient movement, provided ad-
ditional uncertainties. Variation in overall treatment 
time is a factor that could have impacted on ac-
cumulated 'biological' dose, due to the possible onset of 
accelerated mucosal repopulation prior to treatment 
completion. Although it was intended the overall treat-
ment duration would be 12 days, logistical difficulties 
prevented completion in less than 14 days in some pa-
tients. Although 'prolonged' treatments such as this did 
not affect any particular treatment group, it is a factor 
that may deserve revisitation as more becomes known of 
human mucosa] repopulation kinetics. 
4.2. Endpoints 
Concerning the accuracy of the endpoints used, we  
have already drawn attention in a previous report to the 
fact that it is far easier to determine the level of a reac-
tion on any particular examination day, than to estimate 
precisely how long a reaction at any particular grade 
lasts [8]. Factors involved include the matter of judge-
ment that a reaction is changing from one grade to 
another on any particular day. Making this judgement 
more difficult is the fact that subsiding reaction appear-
ances can be different to reaction appearances that are 
still evolving. Anatomical site differences, the presence 
of tumefactions and residual dentition are additional 
problems that we attempted to avoid by concentrating 
on the appearance of the oropharyngeal mucosa. Of the 
three reaction grade duration endpoints used in this 
study, we feel that duration at grade II has probably 
produced the most reliable a/0 and t u2 estimates. Dura-
tion at the Grade I endpoint (erythema) is a difficult 
measure to judge reproducibly, and may not reflect a 
purely cytological endpoint [9]. Estimates based on 
duration at Grade III may be less reliable because only 
37 of the 61 patients experienced this grade. 
4.3. Sample size 
Finally, the issue of sample size, which is one of the 
most important considerations in any study, is clearly an 
important one in this project. Uncertainties due to sam-
ple size perhaps dwarf other sources of error already 
mentioned. The wide confidence intervals around the re- 
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Endpoint: Duration at Grade II  
PROBABILITY OF FIT 
0.1 0.25 	0.5 	0.75 	1.0 
t'12 (hrs) 
Fig. 3. A matrix of probability values that the observed data will fit 
various permutations of all3 and tu2 specified on the axes. 
suits estimated by direct analysis (Table 5), and the dia-
gram referring to goodness of fit to the data of a range 
of permutations of a/Li and t in (Fig. 3), demonstrate 
this uncertainty quite clearly. Of course, these uncertain-
ties are entirely due to the small numerical size of each 
treatment group. It is difficult to know whether a doub-
ling of the sample size would have significantly increas-
ed the precision of our estimate, but this was not an 
option due to logistical and ethical constraints. While 
the logistical constraints of doing this are obvious, the 
ethical arguments are less straightforward. In any 
human volunteer study in which therapeutic benefits 
from the test treatment are not expected to exceed the 
benefit to be obtained from 'conventional' treatment 
[12] (i.e., fractionated palliative radiotherapy or chemo-
therapy), the ethical imperative is to discontinue the 
study after treatment of the minimum number of pa-
tients likely to produce a plausible result from the study. 
After we had become satisfied that a minimum of nine 
patients in each treatment group would allow us to 
resolve a difference in total physical dose of 10% [8] in 
our test system with all its uncertainties, we took the de- 
cision that the result obtained using groups of the stated 
size would satisfy these minimum conditions, i.e., be 
plausible. 
Few published values for the a/0 and t v2  values for 
mucosa are available for comparison with our results. 
Chougule and Supe recently reported ali3 ratios in the 
range 7.68-8.11 Gy for acute mucosal reactions in pa-
tients with head and neck cancer treated with twice daily 
fractionation schedules [4]. Acute reactions in the 
mouse lip are one of the 'nearest' laboratory models. 
Various estimates of alf3 have been obtained using this 
system. Ang et al. derived a value of 8.5 Gy using large 
fractional doses at high dose rate [1]. In a study employ-
ing a range of continuous low dose rate treatments, 
delivered at various dose rates, Scalliet et al. derived a 
value of 7.4 Gy [19]. In a subsequent study which in-
vestigated a range of interfraction intervals using frac-
tionated high and low dose rate irradiations, Stuben et 
al. derived values in the 14.1-18.2 range [21]. Values for 
repair tin were in the 0.5-0.75 h range in the two sets 
of experiments that employed low dose rate irradiation 
[19,211, but were higher (0.9-1.2 h range) in the frac-
tionated high dose rate study conducted by Ang et al. 
[1]. In mouse tongue mucosa, Darr et al. derived an a/13 
ratio of 11.6 Gy and a t 12 value of 0.75 h in a study that 
involved high dose rate irradiation at various interfrac-
tion intervals [11]. Thames et al. concluded that human 
tissue repair t in values are usually slightly longer than 
those obtained in rodents [23]. However, the only value 
for the human mucosa published to date is 2 h or more, 
which grossly exceeds the mouse lip estimates [23]. It 
also exceeds the direct analysis estimates of 1.3 h for 
erythema and 1.1 h for desquarnation in human skin ob-
tained from Turesson and Notter's internal mammary 
irradiation data [26,27]. The 2-h estimate for the human 
mucosa was derived from data obtained in the ran-
domised RTOG trial in advanced head and neck cancer, 
which compared a conventionally fractionated treat-
ment of 66-74 Gy in 7-8 weeks, with the 60 Gy in 5 
weeks utilising twice daily fractions of 1.2 Gy reported 
by Marcial et al. [15]. In this study interfraction interval 
ranged from 3 to 7 h. Both early and late reactions oc-
curred more frequently in patients whose interfraction 
intervals were less than 4.5 h. 'Severe mucositis' oc-
curred in 20 of 72 (28%) patients treated with interfrac-
tion intervals less than 4.5 h, whereas it occurred in only 
one of 20 (5%) of patients treated with longer intervals 
(p = 0.06). Since this was a multi-institution study, in 
which patients were not randomly assigned to specific 
interfraction intervals and treatment was interrupted in 
36% of patients treated on the twice a day schedule, it 
is difficult to know what significance to attach to these 
observations. However, increased mucositis was also 
reported in a pilot study of concomitant boost therapy 
in Poland [3]. In this study the incidence of confluent 
mucositis during the concomitant boost phase of treat- 
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ment was reduced when interfraction interval was in-
creased from 4 to 6 h. Steel et al. noted that in cell line 
experiments shorter t in estimates were obtained from 
dose rate analyses employing a range of low and inter-
mediate dose rates, than from split dose experiments 
using high dose rate irradiation [201. Dale et al. wit-
nessed a similar phenomenon for dose rates up to 25 
Gyth in the C3H mouse jejunum [71, which added 
weight to the suggestion that repair may be a multi-
component process that is not always well described by 
a mono-exponential function. Perhaps this explanation 
provides some reconciliation between the long estimate 
obtained from the RTOG and Polish mucosal data, and 
the short estimate obtained in this project. It could be 
that repair of a rapid component of what is in fact a 
multi-exponential repair process in human mucosa is in-
significant after irradiation at- high dose rate, but is im-
portant during protracted exposure at low dose rate. If 
this is true then the incomplete repair variant of the lin-
ear quadratic model, Which assumes mono-exponential 
repair kinetics, does not provide a perfect description of 
acute mucosal reactions under all conditions as it 
stands. It would also mean that parameters derived from 
dose rate studies, such as this one, should be applied 
with extreme caution to fractionated treatment courses 
delivered at high dose rates. 
5. Conclusions 
This project has produced data that provide a/3 ratios 
of 7-10 Gy and tin values of 0.25-0.5 h for the acutely 
reacting human mucosa when the incomplete repair 
model is applied. The t u2 values are short, however, 
and raise the question as to whether the repair kinetics 
of this tissue are well described by a mono-exponential 
function. Further prospective studies involving multiple 
daily fraction treatment regimes delivered at high dose 
rate, in which interfraction interval is deliberately 
varied, are needed to know whether the parameters de-
rived from this project are applicable to fractionated 
treatment courses at high dose rate. 
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Abstract 
Dose-response relationships have been studied using an ordinal visual scale and reflectance spectrophotometry data from 123 
treatment sites on 110 patients treated with 10 dose fractions over 12-14 days. Dose rates varied between 3 and 240 Gy/h and total 
doses of between 25 and 41 Gy were given using teletherapy apparatus. We found qualitative scoring of erythematous skin reactions 
to be subject to considerable inter- and intra-observer variation. Reflectance spectrophotometry provided more reproducible infor-
mation, some of which was undetectable by naked eye. Baseline erythema readings were significantly higher in male patients and 
at anatomical sites of previous heavy UV exposure. In addition, a pronounced decline in erythema readings during the second week 
of therapy and 'reciprocal vicinity' (abscopal) effects adjacent to the field, undetected by the eye, were observed in a subset of pa-
tients. Meaningful dose-response relationships could be derived only from reflectance data with peak change from the pretreatment 
baseline measure providing the best discrimination. Peak erythema measures following treatment were found to depend on the age 
and gender of the patient as well as the treatment site and its baseline erythema measurement. This was independent of the total 
dose administered or the instantaneous dose rate at which it was delivered. The rate of erythema development was also dose rate 
dependent but only weakly dependent on the biological dose intensity (Gy equiv./day) of the treatment course. The data raise the 
question of whether irradiation-induced erythema is exclusively a secondary phenomenon occurring as a result of basal cell killing. 
The short repair half time value of 0.06 h obtained by direct analysis is perplexing and may reflect a dose rate-dependent 
physiological vasodilatory response to irradiation and/or a multi-component cellular repair process. 
Keywords: Skin; Erythema; Radiotherapy; Dose rate effect; Reflectance spectrophotometry; cs.43 ratio; Repair kinetics 
1. Introduction 
The mammalian integument has proven a fertile area 
for radiobiological research. In particular, observations 
on the mouse and pig have been responsible for much of 
the data which has helped to formulate modern concepts 
of fractionation, dose rate effects and field size effects 
[11,14,17,22,24,25,34,53]. Its accessibility both to the de-
livery of ionising radiation and observation, coupled 
with its non-vital role for laboratory survival in most 
small mammals, has contributed also to its wide ap-
plicability in primary radiobiological research. Labora- 
• Corresponding author.  
tory workers have used a variety of ordinal scoring 
scales for evaluating acute skin reactions. Similar, but 
usually simpler, scoring systems for humans have been 
derived over the past several years. These include the 
RTOG and EORTC scales and the Dische inventory 
[13]. These scales endeavour, as ,much as possible, to 
simplify and standardise observations which have been 
noted in clinical radiotherapy for many years. Most 
human radiobiological data has derived from the use of 
ordinal scales such as those described above [41,50]. 
However, these scales are subject to considerable inter-
and intra-observer variation. Reflectance spectro-
photometry is a quantitative technique which has been 
employed by various workers [33,38,44-48] in an effort 
to overcome these problems. The most extensive experi- 
0167-8140/95/S09.50 © 1995 Elsevier Science Ireland Ltd. All rights reserved 
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ence with the technique of reflectance spectrophoto-
metry, for the assessment of radiation reactions in hu-
mans, comes from the work of Turesson and colleagues 
[43,44,49], concerning the acute skin reactions in the 
treatment of bilateral internal mammary node chains in 
women treated post-operatively for breast cancer. 
Turesson demonstrated that reproducible quantitative 
evaluation of skin reactions was possible, at least up to 
the level of and including dry desquamation Nias [33] 
utilised reflectance spectrophotometry in some thirteen 
patients and was able to demonstrate a dose response 
and fractionation effect, although he took these studies 
no further. Russell et al. [38] also utilised reflectance 
spectrophotometry to assess skin erythema response to 
post-mastectomy radiotherapy, but were unable to 
demonstrate a significant dose-response relationship. 
It is known that the overlapping absorption spectra of 
the main pigments that influence skin colour (deoxy-
haemoglobin, oxy-haemoglobin and melanin) can result 
in incorrect haemoglobin (hence 'erythema') readouts. 
This is of potential importance in clinical radiobio-
logical studies because increases in erythema are 
paralleled by increases in melanin during conventionally 
fractionated courses of radiation. The development by 
Feather, Dawson and colleagues of a unit [10,20,21,23] 
that overcomes the problem of the interdependence of 
the skin pigments on the 'erythema' readout was 
therefore of interest and was used in a series of clinical 
raciiobiological studies that commenced in 1989. 
One of these studies involved the use of this unit to 
assess skin erythema in investigating the effects of frac-
tionated 'low' (medium) dose rate (FLDR) radio-
therapy. This study was designed to identify dose rate, 
fractionation (a/3 ratio) and repair (t in) parameters for 
cutaneous erythema in response to FLDR treatment. 
With a large data set of matched qualitative and quanti-
tative scores, we therefore had the opportunity to per-
form a detailed comparison of these methodologies and 
investigate the influence of various factors (e.g., sex, 
sun-exposure and treatment site). 
It quickly became apparent that the reflectance spec-
trophotometry measures that we were using to assess 
skin reactions in patients were 'noisier' than measures 
obtained in previous studies which had been confined to 
one anatomical site in patients of one gender [44,45]. 
Our patients had been treated palliatively for metastatic 
disease which meant that a variety of anatomical sites, 
subject to varying degrees of prior sun exposure had 
been treated. The patients themselves varied in age and 
sex. We decided, therefore, to investigate the causes of 
variation in reflectance measures obtained in our data 
set to find out whether the factors identified might be re-
sponsible for variations in the parameters that influence 
dose response. The results of this investigation are 
therefore also presented in this report.  
2. Materials and methods 
2.1. Patients 
The Department of Radiation Oncology at the 
Newcastle Mater Misericordiae Hospital, embarked on 
an experimental fractionated low dose rate (FLDR) 
teletherapy project in 1989 [7] following approval by the 
Hunter Area Health Service Regional Ethics Commit-
tee. This project was designed with the aim of assessing 
acute normal tissue end-points (mucosa and skin) in an 
effort to provide iso-effect data for a range of total doses 
and dose rates. This report refers to data from 91 pa-
tients irradiated with 104 individual fields at either 3.0, 
4.8 or 8.2 Gy/h on a Siemens Caesium-137 teletherapy 
unit and a further 19 patients treated at high dose rates 
on a Varian Clinac 1800 at 6 MV, using identical selec-
tion criteria. Consenting patients comprised those with 
a variety of metastatic solid tumours with systemic 
disease in relatively superficial sites, e.g., lymph nodes 
or axial skeleton. Selection criteria are given in Table 1. 
Due to logistical constraints patients were accrued se-
quentially, rather than by random assignment, to treat-
ment according to a central composite design of total 
dose and dose rate points based on the predictions of the 
incomplete repair model applied at medium and low 
dose rates [8]. Treatment allocation was not prospec-
tively stratified according to age, gender or other poten-
tial explanatory variable and the resulting case 
composition of the series grouped according to treat-
ment dose rate is provided in Table 2. 
All patients accrued on to the study were of Cauca-
sian extraction. Most were of Celtic and Anglo-Saxon 
descendancy. The remainder had middle Mediterranean 
Table I 
Patient selection criteria 
Bony and soft tissue metastases 
(I) 	Proven symptomatic metastatic cancer involving sites that 
can be encompassed satisfactorily by modified caesium beam 
at 60 or 80 cm SSD 
(2) A disease site that has not been previously irradiated, is not 
situated in a pressure area and in which there is no evidence 
of skin or subcutaneous involvement by tumour. 
(3) The patient has not received adriamycin, actinomycin D, or 
bleomycin containing regimes, or is being concurrently 
treated with cytotoxic chemotherapy or other agents that 
may modify radiation response. 
(4) Ability to lie still for a period of up to I hour 
(5) Written informed consent for treatment on protocol. 
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Table 2 
Case composition of the study population according to dose rate 
grouping 
Dose rate oups 
3 Gy/h 	4.8 Gy/h 	8.2 Gy/h 	High dose 
rate 
17 
66 
(41-90) 
43 
70 
(43-82) 
44 
71 
(28-88) 
19 
64 
(46-84) 
8 (47) 29 (67) 34 (77) 15 (79) 
6 (35) 26 (60) 30 (68) 8 (42) 
7 14 15 1 
0 10 14 7 
4 7 4 8 
4 6 5 3 
2 6 6 0 
36.1 36.95 36.9 31.05 
(34.5-41.4) (32.8-41.2) (31.3-40.6) (25.1-34.2) 
14 14 14 15 
(12-16) (12-15) (12-18) (12-20) 
101 92 92 144 
(72-273) (57-273) (57-168) (66-400) 
15 27 28 19 
backgrounds. Solar skin damage, of a severity not usual-
ly seen in Europe and the United States, was a common 
occurrence in the study population and the number of 
treatment fields affected by heavy prior sun exposed are 
also detailed in Table 2. ' 
2.2. Irradiation technique 
Teletherapy at low and medium dose rates was 
delivered using a modified Caesium-137 teletherapy unit 
at extended SSD (60-80 cm). Patients were treated using 
direct appositional fields to cover relevant bony or soft 
tissue disease. Tissue equivalent bolus (2 mm) covered 
the entire field during treatment and dose prescription 
was to the point of maximum electronic build up (Dmax) 
which for the Caesium unit used is 1.0 mm below the 
treatment surface. Specially designed low melting point 
alloy collimator cones were constructed to define the 
beam and minimise penumbra. By the use of appropri-
ate lead attenuation filters, instantaneous incident dose 
rates of 3, 4.8 and 8.2 Gy/h were achieved. Fraction 
times varied between 40 and 90 min per day and careful 
consideration was given to patient comfort and immobi-
lisation during treatment. Treatment was administered 
daily (ten fractions) over a total time period of 12-14  
days and optical proximity switches were used to con-
firm patient position and interrupt treatment if signifi-
cant movement occurred [26]. Patients receiving high 
dose rate teletherapy were treated using single 6-MV 
fields to an identical range of body sites for a variety of 
soft tissue and bony metastatic disease. Treatment was 
delivered on a Varian Clinac 1800, with dose prescribed 
to D which is 15 mm below the treatment surface. 
Treatment was administered daily (ten fractions) over a 
total time period of 12-14 days. If patient geometry and 
field size permitted, tissue equivalent bolus (15 mm) was 
used to cover half the field for each treatment. 
2.3. In vivo dosimetry 
To derive estimates of dose relevant to the basal cell 
layer of the skin, skin dose measurements for 'low' dose 
rate treatments on the Caesium unit were performed 
using paired conventional lithium fluoride ther-
moluminescent dosimeters (TLDs) (diameter 4.5 mm, 
thickness 0 8 mm) (Vinten TLD100) which were applied 
to the field centre on each patient under 2 mm of dental 
wax build up on the first day of the treatment course. 
Results were averaged and if the two readings differed 
by more than 10%, the results were discarded and the 
readings repeated. For high dose rate treatments at 6 
MV, paired carbon-loaded TLDs (Vinten) [42] were in-
serted into a tissue equivalent polystyrene holder and 
applied to the field centre on the patient's skin. No ad-
ditional build up was utilised for these measurements. 
Where 15 mm of bolus was present over half the field, 
a pair of conventional lithium fluoride (LiF) TLDs were 
placed beneath the bolus. In all dose-response analyses 
subsequently described in this report, measured skin 
dose rather than prescribed dose has been used. 
2.4. Qualitative erythema scoring 
All patients on treatment were evaluated twice weekly 
by two independent observers, with scored skin reac-
tions according to a modified EORTC/RTOG scale 
(Table 3). Following treatment skin reactions were 
evaluated at least weekly until all signs of reaction had 
subsided. 
2.5. Quantitative erythema measurement 
Reflectance unit 
Reflectance spectrophotometry measurements were 
performed using an instrument (Spectral Research Pty 
Ltd, Leeds, UK) developed by Feather et al. 
[10,20,21,23]. Thirty-four fields Studied prior to the 
unit's arrival in 1991, and included in the present analy-
sis, did not have a full set of reflectance readings (Table 
2). Full details on construction and validation of the 
performance of the unit have been provided by Feather 
Total number 
of fields 
Age, years; 
median (range) 
Male, no. (.4) 
Heavily sun-
exposed fields, 
no. (%) 
Head and neck 
Upper torso 
Lower torso 
Pelvis 
Limbs 
Total measured 
dose, Gy; 
median (range) 
Overall time, 
days; 
median (range) 
Field size, cm2; 
median (range) 
Full set of 
reflectance 
measures, no. 
of fields 
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Table 3 
Modified EORTC/RTOG grading system for acute skin reactions used 
in this project 
Skin 
0 No change over base line 
iA a Follicular faint erythema, epilation, dry desquamation, decreas-
ed sweating 
1B' As above but confluent bright pink erythema 
2 Tender or dusky erythema, patchy moist desquamation. moderate 
oedema 
3 Confluent, moist desquamation other than skin folds, pitting 
oedema 
4 Ulceration, haemorrhage, necrosis 
'This distinction is a local one and therefore represents a modifi-
cation. 
and colleagues [21,23]. Briefly, the unit samples at 150 
different wavelengths throughout the entire optical spec-
trum (400-700 nm) to derive estimates of deoxy-
haemoglobin, oxy-haemoglobin and melanin 'content'. 
Software incorporated within the unit corrects the 
reflected values measured for the influence of absorp-
tion by each pigment on the others prior to output. It 
achieves this by evaluating the gradients of the log in-
verse reflectance spectrum between isobestic points for 
the deoxy- and oxy-haemoglobin absorption spectra at 
527.5, 544 and 573 nm to provide a haemoglobin index 
independent of the oxygenation of the haemoglobin and 
skin melanin content. A combination of this index with 
measurements at 558.5 nm then provides a measure of 
oxygen saturation [21]. Finally, evaluation of the gra-
dients of measurements obtained at 650 and 700 nm pro-
vide a measure of melanin pigmentation that is 
independent of both deoxy- and oxy-haemoglobin [23]. 
If desired, all 150 reflected values across the entire opti-
cal spectrum can be read out. 
Reflectance readings were taken pre-treatment and at 
twice weekly intervals during and at least weekly after 
the course of radiotherapy, until the acute erythematous 
reaction had returned to baseline. Measurements were 
taken in the recumbent position, after 5 min rest in a 
constant ambient temperature of 22°C. Five measure-
ments of the haemoglobin index were obtained at the 
centre of the treatment field and the mean of these used 
to represent the reflectance reading for that day. In a 
similar fashion, five readings were also taken at a 'con-
trol' point at least 3 cm outside the radiotherapy treat-
ment field. The measurement constancy of the 
reflectance unit was checked on a daily basis utilising a 
specific artificial absorbence filter (Wratten filter) (mean 
daily reflectance reading 53.33 S.D. 2.23). 
Pilot reflectance study 
In order to test the usefulness of baseline reflectance 
readings and assess the impact of physiological van- 
ables, treatment related variables unconnected with )1 
ray dose and previous sun-exposure, a control study WE 
designed in which twelve patients (six males, six 11 
males), who were undergoing a course of conventional] 
fractionated external beam radiotherapy, had twic 
weekly reflectance readings performed at sites distant t 
their irradiated field. Three of each of the six patients i 
each group had measurement sites chosen which had lit 
been previously sun-exposed and the remaining thrt 
had sun-exposed measurement sites chosen. In order t 
assess the temporal variability of control readings, a st 
quence of five erythema indices were measured and n 
peated at intervals of 8 min over a 40-min perioc 
During this 40-min measurement period, the pulse ratl 
blood pressure (systolic and diastolic), respiratory rat 
and skin temperature (Medtel instruments), on each c 
the twelve control patients was measured. An average c 
62 measures per patient was obtained. 
2.6. Analytical methodology 
All data was transcribed onto a PC-based tempon 
database (MEDLOG, Systemedica), and simple descrir 
tive statistics and quantal response data, based on th 
erythema measures exceeding given values, wei 
generated directly from this database. The generalise 
linear regression model (type III Statistical Analysis Sy: 
tems) was used to correlate observed reaction gradt 
with reflectance data and to test for the independent e: 
fects of age, sex, site, sun-exposure, measured dose an 
instantaneous dose rate on the dependent variable 
baseline erythema measure, rate of erythema develor 
ment and the various peak erythema measures testec 
These peak measures included: 
(1) Raw peak erythema (Er). Erythema at time t is E 
(2) Peak change in erythema (peak erythema mint 
initial erythema ; — E0). This measure represents a 
absolute change in erythema value. 
(3) Peak erythema index (peak erythema divided b 
initial erythema Er/A). This measure represents a prt 
portional change in erythema measure. Erythema inde 
at time t is E,/E0. 
(4) Peak percentage change in erythema (pea 
erythema minus initial erythema divided by inith 
erythema, all multiplied by 100) 
Ep_-_-.E;) x 100 
E0 
This method also represents a proportional change ii 
erythema measure. 
(5) Duration of reaction at 6 erythema units abov 
baseline. 
(6) Duration of reaction at 12 erythema units abov 
baseline. 
Mean value Coeffi- (%) Mean 	Coeffi- 
cient of value 	cient of 
variation 	 variation 
(%) 
Inter-patient variation 
Males 
Sun-exposed 20.6 (n = 37) 38.9 25 (n = 3) 22.3 
Non-exposed 14.2 (n = 22) 30.3 13.1 (n = 3) 14.5 
Females 
sun-exposed 17.2 (n = 13) 28.9 17.5 (n = 3) • 	 8.6 
Non-exposed 14.5 (n = 17) 31.7 8.1 (n = 3) 29.7 
All 17.4 39.8 16.3 41 
J. W. Denham et al. /Radiotherapy and Oncology 36 ( 1995) 107-120 	 III 
(7) Duration of erythema at 18 units above baseline. 
(8) Area under the total reaction curve. 
Table 4 
Coefficients of inter- and intra-patient variation for the study group 
and the pilot group 
   
The coefficient of variation for inter and intra patient 
variation was calculated using 
S.D./ Y x 100% 
where S.D. is the standard deviation of all sequential 
control erythema values for each individual patient 
(intra-patient variation) and .7 is the mean of each pa-
tient's sequential control erythema values. For inter-
patient variation, S.D. is the standard deviation of all se-
quential control erythema readings for the group or sub 
group under consideration and is the mean for that 
group or sub-group. 
2.7. LQ analytic techniques 
Study group (n = 89 
control sites) 
Intra-patient variation 
mean coefficient of 
variation 12% 
Pilot (n = 12) 
mean coefficient of varia-
tion 11.9% 
A modification of the reciprocal dose plot metho-
dology [14] was used to provide an indirect estimate of 
the a/0 ratio and the half time of repair t 112. This meth-
od requires conversion of the low' dose rate data was 
required to be converted to an 'effective' dose per frac-
tion (d). Dale [8] defined a new parameter K which, 
when multiplied by the dose rate, is analogous to the 
dose per fraction (d) in fractionated high dose rate radia-
tion. K depends upon the parameter A (the repair cons-
tant, units 11 -1) which in the analyses presented herein 
was varied to obtain the most plausible fit of different 
permutations of a/0 and t 12 values to the data. 
Direct estimates of the a/0 ratio and repair half time 
were obtained using the a0est program of Bentzen et al. 
[4]. This program uses individual patient data to derive 
estimates. For the purposes of these analyses, a "re-
sponse" in the individual patient was defined as a peak 
erythema measure exceeding the median peak erythema 
value for the entire study population. 
3. Results 
3.1. Patient variation 
The mean control reflectance values and the coeffi-
cients of variation at an inter- and intra-patient level for 
the study patients and the twelve pilot patients are 
presented in Table 4. Both these groups of patients 
clearly demonstrated differences in control reflectance 
readings, related to both gender and previous sun-
exposure of the site under consideration (for FLDR pa-
tients this control reading was at least 3 cm outside the 
treatment field and for pilot patients these readings were 
derived from another body region). Multiple linear 
regression analysis for the FLDR patients in the pilot 
study, using the same explanatory variables, demon-
strated identical trends and significance values in the 
range 	4-30% range 	5-24% 
The study group had an average of 11.8 sequential readings per patient 
and the pilot group an average of 62. 
two sets of patients. Males with sun-exposed measure-
ment sites had higher baseline reflectance readings in 
both the FLDR study and pilot study patients. The 
study control sites tended to show higher coefficients of 
variation at an inter-patient level in comparison to the 
pilot study patients. Multiple linear regression analyses 
on the FLDR study patients (not shown) demonstrated 
that both the baseline and entire set of out of field con-
trol erythema readings were significantly correlated with 
both gender and site. Although sun-exposure was 
strongly correlated, when considered as a solitary 
variable it failed to maintain significance in the multiple 
regression procedures when measurement sites in the 
head, neck and upper torso, which themselves were fre-
quently heavily sun exposed, were taken into account. 
These sites were associated with higher control erythema 
readings than other less exposed sites such as the lower 
torso and pelvis. Additional findings included an 
association between the baseline erythema measure and 
melanin pigmentation. 
Both the FLDR study and pilot study patient groups 
demonstrated similar intra-patient variability with mean 
coefficients of variation of 12 and 11.9%, respectively. 
The 12 cancer control patients exhibited no systematic 
variation in erythema values over the 4-6-week mea-
surement period nor during the post-treatment measure-
ment period (40 min). No significant linear or non-linear 
trends were seen with measured haemoglobin values and 
any of the physiological parameters studied (blood pres-
sure, pulse rate, respiration and skin temperature). 
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3.2. Time course of observed reactions 
The time course of graded skin reactions and reflec-
tance measures following the FLDR regimes applied in 
this study showed several typical patterns. The reaction 
peak was seen between 30 and 40 days from the com-
mencement of treatment and had returned to baseline 
between 90 and 110 days. It will be noted in Fig. 1 that 
the rate at which erythema developed was more rapid in 
patients treated at high dose rate. In 46% of cases, 
observed graded skin reaction corresponded temporally 
with the measured erythema index (Fig. 2A). In 34% of 
cases a rise in erythema index was clearly seen to precede 
the observable subjective response (Fig. 2B). In 7% of 
cases the observed graded skin reaction clearly preceded 
the rise in measured erythema index, and in a further 4% 
the reflectance score both preceded the rise in observed 
skin reaction and return to baseline well after the 
observed skin reaction had settled. In a small percentage 
of patients (9%) no discernible correlation existed. In 
approximately one third of cases, a clear 'dip' in the 
measured erythema reading, usually seen in the second 
week of treatment, was demonstrated. This 'dip' was not 
detected in the qualitative visual scoring (Fig. 2B) and 
sometimes descended below baseline levels. In 23% of 
cases the measured control reflectance readings, 
measured simultaneously 3 cm outside the treated field, 
appeared to parallel the in-field responses (Fig. 2C). 
These temporal patterns in and out of the field were not 
related to gender, age, site or sun-exposure, but did ap-
pear to be influenced by the dose rate at which treatment 
was delivered. Out of field reactions were more frequent 
and more intense in patients treated at high dose rate. 
3.3. Relationship of reflectance reading to observed skin 
reaction grade 
For identical reflectance erythema readings, male pa-
tients, melanin pigmented and sun-exposed anatomical 
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Fig. 1. Pooled time course data for patients treated at high dose rate 
and for the entire group of patients treated at low' dose rates. 
Reflectance M4asure 
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Fig. 2. (A) Typical patient reaction curve demonstrating close match-
ing of measured erythema index (closed circles) and observed skin 
reaction grade (open bars) with time. (B) Typical patient reaction plot 
demonstrating clear rise in erythema index (E1 E0) (closed circles) 
prior to observed erythema and existence of a dip in erythema measure 
during the second week of therapy. (C) Suggestive temporal relation-
ship of and control erythema readings in a typical patient 
demonstrating this phenomenon. 
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sites were assigned lower visual reaction grades. Divi-
sion of the erythema measure by the baseline measure 
(i.e. Ego) or subtraction (i.e., E, — E0) reduced the size 
of these variations and produced a substantial improve-
ment in the correlation between observed grade and 
reflectance measure. The relationship between erythema 
index and graded score did not vary substantially during 
the time course of the reaction, with similar correlation 
coefficients, slopes and intercepts observed in the early, 
middle and late parts of the reaction. 
Whilst reasonable correlation was found to exist be-
tween reflectance values and the observed skin reaction 
score, good concordance was not (Fig. 3) with substan-
tial overlap in grade assignment. For differences of 15 
units between the observed reading and the baseline 
reading, some 10% of assigned ordinal scores were zero, 
48% of assigned scores were graded at 1 A and 30% at 
1B. It was only below differences of 5 units that there 
was good consensus that no reaction (zero grade) was 
present. It was only above differences of 20 units that 
perfect consensus existed that a reaction was present, 
but there was no consensus as to its grade. 
3.4. Factors influencing initial erythema value 
Initial reflectance values were found to vary from in-
dividual to individual even prior to the application of 
treatment. Results from generalised linear regression 
analysis (not shown) suggested that male patients and 
head and neck sites returned the highest baseline 
erythema values, independent of other variables. In ad-
dition, higher baseline erythema readings were seen to 
correspond with higher baseline melanin readings. 
Fig. 3. Probability of observer assigning a given reaction grade for dif-
ferent changes in erythema measure from the baseline measurement 
(Er - E0). The data points represent data binned at 5-unit intervals. 
3.5. Dose-response relationships 
'Peak erythema' measures (Er) failed to correlate 
with measured surface doses. In some patient subsets, 
small positive relationships were observed but in some, 
small negative relationships were noted and, in all, cor-
relation coefficients were low. The 'peak erythema 
index' (Er/E0)  and 'peak percentage change' ([Er — 
E0 x 100), on the other hand, produced positive cor-
relations with increasing measured dose in all patient 
subsets examined, with correlation coefficients that 
ranged between 0.12 and 0.32 but none that differed 
significantly (statistically) from zero. Area under the 
reaction curve and duration of reaction at 6 units above 
baseline also produced positive dose-response correla-
tions in all patient subsets but with even less significant 
correlation coefficients. Inferior correlations were seen 
for duration of reactions at 12 and 18 units above base-
line due to an increasing number of zero scores in all 
subsets. No significant differences in dose response be-
tween groups treated at 3, 4.8 and 8.2 Gy/h were 
observed (Fig. 4), but a difference between patients 
treated at high dose rate and all patients treated at low 
dose rates was seen and is depicted in the quantal re-
sponse plots presented in Fig. 5. 
Fig. 5 also demonstrates that no dose-response rela-
tionship could be elicited for duration of time spent at 
Grade 1A or 1B observed reaction grades. Unfortunate-
ly no dose-response relationship could be elicited from 
the proportion of patients reaching each reaction grade 
either. 
Fig. 4. Peak erythema index (EVE@ according to total measured dose 
for fields treated at 3, 4.8 and 8.2 Gy/h. 
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Fig. 5. Quantal dose-response plots (where response is defined as a 
peak erythema index [Ep/E0] exceeding 1.9, i.e., a percentage change 
greater than 900/0) for patients treated at high dose rate and in all low 
dose rate groups combined. Closed squares represent response data 
for duration of reaction at Grades IA and B for the patients treated 
at low dose rate, where response frequency corresponds to a peak 
erythema index of 1.9. (For 34 fields studied a full set of reflectance 
measures was not available.) 
3.6. Factors influencing the dose response relationship 
Generalised multiple linear regression models that ex-
amine the influence of two different sets of co-variates  
on peak erythema index are presented in Table 5. In 
both models increasing peak erythema index correlated 
positively and independently with total dose and dose 
rate predicting that doses of 30 Gy at high dose rate 
would produce identical erythema indices as doses in the 
range 36.5-37 Gy at 4.8 Gy/h. This corresponds well to 
the dose-response plots presented in Fig. 5. Increasing 
age, on the other hand, led to less marked rises in peak 
erythema index for the same given dose in both models. 
Although the binary variable sun exposure did not ap-
pear to exert an independent effect on peak erythema 
index, anatomical sites that are often the site of previous 
heavy sun exposure (namely the head and neck and 
upper torso) experienced lower peak erythema indices 
than less exposed sites. 
In the first model presented in Table 5, females ap-
peared to develop greater increases in erythema index 
than males, following the same dose, regardless of age, 
site or dose rate. In the second model, however, in which 
baseline erythema reading was included, the influence of 
gender remained but at considerably diminished 
strength. In this model baseline erythema emerged as a 
powerful inverse determinant of subsequent peak 
erythema index independent of the effect of total dose, 
dose rate, age, site or gender. In separate models (not 
shown) in which absolute (Ep - E0), rather than pro-
portional (Ep/E0), peak change in erythema was used as 
the dependent variable, the influence of gender retained 
significance in spite of the inclusion of baseline 
erythema in the models. 
3.7. Factors influencing the rate of erythema development 
Multiple linear regression modelling, summarised in 
Table 6, confirmed the impression suggested by the time 
70 - 
10 r// 	 
0 28 
Table 5 
Two generalised multiple linear regression models that examine the influence of a range of co-variates on the peak erythema measure obtained 
after radiation. Dependent variable = peak erythema index (Ep/E0) 
Model 1 Model 2 
Coeff S.D. p Value Coeff S.D. p value 
Total dose (GY) 0.06 0.02 <0.01 0.05 0.02 0.02 
Dose rate (GY/b) 0.002 0.001 0.02 0.001 0.001 0.04 
Head and neck (y=1,n=0) -1.1 0.45 0.02 -0.66 0.42 0.12 
Upper torso (y=1,n=0) -1.0 0.46 0.03 -0.79 0.41 0.06 
Lower torso (y=1,n=0) -0.87 0.47 0.07 -0.81 0.42 0.06 
Pelvic (y=1,n=0) -0.94 0.47 0.05 -0.82 0.43 0.06 
Arm (y=1,n=0) -0.5 0.47 0.29 -0.4 0.43 0.35 
Sun exposure (y=1,n=0) -0.15 0.12 0.21 -0.09 0.11 0.39 
Age (years) -0.01 0.004 0.01 -0.009 0.004 0.01 
Gender (m =0, f = 1) 0.27 0.1 0.03 0.1 0.1 0.32 
Baseline erythema (units) Omit Omit Omit -0.03 0.01 <0.01 
Intercept values 1.25 0.87 0.15 2.15 0.81 0.01 
The models differ in that Model 1 does not incorporate the influence of baseline (pretreatment) erythema, which in Model 2 is seen to exert an 
independent influence. (Field size failed to exert an influence in models in which this co-variate was incorporated.) Omit, variable omitted from 
model; Coeff, regression coefficient; S.D., standard deviation of coefficient. 
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Table 6 
Two generalised linear regression models that examine the influence of a range of co-variates on the rate of development of erythema following 
treatment. Dependent variable = rate of erythema development (erythema units/day) 
Model 1 Model 2 
Coeff S.D. p Value Coeff S.D. p value 
Total dose ((jYa) 0.03 0.02 0.02 Omit Omit Omit 
Dose rate (GY/h) 0.002 0.001 0.04 0.002 0.001 0.03 
Head and neck (y= 1,n=0) -1.44 0.44 <0.01 -1.33 0.44 <0.01 
Upper torso (y=1,n=0) -1.76 0.43 <0.01 -1.67 0.43 <0.01 
Lower torso (y=1,n=0) -1.8 0.44 <0.01 -1.69 0.44 <0.01 
Pelvic (y=1,n= 0) -1.87 0.45 <0.01 -1.77 0.45 <0.01 
Arm (y=1,n=0) -1.65 0.44 <0.01 -1.48 0.45 <0.01 
Sun exposure (y= 1,n=0) -0.18 0.11 0.1 -0.19 0.11 0.1 
Age (years) -0.008 0.004 0.04 -0.008 0.004 0.05 
Gender (m = 0, f = 1) -0.19 0.1 0.07 -0.21 0.11 0.05 
Baseline erythema (units) -0.01 0.01 0.28 -0.01 0.01 0.37 
Dose intensity (GY/daYa) Omit Omit Omit 0.24 0.16 0.14 
Intercept value 2.12 0.85 0.01 232 0.68 <0.01 
The models differ in that 'dose intensity' in Model 2 substitutes for 'total dose' in Model 1. (For the purpose of these analyses rate of erythema 
development has been assumed to be linear up to the time of peak erythema measurement and dose has been corrected for biological effect using 
fin values estimated by direct analysis for the complete data set, i.e., alO 7 Gy and t 1,2 0.06 h). Omit, variable not included in model; Coeff, regres-
sion coefficient; S.D., standard deviation of the coefficient. 
course data (presented in Fig. 1) that dose rate exerts an 
influence on the rate of erythema development that is in-
dependent of other variables. Patients treated at high 
dose rate developed corresponding measures of 
erythema more rapidly than patients treated at 'low' 
dose rates. It is of interest that the influence of dose rate 
was independent of the influence of either total dose ad-
ministered or dose intensity (in Gy/day or 'biologically 
equivalent' Gy/day) which exerted only modest (non-
significant) influences themselves. 
3.8. Indirect and direct quantal analysis 
Because dose-response plots and multiple regression 
analyses (not shown) failed to demonstrate a dose rate 
effect in the range 3-8.2 Gy/h, data derived from all 
three groups treated in this range (i.e., 3, 4.8 and 8.2 
Gy/h) were therefore pooled for the purpose of indirect 
analysis using the modified reciprocal dose metho-
dology described in Patients and methods. 
Fig. 6 presents a reciprocal dose plot fitted through 
isoeffect estimates derived from the multiple regression 
procedures. Because the parameter K depends on the re-
pair constant g, the slope of the reciprocal dose plot fits 
a range of permutations of a/0 and tin. The relation-
ship, which is shown in the inset graph in the figure, is 
an inverse one. If a t u2 value of 0.04 h were considered 
appropriate, then the ali3 ratio (intercept of the slope de-
rived from the present data) would be 8 Gy. On the 
other hand, if t 1 ,2 values above 0.2 h were considered 
more appropriate, then the present data would be fitted 
by extremely low, or even negative, values of a/0. Direct  
analysis of the data using the ai3est program provided a 
measure of agreement with this relationship by converg-
ing on an a/13 ratio of 6.9 Gy and a t12 value of 0.06 h. 
It should be noted, however, that the program returned 
indefinite 95% confidence intervals for these estimates. 
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Fig. 6. A reciprocal dose plot based on the proportion of patients 
treated at high dose rate and the entire group of patients treated at dif-
ferent 'low' dose rates (i.e., 3-8.2 Gy/h) whose peak erythema index 
measure exceeded the median value for the whole study population. 
The parameter K depends upon the magnitude of the repair constant 
(see Dale et al. [8]). The inset graph therefore provides the relationship 
between the different permutations of al$ and r i ,2 that provide a fit to 
the data. The x axis of the main graph has been based on a t in value 
of 0.05 h and the data fit a slope that intercepts the x axis at -7.7 Gy. 
A fit to the data is therefore provided by an a10 ratio of 7.7 Gy and 
tu2 of 0.05 h. The inset graph suggests, however, that the fit provided 
by 4 Gy and 0.15 h, for example, might be equally as appropriate. 
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4. Discussion 
4.1. Reflectance spectrophotometry 
The colour of non-pigmented skin is largely determin-
ed by quantity of blood in the dermis, particularly in the 
sub-papillary venous plexus. Work by Dawson et al. 
[10] has confirmed the validity of simplifying the behav-
iour of human skin to that of a closed reflectance cell, 
where it is assumed that fibrous protein, collagen and fat 
do not contribute significantly to the reflectance spec-
trum and that the diffuse reflectance of the lowest col-
lagen layer closely approximates one. Therefore, the 
pigments above this layer, (oxy-haemoglobin, deoxy-
haemoglobin and melanin) are the chief light absorbing 
compounds which determine skin colour. The develop-
ment of the science of photomedicine has stimulated the 
production of a number of reflectance instruments in the 
response to the need to precisely characterise the inflam-
matory response seen in a variety of dermatological con-
ditions [1,6,18,20,31,32,39,40,51,52], since the visual 
assessment of erythema does not fulfil this criteria, even 
when aided by various comparative visual grading scales 
[3]. The reflectance spectrophotometer used in the pres-
ent study has been shown to provide measures that are 
linearly proportional to haemoglobin concentration in 
both the in vivo and in vitro settings [10,19-21,23]. The 
unit utilises the entire optical wavelength for assessing 
the reflectance spectrum and incorporates algorithms to 
provide independent measures of haemoglobin index, its 
oxygen saturation and melanin content. Reflectance 
units used in other reported studies differ in that they 
sample at specific wavelengths and make no correction 
for melanin. This means that caution must be exercised 
when comparing the results obtained in the present pro-
ject with previous studies performed elsewhere. 
We have found the reflectance spectrophotometry 
unit employed in this study capable of reproducible 
erythema readings which typically varied by approx-
imately ± 2-5 erythema units on otherwise unperturbed 
skin. There was no significant inter- or intra-observer 
variation related to the use of the unit and calibration 
tests utilising the Wratten filter produced similar con-
stancy of measured output. The pilot study group results 
indicate a relative constancy of erythema in a compar-
able patient population measured under the same 
physiological conditions. Our control data demon-
strated an intra-patient variability of 12% for this tech-
nique which compares with a value of 31% reported by 
Russell et al. [38]. The reflectance unit used was clearly 
more sensitive than the naked eye in detecting early radi-
ation erythema. Our reflectance data also suggested the 
possibility of a decline in reflectance values during the 
second week of therapy that went undetected by the 
naked eye. This may correspond to the primary and 
secondary waves of erythema observed by early  
radiotherapists treating with orthovoltage apparatus. In 
some instances, the dip in erythema index fell below the 
baseline value suggesting the possibility that an in-field 
vaso-constrictive response may also be contributing the 
overall manifestation of the erythematous response. The 
relationship of erythema index to observed grade ap-
peared to be relatively constant during the entirety of 
the reaction suggesting that other observable changes 
such as desquamation, oedema and increasing pigmen-
tation, did not obviously influence the clinical scoring 
process with respect to erythema. 
4.2. Comparison with qualitative data 
A disappointing lack of concordance between 
measured erythema index and observed grade was evi-
dent with large intra- and even greater inter-observer 
variations leading to substantial overlaps in scoring 
Grade 1A, 1B and 2 skin reactions in this study. For the 
same reflectance erythema reading, greater reaction 
grades were assigned to females and at non-sun-exposed 
less pigmented treatment sites. To some extent, these 
variables are related, in that females generally tended to 
have less previous sun-exposure. It is possible to con-
clude however, that subjective grading in this study 
relatively under-estimated erythema in males and at 
heavily sun-exposed treatment sites. The reason for this 
observation is unclear. It is possible that the naked eye 
and the reflectance spectrophotometer respond to dif-
ferent signals. Perhaps subtle differences in the sub-
epidermal vascular plexus of the type identified by 
Forbes and Argenbright [3] explain the discrepancies we 
observed between reflectance reading and erythema 
score in patients of different sex and at different sites. 
Alternatively, it may be easier to assign a reaction grade 
on a skin that is paler and less pigmented to start with. 
Daniel and Imbrey [9], discussed these problems in con-
siderable detail and concluded that the human eye is an 
excellent device for sensing a quantal event (i.e., a 
change in appearance), but is inadequate in delineating 
graded difference of erythema or, most importantly, 
changes over time. In our study, the derived measures, 
erythema index (E,/E0) and change in erythema 
(E, — E0), reduced the influence of gender and site on 
reaction scoring. This is possibly because, as Daniel and 
Imbrey have pointed out, the eye is good at detecting 
changes which are effectively introduced by these 
derivations. 
4.3. Dose-response relationships 
While it is disappointing that we were unable to define 
a dose-response relationship using our qualitative scale 
of skin reaction, this can not be taken to mean that the 
scale based on the RTOGIEORTC grading criteria has 
no value in the clinic for comparing acute skin reactions. 
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It is pointed out that the range of doses used in the pres-
ent study was relatively small and was in the palliative 
range. Very few patients experienced brisk erythematous 
reactions associated with significant desquamation The 
present study therefore does not exclude the possibility 
that dose-response relationships might be derived in 
groups of patients treated to higher doses and who expe-
rience reactions than span the entire range of the scale 
used (i.e., including desquamation). For example, 
Dutriex and colleagues [15] utilised the ability to dis-
criminate between different grades of desquamation to 
produce a dose-response curve for human skin with 
relatively small patient numbers by simultaneously com-
paring supra-clavicular reactions in the one patient. 
Data from the present study merely show that reflec-
tance Spectrophotometry is a more reliable instrument 
for measuring erythematous skin reactions than the 
naked eye. 
Although more reliable than the naked eye, reflec-
tance measures did not provide the well-defined rela-
tionships between dose administered and erythematous 
response that we were hoping for. Interpatient variabili-
ty in reflectance response and choice of the appropriate 
measure of erythematous change proved to be the great-
est problems. The failure to derive meaningful dose-
response relationships (i.e., with positive slopes and rea-
sonable correlation coefficients) using our raw peak 
erythema (Er) data quite probably stems from the fact 
that peak erythema is so strongly dependent on initial 
erythema measure and that this measure varied con-
siderably in all patient subsets. The use of a control 
erythema obtained simultaneously in unirradiated skin 
outside of the field to correct for systematic variations 
and transient changes in erythema is a theoretically ap-
pealing method of assessing change in erythematous 
measure due to treatment. In -practice, however, selec-
tion of an appropriate control site can be difficult. In the 
present study, for example, in which we used a point 3 
cm from the field edge, we observed clear rises in 
erythema outside of the field that paralleled rises within 
the field in approximately a quarter of all patients. This 
phenomenon, which was recognised by Jolles and 
Mitchell in 1947 [29] in patients treated with or-
thovoltage apparatus (and called by them 'the reciprocal 
vicinity effect'), suggests the possibility that humoral 
factors produced within the field alter capillary blood 
flow both inside and outside the field for some distance. 
Although no patients enrolled in the study had overt 
skin involvement by tumour, underlying nodal or bony 
disease may also have had local effects on blood flow in-
fluencing erythema values obtained. This hypothesis is 
supported by the fact that pre-treatment reflectance 
measures exceeded control measures by up to 3 units in 
approximately 20% of patients. 
Peak measures of proportional change in erythema 
(peak erythema) index (Er/E0) and percentage erythema  
increase ([Er — E0]/E0  x 100) probably provided better 
dose-response relationships in this study, in all patient 
subsets, because these manoeuvres reduce the effect of 
variations in the initial erythema. Baseline erythema dis-
tributions are negatively skewed in all patient subsets 
and division of subsequent readings by baseline 
erythema tends to normalise and reduce the variance of 
the distribution of these values. Duration of erythema at 
given levels above baseline and area under the reaction 
curve probably did not provide better dose-response re-
lationships than peak erythema index because these par-
ameters were so highly correlated. In a separate report 
[12] we have pointed out that duration of oropharyngeal 
mucosal reactions at a given grade can provide a more 
precise measure of effect than peak grade itself (an or-
dinal measure). This is because a range of 'biological' 
doses will produce the same ultimate reaction grade. 
However, erythema index measured by reflectance spec-
trophotometry is a continuous variable, and is *shown 
herein to be a more sensitive measure of erythema than 
erythematous grade assessed by the naked eye. 
4.4. Radiobiological implications 
In our multiple regression analyses, the range of fac-
tors found to influence baseline erythema value, rate of 
erythema development and peak erythema measure in-
dependently of the dose actually delivered is interesting 
because their influences are not well documented in the 
literature. The finding that baseline reflectance ery-
thema values are higher in males and at sun-exposed 
sites such as the head and neck is not surprising, how-
ever, because it is to be expected that patients with 
higher serum haemoglobin concentrations (e.g., male 
patients) and sites where chronic vasodilatory changes 
are present (e.g., heavily solar damaged sites) should 
have greater haemoglobin concentrations measured in 
the subpapillary plexus. 
Although the multiple regression models that address-
ed the influence of factors other than dose on change in 
erythema due to treatment suggested some causes for 
inter-patient variation in response, it must be cautioned 
that the models did not explain the entire variation wit-
nessed in the study. This is not particularly surprising in 
itself. The study by Russell et al. in Amsterdam [38], 
which focussed on one treatment site in one gender, 
identified significant variations in inter-patient response 
to similar radiation doses. Gender, advancing age and 
site emerged in the present study as the most powerful 
sources of inter-patient variation in response. However, 
how these factors can influence the haemoglobin con-
tent of the subpapillary plexus after irradiation is more 
difficult to explain. Unless basal cell radiosensitivity 
varies with these factors, it must be postulated that fac-
tors other than basal cell killing influence degree of 
vasodilation that occurs in response to radiation. Unfor- 
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tunately little is known about the mediators of radiation 
erythema. Inflammatory mediators such as the 
ecosanoids and related compounds, TGF, TNF and 
other cytokines [2,5,27,28,30-32,36,37] have been im-
plicated in the expression of erythema and it is thought 
that the pre-capillary sphincter represents the major vas-
cular target for mediators such as these. Other 
mediators such as histamine and e-amino caproic acid 
may also be involved in the production of erythema via 
altered vascular permeability [16,37]. From work per-
formed in relation to ultraviolet-induced erythema [30] 
there is considerable evidence to indicate that a vasoac-
tive mediator released from the epidermis, diffusing into 
and around dermal blood vessels, represents the most 
appropriate model for the generation of UV-induced 
erythema. Our data suggcst that the reactivity of the 
subpapillary plexus is at least in part influenced by gen-
der, increasing age and, probably, by prior solar 
damage However, whether these factors influence the 
release of vasoactive substances or alter the reactivity of 
the target sites for these substances can not be establish-
ed from the present study and will remain a matter for 
speculation until studies addressing these phenomena 
are undertaken. 
The failure of this study to demonstrate dose rate ef-
fects in the range 3-8.2 Gy/h (Fig. 4) does not necessari-
ly mean that dose rate effects in this range do not exist. 
Substantial inter-patient variations associated with 
heterogeneities in the dose rate subsets with respect to 
age, gender site, etc. (see Table 2), could have quite easi-
ly obscured differences due to dose rate in reflectance 
response over the limited dose range studied. The differ-
ences in dose response demonstrated in the regression 
models shown are therefore almost entirely due to dif-
ferences in erythema produced in the entire group of pa-
tients treated at 'low' dose rate and the group treated at 
high dose rate. Whether these differences are exclusively 
due to differences in basal cell killing in the two dose 
rate ranges is a moot point, however. The finding that 
rate of erythema development inside the field was more 
rapid in patients treated at high dose rate independently 
of the dose administered or its intensity, together with 
the finding that patients treated at high dose rate also 
had more intense out of field erythema changes, could 
suggest the presence of a separate mechanism of 
erythema induction that is not related to basal cell kill-
ing, but which is also dose rate dependent. 
The estimates for the a/t3 ratio and repair half times 
derived by indirect and direct means in this project have 
more interest value than true meaning in our opinion. 
There is little doubt that the size of inter-patient varia-
tions in reflectance response, together with hetero-
geneities in the data set and the limited range of doses 
studied, contributed to the indefinite confidence inter-
vals around the direct estimates of 6.9 Gy for a.113 and 
0.06 h for repair half time obtained. However, the value  
for alt1 estimated from the present data set is not 
dissimilar from previous estimates for treatment courses 
of 2-3 weeks duration [43,49]. It is the repair half time 
estimate that is remarkably short and which deserves 
further consideration [41]. The indirect analysis 
depicted in Fig. 6 suggests that more plausible values for 
t 1 ,2 would not be compatible with the data unless much 
lower (and even negative) values of altit are countenanc-
ed. Of course, the incomplete repair model used in our 
analyses assumes monoexponential repair kinetics. If 
this assumption is incorrect for the basal cells of the 
human skin, as already suggested by Turesson and 
Thames [49], and if an extremely rapid repair process 
that is completely overwhelmed by relatively small frac-
tional doses delivered at high dose rate were to exist, 
then the incomplete repair model could return very 
rapid half time values from data derived from studies 
comparing treatments administered at high and low 
dose rates (such as the present one). However, to return 
a value as low as 0.06 h, the proportion of the overall 
repair process contributed to by a rapid process, that 
has a half time shorter than 5 min, would need to be 
substantial. For this reason, we suspect that dose rate-
dependent mechanisms of erythema production 
unrelated to basal cell killing could be responsible for 
the apparent paradox provided by our analyses. 
Although erythema has long been held to be depen-
dent on basal cell killing, it has often been speculated 
that the relationship is not straightforward and that 
other factors may be operative. Recently Nyman and 
Turesson have shown that reflectance measures of 
erythema bear a relationship with basal cell density mea-
sures in women treated with a variety of fractionation 
schemes in the management of primary breast cancer 
[35]. However, paradoxical results in a group of these 
patients treated on an accelerated fractionation regimen 
suggested that erythema measure and basal cell density 
may not reflect total basal cell kill. The present study 
has been helpful because it has identified factors other 
than basal cell killing that may influence the 
erythematous response and which may be amenable to 
further study. 
We are currently completing a reflectance project 
using varying fraction numbers at high dose rate which 
we hope will provide further data that will help to better 
define the relationship between erythema induction and 
increasing dose at different dose rates. In future studies 
we will heed an important lesson from the present study 
by ensuring that treatment allocation will occur follow-
ing stratification according to gender. age and site, or be 
confined to one site in one gender. 
5. Conclusions 
We conclude that: 
• The erythematom component of the acute skin reac- 
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tion in humans is assessed more reliably using the 
reflectance spectrophotometer than by eye. The unit 
used by us was sensitive to out of field effects and 
dips in erythema during the first and second weeks of 
therapy that went undetected by eye. It was also sen-
sitive to differences in baseline erythema according to 
treatment site, gender and previous UV exposure and 
enabled the generation of derived measures that cor-
related with increasing dose delivered more satisfac-
torily than increasing reaction grade scored by eye. 
• Factors unrelated to dose such as age, gender as well 
as prior sun exposure also contribute to the degree of 
erythema that occurs following irradiation. These 
factors have contributed to but do not entirely ex-
plain the substantial inter-patient variation in re-
sponse observed in this study. 
• Dose rate is a factor that influences both the degree 
of erythematous change and the rate at which the 
change occurs. Mechanisms other than basal cell kill-
ing, however, are implicated by the data. 
• The agl ratio and / In values estimated from the pres-
ent data require cautious interpretation due to the 
operation of mechanisms of erythema induction 
and/or its modification other than basal cell killing. 
• Further work to define the pathophysiological 
mechanisms of erythema induction are necessary. 
• In future radiobiological studies treatment allocation 
should follow stratification according to gender, age, 
site and prior solar damage, or be confined to one site 
in one gender. 
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ABSTRACT 
The time course of erythematous skin reactions has been recorded using a reflectance 
spectrophotometer in 65 patients treated palliatively with 5, 10, 12 and 20 daily treatment 
fractions using different thicknesses of bolus in each treatment field to vary dose per fraction 
across the field at the skin surface. Skin doses in these patients ranged between 0.4 and 5.2 
Gy/fraction. Reactions have also been recorded in the pubic region of an additional 52 patients 
undergoing prostatic irradiation using 30 -32 fractions. Doses at the skin surface in these 
patients was estimated to be approximately 0.4 Gy per fraction. 
The data provide support for findings from a previous study that gender, age, site and prior sun 
exposure influence pre-treatment erythema values and that these factors also influence post-
treatment erythema values independently of the radiation dose administered. In addition, the 
finding that faint erythematous reactions at least 3 cm outside of the irradiated field can be 
recorded is also confirmed. 
Unexpectedly intense erythematous reactions were observed at doses per fraction below 1.5 Gy, 
at the skin surface. This suggests either that the dose response relationship for erythematous skin 
reactions is not linear quadratic, or that erythema is not exclusively initiated by damage to the 
basal cell layer as widely held. An "s" shaped curve appears to fit the dose response data more 
satisfactorily. This finding warrants confirmation and exploration in further purpose designed 
studies. 
Keywords: skin, erythema, radiotherapy, reflectance spectrophotometry, a/13 ratio, fractionation 
parameters 
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INTRODUCTION 
Radiotherapists have been observing the effects of ionising radiation on mammalian skin for the 
better part of the twentieth century. Quantification and qualification of acute radiation effects in 
mammalian skin systems, such as the mouse, rat and pig, have received extensive attention in the 
radiobiological literature, however, apart from the work of Turesson, relatively little systematic 
scientific study of the radiation response of human skin has occurred. [1,5,9,11,12,15] With 
increasing application of the linear quadratic model to experimental data since 1982, derivation 
of a/13 ratios and t1/2 values for acute effects in human skin over a variety of anatomical sites 
would clearly be useful to augment animal data. Fractionation effects and repair values are 
required from clinical radiobiological studies for the safe and rational design of new 
radiotherapeutic protocols (eg hyperfractionated or accelerated radiotherapy). Although the skin 
may not always represent the critical dose-limiting normal tissue for megavoltage radiotherapy, 
knowledge of its response is important for modelling of other acute reacting tissues and for 
treatments with electron or proton beams. The initial stimulus for this project arose from the 
observation that there existed no systematic quantitative observations on the effects of 
fractionated low dose rate (FLDR) radiotherapy in human skin. We have previously reported 
these results [4] and demonstrated that a variety of physiological factors impact on the local 
erythema response over and above the physical dose delivered. These include gender, site of 
irradiation and age. This report also included 19 patients treated with 10 fractions at high dose 
rate. In order to expand this work to cover a larger range of fraction numbers and doses per 
fraction, further studies were designed. This report describes the results obtained with 
reflectance spectrophotometry in two prospective fractionated high dose rate clinical 
radiobiological studies. 
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PATIENTS AND METHODS 
1 	Patients 
1.1 	Palliative reflectance study 
This group consisted of patients with incurable and almost invariably metastatic 
malignancy, having symptoms justifying palliative radiation treatment. 
Consenting patients were of the following fractionation schemes: 
20 Gy/5 fx (n=12) 
30 Gy/10 fx (n=25) 
36 Gy/12 fx (n=14) 
40 Gy/ 20 fx (n=14) 
Exclusion criteria included previous irradiation to the area concerned, previous 
history of significant dermatological illnesses, current or recent known 
photosensitising drug intake, and poor performance status (ECOG > 2). Written 
informed consent was a prerequisite for participation in this study, which was 
approved for activation by the Hunter Area Regional Ethics Committee in March 
1991. A breakdown of the treated group according to age, gender, treatment site 
and prior heavy sun exposure is presented in Table 1. 
1.2 	Hair cortical cell counting project (HCCC) 
Patients undergoing conventional external beam radiotherapy (60-65 Gy using 
30-32 daily fractions) for localised carcinoma of the prostate were eligible for this 
study whose intention was to evaluate the response of hair follicle cortical cells to 
X-rays as well as erythema (at the supra-pubic site only). Written informed 
consent was a prerequisite for participation in this study, which was approved for 
activation by the Hunter Area Regional Ethics committee in April 1993. 
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2 	Irradiation techniques 
2.1 	Palliative reflectance study 
Patients treated on the "palliative reflectance study" were irradiated with 6 MV 
photons at 100 cm SSD on a Varian Clinic 1800. Sites of treatment were 
confined to the truncal portion of the body between larynx and groin. Field 
configurations included single direct fields, or parallel opposed pairs. In order to 
generate a greater number of dose points, patients with field sizes between 100 
cm2 and 175 cm2 , had their field arbitrarily divided up into two sections. The 
first of these sections was treated through a layer of full wax bolus (for 6 MV 
photons, 1.5 cm). The second of the sub-divisions of the treatment field was 
treated with no bolus. This resulted in approximately a 30 to 40% dose 
differential to skin in the two areas concerned. For field sizes greater than 175 
cm2 , the treated field was artificially divided up into three sections in an 
analogous manner with, on this occasion, the third section being treated daily 
through a layer of thin wax bolus (0.75 cm). Fields smaller than 100 cm 2 were 
treated without bolus. A breakdown is provided in Table 1. Reflectance readings 
were obtained in the centre of each of these arbitrary sub-divisions of the field 
and at 3 cm outside of the field, as shown in Figure 1. 
2.2 	Hair cortical cell counting project 
Patients were treated using 6 MV photon with a four-field "box set-up" (AP/PA 
plus opposing laterals) to a target absorbed dose of 60-65 Gy in 30-32 fractions. 
No bolus was used. Reflectance readings were performed at the centre of the 
anterior field only, i.e. in the suprapubic region. Care was taken to separate the 
test and control points from the hair sampling point. Fields were CT-planned to 
cover the prostate gland plus a 1.5 cm margin only. Full details of the hair 
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Right Left 
cortical cell counting technique are given in Potten (1994) [10]. The technique 
involved removal of approximately 100 groin hairs prior to treatment and again 
after a given dose (in this case 4, 8, 16 or 32 fractions). Hair cortical cell density 
has been measured using confocal microscopy and the fractional reduction has 
been used as a measure of follicle 
cell kill. 
Superior 
Test Points 	Control Points 
Inferior 
• = Thick bolus 1.5 cm 
• = Thin bolus 0.75 cm 
• = No bolus 
Figure 1 
Schematic representation of the field sub-division (total field area greater than 175 cm2) into 
differentially bolused areas along with test and control points for reflectance readings in the 
"palliative reflectance" study. 
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3 	In vivo dosimetry 
Paired carbon-loaded TLDs (Vinten) [13] were inserted into a tissue equivalent 
polystyrene holder and applied to the field centre on the patient's skin. No additional 
build up was utilised for these measurements. Where 0.75 cm and 1.5 cm of bolus was 
present on portions of the field, a pair of conventional lithium fluoride (LiF) TLDs were 
placed beneath the bolus. In all dose-response analyses subsequently described on this 
report, measured skin dose rather than prescribed dose has been used. A breakdown of 
measured doses appears in Table 1. 
4 	Reflectance technique 
The reflectance unit employed in this study (Spectral Research Pty Ltd) was designed 
specifically for quantitative haemoglobin estimation in human skin [6] and its evaluation 
in the context of human radiation induced erythema is described by Denham et al (1995) 
[4]. Reflectance readings were obtained prior to treatment and at weekly intervals during 
and after the course of radiotherapy, until visible evidence of the reaction had subsided. 
Measurements were obtained with the patient in a recumbent position, in an air-
conditioned environment, at a constant ambient temperature of 22°C after a five minutes 
rest period. Selected measurement sites were referenced using a small non-permanent 
skin mark which were consistently aligned on subsequent measurements with a reference 
mark on the external surface of the measurement probe. The mean of five separate 
measurements was taken to represent the reflectance reading for that day. "Control" 
measurements were obtained 3 cm outside of the field (Figure 1). 
In this report change in erythema as a result of radiation is expressed as "percentage 
change". This quantity is 
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E1-E0 
	x100 
Where E0 is the erythema measure immediately prior to treatment (i.e. the baseline 
measure) and Et is the measure at any time t subsequently (i.e. during or after treatment). 
5 	Analytical techniques 
All data has been stored on a temporal database (MEDLOG) which permits a limited 
range of statistical manoeuvres, including multiple linear regression, to be performed. 
Indirect analysis was based on isoeffect estimates by probit analysis of peak "percentage 
change" data. In these analyses and in direct analyses using akst [2] a "response" was 
assigned if a patient's peak percentage change value equalled or exceeded the median 
peak value recorded for all patients treated in both studies. 
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RESULTS 
1 	Factors that influence pre- and post-treatment erythema values 
Multiple linear regression procedures in which anatomical site was arbitrarily subdivided 
into four categories (anterior and posterior-chest regions down to the bottom of the rib 
cage, anterior abdomen to include the pubic region and groins, and finally lumbar-sacral 
to include lumbar regions and buttocks) suggested that heavily sun exposed areas such as 
the upper torso had significantly greater pre-treatment erythema values than other sites 
independently of other factors such as age and gender (p<0.05). Non significant trends 
towards greater pre-treatment erythema values (p=0.05-0.2) were noted in patients of 
increasing age. Similar models that addressed the influence of factors other than total 
radiation dose delivered and dose per fraction, such as age, gender, site, sun exposure and 
pre-treatment erythema value on the peak percentage change in erythema recorded during 
or after radiation were also developed. These suggested that lower pre-treatment 
erythema values are significantly associated with greater peak changes in erythema 
independently of other factors including total dose (p<0.01). Non significant trends 
towards younger patients developing greater peak changes in erythema (p=0.05-0.2) were 
also noted. 
Addition of these data sets to the "low dose rate" data set analysed in a previous report in 
this journal [4] amplified the statistical significance of findings presented in that report. 
To summarise the results for the combined series of 183 fields with complete data higher 
pre-treatment erythema are associated with male gender (p<0.01), older patients 
(p<0.05), and at sun exposed anatomical sites (p<0.01). Greater post-treatment erythema, 
on the other hand, are associated with high instantaneous dose rate (p<0.01), lower pre- 
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treatment values (p<0.01) and younger patients (p<0.05) independently of total dose 
administered or dose intensity. A non significant trend towards female patients 
developing greater changes in erythema following treatment (p=0.1) was also present. 
2 	Erythema according to quantity of bolus used on the skin surface 
In Figure 2 peak erythema according to total dose has been presented for the four 
fractionation groups in which different quantities of bolus were applied to the skin 
surface during treatment in the "palliative reflectance" study (i.e. 5, 10, 12 and 20 
fraction groups). Best fit non-linear regression lines have been fitted through data points 
obtained from areas of the field that were unbolused, (i.e. received doses between 16 and 
47% of Dm ax [median 33.7%] at the skin surface), areas bolused with 0.75 cm of tissue 
equivalent material (i.e. received between 88 and 100% of Dm ax [median 94%] at the skin 
surface) and areas fully bolused with 1.5 cm of tissue equivalent matter (i.e. that received 
100% of the estimated Dm a„ dose). Although higher peak percentage change values have 
been recorded in the fully bolused areas in each fractionation group it will be noted that 
the dose response relationship for measured values across all areas of the field is not 
linear or linear quadratic, with higher peak percentage change values recorded in 
unbolused areas in all four fractionation groups than predicted by the linear quadratic 
model using any positive value for a/13. 
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Figure 2 
Peak percentage change in erythema recorded in the four fractionation groups of the "palliative 
reflectance" study according to the total measured dose at the skin surface. 
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3 	The time course of reactions inside and outside of the field 
The maximum erythema values recorded at each attendance in each field have been used 
to compose the time course data for each fractionation group presented in Figure 3. Rate 
of development of erythema is similar for the 10, 12 and 20 fraction groups (i.e. dose per 
fraction in the range 2-3.4 Gy/fraction or 10-17 Gy/week) but appears more rapid in the 5 
fraction group (approximately 4.4 Gy/fraction or approximately 22 Gy/week) and more 
slowly in the 32 fraction group (approximately 0.4 Gy/fraction or 2 Gy/week). Of note is 
the observation that the rate of development of erythema and peak percentage change 
reached in the 32 fraction (0.4 Gy/fraction or 2 Gy/week) group is so great, and 
considerably greater than predicted by the linear quadratic formula using any positive 
value for a/f3. 
Figure 3 
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Figure 3 
The time course of reactions inside of the treatment field grouped according to the number of 
fractions delivered. 
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In 39 (60%)of the 65 patients treated in the "palliative reflectance" project (the 5, 10, 12 
and 20 fraction groups) increases in erythema outside of the treated field, were noted. 
These changes have been grouped and plotted in Figure 4. From this figure it would 
appear that the greatest out of field erythematous changes occurred in the highest dose 
per fraction group (i.e. the 5 fraction group that received dose per fraction of 
approximately 4.4 Gy/day). 
Figure 4 
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Figure 4 
The time course of "reactions" 3 centimetres outside the field in a "control" area grouped 
according to the number of fractions delivered. 
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4 	Indirect and Direct analyses 
Probit analyses have been used to derive "isoeffective doses" for the various fractionation 
groups. For the purposes of these analyses the median peak percentage change value for 
the entire data set (75%) has been used to derive the cut point between a "responding" 
patient (whose peak percentage change equals or exceeds 75%) and a "non-responding" 
patient (whose peak percentage change never reaches 75%). In Figure 5 a reciprocal 
dose (Fe) plot is presented using these estimated isoeffect dose at the 0.5 probability of 
"response" level for each fractionation group. It will be noted that the data points do not 
lie on a single straight line. In particular, the data points for the 20 fraction and the 32 
fraction group are higher against the reciprocal total dose axis (i.e. the "isoeffective dose" 
is lower) than expected. In the figure two regression lines have arbitrarily been fitted. 
The first, which fits the 5, 10 and 12 fraction data points, extrapolates back through the 
dose per fraction axis at -8.5 Gy (to provide an a/f3 ratio of 8.5 Gy). The second which 
passes through the data points for the 20 and 32 fraction groups extrapolates through the 
dose per fraction axis at approximately 1.6 Gy (to provide and a/13 ratio of -1.6 Gy!). As 
expected the data also failed the de Boer test [3] for a linear quadratic fit to the data 
(Figure 6). This confusing picture is reflected in the results produced by direct analysis 
using the ocf3est program. An cc/13 ratio of -5 Gy (indefinite confidence intervals) is 
returned for the "palliative reflectance" project data alone (i.e. 5, 10, 12 and 20 fraction 
groups). When both data sets are analysed together, oci3est converges on an a/13 ratio of - 
9 Gy (again with indefinite confidence intervals). These negative values are due to 
negative values for P. 
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Figure 5 
Reciprocal dose (Fe) plots based on isoeffective doses for the five fractionation groups 
calculated from probit analysis. Two .regression lines have been arbitrarily fitted through the 
data points. One which fits through the 5, 10 and 12 fraction groups extrapolates to an a/13 of 
8.5 Gy. The other which fits the 20 and 32 fraction groups extrapolates to -1.6 Gy. 
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Figure 6 
de Boer Plot: (FHDR) 
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Figure 6 
De Boer plot [3] for isoeffective data from the two studies. The linear quadratic model would be 
satisfied if the data points were to lie on a straight line. 
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DISCUSSION 
When this series of studies commenced we were unaware of how factors such as gender, age, site 
and prior sun exposure can influence erythematous reactions independently of the effects of 
radiation dose. It was only after analysis of reflectance data from our "Low Dose Rate" project 
that we came to appreciate the importance of these factors [4]. By then, however, it was too late 
to prospectively stratify accrual according to these factors as subsequently recommended by us. 
As a result therefore, the precision of the results obtained in the present studies is not as great as 
it could have been. This disappointment, however, was partly offset by confirmatory support 
from the new data sets that factors such as pre-treatment erythema level, age, site and possibly 
gender can exert an influence on erythematous skin reactions that is independent of dose. 
Fortunately, the imprecision of our data was not too great to obscure another potentially 
important fmding. This was that low doses per fraction (i.e. under 2 Gy) produced far more 
intense erythema (as measured by reflectance spectrophotometry) than the linear quadratic model 
would have lead us to expect. We were disinclined, however, to believe the first indication from 
our data that this was true. This indication came from fields treated in the "palliative 
reflectance" study (5, 10, 12 and 20 fraction groups) where portions of each field had been left 
unbolused and portions had been bolused with 0.75 cm and 1.5 cm of tissue equivalent material 
(Figure 2). The peak erythema measured in the unbolused areas were greater than anticipated. It 
was believed that this finding could be due to the release of vasoactive mediators or the 
stimulation of neurovascular reflexes, from the adjacent area of the field that had been bolused 
during treatment (i.e. from the area in the field receiving the highest dose at the basal cell layer). 
This was thought to be plausible because unexpected erythema during the time course of the in-
field reactions had been measured at least 3 cm outside of the irradiated field altogether in a 
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significant proportion of cases (Figure 4). What made us more confident that the unexpectedly 
intense erythema at low doses per fraction was a real finding, however, were the peak erythema 
recorded at doses per fraction to the order of 0.4 Gy in the "hair cortical cell counting" project 
(32 fraction group) (Figure 3). Although these data came from non exposed sites in male 
patients their credibility was less open to doubt due to the quantity of observations obtained and 
from the fact that they were made of an identical site in patients of a similar age. 
Several possibilities were considered to explain the unexpectedly intense erythema observed in 
the unbolused areas in both studies. With the 6 MV beam used dose builds up rapidly below the 
skin surface and approaches 90% of D max occur at approximately 7-9 mm below skin surface. If, 
in addition to mechanisms associated with basal cell killing, neurovascular reflex vasodilatation 
in response to so far undefined dermal/subdermal radiation effects is a contributor to erythema, 
then a potential explanation for unexpected erythema in unbolused areas is to hand. 
Unfortunately, however, we cannot offer, nor know of, any data to support this contention. It 
was also thought possible that the lack of prior sun exposure and the pre-treatment pallor of the 
skin in unbolused areas, were contributing factors to the unexpectedly intense erythema 
measured. Although our multiple regression models confirmed that this was a possibility for the 
measurements obtained in the pubic area, however, they failed to predict the unanticipated 
erythemas measured in the unbolused portions of the fields treated in 5, 10, 12 and 20 fraction 
groups. A further possibility considered was that our reflectance spectrophotometer provides 
non-linear readouts in erythematous response. We wondered if our unit could exaggerate the 
magnitude of faint erythema but not intense erythema. While it is true that an informal 
comparison of our unit with the units at Gothenburg and Amsterdam using various test materials 
confirmed differences in the responsiveness of the three units, there was no suggestion that our 
unit would provide readouts any less linear than the other two (with thanks to Dr Nicola Russell, 
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Amsterdam and Dr Ingela Turesson, Gothenburg, August 1995). In addition, tests performed in 
the development stage of our unit were also considered to confirm linearity in the unit's response 
[6]. Another explanation considered for the intensity of the erythema in the "hair cortical cell" 
project (the 32 fraction group), in particular, was the possibility that recruitment of cells into the 
cell cycle as part of a proliferative response to basal cell damage, which is believed to start 
between 16 and 28 days after the start of radiation treatment [7,15], could lead to sensitisation of 
the cellular population with subsequent release of vasoactive factors out of proportion to the size 
of continuing radiation doses delivered after this point in time. Making this explanation less 
plausible, however, is the information presented in Figure 3. In this figure it is noted that 
disproportionately great increases in erythema for the 0.4 Gy/fraction patients are noted long 
before day 16 of treatment. 
A further possibility is that the radiation dose response curve for erythema is, in fact, "s" shaped 
as suggested in Figure 7. However, caution needs to be exercised in interpreting this pair of 
figures. In Figure 7a, where the peak erythema which each patient has experienced has been 
divided by the total number of fractions delivered, the fact that the higher dose per fraction 
treatments were given over a shorter time frame than the lower dose per fraction treatment (i.e. 
the time factor) is ignored completely. It was felt that the presentation in Figure 7b circumvents 
this problem by presenting the rate of development of the erythematous reaction in each patient 
during the development of the reaction (i.e. the mean change in absolute erythema measure per 
day). 
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Figure 7a 
Percentage change per fractional dose 
(i.e. peak percentage change/number of 
fractions) according to dose per fraction 
for patients treated in both studies. 
Figure 7b 
Percentage change in erythema per day 
during the evolution of reactions 
according to dose per fraction. 
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At first sight it would be tempting to speculate that the "s" shape of the dose response curve 
presented in these figures is caused by a failure to induce the reparative enzymes responsible 
for some of the simpler DNA lesions that cause "sublethal" radiation damage, at low doses 
per fraction. This explanation has been proffered by Joiner et al to explain greater than 
expected effects at low dose per fraction in several laboratory experiments [8]. However, this 
explanation may not be appropriate because these presentations make an assumption which 
could be incorrect, namely, that each new erythematous stimulus adds (quantitatively) to the 
previous one. If this assumption is incorrect and erythematous stimuli caused by low doses 
per fraction were to add to greater degree than erythematous stimuli due to higher doses per 
fraction (perhaps due to the temporary saturation of receptor sites for mediative vasoactive 
substances or for the mediative processes in the subpapillary micro-vasculature themselves) 
then a "s" shaped dose response curve could be produced by this type of analytical 
manoeuvre. Another point of potential importance is the fact that the effect noted by Joiner et 
al has been observed at doses of less than 0.6 Gydraction. 
Whatever explanation is preferred for the apparently "s" shape of the dose response curves, 
presented in Figure 7, there is quite clearly a need to confirm this unexpected suggestion by 
conducting a further purpose designed prospective study. If the finding is confirmed it will 
then be necessary to find an explanation for it that is compatible with the dose modifying 
effect demonstrated by Turesson et al when intervals of 15 minutes are introduced in the 
same fraction of treatment [14], and by us when fractional doses are prolonged to more than 
30 minutes in duration by their delivery at intermediate dose rates [4]. In Turesson's study a 
gap of 15 minutes during the delivery of a 7 Gy fraction was sufficient to reduce its 
"biological effectiveness" as measured by reflectance spectrophotometry, by approximately 
by an approximately similar amount, when delivery was prolonged over 30 minutes. Both of 
these observations would tend to suggest either that a rapid reparative process is operative or 
that refractoriness in the erythematous mediative pathways is induced quite rapidly. 
Perhaps it need not be pointed out that a "s" shaped dose response relationship for erythema 
provides a satisfactory explanation for the variety of a/13 ratios that were obtained by indirect 
and direct analyses. If the erythematous dose response curve were truly "s" shaped it would 
be expected that different values for the a/P ratio would be obtained depending on which 
portion of the dose response curve data used in the analysis came from. For example, if data 
obtained at doses per fraction greater than 1.5 Gy are isolated then a negative a/13 ratio of 
approximately -5 Gy is obtained by direct analysis. On the other hand, data below 1.5 Gy per 
fraction are isolated then a negative cc/13 ratio of -9 Gy is obtained. A positive a/P ratio of 8-9 
Gy can be obtained by indirect analysis of data above 3 Gy per fraction! (Figure 4). This 
possibility could provide an additional explanation for the changes in a/r3 ratio noted by 
Turesson and Thames [15] and Hopewell and Aardweg [7] in studies where different 
experimental designs have been used. 
22 
CONCLUSIONS 
• The finding from our previous study that pre- and post-treatment reflectance values 
vary according to gender, age, site and prior sun exposure is confirmed. 
• Unexpectedly intense erythema following low dose per fraction treatments suggest 
either that the dose response relationship for human erythema is not linear quadratic, or 
that erythema is not exclusively initiated by damage to the basal cell layer. Prospective 
purpose designed studies are necessary to confirm this finding, however. 
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The "palliative reflectance" study 
The "hair cortical cell" 
project 
5 fraction 10 fraction 12 fraction 20 fraction 32 fraction 
n 12 25 14 14 52 
Male/Female 7/5 18/7 11/3 9/5 52/0 
Age (years) 67.5(46-84) 62(40-84) 62.5(23-75) 65(42-80) 71(57-77) 
Ant Chest 5 9 9 9 0 
Post Chest 1 1 0 0 0 
Abdomen 1 2 3 4 52 
Lumbar-Sacral 5 12 2 1 0 
Other 0 2 0 0 0 
Heavy sun exposure Y/N 4/8 12/13 5/9 5/9 0/52 
Fully bolused areas: 
22.1(17-26.1) 
4.4(3.6-5.2) 
31.3(25.9-34.2) 
3.1(2.6-3.4) 
40.4(30.6-44.4) 
3.4(2.5-3.7) 
47.2(37-56) 
2.4(1.8-2.8) 
- 
- 
Total dose (Gy) 
Dose per fraction (Gy) 
Unbolused areas: 
7.2(4.3-9) 
1.4(0.8-1.8) 
7.5(4.4-15.9) 
0.75(0.4-1.59) 
14.4(7.2-18.4) 
1.2(0.6-1.5) 
18.9(8.2-25.1) 
0.95(0.4-1.3) 
13.44(0.42-16.32) 
0.42(0.01-0.51) 
Total dose (Gy) 
Dose per fraction (Gy) 
Total field size (cm) 121(49-400) 159(66-1495) 124(81-539) 125(49-578) 75(54-105) 
Overall time (days) 8(5-27) 15(12-20) 19(15-36) 30(28-33) 50(36-64) 
Specified are median values (ranges) and absolute patient numbers 
Table 1 Case composition of the two study groups 
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FIGURE LEGENDS 
Figure 1 	Schematic representation of the field sub-division (total field area greater than 
175 cm2) into differentially bolused areas along with test and control points 
for reflectance readings in the "palliative reflectance" study. 
Figure 2 	Peak percentage change in erythema recorded in the four fractionation groups 
of the "palliative reflectance" study according to the total measured dose at the 
skin surface. 
Figure 3 	The time course of reactions inside of the treatment field grouped according to 
the number of fractions delivered. 
Figure 4 	The time course of "reactions" 3 centimetres outside the field in a "control" 
area grouped according to the number of fractions delivered. 
Figure 5 	Reciprocal dose (Fe) plots based on isoeffective doses for the five fractionation 
groups calculated from probit analysis. Two regression lines have been 
arbitrarily fitted through the data points. One which fits through the 5, 10 and 
12 fraction groups extrapolates to an a/13 of 8.5 Gy. The other which fits the 
20 and 32 fraction groups extrapolates to -1.6 Gy. 
Figure 6 	De Boer plot [3] for isoeffective data from the two studies. The linear 
quadratic model would be satisfied if the data points were to lie on a straight 
line. 
Figure 7a 	Percentage change per fractional dose (i.e. peak percentage change/number of 
fractions) according to dose per fraction for patients treated in both studies. 
Figure 7b 	Percentage change in erythema per day during the evolution of reactions 
according to dose per fraction. 
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Low dose rate teletherapy and tumour response 
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SUMMARY 
Tumour responses in 25 patients with 
locally advanced head and neck cancer, 
treated on an experimental fractionat-
ed low dose rate (FLDR) teletherapy 
program are reported. Treatment was 
given at dose rates ranging from 1.8 to 
3 Gy/h to a range of total doses from 
32-38 Gy, with palliative intent. The 
total doses delivered have been pre-
dicted by the linear quadratic formula 
to be equivalent to 33-41 Gy using 
conventionally fractionated high dose 
rate treatment, in terms of acute nor-
mal tissue effects. A complete response 
rate (no visible or palpable disease 2 
months after treatment) was observed 
in 28% of cases. Analysis of these 
response rates suggests that the linear 
quadratic formula may underestimate 
the anti-tumour effect of FLDR tele-
therapy at the various dose rates and 
total dose permutations in this study. 
INTRODUCTION 
There has been considerable debate in 
the world of clinical radiobiology as to 
whether low dose rate (LDR) radio-
therapy is intrinsically associated with 
a therapeutic gain in considering nor-
mal tissue effect and tumour cell kill. 
Key words: dose rate effect; head and neck 
cancer; incomplete repair model; linear 
quadratic model; low dose rate teletherapy; 
palliative treatment. 
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Complicating factors such as the small-
er treatment volumes and heteroge-
neous dose and dose rate distributions 
typically seen in clinical brachytherapy 
have made direct comparison of treat-
ments at various dose rates very diffi-
cult. Recent evidence from laboratory 
studies, clinical studies and biomath-
ematical considerations suggests that 
lowering of the dose rate itself may well 
be responsible for a therapeutic 
differential. 18 
Data on normal tissue damage end-
points and tumour control rates for 
dose rates less than 1 cGy/min have 
been derived from extensive clinical 
brachytherapy experience. However the 
intermediate dose range between 1 cGy/ 
min and 50 cGy/min has had less atten-
tion. In particular, in terms of external 
beam teletherapy, only a small number 
of groups have reported the effects of 
this modality on tumour response rates 
and/or normal tissue effects. 6- '° An 
experimental fractionated low dose rate 
(FLDR) teletherapy project was de-
signed with the aim of accurately as-
sessing acute normal tissue end-points 
in terms of mucosal and skin responses 
in an effort to provide systematic iso-
effect data for a range of total doses 
and dose rates using external beam 
teletherapy from a Caesium-137 tele-
therapy unit.' Up to the present time 
patients have been treated at 1.8 and 
3.0 Gy per hour, to total doses that 
have been predicted by the linear 
quadratic formula to be approximately 
equivalent in terms of acute normal 
tissue responses to 33-41 Gy using 
fractionated high dose rates (FHDR)." 
This study was not primarily designed 
to analyse tumour response rates, as it 
was recognized that patients with incur-
able locally advanced head and neck 
cancer would comprise a relatively  
heterogeneous population with limited 
life expectancy and were treated with 
purely palliative intent. It was not 
anticipated that any complete re-
sponses would be seen and therefore 
skin and mucosal reactions and pallia-
tion were chosen as the primary end-
points for the study. However, since the 
project commenced, a number of very 
impressive tumour responses have been 
observed. We have therefore decided 
to prospectively examine these in detail 
and will reserve future reports for final 
analysis of the normal tissue end-points 
for the various permutations of dose 
and dose rate used.' 
METHODS 
Patients reported on in this interim 
analysis were treated on an experi-
mental FLDR teletherapy programme 
at the Newcastle Mater Misericordiae 
Hospital. All patients were treated with 
palliative intent and selection criteria 
for consenting patients are given in 
Table 1. There were five T.,N o, one 
T3N I , one T 3N,, one T 4N 2 and 10 T 4N 3 
patients entered on this study and 
considered by the authors to have 
incurable disease (seven patients pre-
sented with recurrent disease post-
surgery).' 2 Patients were treated to total 
doses of: (i) 32 Gy at 3 Gy/h (n = 8); 
(ii) 36 Gy at 3 Gy/h (n = 8); and (iii) 
38 Gy at 1.8 Gy/h (n = 9). 
Patients were treated on a Caesium 
tele therapy unit, operating at extended 
skin, source distance, designed to deliv-
er treatment at the dose rate specified. 
Full technical and set-up details are 
given in a previous publication.' Patients 
were treated in a total of 10 daily 
fractions, with right and left lateral 
opposing fields and the dose was spec-
ified to the mid-point. All surface doses 
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were confirmed with thermo-lumines-
cent dosimetry. Patients were reviewed 
twice weekly while on treatment for 
scoring of skin and mucosal reactions 
and bi-dimensional measurement of 
assessable disease. Response rates were 
assessed in the usual manner, with a 
cOmplete response being defined as the 
absence of palpable and/or visual dis-
ease, at 2 months post-treatment and 
maintained for a minimum of 4 weeks; 
a partial response being > 50% de-
crease in the bi-dimensional product of 
the tumour; stable disease being < 50% 
increase in the bi-dimensional product; 
and progressive disease being > 25% 
increase in the bi-dimensional product. 
All patients were followed up after 
treatment at 2-4 weekly intervals for 
identical end-point assessment. 
RESULTS 
Seven of the 25 patients (28%) had a 
complete response to therapy. Fifteen 
patients (60%) had various other com-
binations of partial or complete re-
sponse at the primary and/or neck site. 
The remaining 12% of patients had 
stable disease at one or both sites. 
Complete responses were maintained 
on average for a period of 75 days, and 
the average duration of complete relief 
of symptoms was 109 days. A complete 
response rate of 28% (7/25) at 2 months 
post-treatment has been maintained 
in two patients (each 300+ days). 
Four patients received further radio- 
Table 1 Patient selection criteria 
1. Patients with squamous carcinoma of the 
head and neck that fulfil the RTOG 
modification of the American Joint 
Committee stage grouping criteria in the 
categories IVB, C, D and V excepting 
oral cavity tumours and laryngeal 
tumours that may be amenable to 
surgery. 
2. Patients under 80 years of age with an 
anticipated survival of more than 8 
weeks. 
3. Patients who do not have intercurrent 
illnesses such as dementia, severe 
epilepsy, incontinence and severe 
musculo-skeletal disorders that are likely 
to make treatment lasting several hours 
each day difficult. 
4. Patients who do not have severe dental 
caries requiring major dental work prior 
to treatment. 
5. No prior treatment (radiation or 
chemotherapy). 
6. Written informed consent to treatment 
on protocol. 
therapy to the head and neck region 
with conventional external beam, 2-6 
months following FLDR. One of these 
patients was classified as a complete 
responder to FLDR prior to this addi-
tional treatment. 
Theoretical predictions 
Application of Dale's modification of 
the linear quadratic formula to the total 
doses and dose rates used in this study 
reveals that doses of 32, 36 and 38 Gy 
at 3, 3 and 1.8 Gy/h respectively, are 
equivalent to 33-41 Gy using FHDR 
(2 Gy/fraction, 5 fractions/week). These 
figures are derived assuming a tumour 
a113 ratio equal to 25, and a repair 
constant (p.) equal to 0.69 h. -1 This 
approach has neglected tumour prolif-
eration and has assumed complete re-
pair between the FLDR treatments 
(see Appendix I)." 
The radiation therapy oncology 
group (RTOG) has published an algo-
rithm derived from a logistic regression 
analysis for various head and neck 
cancer sites, based on one of their large 
head and neck protocol databases.° 
This algorithm uses a standardized 
coding for primary site, tumour stage 
and Karnofsky status, to calculate a 
probability of complete response 3 
months after therapy. If this algorithm 
is applied to the present group of 
patients, then a 51% probability of 
complete tumour clearance is expected 
using conventional FHDR to a median 
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Fig. 1 Local control probabilities vs dose for 
this series (LDR), Griffin et a/. , '' Deacon ' 4 and 
Trott.' 
dose of 65-68 Gy as employed by the 
RTOG. Four the 25 patients in this 
study are unsuitable for inclusion in 
this algorithm due to their having head 
and neck primary sites not applicable 
to the RTOG database. Figure 1 dem-
onstrates the observed probability of 
complete tumour clearance in the head 
and neck group, plotted on the same 
graphic representation as RTOG data-
base predictions, with two other data 
sets superimposed for comparison. The 
tumour control curves from Deacon 
represent nasopharynx and tonsillar 
data," and the curve from Trott is 
based on tumour control data from 
carcinoma of the larynx.° In this rep-
resentation the FLDR data from this 
study are expressed in terms of dose 
normalized to conventional FHDR. 
DISCUSSION 
The primary aim of this project was to 
test the predictions of the linear quad-
ratic formula in the intermediate dose 
range (in terms of acute normal tissue 
toxicity). However it has become ob-
vious to the treating clinicians that 
a higher percentage of complete re-
sponses than would have been pre-
dicted simply from mathematically 
equivalent total doses, or even from 
radiobiologically equivalent doses, has 
been seen. This is demonstrated in 
Figure 1, which suggests by extrapola-
tion that virtually no T 3—T4 head and 
neck tumour would be expected to 
respond completely to doses between 
33 and 41 Gy (FHDR). The series from 
Deacon" and Trott," of course, use 
varying definitions for local control at 
different time points. The RTOG ex-
perience, however, uses complete tu-
mour clearance at 3 months as its basic 
reference. This might suggest that the 
biological activity of the physical doses 
used for the present study is, in fact, 
considerably higher than the linear 
quadratic formula predicts. Using the 
linear quadratic approach, of course, 
requires some assumptions regarding 
the most appropriate a113 ratio to use 
for squamous cell carcinoma of the 
head and neck, and the most appropri-
ate repair half-time and repair mod-
el. 1637 A tumour a/13 ratio of 25 Gy was 
nominally chosen, although the choice 
of a lower value would not significantly 
alter the predicted equivalent doses. 
In the present example we elected to 
neglect the effect of tumour cell prolif-
eration, and current evidence suggests 
that this is reasonable for a total treat-
ment duration of only 12-14 days. It is 
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quite possible that the observed increase 
in biological effect may be partly due 
to the shorter overall time used in this 
study. Current evidence suggests that 
head and neck cancer may exhibit re-
population rates in the order of 
0.4-0.7 Gy/day'839 and therefore the 
FHDR doses used for comparative 
purposes should perhaps be some 
5-8 Gy lower. This interim analysis 
regarding tumour control rates suggests 
the need for further data obtained from 
patients treated to higher total doses 
than were used in this study. Pierquin's 
study drew a similar conclusion as they 
used external beam teletherapy at low 
dose rates, to a total dose of approxi-
mately 4500 cGy, and observed a signif-
icantly higher complete response rate 
in the LDR arm. 6.'° This was at the cost 
of a significant number of late necroses 
and we would recommended that before 
further dose escalations are made, cur-
rent radiobiological predictions should 
be examined in more detail, particularly 
in the area of dose modifications re-
quired in the intermediate dose range 
between low and high dose rates. Bio-
logical efficiency is expected to vary 
significantly in this range, but substan-
tial changes in the therapeutic ratio are 
not anticipated. 202' In fact it is only at 
dose rates below 1 Gy/li that clinically 
useful improvements in the therapeutic 
ratio are expected. The decision to test 
higher doses should therefore await an 
analysis of the anti-tumour effects in 
patients treated at 0.8 Gy/h, as is 
planned in the completion of this pres-
ent study. Obviously, if even greater 
anti-tumour effects were to be observed 
at the same levels of normal tissue 
reaction observed at high dose rates, a 
firm case for testing high doses could 
be established. 
The observed response rates to 
FLDR in this study must be viewed 
with caution as the patient numbers 
involved in this report are relatively 
small. Direct randomized comparison 
with an ostensibly equivalent FHDR 
treatment would be required to defini-
tively establish tissue response equiva-
lents for each regime. Survival pros-
pects for many of the study patients 
were limited, and suggest the need to 
obtain systematic data at other body 
sites to further assess tumour response 
rates and durability of response. 
The data also indicate that good 
symptom control may be achieved by 
this modality. It is not possible to 
speculate whether these palliative re- 
sponses are sustained for a longer 
period than with FHDR. 
ACKNOWLEDGEMENTS 
This study was supported by grants 
from the Hunter Valley Cancer Appeal, 
New South Wales State Cancer Council 
and National Health and Medical Re-
search Council. 
REFERENCES 
1. Cooper SG, Cardew AP, Ferguson S a 
al Low dose rate teletherapy using a 
Telecaesium 17 unit: Radiobiological, 
physical, and clinical considerations.Aus-
tmlas. Radial. 1990; 4: 241-6. 
2. Dutrieux J. Expression of the dose rate 
effect in clinical curietherapy. Radiother. 
OncoL 1989; 15: 25-7. 
3. Hall EJ. Radiobiology for the Radiologist, 
3rd edn, JB Lippincott & Co., Philadel-
phia, 1988; 107-16. 
4. Hill RP, Bush RS. The effect of continu-
ous or fractionated irradiation on a mu-
rine sarcoma. Br. J. RadioL 1973; 46: 
167-74. 
5. Mann LA, Smith CE, Langston MY, 
Quashie D, Dillehay LE. Response of 
glioblastoma cell lines to low dose rate 
irradiation. Int. J. Radiat. OncoL BioL 
Phys. 1991; 21: 397-402. 
6. Pierquin B, Calitchi E, Mazeron 1, Le 
Bouigeois J, Leung S. A comparison be-
tween low dose rate radiotherapy and 
conventionally fractionated irradiation in 
moderately extensive cancers of the oro-
pharyroc. Int. J. Radix. OncoL BioL Phys. 
1985; 11: 451-9. 
7. Wilson JF. Low dose rate teletherapy of 
unresectable carcinoma of the pancreas. 
Results of a pilot study. AJR 1978; 11: 
1105-10. 
8. Nilsson P, Thames HD, Joiner MC. A 
generalised formulation of the incom-
plete-repair model for cell survival and 
tissue response to fractionated low dose 
rate irradiation. Int. J. Radio:. OncoL BioL 
Phys. 1990; 57(1): 127-42. 
9. Kuipers LI. Clinical experience with low 
dose rate therapy at the Rotterdam 
Radiotherapy Institute. AIR 1978; 131: 
1105-10. 
10. Pierquin B, Calitchi E, Mazeron J, Le 
Bouigeois J, Leung S. Update on low 
dose rate irradiation for cancers of the 
oropharynx - May 1986.1m. J. Radix. 
OncoL BioL Phys. 1986; 1: 259-61. 
11. Dale RG. The application of the linear-
quadratic dose-effect equation to frac-
tionated and protracted radiotherapy. Br. 
J. RadioL 1985; 58: 515-28. 
12. TNM classification of malignant tumours. 
Geneva: UICC. Springer-Verlag, 1989. 
13. Griffin TW, Pajak TF, Gillespie BW et al. 
Predicting the response of head and neck 
cancers to radiation therapy with a multi-
variate modelling system: An analysis of 
the RTOG head and neck registry. Int. J. 
OncoL BioL Phys. 1984; 10(4): 
481-7. 
14. Deacon JM. MD thesis, London Univer-
sity, 1987. 
15. Trott KR. Differences between mouse 
and human tumours that affect their re- 
sponses to radiotherapy. In: Kallman RF 
(ed.). Rodent tumour models in experimen-
tal cancer therapy. Pennagon Press, NY. 
1987; 6-11. 
16. Stiiben G, Landuyt W, Van der Schueren 
E, Van der Kogel AJ, Reijnders A. Esti-
mation of repair parameters in mouse lip 
mucosa during continuous and fraction-
ated low dose-rate irradiation. Radiother. 
Oncol. 1991; 20: 8-45. 
/7. Withers HR, Taylor JMG, Maciejewski 
B. The hazard of accelerated tumour 
clonogen repopulation during radio-
therapy. Acta OncoL 27 Fasc. 1988; 2: 
11-146. 
18. Lindstrom MJ, Fowler JF. Re-analysis of 
the time factor in local control by radio-
therapy on T3-T4 squamous cell carci-
noma of the larynx. Int. J. Radix. One& 
BioL Phys. 1991; 21(3): 813-17. 
19. Barton MB, Keane TJ, Gadalla T, Maki 
E. The effect of treatmeni time and treat-
ment interruption on tumour control fol-
lowing radical radiotherapy of laryngeal 
cancer.Radiother. OncoL 1992; 23: 137-43. 
20. Fowler JF. Dose-rate effects in normal 
tissues. In: Brachytherapy 2. Nucletron 
International BV, Leersum. 1989; 26-40. 
21. Steel GG, Kelland LR, Peacock JH. The 
radiological basis for low dose-rate radio-
therapy. In: Brachytherapy 2. Nucletron 
International BV, Leersum. 1989; 15-25. 
APPENDIX I 
For fractionated low dose treatment we 
assume that repair is complete between 
fractions and that mono-exponential 
repair kinetics are followed. 
For low-intermediate dose rates 
Dale" has shown: 
1 2R 	 { 1 1 RE - 1 + 	 (1 e-AT)} 
1-1,(a/R) 
where RE is the relative biological 
effectiveness, R is the dose rate (Gy/h) 
and a/f3 is the ratio of single to multi-
hit killing (Gy-1 ). 
In analogous manner, for fractionated 
high dose treatment the RE is given as: 
fZE = 1 + ga/13) 2 
where d is the dose per fraction (Gy). 
Iso-effective doses for the FHDR and 
FLDR regimes may be obtained by 
equating the extrapolated response 
doses (ERD) of each: 
ERDFHDR X DFHDR 	3 
ERDFLDR X DFLDR 4 
By substituting equations 1 and 2 
into 3 and 4, respectively, it is trivial to 
obtain total dose FHDR equivalents. 
Note that Nilsson et al. used an alter-
native approach utilizing the incom-
plete repair modification of the LQ 
model to obtain almost identical pre-
dictions (HD Thames, pers. comm.).' 
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A MOVEMENT DETECTION SYSTEM FOR 
PATIENT MONITORING IN LOW DOSE RATE 
TELETHERAPY 
S. J. Howlett, J. W. Denham, S. A. Simpson, D. Pomare, D. Schmiedeberg, 
W. Dredge, R. Sadler and P. Hanbury 
ABSTRACT 
In an attempt to establish isoeffective conditions between the low and high dose rate ranges for human acute skin 
and mucosal reactions using teletherapy equipment, the Department of Radiation Oncology, Newcastle Mater 
Misericordiae Hospital, is currently conducting a Low Dose Rate (LDR) teletherapy program on a suitably modified 
caesium unit. In the course of treatment, maintaining patient position is crucial to an accurately delivered dose. This 
paper describes the development and use of an "in-house" movement detection system to achieve this goal. 
Introduction 
For this program patients are treated either semi-reclin-
ing in a modified dental chair or lying on a mobile treat-
ment couch. In head and neck cases some immobilisation 
is achieved with customised polystyrene headrests. None-
theless, since patients are required to maintain a fixed posi-
tion over periods in excess of one hour movement will 
occur and so patients must be carefully monitored. Prior to 
the introduction of the proximity detector, patient move-
ment was detected by the treatment radiographer monitor-
ing a closed circuit television with a relevant outline of the 
patient drawn on the screen. Such a method has obvious 
shortcomings and it was felt that a reliable automated sys-
tem should be in use. Through a combined staff input the 
department has achieved such a system. 
System Description 
The unit consists of three infra-red photoelectric prox-
imity switches mounted on adjustable arms so as to detect 
movement in three separate directions. The arms are con-
nected to a mobile support and so the unit is readily 
adjustable to individual treatments. (Fig. 1). The switches 
are wired to a control box mounted on a wall of the treat-
ment room for easy viewing by both radiographer and 
patient. LED indicators on the control box display high, in, 
and low ranges for each channel in response to preset dis-
tance parameters: From the control box the signal is trans-
mitted to the operator console where an in/out indication is 
given. Once the system indicates out of range in any direc-
tion there is a set time delay before the teletherapy 
machine is automatically switched off. Length of time de-
lay along with the scanning range is adjustable (see Fig. 2 
for specifications). 
Development 
The detector is the result of a combination of ideas and 
efforts from various divisions of the hospital staff namely 
clinicians, physics, electronics, radiography and mechani-
cal. This combination resulted in requirements being 
matched by capabilities. Some time was required in the 
S. J. Howlen. J. W. Denham. S. A. Simpson. D. Pomare. 
D. Schmiedebere. W. Dredge. R. Saddler. P. Hanbury. 
Department of Radiation Oncology 
Newcastle Mater Misericordiae Hospital. 
Address for correspondence: 
Mr. S. J. Howlett 
Department of Radiation Oncology 
Newcastle Mater Misericordiae Hospital 
Waratah NSW 2298 
manufacture of a suitable mobile support and in the remis-
sion tests of suitable target material. No similar device is 
known to be in use in the radiation oncology area. While 
the idea and basic design is simple, the end result is a 
robust and reliable movement detection system. 
Fig. 1: The Movement Detection System. 
Set up Procedure 
Normal treatment requires patient positioning by the 
radiographer in either chair or bed. correctly aligned with 
the caesium unit. Once this is achieved the detector is 
placed conveniently so that the three switches can reflect 
off the target. which has been placed in a position close to 
the field. (Fig. 3). The target is a thin white perspex circle 
156 The Radiographer —Vol. 39. No. 4. December 1992 
S. J. HOWLETT, J. W. DENHAM, S. A. SIMPSON, D. POMARE, D. SCHMIEDEBERG, W. DREDGE, R. SADLER AND P. HANBURY 
of 3 cm diameter mounted on a raised cylindrical piece of 
clear perspex. It is raised in order to avoid reflections off 
the skin causing interference. Once the target is positioned. 
usually by double sided tape or similar, the detector arms 
are aligned by the use of a 50 cm pointer. This is the preset 
scanning distance with a tolerance set at ± 1 cm. Any 
movement outside of this tolerance causes the unit to 
switch off after a 30 second delay. In the case of head and 
neck patients a special cloth cap with velcro is used to 
allow placement of the target. 
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Fig. 2: Specifications of the SICK SENSWICK photoelec-
tric proximity switches utilised in the system. (P/No 
WT 36-N 710). 
Fig. 3: The system set up to monitor patient movement. 
Performance 
To date some 20 patients have had their treatments mon-
itored by this system with the closed circuit television used 
as a back up. While some minor adjustments have been 
necessary, overall the system has been a success. In prac-
tice, it was found that only 2 sensors were required to de-
tect adequately any movement outside the tolerances 
which led to an easier set up procedure. The system not 
only performed reliably but actually acted as an educating 
mechanism for patients regarding movement during treat-
ment. Indeed, some patients monitored their own move-
ment by observing the panel indicator lights and making 
appropriate adjustments to their position within the 30 sec-
ond time delay thus avoiding breaks in treatment. 
Conclusion 
The development of the movement detection system for 
LDR teletherapy at this department is an innovation which 
has proved successful in improving the quality of treat-
ment to LDR patients. It is the result of a combined staff 
effort directed at achieving this improvement. The LDR 
program is anticipated to continue here for another 12 
months and this system will form an integral part of the 
treatments delivered. 
Paper submitted July 1992. Paper accepted September 
1992. Peer reviewed. 
PRESS RELEASE 
NEW APPOINTMENTS FOR LONG 
STANDING TEAM MEMBERS 
Two long standing members of the Du Pont Health Care team have received new appointments, effec-
tive from 1 October 1992. 
Former Sales and Marketing Manager — Diagnostic Imaging, Peter Carmody. has become Group 
Manner — Health Care. Wayne Melville has been appointed National Sales Manager for Diagnostic 
Imaging, Biotechno-logy and Imagine Agents Groups. 
Peter. who celebrated 20 years in the Health Care field with Du Pont in September 1992. will now have 
overall responsibility for the four Health Care groups — Diagnostic Imaging, Biotechnol-ogy. Imaging 
Agents and Din-nostic Systems. He will also retain responsibility for marketing and strategy in 
Diagnostic Imaging. 
The Diagnostic Imagine sales group will be manae.ed by Wayne. who will also manage the sales 
groups and retain the marketing and strategic responsibilities for both Biotechnology and Imaging 
Agents. 
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Abstract 
The purpose of this study was to determine the influence of changes in dose rate over the range 0.8-240 Gy/h on acute 
oropharyngeal mucosal reactions in human subjects, and to estimate the values of the important parameters that influence these 
reactions. Sixty-one patients requiring radiotherapy to palliate incurable head and neck cancer were treated on a telecaesium unit, 
using opposing lateral portals to total midline doses, varying between 30 and 42 Gy in 10 daily fractions over 2 weeks, at dose 
rates of 0.8, 1.8, 3.0 and 240 Gy/h according to a central composite study design. The severity and time course of reactions were 
charted at least twice weekly for each patient, using the EORTC/RTOG acute mucosa] reaction grading system. Duration of reac-
tion at each grade was observed to provide a more sensitive reflection of effect than the proportion of patients reaching any particu-
lar reaction grade. Analysis of duration by direct and indirect methods suggest ala ratios in the range 7-10 Gy and half-time 0 1 ,2) 
values in the range 0.27-0.5 h, if mono-exponential repair kinetics are assumed. The t 1 ,2 values are short and raise the question 
as to whether the repair kinetics of this tissue are well described by a mono-exponential function. Further prospective studies involv-
ing multiple daily fraction treatment regimes delivered at high dose rate, in which interfraction interval is deliberately varied, are 
needed to find out whether the parameters derived from this project are applicable to fractionated treatment courses at high dose 
rate. 
Keywords: Mucosa; Low dose rate; High dose rate; Alpha/beta ratio; Repair kinetics 
I. Introduction 
Over recent years, considerable progress has taken 
place towards the development of models that will be 
helpful to clinicians in estimating the effects that are 
likely to be observed for many commonly used permuta-
tions of total dose, fractionation, and dose rate. The in-
complete repair model, for example, provides very 
reasonable fits to many sets of laboratory and clinical 
data [23,24]. Of course, few clinical data are generated 
with the specific intention of defining the values of the 
parameters of the predictive models, therefore much of 
what is known is based on the re-analysis of historical 
clinical data [23]. In the past few years, increasing in-
terest in the use of accelerated fractionation schedules 
• Corresponding author, Tel.: +61 (0)49 211177; Fax.: +61 (0)49 
602566.  
delivering more than one treatment fraction per day has 
drawn attention to the importance of the rate at which 
repair occurs between fractions [10,14,15,18,28]. The 
process, which for operational purposes is considered, 
mono-exponential in the incomplete repair model [22], 
is best described by its half-time Ow). Unfortunately, a 
dearth of relevant clinical data has prevented suitable 
values for this parameter from being derived with any 
certainty for any acute or late reacting human tissue. At 
the present time, therefore, a better understanding exists 
concerning appropriate values for alti than for t in [23]. 
Increasing use of accelerated and hyperfractionated 
treatment regimes in locally advanced head and neck 
cancer has also drawn attention to the importance of the 
severity of acute mucosal reactions in determining treat-
ment tolerance [18,25]. 
The fractionated low dose rate (FLDR) teletherapy 
project at the Mater Hospital, Newcastle, Australia [5], 
0167-8140/95/509.50 C) 1995 Elsevier Science Ireland Ltd. All rights reserved 
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• vias therefore designed in response to the need for more 
- prospective clinical data to describe all3 ratio, and t in 
parameters, for acute mucosal reactions as well as the 
dose rate effect itself. This has been done by examining 
reactions caused by identically fractionated treatment 
regimes, delivered at low to medium dose rates (i.e., 
under 10 Gy/h), and at high dose rate (240 Gy/h). This 
report describes the indirect and direct quantal analysis 
of these data and discusses the implications and remain-
ing uncertainties of our results. 
2. Patients, materials and methods 
2.1. Patients 
The 61 patients enrolled for treatment on this project 
had locally advanced squamous cancer of the head and 
neck (RTOG modification of AJCC criteria Stages NC 
and V [161), deemed incurable by any means, by the 
multidisciplinary consultative head and neck clinic of 
the Mater Hospital, and suitable for palliative treatment 
only. Also included were four patients with lesser stage 
disease, but concurrent incurable second primary 
cancers arising from other sites (two from lung, one 
from pancreas, one from cervix). Ineligibility criteria in-
cluded severe intercurrent illness likely to result in fail-
ure to comply with the treatment and follow-up 
monitoring laid down below. Also ineligible were pa-
tients who had received prior treatment for head and 
neck cancer, including previous radiotherapy or chemo-
therapy. Informed, written consent to participate was 
the final prerequisite for entry. The study protocol was 
approved by the Hunter Area Research Ethics Commit-
tee in September 1988. 
2.2. Treatment details 
Technical details of the pioject have been published 
elsewhere [5]. Briefly, a Siemens Caesium teletherapy 
unit has been adapted to treat at 80 cm SSD, using 
specially designed rectangular collimating cones pro-
viding field sizes of between 80 and 168 cm 2 (median 
size used 100 cm 2). Adjustments to instantaneous dose 
rate has been achieved using lead filters. Treatments 
have been conducted using large opposing equally 
weighted lateral beams, with dose and instantaneous 
dose rate specified at the midplane point on the central 
axes. All 51 patients treated at low dose rate received 10- 
week daily treatment fractions with both fields treated 
on each treatment day. Beam direction has been achiev-
ed through the use from front and back pointers and 
verified using portal films. Dosimetry based on water 
phantom depth dose measurements for each individual 
treatment cone, has been verified during treatment using 
entrance and exit thermoluminescent dosimetry on the 
central axes of the beam. All treatments have been con-
ducted with the patients sitting or semi-reclining in a 
dental chair, modified for comfort with a customised  
headrest to minimise movement of the head. In addition 
to the monitoring of patient movement by the operator 
(SAS) on closed circuit television, a specifically designed 
optical proximity switch was used as a failsafe mecha-
nism to temporarily suspend treatment if a predetermin-
ed degree of excessive movement had taken place. The 
operation of this switch is reported elsewhere [13]. Rest 
breaks were allowed at frequent intervals during each 
daily treatment because the shortest treatment was I h 
4 min per day in the patient group treated to 32 Gy total 
dose at 3 Gy/h. 
The 10 patients treated at high dose rate on this pro-
ject were treated using opposing lateral 6 MV beams on 
a Varian Clinac 1800 linear accelerator. Once again, all 
patients had 10 daily fractions with both fields treated 
each day and dose specified at the midplane point on the 
central axes of the beams. All treatments were con-
ducted with the patient supine. 
Anti-fungal prophylaxis was not administered to any 
of the patients. 
2.3. Study design 
As previously described [5], a modification to the cen-
tral composite design concept has been used in this pro-
ject, with the aim of determining isoeffective doses for 
10 daily fractions delivered at 0.8, 1.8, 3.0 and 240 Gy/h 
(high dose rate). The central point of the composite de-
sign was 38 Gy at 1.8 Gy/h. The dosing levels at each 
dose rate selected have been structured around isoeffect 
predictions, using the incomplete repair model [7,17], 
and separated by intervals of approximately 10% in total 
absorbed dose. This decision was based in part on the 
need to establish the sensitivity of the endpoints used 
[8], and ensure adequate sample size. For logistic 
reasons, allocation to each group was determined con-
secutively (as opposed to random assignment). The final 
dosing groups are described in Table 1. 
2.4. Study endpoints 
Oropharyngeal mucosal reactions were graded at least 
twice weekly during treatment and after, until full recov- 
Table 1 
Details of 'dosing' groups used in the project; total dose and instan-
taneous dose rate is specified at the midplane in the central axes of the 
beam 
Dose rate Total dose No. of 	No. of 
	
Overall time 
(GY/11) 	(GY) 	patients 	fractions 
	(days) 
240 30 10 10 12-14 
3 32 10 10 12-14 
3 36 9 10 12-14 
1.8 38 10 10 12-14 
0.8 36 7 10 12-14 
0.8 38 6 10 12-14 
0.8 42 9 10 12-14 
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Table 2 
Mucosal grading criteria used in FLDR study (EORTC/RTOG toxic-
ity criteria) 
Mucous membrane 
0 	No change over base line 
I 	Injection; mild pain not requiring analgesics 
II Patchy mucositis which may produce an inflammatory 
serosanguinous discharge; may experience moderate pain re-
quiring analgesics 
III Confluent fibrinous mucositis; may include severe pain requir-
ing narcotics 
IV Ulceration, haemorrhage or necrosis 
ery had taken place using the EORTC/RTOG acute 
reaction grading criteria (Table 2). Often observations 
were obtained more frequently to better estimate the day 
on which the reaction changed from one grade to 
another. Time in days, from the start of treatment, to 
the onset and recovery from each reaction grade was 
recorded for each patient in addition to the peak grade 
reached. This enabled calculation of the duration of 
time that each patient spent at each reaction grade. Also 
measured were qualitative skin reactions using a modifi-
cation of the EORTC/RTOG acute reaction grading cri-
teria (Table 2), and reflectance spectrophotometry skin 
readings and tumour response rates reported elsewhere 
[9,12]. 
2.5. Analytical methods 
All data were entered onto a temporal database 
(MEDLOG). Non-parametric exact tests such as the 
Fisher, Wilcoxon and Kruskal-Wallis tests, were per-
formed using the StatXact, software package. Direct 
estimates of a/0 and t in were derived using the cr/i3est 
program [2]. Log likelihood based 'goodness of fit' pro-
babilities were derived using a custom designed spread- 
sheet program on Lotus 1-2-3, while FLDR reciprocal 
dose plots [19], and other curve-fitting procedures were 
carried out using the Sigmaplot software package. 
Reciprocal dose plots were derived using the method 
used by Scalliet et al. [19], and described by Dale et al. 
[6]. A dose rate correction factor 'IC' is applied to each 
dose rate to derive an equivalent fractional dose `d'. Full 
details are given in Scalliet et al. [19]. 
3. Results 
3.1. Time course of reactions 
Complete data sets (i.e., days to onset, recovery and 
duration of each reaction grade) for 56 of the 61 patients 
were collected. Death due to intercurrent causes in four 
patients, (one from myocardial infarction; one from 
cerebrovascular accident; and two from pneumonia), 
and haemorrhage from the primary tumour in one pa-
tient occurred after treatment but prior to full recovery 
of all mucosal reactions, and therefore prevented calcu-
lation of reduction durations at all grades in the remain-
ing five patients. In Table 3, median times for each 
group of patients to reach and recover from each reac-
tion grade are presented. It will be noted that median 
time to recovery from each reaction grade increases as 
total dose increases. Data concerning the duration of 
time spent at each reaction grade for each group, 
together with the proportions in each group that reach 
each reaction grade, are summarised in Table 4. These 
data confirm the impression gained from Table 3 that 
reaction duration increases with total dose. Strong lin-
ear relationships were found to exist between the dura-
tion of time spent at any one reaction grade and 
another. 
3.2. Isoeffect conditions 
ED50 (0.5 probability of reaction duration reaching a 
specific value) estimates at each dose rate, have been de- 
Table 3 
Median times in days (range in parentheses) to the onset and recovery from reactions at Grades I, II and III level (the values with asterisks are 
derived from data obtained from less than five patients) 
Group 	 Onset 
 
Recovery 
    
Grade I 
 
Grade II 	Grade III 
 
Grade III 
 
Grade II 	Grade I 
           
median (range) median (range) median (range) median (range) median (range) median (range) 
30 Gy @ 240/h 7.5 (6-9) 12.5 (9-16) 16 (11-23) 20 (16-31) 23 (13-33) 26.5 (18-46) 
32 Gy @ 3/6 8 (2-14) 13 (11-18) 17' (15-17) 19* (18-20) 21.5 (17-28) 25 (17-33) 
36 Gy 	3/h 11 (4-12) 13.5 (9-16) 16.5* (14-18) 21* (18-28) 26 (21-31) 27.5 (16-37) 
38 Gy @ 1.8/h 6.5 (3-11) 10.5 (7-15) 15.5 (10-22) 22 (17-30) 24 (21-37) 27.5 (24-44) 
36 Gy @ 0.8/h 10.5 (5-14) 15 (6-17) 15* (8-17) 17* (17-20) 23.5 (21-30) 26 (23-37) 
38 Gy @ 0.8/h 10 (5-13) 14 (7-16) 17.5 (12-22) 20 (18-24) 22.5 (16-27) 27 (21-37) 
42 Gy @ 0.8/h 8 (5-10) 12 (7-16) 15 (9-18) 21 (18-24) 26 (19-31) 31 (26-36) 
Table 4 
Median times in days spent at each reaction grade; proportions reaching each grade are also provided 
Group 	 n 	Duration of time spent at: Proportions reaching: EDso (Gy) 
Grade I Grade II Grade III Grade I 	Grade II Grade m 
n median (range) n median (range) n median (range) 
30 Gy 12 240/h 	10 
32 Gy 	3/h 	10 @ 
36 Gy @ 3/h 	9 
38 Gy @ I.8/h 	10 
36 Gy @ 0.8/h 	6 
38 Gy a 0.8/h 	7 
42 Gy @ 0.8/h 	9 
Composite group: 
37 Gy ap 0.8/h 	13 
(= 36 + 38 Gy 
groups) 
Wilcoxon I-S Exact 
p values 
10 
10 
8 
10 
6 
6 
6 
12 
19 
16.5 1 
192 
22.5 
14.5 
20 
25.54 
19 3 
1 vs. 2 
3 vs. 4 
(11-37) 
(7-28) 
(9-30) 
(91 -7-3)3) 29 
(11 -25) 
(16-30) 
(9-29) 
0.27 
0.04 
10 
10 
8 
10 
6 
6 
7 
12 
12 
8 1 
12.5 2 
14 
8.5 
11.5 
134 
103 
1 vs. 2 
3 vs. 4 
(3-17) 
(00:1161 
(11-24) 
(5-18) 
(2-16) 
(11-29) 
(2-18) 
0.028 
0.086 
10 
10 
9 
10 
6 
6 
9 
12 
3.5 
0 1 
4 2 
2 
1 
2.5 
7 4 
1.5 3 
I vs. 2 
3 vs. 4 
(0-8) 
(0-5) 
(0-10) 
(0-10) 
(0-9) 
(0-8) 
(0-9) 
(0-9) 
0.03 
0.21 
10/10 	10/10 
10/10 9/10 
9/9 	8/9 
10/10 	10/10 
6/6 6/6 
7/7 	7/7 
9/9 9/9 
13/13 	13/13 
Fisher Exact 1 vs. 2 
p values 	3 vs. 4 
7/10 
3/10 1 
6/9 2 
7/10 
3/6 
6/7 
6/8 4 
9/13 3 
0.628 
0.128  
30 
35.5 
36.5 
39 
I 
0.038 
• 0.8Gy/hr. 
• 1.8Gyittr. 
• 3GYfre. 
• HDR 
0.038 - 
0.90 
8 	8 	10 
Ara/Bra Ratio 7-- 
0.0 0.2 0.4 0.6 0.8 
7 1/2 Hrs) 	- 
0.024 
- . 2 
d or KR (Gy) 
3 
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Fe Plot Mucosa, Data (Duration at Gd. 2) 
Fe Plot of MDR and MR Muoasal ED50 Data based Duration at Gd. 2 
Repair Half Time = 0.2- 0.25 hrs gives best straight line frt. (see inset) 
Alpha/Bets Rao = 7.6 - 8.5 (see inset) 
95% Confidence Inteivats 	 
Fig. 1. Reciprocal dose plot for ED50 estimates for reaction durations 
at Grade II level. The inset graph describes correlation coefficient 
values (rho) for a straight line fit to the data points using various 
values of ali3 and f in. Best fit conditions are achieved by a/0 values 
in the range 7.6-8.5 Gy and t in values in the range 0.2-0.25 h. 
rived by interpolation from median and mean reaction 
durations at each reaction grade, as well as from the 
proportions in each treatment group whose reactions 
equal or exceed the median duration of reactions at each 
grade for the entire study population (Table 4). These 
estimates suggest that reactions to 30 Gy at 240 Gy/h are 
approximately equivalent to those caused by 35.5 Gy at 
3 Gy/h (range 34.5-37 Gy), 36.5 Gy at 1.8 Gy/h (range 
34.5-38 Gy), and 39 Gy at 0.8 Gy/h (range 38-40 Gy) 
at the three grades examined. 
The ED 50 estimates for Grade II reactions have been 
plotted on a modified reciprocal dose plot (Fig. I). Best  
fit conditions are achieved by alf3 values in the range 
7.6-8.5 Gy, and t 1 ,2  in the range 0.2-0.25 h. 
3.3. Direct gum:tat analysis, statistical uncertainty 
estimates 
Direct quantal estimates of crift and t in, using the 
proportion of each group whose duration of reaction at 
each different reaction grade, equals or exceeds the me-
dian value obtained for the entire patient population 
combined, are provided in Table 5. Convergence on al$ 
estimates in the ranges a/t3 6.7-10.4 Gy and t in 
0.19-0.49 h are consistent with the results produced by 
the reciprocal dose plot methodology. It will be noted, 
however, that the 95% confidence intervals are quite 
wide, providing reason to explore the issue of statistical 
confidence further. 
In Fig. 2, predictions of response proportions derived 
from the incomplete repair model are superimposed on 
the quantal responses actually observed in this project. 
It will be noted that while the alf3 and t in parameters 
estimated for Grade II reactions (namely a/f1 = 8, 
= 0.25 h) provide a reasonable fit to the data, the 
parameters ali3 = 15, t in = 0.75 h, provide a poor fit. In 
order to measure the goodness of fit of any given pair 
of parameter values to the observed data, the log 
likelihood ratio test for similarity between observed and 
expected binomial proportions was applied to a range of 
a/fl and t 1,2 permutations, between cc/13 5-15 Gy and t in 
0.1-0.75 h. The results of this procedure for reactions at 
Grade H level are summarised in Fig. 3 and are in rea-
sonable agreement with the direct analysis. This figure 
indicates that all3 values in the range 7.5-10 and t in in 
the range 0.2-0.55 h have a probability greater than 0.5 
of fitting the data. Parameter values outside these ranges 
provide rapidly declining probabilities of fit, particular-
ly for t in times below 0.2 h and alf3 values above 15. 
4. Discussion 
An al f3 estimate in the range 7-10 Gy, is entirely 
consistent with previous estimates [4,23). The t in esti- 
Table 5 
Direct computations using the cdOest program of agi and t in  using the numerical proportion of patients in each group whose reaction durations 
equalled or exceeded the median duration of reactions at each reaction grade for the entire study population (the 95% CI for a113 and t in at Grades 
I and III are indefinite) 
a/f3 (95% Cl) t in (95% CI) 
Grade I Logistic 10.3 Gy (-) 0.18 h (-) 
Poisson 10.4 Gy (-) 0.19 h (-) 
Grade II Logistic 9.0 Gy (4.7-22.7) 0.24 h (0.13-1.9) 
Poisson 9.3 Gy (5.8-17.9) 0.25 h (0.14-1.5 ) 
Grade III Logistic 6.6 Gy (-) 0.43 h (-) 
Poisson 6.7 Gy (-) 0.49 h (-) 
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Fit of data to a family of predicted dose response curves 
generated using the incomplete repair model 
1.0 
0.9 
0.8 
0.7 
.2. 0.6 
T:t a: 
Do 0.5 
a.- 
0.4 
0.3 
0.2 
0.1 
0.0 
1.0 
0.9 
0.8 
0.7 
Z• 0.6 
• c 
1 0-5 
tr_ 
0.4 
0.3 
02 
0.1 
0.0 
For c1f3 = 8 Gy, Repair Half-time = 0.25Hrs For a/13 = 15 Gy, Repair Half-time = 0.75 Hrs 
Fig. 2. Observed quantal responses superimposed on predicted response probability curves that were based on two different permutations of alli 
and t in i.e., 8 Gy and 0.25 h and 15 Gy and 0.75 h. (N.B. The 'composite' group treated to 37 Gy at 0.8 Gy is formed from the groups treated 
to 36 and 38 Gy has been plotted.) 
mate (range 0.25-0.5 h), however, is short and raises the 
question of the magnitude of uncertainties that may 
have impacted on the result. 
These uncertainties can be addressed under three 
headings: technical aspects, the accuracy of the end-
points used, and sample size considerations. 
4.1. Technical aspects 	. 
Turning first to the technical aspects it is clear that a 
number of factors could have impacted on dosimetric 
uncertainties. As discussed in an earlier report [5], the 
telecaesium beams used were not perfectly flat even at 
the 80-cm SSD used. Contour variations, scattering con-
ditions and, above all, patient movement, provided ad-
ditional uncertainties. Variation in overall treatment 
time is a factor that could have impacted on ac-
cumulated 'biological' dose, due to the possible onset of 
accelerated mucosal repopulation prior to treatment 
completion. Although it was intended the overall treat-
ment duration would be 12 days, logistical difficulties 
prevented completion in less than 14 days in some pa-
tients. Although 'prolonged' treatments such as this did 
not affect any particular treatment group, it is a factor 
that may deserve revisitation as more becomes known of 
human mucosal repopulation kinetics. 
4.2. Endpoints 
Concerning the accuracy of the endpoints used, we 
have already drawn attention in a previous report to the 
fact that it is far easier to determine the level of a reac-
tion on any particular examination day, than to estimate 
precisely how long a reaction at any particular grade 
lasts [8]. Factors involved include the matter of judge-
ment that a reaction is changing from one grade to 
another on any particular day. Making this judgement 
more difficult is the fact that subsiding reaction appear-
ances can be different to reaction appearances that are 
still evolving. Anatomical site differences, the presence 
of tumefactions and residual dentition are additional 
problems that we attempted to avoid by concentrating 
on the appearance of the oropharyngeal mucosa. Of the 
three reaction grade duration endpoints used in this 
study, we feel that duration at grade II has probably 
produced the most reliable ali3 and t in estimates. Dura-
tion at the Grade I endpoint (erythema) is a difficult 
measure to judge reproducibly, and may not reflect a 
purely cytological endpoint [9]. Estimates based on 
duration at Grade III may be less reliable because only 
37 of the 61 patients experienced this grade. 
4.3. Sample size 
Finally, the issue of sample size, which is one of the 
most important considerations in any study, is clearly an 
important one in this project. Uncertainties due to sam-
ple size perhaps dwarf other sources of error already 
mentioned. The wide confidence intervals around the re- 
15 — 0. 1 
Thames a/I3 est; 
o Poisson model 
x Logistic model 
5 
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End oint: Dur tion t Grade II 
PROBABILITY OF FIT 
III 
0.1 0.25 	0.5 	0.75 	1.0 
V/2 (hrs) 
Fig. 3. A matrix of probability values that the observed data will fit 
various permutations of all3 and t 12 specified on the axes. 
sults estimated by direct analysis (Table 5), and the dia-
gram referring to goodness of fit to the data of a range 
of permutations of a113 and t in (Fig. 3), demonstrate 
this uncertainty quite clearly. Of course, these uncertain-
ties are entirely due to the small numerical size of each 
treatment group. It is difficult to know whether a doub-
ling of the sample size would have significantly increas-
ed the precision of our estimate, but this was not an 
option due to logistical and ethical constraints. While 
the logistical constraints of doing this are obvious, the 
ethical arguments are less straightforward. In any 
human volunteer study in which therapeutic benefits 
from the test treatment are not expected to exceed the 
benefit to be obtained from 'conventional' treatment 
[12] (i.e., fractionated palliative radiotherapy or chemo-
therapy), the ethical imperative is to discontinue the 
study after treatment of the minimum number of pa-
tients likely to produce a plausible result from the study. 
After we had become satisfied that a minimum of nine 
patients in each treatment group would allow us to 
resolve a difference in total physical dose of 10% [8] in 
our test system with all its uncertainties, we took the de- 
cision that the result obtained using groups of the stated 
size would satisfy these minimum conditions, i.e., be 
plausible. 
Few published values for the agl and t in  values for 
mucosa are available for comparison with our results. 
Chougule and Supe recently reported a/13 ratios in the 
range 7.68-8.11 Gy for acute mucosal reactions in pa-
tients with head and neck cancer treated with twice daily 
fractionation schedules [4]. Acute reactions in the 
mouse lip are one of the 'nearest' laboratory models. 
Various estimates of a/I3 have been obtained using this 
system. Ang et al. derived a value of 8.5 Gy using large 
fractional doses at high dose rate [1]. In a study employ-
ing a range of continuous low dose rate treatments, 
delivered at various dose rates, Scalliet et al. derived a 
value of 7.4 Gy [19]. In a subsequent study which in-
vestigated a range of interfraction intervals using frac-
tionated high and low dose rate irradiations, Stuben et 
al. derived values in the 14.1-18.2 range [21]. Values for 
repair tin were in the 0.5-0.75 h range in the two sets 
of experiments that employed low dose rate irradiation 
[19,21], but were higher (0.9-1.2 h range) in the frac-
tionated high dose rate study conducted by Ang et al. 
[1]. In mouse tongue mucosa, Darr et al. derived an al0 
ratio of 11.6 Gy and a t in value of 0.75 h in a study that 
involved high dose rate irradiation at various interfrac-
tion intervals [11]. Thames et al. concluded that human 
tissue repair t in values are usually slightly longer than 
those obtained in rodents [23]. However, the only value 
for the human mucosa published to date is 2 h or more, 
which grossly exceeds the mouse lip estimates [23]. It 
also exceeds the direct analysis estimates of 1.3 h for 
erythema and 1.1 h for desquamation in human skin ob-
tained from Turesson and Notter's internal mammary 
irradiation data [26,27]. The 2-h estimate for the human 
mucosa was derived from data obtained in the ran-
domised RTOG trial in advanced head and neck cancer, 
which compared a conventionally fractionated treat-
ment of 66-74 Gy in 7-8 weeks, with the 60 Gy in 5 
weeks utilising twice daily fractions of 1.2 Gy reported 
by Marcial et al. [15]. In this study interfraction interval 
ranged from 3 to 7 h. Both early and late reactions oc-
curred more frequently in patients whose interfraction 
intervals were less than 4.5 h. 'Severe mucositis' oc-
curred in 20 of 72 (28%) patients treated with interfrac-
tion intervals less than 4.5 h, whereas it occurred in only 
one of 20 (5%) of patients treated with longer intervals 
(p = 0.06). Since this was a multi-institution study, in 
which patients were not randomly assigned to specific 
interfraction intervals and treatment was interrupted in 
36% of patients treated on the twice a day schedule, it 
is difficult to know what significance to attach to these 
observations. However, increased mucositis was also 
reported in a pilot study of concomitant boost therapy 
in Poland [3]. In this study the incidence of confluent 
mucositis during the concomitant boost phase of treat- 
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ment was reduced when interfraction interval was in-
creased from 4 to 6 h. Steel et al. noted that in cell line 
experiments shorter t 1,2 estimates were obtained from 
dose rate analyses employing a range of low and inter-
mediate dose rates, than from split dose experiments 
using high dose rate irradiation [20]. Dale et al. wit-
nessed a similar phenomenon for dose rates up to 25 
Gy/h in the C3H mouse jejunum [7], which added 
weight to the suggestion that repair may be a multi-
component process that is not always well described by 
a mono-exponential function. Perhaps this explanation 
provides some reconciliation between the long estimate 
obtained from the RTOG and Polish mucosal data, and 
the short estimate obtained in this project. It could be 
that repair of a rapid component of what is in fact a 
multi-exponential repair process in human mucosa is in-
significant after irradiation at high dose rate, but is im-
portant during protracted exposure at low dose rate. If 
this is true then the incomplete repair variant of the lin-
ear quadratic model, which assumes mono-exponential 
repair kinetics, does not provide a perfect description of 
acute mucosal reactions under all conditions as it 
stands. It would also mean that parameters derived from 
dose rate studies, such as this one, should be applied 
with extreme caution to fractionated treatment courses 
delivered at high dose rates. 
5. Conclusions 
This project has produced data that provide all ratios 
of 7-10 Gy and t 1 ,2 values of 0.25-0.5 h for the acutely 
reacting human mucosa when the incomplete repair 
model is applied. The t 12 values are short, however, 
and raise the question as to whether the repair kinetics 
of this tissue are well described by a mono-exponential 
function. Further prospective studies involving multiple 
daily fraction treatment regimes delivered at high dose 
rate, in which interfraction interval is deliberately 
varied, are needed to know whether the parameters de-
rived from this project are applicable to fractionated 
treatment courses at high dose rate. 
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